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Abstract 
The aims of this PhD research were to discover bioactive compounds from marine 
invertebrates and to study their ecological role in the marine environment. A total of 75 compounds 
has been isolated from 13 organisms. The crude extracts from sponges were screened in a cytotoxicity 
assay against HeLa cancer cells, whereas those from nudibranchs were tested for their toxicity against 
the brine shrimp Artemia salina and/or unpalatability against the shrimp Palaemon serenus. Structure 
elucidation of the isolated compounds was carried out by 1D and 2D nuclear magnetic resonance 
(NMR) and mass spectrometry (MS) to establish their planar structures and relative configurations. 
The absolute configuration of several compounds was determined by X-ray crystallography. Selected 
purified compounds were also tested in antimalarial assays.  
Various class of alkaloids was investigated from two Indonesian sponges, 
Acanthostrongylophora ingens and Stylissa carteri. Acanthocylamine A (2.45), a new 3-
alkylpiperidine alkaloid, was isolated from the extract of A. ingens, along with a rare gorgonian 
compound, villagorgin A (2.52). Acanthocyclamine A (2.45) inhibited the chloroquine-sensitive 
parasite Plasmodium falciparum (3D7 cells) with an IC50 value of 2.5 µM. Study of the chemistry of 
S. carteri yielded five known bromopyrroles (2.53, 2.56-2.59) and two new compounds, namely 4-
bromopyrrole-3-(N-methoxymethyl) carboxamide (2.54) and 4-bromopyrrole-3-(N-methoxymethyl) 
carboxamide (2.55).  
 The secondary metabolites of a xeniid coral and three cryptic nudibranchs Phyllodesmium 
spp. were investigated for a comparative study. In the ecological assays against the shrimp P. serenus, 
the extracts of P. lizardense and P. poindimiei were moderately distasteful, whereas that of P. 
longicirrum was strongly unpalatable. P. lizardense and its soft coral substrate contained twelve 
sesquiterpenes from germacrene (3.14, 3.16, 3.28), guaiane (3.17, 3.26), muurolene (3.1-3.3, 3.5, 
3.31, 3.38) and cubebane (3.37) classes, in addition to gorgosterol (3.27). Based on the sesquiterpene 
composition, we propose that P. lizardense may be feeding on both Xenia sp. and Heteroxenia sp. 
Exploration of the secondary metabolites from P. poindimiei was reported for the first time. Three 
known pregnane steroids (3.44, 3.45, 3.47) were obtained from the cerata extract of P. poindimiei, 
along with punaglandin-8 (3.53) and its new epoxy derivative (3.54). The unpalatability of P. 
poindimiei in the assay was probably associated with punaglandins, since pregnane steroids have 
already been proposed to play a role in reproductive function. Furthermore, purification of the cerata 
extract of P. longicirrum yielded seven known cembranolides (3.67, 3.69, 3.72, 3.75, 3.76, 3.78, 3.89) 
and five new cembranolides (3.83, 3.84, 3.88, 3.90, 3.91). The rejection of pellets containing 
cembranolides was in agreement with literature. 
 Four species of mollusks of the family Chromodoriidae were studied. The first species was 
Goniobranchus coi whose mantle and gut extracts contained four known rearranged spongian 
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diterpenes (4.3, 4.8, 4.65, 4.66) and a new chromolactol (4.62). The second species, Ardeadoris 
egretta, was found to contain seven known spongian diterpenes (4.15, 4.20, 4.32, 4.72, 4.74-4.76) as 
well as two new compounds, a dendrillol-sterol conjugate (4.73) and 7α-hydroxy-dendrillol-3 (4.77). 
The mantle and gut extracts of the third species, Miamira magnifica, yielded six known hydroxy-
polybromodiphenyl ethers (OH-PBDEs) (4.85, 4.86, 4.88-4.91) and a new 1-hydroxy-3,4,2’,4’-
tetrabromo-diphenyl ether (4.87). In comparison, M. miamirana contained three known methoxy-
polybromodiphenyl ethers (OMe-PBDEs) (4.105-4.107). There was an indication that Miamira spp. 
selectively incorporate OH- and OMe-PBDEs with a fewer number of bromine substituents due to 
the significant predator deterrent activity and the low toxicity of these compounds. 
 A series of furanosesquiterpenes were isolated from chromodorid and dendrodorid 
nudibranchs. Investigation of the chromodorid nudibranchs, Ceratosoma trilobatum and Ceratosoma 
brevicaudatum, yielded 11 known furanosesquiterpenes (5.2, 5.3, 5.14, 5.16, 5.17, 5.21, 5.23, 5.26, 
5.31), including dendrolasin (5.1) and furodysinin (5.8). Dendrolasin (5.1) was found to be the major 
component in the digestive tissue. Whilst, furodysinin (5.8) was selectively sequestered in the mantle 
of these nudibranchs, emphasizing its function as a putative chemical defense. From the dendrodorid 
nudibranchs, Dendrodoris krusensternii and Dendrodoris nigra, drimane sesquiterpenes containing 
fatty acid side chains (5.33) were isolated from the mantle, gut and egg masses. These drimane 
sesquiterpenes were hypothesized to play a role in the reproductive function, rather than in chemical 
defense due to their inactivity in the ecological assay. A minor compound, cinnamolide (5.39), was 
also obtained from the mantle of D. krusensternii. The unusual presence of cinnamolide (5.39) in D. 
krusensternii from Australia indicated that the composition of drimane sesquiterpenes in dorid 
nudibranchs is may be affected by geographical location.  
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CHAPTER 1! 
Introduction to Marine Natural Products  
 
1.1.!Overview of marine natural products  
Natural products or secondary metabolites are organic compounds produced by living 
organisms as characteristic chemical markers. Unlike primary metabolites, these compounds are not 
essential for growth and development. Nevertheless, they may possess biological activities that can 
be utilized with immense benefit as potential drugs. Notably, terrestrial natural products have been 
employed to treat ailments for millennia in various civilizations, such as by the Egyptian, Greeks, 
Romans, Chinese, Arabs and Indians.1  
Contrasting to its terrestrial counterpart, the marine environment had remained untapped until 
the middle of the 20th century. It was not until the invention of the Self-Contained Underwater 
Breathing Apparatus (SCUBA) technique for diving in the 1950s that the exploration of marine 
resources was made possible. Driven by its vast and diverse resources, the marine ecosystem has 
attracted the attention of researchers from multidisciplinary backgrounds ever since.  
The purpose of exploring marine natural products (MNPs) is based on two main points: 
biomedical importance and ecological relevance. The discovery of marine secondary metabolites with 
distinctive chemistry and fascinating pharmacological activities has sparked the development of new 
classes of therapeutic agents.2 These novel marine compounds have been mainly isolated from the 
tissues of soft-bodied marine invertebrates and from marine microbes. Owing to the biological 
activities of these chemicals, it has been speculated that they serve antipredatory and allelopathy 
purposes.3  
   
1.1.1.!Marine natural products as the sources of drug discovery 
Since the 1970s, the discovery of novel compounds from marine origin has flourished. 
Reinforced by the development of marine chemical biology to decipher the enzymatic and the genetic 
basis of the isolated secondary metabolites, the search for drugs from the sea has progressed 
significantly. As a result, a plethora of marine compounds with significant bioactivities has been 
reported from various sources, such as sponges, mollusks and corals. 
The first report of a marine drug was spongouridine (1.1) from the Caribbean sponge 
Cryptotethya crypta by Bergmann and Feeney in 1951.4 The isolation of spongouridine (1.1) led to 
the synthesis of two analogs, Ara-A (vidarabine) (1.2) and Ara-C (cytarabine) (1.3) with potent 
antitumor activities.5 Further metabolic activation of Ara-C (1.3) to the corresponding triphosphate 
generates a substrate mimic of deoxycytidine 5’-triphosphate that inhibits DNA polymerase as well 
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as DNA repair enzymes upon incorporation into the DNA backbone. These were crucial findings that 
opened avenues for the utilization of nucleoside chemistry for antiviral chemotherapy.2  
 
 
 
Another anticancer agent, namely halichondrin A (1.4) was obtained from the sponge 
Halichondria okadai by Hirata and Uemura in 1986.6 Halichondrin A (1.4) is a tubulin inhibitor that 
interacts with the vinca binding site of β-tubulin and contributes to microtubule dynamics. These are 
unique characteristics of halichondrin A (1.4) compared to other antitubulin agents.7 The macrocyclic 
portion of halichondrin A (1.4) was found to be responsible for its biological activity and was 
subsequently optimized by modifying the macrolactone functionality to give eribulin mesylate (1.5).8 
This compound has been marketed by Eisai Pharmaceutical under the brand name Halaven® for the 
treatment of drug refractory breast cancer.9 
 
 
 
A notable discovery of an anticancer compound from a mollusk is demonstrated by the 
isolation of ecteinascidin 743 (ET-743) or trabectedin (1.6) from the tunicate Ecteinascidia turbinata. 
The characterization of ET-743 (1.6) required the development of sensitive NMR techniques, 
therefore its elucidation was completed 20 years after its discovery.10,11 The commercialization of 
ET-743 (1.6) by Pharmamar under the trade name Yondelis® encountered challenges in compound 
supply. Recently, the problem has been overcame by preparing ET-743 (1.6) semisynthetically from 
cyanosafracin B (1.7), a compound produced by the bacterium Pseudomonas fluorescens.12,13 ET-743 
(1.6) works by interacting with DNA in cancer cells that leads to a G2/M block, a cell cycle 
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checkpoint that prevents cell mitosis before DNA reparation. This action is then followed by ensuing 
p53-independent apoptosis, leading to cell death. Yondelis® has been marketed for the treatment of 
soft tissue sarcomas and relapsed ovarian cancer. It is also has been tested in clinical trials against 
other tumor types.2 
 
 
  
 Another drug candidate obtained from a mollusk was dolastatin 10 (1.8) from the sea hare 
Dolabella auricularia.14 Further study found that dolastatin 10 (1.8) is originally produced by the 
cyanobacteria Symploca sp,15 indicating that the sea hare is feeding on the cyanobacteria. Dolastatin 
10 (1.8) exhibited activity against Hodgkins lymphoma cells, but was found to lack efficacy and 
induced peripheral neuropathy in Phase I and Phase II clinical trials. The problem was solved by 
linking the dolastation 10 analog, monomethyl auristatin E (1.9), to an antibody that targets CD30, a 
cell membrane protein of Hodgkin’s lymphoma cells. This trial was highly effective and well 
tolerated, leading to the commercialization of bretuximab vendotin (1.10)16 by Seattle Genetics under 
the brand name Adsetris®. 
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 An additional mollusk-derived compound with anticancer activity is jorumycin (1.11) from 
the Pacific nudibranch Jorunna funebris.17 The derivative of jorumycin (1.12) is currently in Phase 
II clinical trials under the brand name Zalypsis®. In preclinical in vivo studies, Zalypsis® exhibited 
significant activities against breast, prostate and renal cancer cells. The side effects currently 
associated with Zalypsis® treatment are reversible hematological disorder or liver enzymes 
imbalance.18 
 
 
 Drug candidates from corals currently entering Phase I clinical trial are pseudopterosins (1.13-
1.16).2 These metabolites were isolated from the extract of the octocoral Pseudopterogorgia 
elisabethae and have been reported to exhibit antiinflammatory and analgesic activity.19,20 
Pseudopterosin A (1.13), in particular, has been reported to reduce topical inflammation in a mouse 
model. Pseudopterosins A-D (1.13-1.16) augment re-epithelialization processes with qualitative 
enhancement in the early wound healing process.18 Recent biosynthetic studies of the Caribbean 
octocoral P. elisabethae and P. bipinnata have suggested that the coral symbiont, Symbiodinium sp., 
is the actual producer of pseudopterosins A (1.13) and D (1.16).21,22 These diterpene glycosides have 
been found in a higher concentration in the tips of P. elisabethae colonies and have been correlated 
to the greater abundance of the symbiont.20   
 
 
 
The ultimate goal of marine natural products research is to discover novel compounds with 
significant biological activities. The commercialized drugs described above highlight the success 
stories of compounds from marine invertebrates and microorganisms. Up to date, 13 drug candidates 
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of marine origin are currently in clinical trials for anticancer activity (11), cognition (1) and 
schizophrenia treatments (1) as well as wound healing (1). Figure 1.1A shows the collected sources 
of the marine drugs that have been marketed commercially, whereas Figure 1.1B displays the actual 
sources of the bioactive agents.2 The latter figure also indicates that many marine compounds are, in 
fact, produced by the associated microbes. This finding has initiated various studies to culture bacteria 
and fungi symbionts from various sources, including marine sediments and the tissues of 
macroorganisms. Only 1% of marine bacteria have been cultured,23 whereas the rest is largely 
unknown and thus the exploration of these bacteria is still ongoing.  
 
 
 
Figure 1.1. Collected sources of marine natural products used as approved drugs or are in clinical 
trials (A) and the actual sources of marine natural products (B). Cyanobacteria are 
distinguished from other bacteria due to their physiological and metabolic differences 
(adapted from Gerwick and Moore, 2012)2 
 
1.1.2.!The chemical ecology of marine natural products 
Secondary metabolites isolated from marine invertebrates have been long attributed to a 
defensive function. This hypothesis is postulated based on the “adaptationist” standpoint, in which 
secondary metabolites that are structurally complex and present in high concentrations should provide 
service for the producing organisms. In shell-less marine invertebrates, the presence of unique 
secondary metabolites may compensate for the lack of physical defense. The defensive metabolites 
that are developed by marine invertebrates are mainly used as allomones (predator deterrence), 
allelopathy (antifouling, inhibition of overgrowth) and UV protection (for tropical habitat).3 
Other theories speculated that these secondary metabolites do not link to any ecological 
functions. Instead, they may be an accumulation of side products of biosynthetic pathways, products 
of failed enzymatic activities or products of waste and detoxification. Other metabolites may have 
functions in the distant past and are currently generated because their biosynthetic pathways are 
linked to the functional metabolites. Moreover, selective pressures on the species may not be intense 
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enough to eliminate certain biosynthetic pathways. These theories are more difficult to prove, due to 
the increasing evidence of the putative defense roles of secondary metabolites.3  
Sponges (Porifera) are primitive sessile marine invertebrates that play a role as filter feeders.  
Despite their sessile existence, sponges are avoided by fishes due to the presence of deterrent natural 
products. The use of secondary metabolites as chemical defense is exemplified by latrunculin A 
(1.17), a macrocyclic alkaloid from the Red Sea sponge Latrunculia magnifica. Field observations 
indicate that specimens of L. magnifica grow exposed and are avoided by fish within their vicinity. 
When squeezed, L. magnifica exudes a reddish juice that kills the fish Gambusia affinis in the aquaria 
within a few minutes.24  
 
 
 
Some sponges may have the ability to activate their chemical defense upon physical damage. 
The tropical sponge Aplysinella rhax has been shown to convert psammaplin A sulfate (1.18) to 
psammaplin A (1.19). When the sponge tissue is stabbed, there is a trend of a decreasing concentration 
of psammaplin A sulfate (1.18) and an increasing concentration of psammaplin A (1.19) in the 
removed tissue. In contrast, no change of psammaplin concentrations was detected in the intact 
sponges. Both psammaplin A sulfate (1.18) and psammaplin A (1.19) were distasteful to reef fish 
compared to controls. In a feeding assay against the pufferfish Canthigaster solandri, the extract of 
the wounded tissue was more distasteful than that of the intact sponge tissue. A. rhax also has the 
ability to localize some compounds in response to predation. The authors therefore suggested that 
wound-activated defense in sponges may be more common than previously assumed.25  
Further study of the ecology of sponges has suggested that geographical location correlates 
with the toxicity of sponges. Sponges living in tropical habitats have been found to be more 
chemically defended, compared to those of temperate and cold waters. This is due to the increasing 
competition for food resources in tropical waters that will result in more optimized defense strategies 
and more specialized feeding habits.26 
Sponge-feeding nudibranchs are usually typified by their bright coloration and the ability to 
sequester defensive metabolites from their preys. Related to latrunculin A (1.17), recently our group 
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demonstrated that this alkaloid has been selectively accumulated by some closely related nudibranchs 
Chromodoris spp. Latrunculin A (1.17) shows 100% toxicity against brine shrimp at 0.06 mg/mL and 
is distasteful to the shrimp Palaemon serenus with an ED50 value of 4.2 mg/mL.27  
Another notable example of a chemically defended nudibranch is Cadlina luteomarginata that 
incorporates a series of sesquiterpenes (1.20-1.22) including those containing isonitriles, 
isothiocyanates and formamides from its diet. These compounds were accumulated in the mantle 
tissue and were probably sequestered from Axinella spp. that were found in the vicinity of the 
mollusk.28 
Marine isocyanoterpenes are commonly found in Phyllidiid nudibranchs and are potentially 
derived from Halichondridae sponges.29 Preliminary studies have reported that the mucus of the 
nudibranch Phyllidia varicosa was toxic to various crustaceans and fish, but not to the nudibranch 
Placobranchus ianthobapsus or the crab Metapograpsus messor.30 Although these results indicate 
the selective toxicity of the mucus of P. varicosa, the chemical composition of the mucus used for 
the experiment was unknown and these studies were not replicated.29 Other studies by Gunthorpe and 
Cameron (1987) demonstrated the toxicity of Phyllidiid nudibranch extracts against common 
bacteria, fungi and the mosquitofish G. affinis. In particular, 2-isocyanoallopupukeanane (1.23) was 
toxic against the killifish Oryzias latipes with an LC50 of 10 µg/mL.31 
A study by Dumdei et al (1997) showed direct evidence for the transfer of isocyanoterpenes 
from the Australian sponge Acanthella cavernosa to the nudibranch P. pustulosa.32 Preliminary field 
experiments by Garson et al (2000) showed that both the crude extract and the fractions containing 
isocyanoterpenes of the same sponge deterred fish feeding, but the isolated axisonitrile-3 (1.24) did 
not.33 Recent analysis of the crude extracts of A. cavernosa from Guam that contained 
isocyanoterpenes showed that they deterred feeding by natural assemblages of reef fish at 1% and 
0.2% dry weights (natural concentration was 2.9% dry weight). Furthermore, the crude extracts of 
various Phyllidiid nudibranchs, i.e. P. varicosa and P. elegans in Guam repelled fish at natural 
concentrations.34  
Cortesi and Cheney (2010) investigated the relationship between conspicuousness and the 
toxicity of extracts of several Australian Phyllidia spp. They found that this correlation was 
independent of the phylogenetic relationship between organisms.35 P. ocellata is relatively less 
conspicuous than P. varicosa. The extract of P. ocellata was found to contain 10α-isocyano-4-
amorphene (1.25) that was mildly toxic to brine shrimp. On the other hand, P. varicosa is known to 
sequester 2-isocyanopupukeanane (1.26) and 9-isocyanopupukeanane (1.27) that are more toxic to 
brine shrimp. These results indicated the direct correlation between conspicuosness and toxicity in 
nudibranchs.36 
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One of the earliest studies of the chemical ecology of corals was carried out by Weinheimer 
and Spraggins in 1969. From the extract of the gorgonian Plexaura homomalla, they isolated two 
prostaglandin (PGA) derivatives: 15R-PGA2 (1.28) and its diester (1.29).37 The addition of 15R-PGA2 
(1.28) to food pellets resulted in the high rejection of killifish, as reported by Gerhart.38,39  
Another example of chemical defense in soft corals in the form of toxicity and feeding 
deterrence is demonstrated by Sinularia flexibilis and Sinularia maxima. In an ecological experiment, 
the extract of S. flexibilis was ichthyotoxic and killed all G. affinis in less than 45 mins.40 The 
ichthyotoxicity of S. flexibilis was initially assumed to be derived from its major metabolites (1.30-
1.31). Later, it was found that sinulariolide (1.30)41 and flexibilide (1.31)42 were not toxic in separate 
assays. Instead, the ichthyotoxicity of S. flexibilis was possibly contributed by the flexibilide 
derivative (1.33). Cembrane 1.33 has been reported to exhibit 100 times more toxicity compared to 
flexibilide (1.31), possibly due to the loss of an epoxide moiety at C-11/C-12.43 A feeding deterrent 
assay by Aceret et al (2001) reported that sinulariolide (1.30) and flexibilide (1.31) were palatable to 
G. affinis at 1% concentration, but were strongly avoided at 10% concentration. In contrast, 
dihydroflexibilide (1.32) was distasteful at 1% concentration in the same assay. The authors suggested 
that individual compounds may stimulate different feeding responses in an organism such as G. affinis 
that has a capability to differentiate closely related secondary metabolites.44 Wylie and Paul (1989) 
also reported that the lipid-soluble extracts of three species of Sinularia, i.e. Sinularia sp., S. maxima 
and S. polydactyla collected in Guam were deterrent against carnivorous fishes. Cembrane 1.34 was 
found as the major diterpene from S. maxima and was responsible for this deterrent activity.45  
Recent studies of chemical ecology of gorgonian corals are focusing on the defense against 
predators and competitors. These types of defense have been exhibited by the non-native Brazilian 
soft coral Stereonephtya aff. curvata. The n-hexane extract of S. aff. curvata acted as a fish feeding 
deterrent and caused tissue necrosis of the endemic Brazilian soft coral Phyllogorgia dillatata within 
three weeks, presumably owing to the chemical defense of the invasive species.46 Ainigmaptilone A 
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(1.35) from the Antarctic gorgonian coral Ainigmaptilon antarcticus also deterred the sea star 
Odantaster validus and inhibited the growth of sympatric bacteria and diatoms.47 
 
 
 
1.2.!Aims of this study 
The aims of this PhD research were to discover bioactive compounds from marine 
invertebrates and to study their ecological roles in the marine environment. The chemistry of 
Indonesian marine sponges and Australian mollusks were investigated. The association between the 
cryptic nudibranch Phyllodesmium lizardense and its soft coral diet was also inspected. The 
purification of compounds was carried out by means of NP or RP flash chromatography and HPLC. 
The purified compounds were elucidated by extensive 1D and 2D NMR experiments and mass 
spectrometry to determine their planar structures and relative configurations. Further X-ray 
crystallography and electronic circular dichroism (ECD) analyses were also employed to establish 
the absolute configuration of several compounds. For the purpose of drug discovery, the extracts of 
marine sponges were screened for cytotoxicity assay against HeLa cancer cells. Selected metabolites 
were also tested for antimalarial inhibitory activity against chloroquine-sensitive parasites 
Plasmodium falciparum 3D7. The extracts of nudibranchs were also subjected to toxicity assays 
against the brine shrimp Artemia salina and unpalatability assays against the rock-pool shrimp 
Palaemon serenus to investigate their ecological functions. 
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CHAPTER 2! 
Alkaloids from Indonesian sponges 
 
2.1.!Introduction 
 This chapter discusses the isolation of alkaloids from two species of Indonesian sponges. 
Investigation of the secondary metabolites of Acanthostrongylophora ingens has yielded a new 3-
alkylpiperidine, acanthocylamine A (2.45) and an indoloquinolizidine alkaloid with an imidazole 
moiety (2.52). The isolation of a series of bromopyrroles (2.55-2.61) from the extract of Stylissa 
carteri is also presented. Sections 2.1.1.-2.1.2. highlight the previously reported alkaloids from 
Haplosclerid sponges and Stylissa carteri. The isolation and structure elucidation of alkaloids from 
Acanthostrongylophyra ingens and Stylissa carteri is discussed in section 2.2.1. and section 2.2.2., 
respectively.  
 
2.1.1.!3-Alkylpiperidines from Haplosclerid sponges 
 Sponges of the order Haplosclerida are known to produce a diverse array of biologically-
potent metabolites whose carbon frameworks belong to the 3-alkylpiperidine (3-AP) group of 
alkaloids.  Indeed, 3-AP compounds can be considered as a chemotaxonomic marker for this 
particular order.48,49 3-APs with conjoint piperidine rings, in particular, have been reported from 
various genera, i.e. Haliclona sp.,50–52 Xestospongia sp.,53 Arenosclera brasiliensis,54 Halichondria 
sp.,55,56 Pachychalina alcaloidifera,57 Amphimedon sp.,58 and Neopetrosia proxima.59,60  This group 
of bis-piperidines has two connecting chains or “spacer groups” that vary in length as well as in 
double bond location and may show enantiomeric relationships with respect to the overall 
configuration of stereogenic centers. The structure elucidation of this group of compounds has been 
shown to be challenging, mainly due to the congested aliphatic region in the 1H NMR spectra.  
 Halicyclamines A (2.1)50 and B (2.2)53 have been isolated from the Indonesian sponges of the 
genus Haliclona and Xestospongia, respectively. The relative configurations of both compounds were 
determined by using 2D NMR J-resolved data,50,53 in conjunction with biogenetic approach50,53 and 
X-ray crystallographic analysis.6 Alkaloid 2.1 exhibited significant activity as an inhibitor of the 
enzyme inosine monophosphate dehydrogenase (IMPDH),50 as a cytotoxic agent against P388 murine 
leukemia cells,58 as an anti-tuberculosis61 and anti-dormant mycobacterial agent.62 Related to 2.1, 
tetradehydrohalicyclamine A (2.3) and 22-hydroxy-halicyclamine A (2.4) were obtained from the 
Japanese sponge, Amphimedon sp. and were also found to inhibit P388 murine leukemia cells.58 
Chapter 2: Alkaloids from Indonesian sponges 
! 11!
 
 
Attempts toward the total synthesis of 2.1 have been reported by several groups to determine 
its absolute configuration. The main challenges on the synthesis of 2.1 are the establishment of the 
stereogenic centers of the bis-piperidine core and the assembly of the macrocyclic chains with 
controlled stereochemistry of the double bonds.63 The Marazano group partially synthesized 2.1 by 
means of a biomimetic approach. They performed the macrocyclization of the bis-piperidine ring 
with the same relative configuration to 2.1 through the nucleophilic addition of aminopentadienal to 
a 2,3-dihydropyridinium salt (Scheme 2.1a).64 On the other hand, Molander and Cadoret (2011) 
performed a stereoselective Diels-Alder condensation in their synthesis of the stereogenic triad of the 
bicyclic core of 2.1 (Scheme 2.1b). Although the correct stereochemistry of the bis-piperidine 
framework was achieved, the total yield of the product was low (1.27%).63  
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Scheme 2.1. (a) Biomimetic synthetic approach of 2.164; (b) Proposed retrosynthesis of 2.163 
 
Our group has described 3-AP metabolites from two different sponges, i.e. 
haliclonacyclamines A-D (2.5-2.8) from the Australian sponge Haliclona sp.51,52 and 
tetradehydrohaliclonacyclamine A (2.11) from the Indonesian sponge Halichondria sp.56 The 
absolute configurations of these metabolites were solved by means of X-ray crystallography using 
Cu-Kα radiation.56,65 Both 2.5 and 2.6 were established as 2R, 3R, 7R and 9R,65 whereas 2.11 overall 
showed the opposite configuration.56 Alkaloids 2.4-2.7 and 2.11 were reported to exhibit cytotoxicity 
against P388 murine leukemia cells51,52,65 and antimicrobial activities.66,67 From an ecological 
standpoint, 2.5-2.8 have been shown to play a significant role as feeding deterrents to reef fish and to 
act as inhibitors of larval metamorphosis.68–70  The Sulikowski group reported the total synthesis of 
2.7 that involved the stereoselective hydrogenation of an unsaturated macrocyclic bis-piperidine ring 
with a stereochemically dynamic nitrogen atom (a and b) to generate two diastereomers (c and d). 
The total synthesis of 2.7 elaborated a ring closing alkyne metathesis (RCAM) reaction from d, 
followed by semihydrogenation to introduce the cis olefin at C-25/C-26 (Scheme 2.2).71 
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Scheme 2.2. The synthesis strategy of haliclonacyclamine C (R = H ; X =  O; CH2; Y = -CCH3)71 
 
The Kashman group investigated the chemistry of Halichondria sp. collected from the Red 
Sea and isolated halichondramine (2.17). The stereochemistry of each piperidine ring of 2.17 was 
established by extensive NMR experiments, but that between the two piperidine rings were 
unresolved due to the severely overlapping 1H NMR signals. The relative configuration of 2.17 shown 
below was proposed based on biogenetic arguments.55 Haliclonacyclamine E (2.9) was obtained 
along with arenosclerins A-C (2.12-2.14) from the endemic Brazilian sponge, Arenosclera 
brasiliensis,54 whose extract exhibited cytotoxicity and antimicrobial activities.72 Arenosclerins 2.12-
2.14 exemplified the first isolation of 3-APs with a hydroxy substituent in the bridging alkyl chain 
and with different relative configurations of the bis-piperidine ring system. NOESY and ROESY data, 
in comparison with data reported for haliclonacyclamines, were used to differentiate their 
stereochemistry. Additional 3-APs, haliclonacyclamine F (2.10) and arenosclerins D-E (2.15-2.16), 
were isolated from another Brazilian sponge, Pachychalina alcaloidifera.57  These compounds were 
obtained together with other bis-piperidine alkaloids, such as madangamine F, ingenamine G and 
cyclostelletamines, that highlighted the secondary metabolite diversity in this particular sponge. In a 
panel of cytotoxicity assays against SF-295 (human central nervous system), MDA-MB435 (human 
breast), HCT8 (colon) and HL-60 (leukemia) cancer cells, 2.10 and 2.15 were shown to be more 
active than 2.16 and madangamine F. These results suggested that the cytotoxic activity of these 
alkaloids may depend on the three-dimensional structures of the compounds.57 
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 The sponge Neopetrosia maxima from Puerto Rico and the Bahamas has been reported to 
contain neopetrosiamine A (2.18)59 and xestoproxamines A-C (2.19-2.21).60 Alkaloid 2.20 was 
closely related to 2.5 with identical relative configurations of the bis-piperidine rings. In comparison, 
the assignment of the stereostructures of xestoproxamines 2.19-2.21 was conducted by means of 
NMR and integrated degradation CD analysis. The latter technique was performed using the Hofman 
method to eliminate the suitable quaternary nitrogen atoms in 2.21 and to provide a terminal olefin 
(Δ21). The next step was the insertion of chromophore next to the secondary methyl branch to the 
degradation product. This was carried out by subjecting the product to cross methatesis with a styrenyl 
derivative and to generate a suitable molecule for a CD analysis. The absolute configuration of the 
methyl group in 2.21 was then determined separately from the bis-piperidine core.60 Alkaloid 2.18 
has been demonstrated to show inhibitory activity against MALME-3M (melanoma), CCRF-CEM 
(leukemia) and MCF7 (breast) cancer cells, as well as antituberculosis and antiplasmodial activities.59 
Meanwhile, xestoproxamines 2.19-2.21 showed modest activity against human colon tumor cells 
(HCT-116).60 Model studies toward the synthesis of 2.21 have been reported by employing the 
generation of an alkylidene dihydropyridine intermediate from a tricyclic pyridine derivative. The 
installment of the bis-piperidine ring with apparent control of relative stereochemistry of the 
stereogenic centers was then conducted by catalytic hydrogenation of the intermediate (Scheme 
2.3).73  
 
 
Scheme 2.3. The synthesis strategy of xestoproxamine C73 
 
2.1.2.!Bromopyrroles from Stylissa carteri 
 The sponge Stylissa carteri has been shown to contain oroidin (2.22) derivatives containing 
11 carbons with varied cyclization of the carboxamide ring. These alkaloids are of interest mainly 
due to their profound bioactivities as protein kinase inhibitors.74 Stylissa carteri has multiple 
synonymized names in the literature such as Acanthella carteri, Acanthella aurantiaca, Axinella 
carteri and Phakellia carteri.75 Dibromoisophakellin (2.24) was isolated during early work on the 
Madagascar Acanthella carteri in 1986. The locations of the bromine substituents in 2.24 were 
assigned by NMR analysis of the debromination product. The absolute configuration of the 
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asymmetric centers was further determined by X-ray crystallography analysis as 6S, 10R.76 Alkaloid 
2.24 was reisolated from Axinella carteri collected from the Phillipines, along with its enantiomer, 
dibromocantharelline (2.26) and the related derivative, ugibohlin (2.27).77  
 
 
 
The Proksch group also investigated the alkaloid metabolites in Axinella carteri collected 
from two locations in Indonesia, i.e. Java and Sumatra islands, as well as from Mindoro, the 
Philipines. Proksch and co-workers (1995) isolated five bromopyrroles (2.22-2.23, 2.25, 2.28-2.29). 
Further, they tested these compounds for insecticidal activity against the African cotton leaf worm 
(moth), Spodoptera littoralis and cytotoxicity against L5178y mouse lymphoma cells. In both assays, 
hymenialdysin (2.28) was found to be active. It was interesting to note that the alkaloid content of the 
various specimens of A. carteri was found to be similar, despite the different geographical locations. 
These results suggested that these alkaloids were either biosynthesized de novo by the sponges or 
produced by the microbial symbionts.78 The same group also isolated additional hymenialdisins 
(2.28-2.31) possessing both geometrical configurations of the Δ10,11 double bond and bromopyrroles 
2.32-2.35 from two Indonesian S. carteri collected from Ambon and Sulawesi.79 The Andersen group 
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further investigated S. carteri from Latondu island, Sulawesi and isolated latonduines A (2.36) and B 
(2.37) that contain an unprecedented six-membered amino-pyrimidine ring. 80   
Several bromopyrroles containing a dimeric polycyclic ring system have also been reported. 
Carteramine A (2.38) was isolated from the Japanese sponge S. carteri and was found to possess anti-
inflammatory activity (IC50 5 µM). Alkaloid 2.38 is a dimeric oroidin derivative and closely related 
to the palau’amine class of compounds that are typified by the presence of a chlorinated 7-azabicyclo-
[3.3.0]-octane ring system.81 Polycyclic alkaloids belonging to the pyrrole-2-aminoimidazole (P-2-
AI) class, namely stylissazoles A-C (2.39-2.41), were obtained from S. carteri collected from the 
Solomon Islands. Alkaloids 2.39-2.41 exemplify the diversity of P-2-AI metabolites with 
dimerization involving N-C bonds that suggested stylissazoles are derived from clathrodin and 
brominated hymenidin.82 Another rare finding was the isolation of hanishin (2.42), a degraded 
bromopyrrole containing a 9 carbon skeleton, together with  bromopyrrole amides (2.43-2.44) from 
the Red Sea Acanthella carteri. In an anticancer assay, 2.42 was found to be active against NSLC-
N6 (human non small cell lung carcinoma) cells with an IC50 value of 9.7 µg/mL.83 
The isolation of bromopyrroles with similar scaffolds from sponges suggested that they are 
derived from a common precursor (Scheme 2.4). The first biosynthetic studies of a bromopyrrole 
using a radiolabelled precursor were conducted by the Kerr group (1999). They investigated the 
biosynthesis of stevensine (2.33) in a cell culture of the sponge Teichaxinella morchella. The results 
showed that 2.33 was derived from histidine, ornithine and proline, but not arginine. It is thus 
proposed that ornithine and proline can be converted into 4,5-dibromopyrrole-carboxylic acid (a) 
prior to bromination. Furthermore, histidine is transformed into 3-amino-1-(2-aminoimidazolyl)-
prop-1-ene (b) to generate oroidin (2.22), followed by cyclisation to produce 2.33.84 
The latonduines (2.36-2.37), however, cannot be derived from oroidin (2.22) due to the 
presence of six-membered amino pyrimidine ring. The Andersen group suggested that 2.37 is derived 
from 4,5-dibromopyrrole-2-carboxylic acid, ornithine and guanidine. The decarboxylation of 2.37 
then generates 2.36. Hymenialdisin 2.31 might also arise from the cyclization of the carboxylic acid 
moiety from ornithine and a guanidine nitrogen of intermediate d to generate the oxoaminoimidazole 
ring.80  
Further dimerization of pyrrole amino imidazole alkaloids is exemplified by the postulated 
biosynthetic pathway of stylissazoles (2.39-2.41). Al Mourabit et al. (2010) proposed the formation 
of 2.39-2.41 from the condensation of hymenidin and clathrodin tautomers that are connected via an 
N-C bond. The reaction of hymenidin tautomer I and clathrodin tautomer IV generates intermediate 
g, that is further oxidized and cyclized to give 2.39. Upon reacting with hymenidin tautomer III, 
clathrodin tautomer IV produces intermediate h.  Further oxidation and cyclisation of the 
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carboxamide ring generates 2.40. Compound 2.41 is then formed from the cyclisation of the imidazole 
ring in 2.40. The selection of the reacting tautomers in nature, however, is currently unknown.82  
 
 
Scheme 2.4.  Proposed biosynthetic pathways: (i) Stevensine (2.33)84 (ii) Latonduines (2.37-2.38)80 
(iii) Stylissazoles (2.39-2.41) 82 
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Due to their abundance in nature, polybrominated organic compounds have been proposed to 
be biosynthesized by marine bacteria. However, the identification and characterization of the 
biosynthetic gene clusters of bromopyrroles and bromophenols (bmp 1-8) have only been reported 
recently by the Moore group from Pseudoalteromonas luteoviolacea and P. phenolica.85,86 Bmp2 and 
8 were found to play a role in the biosynthesis of bromopyrroles in particular. Bmp2 catalyzes the 
bromination of pyrrole,85 whereas bmp8 functions in the dehalogenation process.86  
 
2.2.!Results and discussion 
2.2.1.!Alkaloids from Acanthostrongylophora ingens 
Approximately 200 g (wet wt.) of A. ingens (W-74-08) was collected at a dive site in the 
Wakatobi Marine National Park, Sulawesi, Indonesia in April 2008. The sponge was macerated with 
methanol to yield 17 g of a brown gum. In a preliminary screening, the crude methanolic extract of 
A. ingens exhibited 40% inhibition toward HeLa (cervix) cancer cells at a concentration of 30 µg/mL. 
A small portion of the extract was defatted using hexanes, and then subjected to RP chromatographic 
fractionation. Fraction 4 of the RP flash chromatography was further separated by normal phase flash 
chromatography using hexanes/isopropanol/Et3N (20:1:4) to afford acanthocyclamine A (2.45), 
whereas fraction 3 of the RP flash chromatography was purified by RP HPLC to obtain villagorgin 
A (2.52). The isolation scheme of 2.45 and 2.52 is presented in Scheme 2.5. 
 
 
Scheme 2.5. Isolation procedure of alkaloids from A. ingens 
 
Acanthocyclamine A (2.45) was obtained as white crystals that gave an ion cluster at m/z 
385.8581 [M+H]+ (calcd. for 385.3577) in the (+)-HRESIMS. This molecular mass is appropriate for 
Acanthostrongylophora ingens (W-74-08) 
(~ 200 g wet wt.)
- RP flash chromatography (20-100% MeOH/water)
Fraction 3
-Extracted with methanol (3 x 500 mL)
-Partitioned against hexane (3 x 375 mL)
MeOH extract (17 g)
- Cation exchange resin column (5% NH4OH/MeOH)
- NP flash chromatography (hexanes/IPA/Et3N (20:1:4))
2.45 (20.0 mg)
Fraction 4
- RP HPLC (20% MeCN/water)
2.52 (6.0 mg)
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a molecular formula of C26H44N2 that requires six degrees of unsaturation. The 1H NMR spectrum of 
2.45 showed four alkene signals (δH 5.42 (2H), 5.33, 5.22), eleven methylene signals adjacent to the 
nitrogen of tertiary amines (δH 3.16, 2.81, 2.88, 2.78, 2.69, 2.65, 2.64, 2.63, 2.35, 2.32, 1.96) and a 
distinctive quartet at δH 0.78. By comparison with equivalent data for haliclonacylamines (2.5-2.8 and 
2.11), these proton signals were diagnostic for 3-AP metabolites. However, the majority of proton 
signals were broad, overlapping multiplets, and it was initially difficult to extract structural detail. 
The 13C NMR and DEPT data further confirmed the occurrence of 26 carbons in the molecule, 
comprising twelve methylene signals between δC 19.8 and δC 34.1; four methine signals at δC 33.5, 
δC 35.5, δC 38.5 and δC 45.0; four alkene signals at δC 129.0, δC 129.6 and δC 130.5 (2C), as well as 
six methylenes attached to nitrogen that had chemical shifts between δC 44.8 and δC 59.3. The 
occurrence of two double bonds suggested that the molecule is tetracyclic.  
 
 
Figure 2.1. Selected DQF-COSY and HMBC correlations of 2.45 
 
The structure elucidation of 2.45 was initiated by assigning its bis-piperidine core based on 
the DQFCOSY and HMBC data (Figure 2.1). In ring A, a triplet signal at δH 2.81 (J = 11.4 Hz) was 
diagnostic for a methylene proton (H-1a) next to the nitrogen and showed correlations to H-2 in the 
DQFCOSY spectrum. Correlations from H-1a to C-3 and from H-5a to C-4 were deduced from the 
HMBC experiment. The connection between ring A and the C-11/C-18 spacer group was drawn from 
the HMBC cross-peaks of H-11/C-1 and H-11/C-5, whereas that between ring A and the C-19/C-26 
spacer group was observed from the H-25/C-2 and H-26/C-2 crosspeaks in both HMBC and HSQC-
TOCSY spectra.  In ring B, the prominent signal in the 1H NMR spectrum (δH 0.78, q, 12.4, H8b) 
was used to assign nearby proton signals H-6a/H-6b, H-7, H-9, and H-10a/H-10b via 1D-TOCSY 
experiments.  The HMBC correlations from H-17 and H-18a to C-7 revealed the connection between 
ring B and the C-11/C-18 spacer group. Moreover, a connection to the C-19/C-26 spacer group was 
evident from the HMBC correlation between H-19a and C-10. The linking of the two piperidine rings 
was observed from the HMBC correlations between H-7 and C-3, as well as between H-4 and C-9. 
N
N1
3 79
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The absence of correlations between H-3 and H-9 in the DQF-COSY spectrum suggested the dihedral 
angle between the two protons was close to 90º.  
 
 
Figure 2.2. 1D-TOCSY data (mixing time 40 ms) of 2.45: A) 1H NMR proton spectrum of 2.45; B) 
Irradiation of H-19a showing correlations to H-20, H-21 and H-22; C) Irradiation of H-
17 showing correlations to H-6, H-7, H-8, H-14, H-15, H-16 and H-18; D) Irradiation of 
H-8 showing correlations to H-6, H-7, H-9, H-10, H-17 and H-18 
 
1D-TOCSY experiments were proved valuable in the assignment of the double bond positions 
in the individual spacer groups (Figure 2.2). Irradiation of H-17 revealed correlations to H-14, H-15, 
H-16 and H-18. DQFCOSY data showed the correlations between H-13 and the allylic proton signal 
(H-14), as well as between H-12 and H-11. Due to the overlap of alkene proton signals, the relative 
configuration of the C-15/C-16 double bond was deduced from the chemical shifts of the two allylic 
carbons at δC 27.1 (C-14) and δC 23.3 (C-17) that revealed Z stereochemistry.87 In an HSQC-TOCSY 
experiment, H-19a showed correlations to the neighboring carbons C-20/C-21/C-22.  The DQFCOSY 
data further exhibited correlations between H-22/H-23 and H-24/H-25. A Z configuration for the C-
23/C-24 double bond was suggested by the 10.8 Hz coupling constant between H-23 and H-24. This 
was further confirmed by the chemical shifts of the neighboring allylic carbons (δC 24.9 (C-22) and 
δC 25.1 (C-25)).87 The complete 1H and 13C NMR data of 2.45 is presented in Table 2.1. 
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Table 2.1. The 1H and 13C NMR assignments of 2.45 
C δH a δCb DQFCOSY HMBCc 
1 2.81 (t, 11.4) 56.2 2 2, 3, 5a, 11, 26 
 2.35 (dd, 11.4, 6)    
2 1.90 (m) 38.3 1, 26 1a, 3, 4a, 4b, 25a, 26a, 26b 
3 1.96 (m) 33.3 4b 4a, 4b, 7, 25a 
4 1.98 (m) 34.3 3 3, 5a 
 1.72 (m)    
5 2.88 (m) 44.6 - 1a, 1b, 3, 4a, 4b, 11 
 2.32 (m)    
6 2.63 (m) 55.8 7 7, 8b, 10a, 10b 
 1.96 (t, 11)    
7 1.54 (m) 35.3 6b, 8b, 18b 6b, 8a, 8b, 10a, 17, 18a 
8 2.58 (brd, 12.4) 33.7 7, 9 3, 6b, 10a, 18ad 
 0.78 (q, 12.4 Hz)    
9 1.80 (t, 12.4 Hz) 44.8 8b, 10b 4a, 4b, 8b, 10b 
10 2.78 (dd, 10.3, 4.2) 59.1 9 3, 6a, 6b, 8a, 8b, 19a 
 2.69 (t, 12.4)    
11 2.65 (m) 54.4 - 12a, 12b, 13a, 13b 
12 1.55 (m) 27.8 - 11, 13a, 13b, 14, 16 
 1.33 (m)    
13 1.67 (m) 25.7 14 11, 12b, 14 
 1.47 (m)    
14 1.97 (m) 26.9 13, 15 12a, 12b, 13a, 15, 16 
15 5.42 (dd, 19.0, 7.2) 128.8 14, 16 12a, 12b, 14, 17 
16 5.33 (m) 130.3 15, 17 14, 17, 18b 
17 2.14 (m) 23.1 16, 18a 15, 16, 18a, 18b 
18 1.69 (m) 32.8 7, 17 16, 17, 8b 
 0.89 (m)    
19 3.16 (m) 55.4 20a, 20b 6b, 21 
 2.64 (m)    
20 1.62 (m) 19.6 19a, 19b, 21a 19a, 19b, 21, 22 
 1.36 (m)    
21 1.46 (m) 29.1 20a, 22a 19a, 19b, 20a, 22a, 23 
22 2.44 (m) 24.7 21, 23 23, 24 
 1.82 (m)    
23 5.22 (dt, 10.8, 3.0) 129.4 22a, 24 21, 22b, 25a 
24 5.42 (dt, 10.8, 3.0) 130.3 23, 25a 22b, 25a, 26b 
25 2.45 (q, 12.8) 24.9 24, 26 23, 24 
 1.67 (m)    
26 1.49 (m) 33.9 2, 25b 1a, 24, 25a, 25b 
 1.31 (q, 13.4)    
aChemical shifts (ppm) referenced to CHCl3 (δH 7.26  ppm) at 500 MHz. 
bChemical shifts (ppm) referenced to CHCl3 (δC 77.0 ppm) at 125 MHz  
cHMBC correlations reported are from C to H 
dWeak correlations    
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Figure 2.3. Selected NOESY correlations of 2.45 
 
The relative configuration of the two piperidine rings were established from the 2D-NOESY 
data (Figure 2.3) and J values analysis. In ring A, the N-bearing methylene signal (H-1ax) presented 
an 11.4 Hz coupling to its vicinal neighbour (H-2) that suggested both H-1a and H-2 were axial. In 
ring B, the upfield quartet assigned to H-8ax (δH 0.78) showed a vicinal coupling constant of 12.2 Hz 
to H-7ax and H-9ax, indicating that they were trans-diaxial. A correlation between H-7ax and H-9ax 
was also evident in the NOESY data. The overlapping signals for H-1ax (δH 2.81), H-5ax (δH 2.88) 
and H-10ax (δH 2.78) complicated detailed interpretation of the NOESY data.  
 
 
Figure 2.4. The ORTEP3 view of 2.45 
 
To complete the stereochemical determination of 2.45, the compound was recrystallized from 
a mixture of hexanes/isopropanol (24:1) by employing a diffusion method to obtain colorless crystals.  
X-ray single crystal analysis was carried out at 190 K to determine the crystal system of 2.45 as 
orthorhombic (P21).  Figure 2.4 shows the ORTEP3 diagram revealed that H-3 was in an equatorial 
orientation and confirmed the relative stereochemistry deduced by NMR. The absolute configuration 
of 2.45 was established by anomalous dispersion effects as 2R, 3R, 7R and 9R (Figure 2.3).  This 
absolute configuration is identical to that of 2.5 and 2.6, but opposite to that of 2.11.56,65  The double 
bonds in 2.45 were located between C-15/C-16 and between C-23/C-24 in agreement with the NMR 
data. The crystal structure also revealed the occurrence of 2.45 as a monohydrate with the water 
molecule bridging adjacent molecules through H-bonds to the tertiary amines to form a polymeric 
chain (O3-H---N1 2.06 Å, 171.3° and O3-H---N2 2.10 Å, 164.2°). Specific rotation measurements 
were carried out on crystalline 2.45 and on the residual mother liquor and gave [α]23D values of -26.5 
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(c 0.073, CHCl3) and -40.6 (c 0.100, CHCl3), respectively. In an antimalarial assay conducted by the 
research group of A/Prof. Katherine Andrews (Eskitis Institute, Griffith University), 
acanthocyclamine A (2.45) showed a significant inhibition activity against Plasmodium falciparum 
(3D7 cells) with an IC50 value of 2.5 µM.  
 
!
 
Scheme 2.6. The biosynthetic pathway proposed for 2.4556,65,88–90 
 
The proposed biosynthesis of 2.45 (Scheme 2.6) is related to that of manzamine B (2.50) as 
hypothesized by Baldwin et al.88–90 and of 2.5 and 2.11 as suggested by our research group.56,65 The 
main building block of 2.45 could be a nicotinic acid unit48,91 with sequential addition of two-carbon 
units through the polyketide pathway, followed by the loss of carboxylate moieties to produce the 
macrocyclic intermediate 2.46. Condensation via Diels-Alder endo-cyclization then produces 
intermediate 2.47 with H-3 and H-9 in a cis relationship. Intermediate 2.47 produces 2.45 via a ring 
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opening that involves bond cleavage followed by reduction of the iminium cation and the double 
bonds at C-1/C-2 and C-7/C-8. The biosynthesis of 2.45 differs from that of the manzamines in the 
nature of the skeletal rearrangement (Scheme 2.6). In 2.50,92 a final oxidation step generates the 
epoxide functionality. The pivotal redox step before aldehyde formation is absent in the proposed 
biosynthetic pathways leading to 2.5-2.8, 2.11 and 2.45. Alternatively, reduction of the iminium 
system of 2.48 leads to keramaphidin B (2.51), a 3AP-alkaloid isolated from the Japanese 
Amphimedon sp.93 and from Xestospongia ingens collected from Papua New Guinea.94 The taxonomy 
of the latter sponge has recently been revised to Acanthostrongylophora ingens.75  
The 1H NMR spectrum of fraction 3 of the NP flash chromatography showed signals for an 
additional alkaloid. A portion of this fraction was passed through a cation exchange column to obtain 
the free base form prior to HRESIMS analysis. A molecular formula of C16H16N4 was inferred from 
the molecular ion peak at m/z 265.1450 [M+H]+ (calcd. for 265.1448), that required 11 degrees of 
unsaturation. The remaining portion of fraction 3 was then subjected to repetitive RP HPLC using a 
gradient of MeCN/H2O with 0.1% TFA. The resulting sub-fraction B of the RP HPLC was a mixture 
of two compounds in a ratio of 2:1 based on the 1H NMR signal integration. The 1H NMR spectrum 
of the major component (2.52) in CD3OD showed the presence of five aromatic protons (δH 8.90, 
7.52, 7.39, 7.18, 7.09), an N-bearing methine (δH 5.16), allylic methylenes (δH 3.74, 3.47, 3.26, 3.19) 
and N-bearing methylenes (δH 4.85, 4.66, 4.09, 3.80). The 13C NMR data of the major component 
(2.52) displayed only 14 signals for an aromatic ring (δC 136.3, 124.3, 121.2, 119.6, 112.9), a methine 
(δC 59.6), methylenes (δC 54.6, 50.1, 28.8, 20.6) and quaternary carbons (δC 139.0, 128.6, 127.1, 
107.9). The HRESIMS spectrum obtained from the CD3OD solution of sub-fraction B of the RP 
HPLC showed a molecular ion peak at m/z 268.1645 [M+H]+ (calcd. for 268.1636, C16H14N42H3) for 
a 3Da increase, suggesting the presence of three exchangeable protons in the alkaloid.  
Figure 2.5 shows the assignment of fragments of the major component (2.52) based on the 2D 
NMR data. The presence of an indole moiety in 2.52 was deduced from the HMBC correlations 
between H-9/C-7, H-9/C-13 and H-12/C-8. There were also HMBC correlations from H-5a and H-
6b to C-7 as well as from H-5a and H-5b to C-3 that suggested a tetrahydro-β-carboline skeleton 
(Fragment A). Fragment B of the major compound that contained -C5H6N2 was next investigated. 
This fragment was composed of signals at δH 8.90 (CH); 3.74 and 3.47 (CH2); 4.85 and 4.65 (CH2) 
in the 1H data. In the HSQC spectrum, these proton signals correlated to carbon signals at δC 136.3, 
28.8 and 50.1, respectively. The aromatic proton at δH 8.90 (s) showed an HMBC correlation to a 
quaternary carbon at δC 128.6, suggesting the presence of a disubstituted imidazole.95 Additionally, 
the methylene proton at δH 3.74 was correlated to a signal at  δC 54.6 (C-5) and was assigned to H-
14. To match the molecular formula deduced by mass spectrometry, there remained two carbon 
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signals to locate; these were anticipated to be quaternary, but no evidence for their presence could be 
detected in the HMBC spectrum. The lack of HMBC correlations observed from the imidazole and 
the methylene signals impeded the structure elucidation of the alkaloid. Further dereplication analysis 
using the Marinlit database based on the MS data and the 1H NMR key features was then carried out 
to identify the major compound as villagorgin A.96  
 
 
Figure 2.5. Assignment of fragments in 2.52 based on HMBC correlations 
 
Villagorgin A was reported for the first time from the gorgonian Villagorgia rubra as the free 
base (2.52a). Due to its presence as a TFA salt, the 1H and 13C NMR data of 2.52 from our work did 
not match well with those of literature (see Table 2.2). The protonation sites in 2.52 are driven by the 
basicity of the N-atoms in the molecule.  The tertiary amine of the tetrahydro-β-carboline moiety is 
more basic than the indole nitrogen and hence is more susceptible to protonation.97,98 The positive 
charge introduced on the tertiary amine of the tetrahydro-β-carboline also has a strong electrostatic 
destabilizing effect toward further protonation.49 The positively charged nitrogen in 2.52 was thus 
assigned to N-4.  
 
 
Scheme 2.7. Reversible deuteration of 2.52 upon contact with CD3OD 
 
Also important was the characteristic reactivity of the imidazole component, whose proton at 
C-2 (imidazole numbering) is exchangeable with deuterium in CD3OD99 or D2O.100–103 In the 1H 
NMR data of 2.52, the imidazole proton (H-17) at δH 8.90 showed typical characteristics of an 
exchangeable proton by appearing as a broad singlet with the signal integrated for < 1 H. To detect 
the occurrence of H-D exchange in the imidazole ring of 2.52, a deuterium exchange experiment was 
conducted. The experiment was performed by dissolving 2.52 in CD3OD. The sample was then 
recovered and re-dissolved in proteo DMSO prior to 2H NMR analysis (90° pulse, 4000 scans) to 
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prevent it from exchanging back to its non-deuterated form (Scheme 2.7). Figure 2.6 shows the 2H 
NMR spectra of 2.52 in DMSO, in which the deuterated imidazole signal resonated at δD 8.46.  
 
 
Figure 2.6. 2H NMR spectrum of 2.52 in DMSO (residual signals are marked) 
 
H-17 of the imidazole may undergo deprotonation prior to deuterium exchange in CD3OD. 
The mechanism involves the N-16 protonation followed by C-17 deprotonation. The short-lived N-
heterocyclic carbene (NHC) then accepts a deuteron from the solvent in a fast reaction (Scheme 2.8).99 
The remaining deuteration sites in 2.52 were the –NH of the imidazole (N-18) and the tertiary amine 
of the tetrahydro-β-carboline (N-4) due to pKa values of 14.2 and 8.6, respectively.99 The –NH of 
indole ring was the least basic (pKa -3.5)97,98 compared to the other nitrogen atoms and thus was not 
deuterated. 
 
 
Scheme 2.8. Deprotonation of C-2 in imidazole ring systems99 
 
The relationship between H-3 and NH-4 in 2.52 was next considered. In the 1H NMR data of 
2.52, the signal at H-3 was resonated at δH 5.16 (br d, 8.6). By comparison, the H-3 signal in 2.52a 
resonated at δH 3.83 (dt, 11.0, 3.7). The difference of the 3JH-3/H-14 value in 2.52 and 2.52a suggested 
a different configuration at either C-3 or N-4. Espada and co-workers (1993) determined a trans-
linkage between H-3 and the lone pair of N-4 in 2.52a based on the ROESY correlations between H-
3 and the axial proton H-20.96 In our current work, it was not feasible to run NOESY on the protonated 
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villagorgin A (2.52) due to the poor condition of the sample and its presence as a mixture. Table 2.2 
shows the 1H NMR data comparison of villagorgin A as a TFA salt (2.52) and of the original fraction 
of NP flash chromatography containing villagorgin A as a free base (2.52a). As shown, the proton 
chemical shift values of the quinolizidine ring in 2.52a from our current study did not match those 
reported by Espada et al (1993). The discrepancies in these chemical shift values may indicate that 
the fraction containing villagorgin A was partially protonated, even after the fraction had been passed 
through the cation ion exchange column.   
 
 
Table 2.2.  The 1H and 13C NMR data of villagorgin A as a TFA salt (2.52) and as the free base 
(2.52a) 
Position 2.52 (current study) 2.52a (current study) 2.52a (Espada, et al, 1993)a 
δH
b δCc δHb δCc δHd δCd!
NH-1 n/de - n/de - 10.86 (s) -!
2 - n/de - 131.4 - 135.1!
3 5.16 (br d, 8.6) 59.6 4.29 (br d, 11.0) 57.5 3.83 (dt, 11.0, 3.7) 58.4!
5 4.09 (dd, 11.9, 4.8) 54.6 3.59 (m) 52.7 3.33 (m) 54.0!
 3.80 (dd, 11.9, 4.8)  3.19 (m)  2.87 (ddd, 22.5, 12.0, 
4.0) 
!
6 3.26 (m) 20.6 3.09 (m) 20.3 3.00 (m) 22.3!
 3.19 (m)  2.93 (br d, 15.3)  2.79 (dt, 16.0, 2.0) !
7 - 107.9 - 106.0 - 108.5!
8 - 127.1 - 126.4 - 128.1!
9 7.52 (d, 8.0) 119.6 7.45 (d, 8.0) 117.7 7.41 (d, 7.5) 118.8!
10 7.09 (ddd, 8.0, 1.0) 121.2 7.02 (td, 8.0, 1.0 ) 118.9 6.98 (ddd, 14.5, 7.5, 0.5) 111.9!
11 7.18 (ddd, 8.0, 1.0) 124.3 7.11 (td, 8.0, 1.0 ) 121.6 7.06 (ddd, 16.0, 7.5, 1.0) 122.3!
12 7.39 (d, 8.0) 112.9 7.34 (d, 8.0) 110.9 7.30 (d, 7.5) 112.0!
13 - 139.0 - 137.2 - 138.5!
14 3.74 (m) 28.8 n/de n/de 3.36 (m) 29.2!
 3.47 (m)    2.72 (m) !
15 - 128.6 - 126.6 - 129.7!
17 8.90 (s) 136.3 7.86 (s) 134.8 7.57 (s) 135.2!
NH-18 n/de - n/de - 10.86 (s) -!
19 - n/de - 125.2 - 127.3!
20 4.85f 50.1 4.23 (d, 13.0) 51.3 3.99 (d, 13.0) 53.4!
 4.66 (br s)  3.95 (d, 13.0)  3.62 (dt, 13.0) !
aSee ref. 96; b500 MHz, referenced to CD3OD (δH 3.31); cTaken from 2D spectra (125 MHz, referenced to CH3OH (δC 
49.2)); dData taken in CD3OD, NMR field strength was not reported; en/d – not detected;  fOverlapping signals 
!
 
It is noteworthy that the multiplicity and coupling constants of H-5, H-10 and H-11 in 
villagorgin A were described by Espada et al (1993) as a doublet of doublet of doublets (ddd). H-5 
was falsely described to have J values of 22.5, 11.9 and 4.8 Hz.96 In the current study, H-5 was 
observed as a doublet of doublets with geminal and vicinal coupling constant values of 11.9 and 4.8 
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Hz, respectively. The ortho coupling constant values of H-10 and H-11 were incorrectly stated by 
Espada et al (1993) as 14.5 Hz and 16.0 Hz, respectively.96  In our work, H-10 and H-11 were 
observed as a triplet of doublets with 3J values of 8.0 and 1.0 Hz. The 13C signal for C-10 was also 
mistakenly reported by Espada and co-workers (1993) at δC 111.9,96  whereas that from the current 
study was observed at δC 118.9. 
The minor component that was present along with 2.52 in the mixture was briefly investigated. 
Its 1H NMR spectrum was severely obscured due to the minute quantity and only partial data could 
be extracted. There were signals for aromatic protons (δH 8.90, 7.52, 7.35, 7.16, 7.09), an N-bearing 
methine (δH 5.10) and allylic methylenes (δH 3.90, 3.75, 3.51, 3.19). Based on 1H NMR data 
comparison with those of 2.52, the signals at δH 5.10 and 8.90 probably belonged to quinolizidine and 
imidazole rings, respectively. The observed quinolizidine proton at δH 5.10 (dd, 9.0, 5.0) was different 
from that of 2.52 that resonated at δH 5.16 (br d, 8.6). Also different was the imidazole proton that 
was correlated to a quaternary carbon at δC 119.8 in the HMBC spectra. Dereplication analysis of 
these partial NMR data indicated similarity with some of the data of lissoclin C (2.53)104 and 
halichondramine (2.54).105 These alkaloids have been reported from the ascidian Lissoclinum sp.104 
and a marine sponge of the order Haplosclerida, respectively.105 The MS data of the minor compound, 
however, did not match with any of these literature compounds, therefore its structure elucidation 
remains inconclusive. 
 
2.2.2.!Bromopyrroles from S. carteri 
The crude methanolic extract of S. carteri exhibited 60% cytotoxicity against HeLa cancer 
cells at a concentration of 30 µg/mL. The methanol extract was then partitioned against ethyl acetate. 
The resulting ethyl acetate fraction was subjected to NP flash chromatography with a gradient of 
hexanes/DCM/EtOAc/MeOH to give 13 fractions. Fractions 8 and 10 were further purified by RP 
HPLC to afford seven bromopyrrole alkaloids (2.57-2.61) as shown in Scheme 2.9.  
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Scheme 2.9. Isolation procedure of bromopyrroles from S. carteri 
!
!
!
Bromopyrrole 2.55 was isolated as an amorphous powder and was the major compound 
collected from the ethyl acetate extract of S. carteri. The (-)-LRESIMS of compound 2.55 showed a 
cluster of molecular peaks at m/z 187/189 [M-H]- in a ratio of 1:1 that indicated the presence of a 
monobrominated compound. Further analysis by (-)-HRESIMS determined a molecular formula of 
C5H5N2O79Br, representing four degrees of unsaturation. The proton NMR spectrum of 2.55 in 
deuterated chloroform showed the presence of an NH proton for the pyrrole ring (δH 9.60), two 
pyrrole protons (δH 6.60 and 6.95) and -CONH2 proton (δH 5.30 (2H)). Based on data comparison 
with those of literature, compound 2.55 was identified as 4-bromo-1H-pyrrole-3-carboxamide that 
was initially isolated from S. massa and S. flabelliformis.106  
Compound 2.56 was a new compound and was isolated as an amorphous powder. The (-)-
LRESIMS of compound 2.56 showed major ion clusters at m/z 217/219 [M-H]- that also indicated a 
monobrominated compound. This mass was 30 Da higher than that of compound 2.55 and thus 
suggested an additional –CH2OH group.  Further analysis by (-)-HRESIMS determined a molecular 
Stylissa carteri
(~200 g wet wt.)
- NP flash chromatography 
(100% hexanes ! 100% MeOH)
Fraction 8
-Extracted with methanol (3 x 500 mL)
-Partitioned against EtOAc (5 x 10 mL) 
EtOAc extract (5 g)
2.59 (8.4 mg)
2.60 (2.9 mg)
2.61 (2.9 mg)
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- RP HPLC (30% MeCN/water)
2.55 (14.1 mg)
2.56 (4.2 mg)
2.57 (1.6 mg)
2.58 (3.9 mg)
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formula of C6H7N2O279Br that revealed four double bond equivalents. The 1H NMR data of 2.56 
showed a similar bromopyrrole framework to compound 2.55 with additional hydroxy (δH 5.35) and 
methylene protons (δH 4.91, 2H). The HMBC analysis (Figure 2.7) showed correlations from the 
pyrrole proton signal at δH 6.95 (H-2) to signals at δC 97.4 (C-3), δC 111.8 (C-4) and δC 125.1 (C-5); 
whereas, the other pyrrole proton signal at δH 6.60 (H-5) showed correlation to a signal at δC 121.8 
(C-2). Additionally, methylene proton signals at δH 4.91 were correlated to a signal at δC 161.1 (-
CONH-), revealing their attachment to the carboxamide moiety. Compound 2.56 was thus identified 
as 4-bromopyrrole-3-(N-hydroxymethyl) carboxamide.  
 
 
Figure 2.7. Selected HMBC correlations of 2.56 
 
Another new compound from fraction 8 of the NP flash chromatography was compound 2.57 
that was also isolated as an amorphous powder. The (-)-LRESIMS of 2.57 indicated the occurrence 
of a single brominated compound by displaying 1:1 ion clusters at m/z 231/233 [M-H]-. The addition 
of 44 Da mass to that of 2.55, suggesting the presence of a –CH2OCH3 moiety. The (-)-HRESIMS 
analysis revealed a molecular formula of C7H9N2O279Br. The presence of the bromopyrrole scaffold 
was evident from the 1H NMR data that displayed signals for an -NH pyrrole (δH 9.40), pyrroles (δH 
6.95 and 6.59), as well as an amide (δH 6.40). There were also two sets of methylene (δH 4.85 and 
4.83) and methoxy signals (δH 3.38 and 3.37). The appearance of two sets of proton signals in 2.57 
indicated the presence of a mixture of amide rotamers (Figure 2.8)  with a ratio of 3:1 as suggested 
by the integration of proton signals. The major component was proposed to have an anti C-N rotamer 
based on the 1H NMR data comparison with those of similar bromopyrroles.107,108  
 
 
Figure 2.8. Amide rotamers in 2.57 (R = pyrrole ring, R’ = -CH2OMe) 
 
The HMBC analysis (Figure 2.9) showed correlations of the pyrrole signal at δH 6.95 (H-2) 
to signals at δC 116.7 (C-5) and δC 125.2 (C-3); whereas the pyrrole signal at δH 6.59 (H-5) showed 
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correlation to signals at δC 121.9 (C-2) and δC 125.2 (C-3). The methylene signal at δH 4.84 was 
correlated to signals at δC 56.0 (-OCH3) and δC 160.2 (-CONH2). The methoxy signal at δH 3.37 also 
showed correlations to the methylene signal at δC 71.2. Compound 2.57 was thus assigned as 4-
bromopyrrole-3-(N-methoxymethyl) carboxamide.  
 
 
Figure 2.9. Selected HMBC correlations of 2.57 
   
Compound 2.58 showed a single ion cluster in the (-)-LRESIMS analysis at m/z 265/267/269 
[M-H]- in a ratio of 1:2:1, suggesting the presence of a dibrominated compound. In agreement with 
this, the 1H NMR spectrum showed only one pyrrole proton signal (δH 6.60). Broad singlets at δH 
9.43 and δH 5.50 indicated the presence of –NH and –CONH2 protons, respectively. The HMBC 
experiment displayed correlations from the pyrrole signal to carbon signals at δC 106.2 and δC 125.9, 
as well as a one-bond coupling carbon signal at δC 113.1. These NMR data were comparable to those 
of 3,4-dibromopyrrole-2-carboxamide from the Patagonian bryozoan Aspidostoma giganteum.109  
Also isolated was compound 2.59 that showed an -NH singlet proton (δH 7.86) and two 
doublets (δH 6.99 and 6.71) that represented α, β-protons in a pyrrole ring. Additionally, two sets of 
signals of methylene protons at δH 3.49 (m) and δH 2.81 (m) were observed in the 1H NMR spectrum. 
Comparison of these data with those of literature suggested the presence of aldisin.110 Aldisin was 
initially isolated from the Madagascar sponge S. carteri,111,112 and was subsequently reported from 
other species such as S. massa,113,114 Pseudoaxinyssa spp.115,116 and Axinella sp.117  
Compound 2.60 showed a single ion cluster at m/z 265/267 [M+Na]+ by (+)-LRESIMS 
analysis and was further revealed to have the molecular formula of C8H7N2O279Br by (+)-HRESIMS. 
From these data, compound 2.60 had a bromine substituent and six double bond equivalents. The 1H 
NMR profile of compound 2.60 was quite similar to that of compound 2.59, except that a singlet 
proton signal was observed at δH 6.80 (1H) that suggested a substituent at either C-2 or C-3. The 1H 
NMR data comparison of 2.60 with those of literature indicated that this chemical shift was 
appropriate for the α-proton of the pyrrole ring and so suggested a substituent at C-3. Compound 2.60 
was thus identified as 3-bromoaldisin that has been reported from Stylissa spp.106,114,118  
Compound 2.61 displayed a molecular weight of 230/232 for a monobrominated alkaloid and 
showed ion clusters with m/z of 253/255 [M+Na]+ and m/z of 229/231 [M-H]- in the (+)- and (-)-
LRESIMS, respectively.  In the 1H NMR spectrum, there were signals for two pyrroles (δH 7.10 and 
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6.81), two methylenes (δH 3.51 and 3.73) and an oxygenated methine (δH 5.63). Dereplication analysis 
of these data led to the identification of mukanadin C, that was first reported from the sponge Agelas 
nakamurai.112 The same compound was also detected in the extract of Axinella verrucosa108 and 
Stylissa massa.114  
In a series of protein kinase inhibitor assays, bromopyrroles 2.55, 2.59, 2.60 and 2.61 have 
been found to be potent inhibitors of kinases that play important roles in cell proliferation (CLK-1 
and CDK-5) as well as diabetes and neurodegenerative disorders (GSK-3, DYKR1A and CK-1). 
Bromopyrroles 2.55 and 2.59 specifically inhibited kinase CLK-1 with IC50 values of 7.5 and 13.4 
µM, respectively, but were inactive against CDK-5. Similarly, both compounds showed activity 
against DYRK1A (IC50 14.9 and 50.6 µM) and CK-1 (IC50 18.7 and 25.6 µM), but did not against 
GSK-3. On the contrary, compounds 2.60 and 2.61 showed broad activities against all kinases tested 
with IC50 values ranging between 0.5-27.6 µM. 114 
 
2.3.!Conclusions 
In a preliminary screening, the crude methanolic extracts of the Indonesian sponges, 
Acanthostrongylophora ingens and Stylissa carteri were found to be cytotoxic against HeLa cancer 
cells at 30 µg/mL. The chemical analysis of the extract of A. ingens has yielded a new 3-
alkylpiperidine alkaloids, acanthocyclamine A (2.45), whose absolute configuration has been 
established by an X-ray crystallographic analysis. The purified acanthocyclamine A (2.45) was also 
tested in the antimalarial assay and it exhibited a significant activity against the chloroquine-sensitive 
parasites Plasmodium falciparum (3D7 cells) with an IC50 value of 2.5 µM. From the extract of 
Stylissa carteri, various bromopyrrole alkaloids were also obtained including two new compounds. 
The structures of the new bromopyrroles were elucidated based on 1D and 2D NMR analyses.
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CHAPTER 3! 
Chemical analysis of cryptic nudibranchs of the genus Phyllodesmium 
 
3.1.!Introduction 
This study investigates the secondary metabolites from the Australian xeniid coral and 
nudibranchs of the genus Phyllodesmium. The extracts of P. lizardense and its soft coral substrate, 
were found to contain sesquiterpenes from germacrene, guaiane, muurolene and cubebane classes 
The extraction and purification of the cerata extract of P. poindimiei yielded various pregnane steroids 
and punaglandins (chlorinated prostaglandins); whereas that of P. longicirrum contained a series of 
cembrane diterpenes.  
In this chapter, the morphology of aeolidian nudibranchs Phyllodesmium spp. is highlighted 
in Section 3.1.1. The next section (Section 3.1.2.) describes the previously reported secondary 
metabolites from Phyllodesmium spp. and the soft coral Heteroxenia sp. The analysis of the soft coral 
substrate of P. lizardense is presented in Section 3.2.1. The specimens of P. lizardense were collected 
in two batches and are discussed separately in sections 3.2.2.1. and 3.2.2.2. The isolation and structure 
elucidation of secondary metabolites from P. poindimiei are described in Section 3.2.4. Also 
presented in Section 3.2.6. is the chemistry of P. longicirrum.  
  
3.1.1.!The morphology of aeolidian nudibranchs of the genus Phyllodesmium  
 Opistobranchia (Mollusca, Gastropoda) are shell-less marine mollusks that develop defense 
strategies by mimicking coloration and shape of their prey, forming spicules in their epidermal tissues 
and storing biochemicals in their body.119 Within the Opistobranchia, mollusks from the sub-order 
Aeolidoidea are distinguished by their ability to develop a cnidosac, an anatomical feature that 
contains cnydocyst or kleptocnides (stinging cells) at the end of their dorsal appendages (Figure 
3.1).120  
 
Figure 3.1. The general anatomy of aeolid nudibranchs (A: anus; CA: cerata; CN: cnidosac; MA: 
stomach; MDD: digestive gland; MU: mouth; RH: rhinophores)121  
!
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Aeolids of the genus Phyllodesmium are interesting since they do not obtain stinging cells 
from their preys, thus their cnidosacs have become useless. As part of their defense strategy against 
predators, Phyllodesmium spp. are not only mimicking their substrate, but may also concentrate the 
secondary metabolites from their diet in the cerata. Phyllodesmium is the only genus that sequesters 
and incorporates diverse chemicals, depending on the food source.120 The various species of 
Phyllodesmium are distinguished by their external color pattern, the shape of cerata, digestive gland 
ramification, differences in radular morphology and anal position. Phyllodesmium mollusks usually 
feed on octocorals and host symbiotic dinoflagellate from the genus Symbiodinium in their digestive 
glandular cells122 to obtain energy from photosynthesis.120 
!
3.1.2.! Reported compounds from Phyllodesmium spp. and the soft coral Heteroxenia sp. 
 The sequestration of chemicals by Phyllodesmium has influenced the speciation and evolution 
of this genus. Affeld et al. (2009) reported the isolation of α-muurolene (3.1), 3β-hydroxy-α-
muurolene (3.2) and 3β-acetoxy-α-muurolene (3.3) from the Australian P. lizardense.123 All three 
compounds have also been reported from Heteroxenia sp. collected from the Philippines. 
Additionally, Heteroxenia sp. extract was also reported to contain 6-hydroxy-α-muurolene (3.4), 7α-
hydroxy-α-muurolene (3.5) and 7α-acetoxy-α-muurolene (3.6).124,125 Terpenes 3.3 and 3.4 exhibited 
activities against the plant pathogenic fungus C. cucumerinum and the Gram-positive bacterium, B. 
subtilis. The 6-OH group in 3.4 appeared to be crucial for its bioactivity, based on the fact that 3.4 
was more active than 3.3 in both assays. Furthermore, 3.4 was lethal in the brine shrimp assay with 
an LD50 of 6.5 µg/mL, whereas 3.3 was inactive.125  
The initial investigation of the secondary metabolites from P. longicirrum (= P. longicirra) 
yielded thunbergol (3.7) as the major compound, along with epoxythunbergol (3.8) and 
trocheliophorol (3.9). These cembrane diterpenes were also found in the extract of the food source, 
Sarcophyton trocheliophorum, suggesting a predator-prey relationship between the aeolid nudibranch 
and the soft coral.126  In contrast to previous finding, recent study of P. longicirrum afforded four 
polycyclic diterpenes (3.10-3.13) bearing chatancin skeletons. Diterpene 3.10 was reported to exhibit 
significant deterrent activity in a fish feeding assay.127   
 To the best of our knowledge, the chemical analysis of the cerata extract of P. poindimiei has 
not been reported elsewhere. This study thus reports the secondary metabolites of P. poindimiei for 
the first time.  
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3.2.!Results and discussion 
3.2.1.!Secondary metabolites from the soft coral substrate of Phyllodesmium lizardense 
Specimens of P. lizardense were collected, along with its soft coral diet in June 2014 from 
Lizard Island, QLD. Separation and purification of the diethyl ether extract of the soft coral yielded 
sesquiterpenes bearing germacrene (3.14, 3.16) and guaiane (3.17, 3.26) skeletons as presented in 
Scheme 3.1.  
 
 
 
Germacrene C (3.14) was obtained from the hexane fraction of the NP flash chromatography, 
implying that the compound was a hydrocarbon. A GC-MS analysis to determine the molecular mass 
of 3.14 was attempted, however the presence of minor components in this fraction impeded the 
measurement. The molecular formula of 3.14 was then deduced from the 13C NMR data. Terpene 
3.14 contained 15 carbons comprising four methyls (δC 16.5-22.3), four methylenes (δC 27.6-39.9), 
three sp2 methines (δC 121.6-129.6), one sp3 methine (δC 36.6) and three quaternary carbons (δC 127.1-
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145.4). These carbon data fitted a molecular formula of C15H24. In the 1H NMR spectra, there were 
signals for three alkenes (δH 4.93-6.23), four methylenes (δH 1.74-3.16), two vinyl methyls (δH 1.14 
and 1.57) and an isopropyl group (δH 2.38, 1.09, 1.08). Dereplication analysis of these 1H and 13C 
NMR data led to the identification of germacrene C that has been previously isolated from the dry 
fruits of Kadsura japonica128 and also from soft corals.124,19 
 
 
Scheme 3.1. Isolation process of sesquiterpenes from the soft coral substrate of P. lizardense. 
 
Morikawa and Hirose (1969) determined the double bond configurations in 3.14 by 
comparison to those of pregeijerene (3.15) from Geijera parviflora leaves.130 The cis configuration 
of the ∆6,7 double bond in 3.15 was established from the mutual coupling constant of 10 Hz between 
H-6 and H-7. The cis and trans configurations of the cyclodecadiene (∆4,5 and ∆6,7 double bonds) in 
3.15 were deduced from the UV spectrum that showed a maximum at 251 nm (ε 9100) and a minimum 
at 228 nm (ε 5250). The relative configuration of the ∆1,10 double bond in 3.15 could not be determined 
from chemical evidence, however the proposed biogenetic origin of 3.15 from farnesyl pyrophosphate 
suggested that it might be trans (Scheme 3.2). This hypothesis was supported by the X-ray analysis 
of the silver nitrate adduct of 3.15.131  
 
Soft coral substrate of Phyllodesmium
lizardense. (22 g wet wt.)
Et2O extract (563 mg)
- NP flash chromatography 
(100% hexanes ! 100% DCM)
8 fractions
Fraction DFraction A Fraction E
3.14 (236 mg)
3.17 (1.2 mg)
3.26 (1.5 mg)
3.27 (2.2 mg)
3.16 
(mixture, 50 mg)
Subfraction 3 and 4
RP HPLC
(100% MeOH)
-Extracted with acetone (7 x 50 ml)
-Partitioned against Et2O (3 x 15 ml)
Subfraction 1
- NP flash chromatography 
(100% hexanes ! 100% DCM)
- NP flash chromatography 
(100% hexanes ! 100% DCM)
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Scheme 3.2. The proposed biogenetic pathway of pregeijerene (3.15)130 
 
The 1H NMR data of 3.14 isolated in this study were in good agreement with those reported 
by Morikawa and Hirose (1969)128 as well as by Kashman (1978)124 and Kitagawa (1986)19 groups. 
Recent reports of the isolation of 3.14 from cherry tomato, Lycopersicon esculentum132 and valerian 
flower plant, Valeriana officinalis133 provided 13C NMR data that were comparable to those of the 
same compound from the current work. It should be noted that the NMR spectra of these various 
germacrene-C samples were run in different solvents (Table 3.1).   
 
 
Table 3.1. Comparison of the 13C NMR data of 3.14 with those from recent literature 
C 3.14a Colby et al (1998)b Yeo et al (2013)c 
1 125.0 125.7 126.6 
2 27.6 28.3 29.1 
3 39.8 40.5 41.4 
4 127.1 127.5 127.9 
5 129.6 130.4 131.5 
6 121.6 122.6 123.6 
7 145.4 145.7 145.3 
8 31.7 32.2 33.2 
9 39.9 40.6 41.6 
10 141.4 141.5 142.3 
11 36.6 37.3 38.4 
12 22.3 22.4 23.6 
13 22.0 22.8 23.3 
14 20.5 21.1  21.8 
15 16.5 17.0 17.8 
aCDCl3 (125 MHz); bC6D6 (150 MHz); cC6D14 (125 MHz) 
 
A second germacrene type compound was isolated in fraction 4 of the NP flash 
chromatography of the soft coral extract. Compound 3.16 gave a molecular ion peak at m/z 222 [M+] 
in the GC-MS that corresponded to a molecular formula of C15H26O. Comparison of the molecular 
mass of 3.16 and that of 3.14 showed 18 mass units different, indicating the presence of an additional 
hydroxy group. The 1H NMR data comparison between those of 3.16 and 3.14 revealed noticeable 
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differences. The alkene signals H-5 at δH 5.25 (d) and H-6 at δH 5.19 (dd) showed a 3JH-5/H-6 value of 
15.7 Hz in 3.16, as opposed to 9.4 Hz in 3.14, indicating the loss of a diene system. The 3JH-5/H-6 value 
was appropriate for a trans-configured ∆5,6 double bond.134 The position of the hydroxy group was 
assigned based on the C-4 signal that was resonated at δC 73.3 and thus replaced the double bond at 
C-4 (δC 127.1) that was previously observed in 3.14. These NMR data were consistent to those 
reported for germacra-1(10),5-dien-4-ol (3.16).135 This compound has been reported from plants136–
139 and from soft corals.135,140  
 
 
Figure 3.2. Candidate structures of 3.16 
Table 3.2. The 13C NMR data of 3.16 in CDCl3 compared to previous data 
H 3.16a 3.16ab,c 3.16bd,e 
1 129.1 129.1 128.8 
2 23.8 24.8 23.6 
3 39.7 40.8 39.6 
4 73.3 73.1 73.0 
5 140.3 139.9 140 
6 126.0 130.4 125.7 
7 53.1 52.8 52.8 
8 26.1 26.7 25.9 
9 41.5 41.3 41.2 
10 132.8 132.3 132.5 
11 33.2 32.9 33.0 
12f 20.8 19.0 20.6 
13f 19.1 20.6 18.9 
14 16.8 16.7 16.7 
15 30.9 23.6 30.7 
Bold texts indicate chemical shifts differences; a125 MHz; b100 MHz; cSee 
ref. 139; d75 MHz; eSee ref. 138; fInterchangeable 
 
In a germacrolide system, H-7 is usually drawn as α−oriented,141 thus the configuration at C-
4 relative to that at C-7 was next considered. By adopting a chair-chair conformation as previously 
described by Izac et al (1982), Cornwell et al (2001) and Sutour et al (2015) for 
germacradienols,135,138,139 3.16 may present as two possible diastereomers at C-4 where Me-15 is 
either axial (3.16a) or equatorial (3.16b) (Figure 3.2). The two diastereomers have been reported from 
marine and terrestrial origins,18,19,22,23 despite having closely identical 1H NMR data. As a result, the 
identification of 3.16a and 3.16b is ambiguous in the early papers. Bohlmann et al (1984) 
differentiated 3.16a and 3.16b based on the alternate proton chemical shift between H-5 and H-6 and 
also by NOE experiments conducted on 3.16b.136 The complete 13C NMR data of 3.16a and 3.16b 
H
OH10
4 7 11
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15
HHO
3.16a 3.16b
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were not reported until recently.139,142 Sutour and co-workers (2015) suggested that 3.16a and 3.16b 
could be distinguished by the 13C NMR data.139 Notably, the chemical shift of Me-15 is distinctive 
for both diastereomers. The chemical shift of Me-15 is δC 23.6 in 3.16a and δC 30.7 in 3.16b. The 
upfield shift value for C-15 in 3.16a is due to the γ-steric effect associated with C-2 and C-6.139 A 
comparison of the 13C NMR data of 3.16 with those from previous work is presented in Table 3.2. 
The signal of Me-15 in 3.16 was resonated at δC 30.9 and thus should be equatorially orientated. The 
relative configuration at C-4 of 3.16 was thus deduced as 4S*.The [α]D value of 3.16 was +50, 
showing an opposite sign to that reported in the literature (-112),137 hence 3.16 may be the enantiomer 
of (-)-germacra-1(10),5-dien-4β-ol. Compound 3.16 has been isolated by Izac et al (1982) and Jurek 
et al (1993) from soft corals, however, they incorrectly drawn the relative configuration of –OH at C-
4 in 3.16 as α.135,140  
Terpene 3.17 from the soft coral extract was isolated as a minor component. An extra spot 
appeared in the baseline of the NP TLC plate when the fraction containing 3.14 was eluted with 
hexane. This was an indication for a minor artifact following contact with silica. By NP flash 
chromatography, 3.17 was eluted with hexanes/DCM (3:1). The GC-MS analysis of 3.17 showed a 
molecular ion peak at m/z 220 [M+], which was 16 mass units different to that of 3.14. Thus, a 
molecular formula of C15H24O was considered, implying four double bond equivalents. The loss of 
water was apparent from the fragmentation to m/z 202 [M-H2O]+, followed by the loss of a methyl as 
indicated by fragmentation to m/z 187 [M-H2O-Me]+ in the GC-MS. The HSQC and HMBC data of 
3.17 revealed signals for three methyls (δC 21.4-24.1), an sp2 methylene (δC 106.6), four sp3 
methylenes (δC 24.9-40.3), an sp2 methine (δC 121.5), three sp3 methines (δC 37.5-55.0), two 
trisubstituted alkenes (δC 149.8-154.0) and an oxygenated quaternary carbon (δC 80.8). The remaining 
two degrees of unsaturation were then attributed to the molecule’s bicyclic skeleton. These spectral 
features provided the planar structure for a guaiane-type sesquiterpene. Based on data comparison 
with those reported in the literature, 3.17 was identified as guaiane alcohol, also known as alismol.143–
145 
It was not possible to deduce the configuration of the H-1/H-5 linkage of 3.17 from the 
coupling constant between the two protons due to the overlapping multiplet signals. Two 
diastereomers with a trans- and cis-configured bridge junction were then considered. The software 
program ChemBio3D Ultra 15.0 (Cambridge) was employed to model both diastereomers by using 
MM2 force field for energy minimization to an RMS of 0.1 (Figure 3.3). If H-1 and H-5 were cis-
configured as in 3.17b, a coupling constant of 5-6 Hz between H-5 and H-6 should be observed, as a 
result of the dihedral angle of 38°. On the other hand, a trans-linkage between H-1 and H-5 in 3.17a 
provided a dihedral angle of 93° between H-5 and H-6 and would give JH-5/H-6 < 1 Hz. The appearance 
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of H-6 as a broad singlet with a small J value therefore is consistent with the relative configuration 
shown for 3.17a.   
 
 
Figure 3.3. Molecular modeling for trans-configured H-1/H-5 for guaiane alcohol (3.17a) and its C-
5 epimer (3.17b) showing the predicted dihedral angle between H-5 and H-6 
 
Bowden and co-workers (1980) reported 3.17 from the soft coral Nephthea chabrolii.143 They 
also isolated a crystalline guaiane-diol (3.18) from the soft coral Lemnalia africana, whose relative 
configuration was determined based on an X-ray crystallographic study by the Clardy group that was 
never published. The relative configuration of 3.17 was then deduced by chemical derivatization 
studies (Scheme 3.3).  
 
 
Scheme 3.3. The determination of relative configuration of 3.17 by Bowden et al (1980)143 
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Bowden and co-workers (1980) reacted the diol 3.18 with m-chloroperbenzoic acid to produce 
a tricyclic compound 3.19 and an epoxy-guaiane 3.20. Similarly, the epoxidation of 3.17 with excess 
peracid, followed by an excess of LiAlH4 in ether also afforded 3.19 and 3.20, in addition to 3.21 and 
3.22. Since 3.17 and 3.18 produced the same products (3.19 and 3.20), the relative configuration of 
3.17 from N. chabrolii should be the same as that of 3.18 and thus was established as 1S*, 4R*, 5S*.143  
 
 
 
Guaiane alcohol (3.17) was also reported from the Chinese rhizome Alisma orientale and was 
named as alismol based on its origin. It was reported to inhibit contraction of isolated bladder smooth 
muscle in guinea pig. In the original work, the planar structure of 3.17 was established by the 
combination of NMR and chemical degradation studies involving epoxidation and ozonolysis.144 
These studies led Oshima and colleagues (1983) to deduce a cis ring fusion. This relative 
configuration was later revised to a trans ring junction by Yoshikawa et al. (1992) based on the NOE 
studies of the structurally related orientalols A-C (3.23-3.25) from the same plant. The orientalols 
(3.23-3.25) showed correlations between Me-15 and H-1, as well as, between Me-14 and H-5, 
confirming them as trans diastereomers.145  
The 13C NMR data of 3.17 from P. lizardense in CDCl3 were consistent with those obtained 
in CCl4 and CD3OD as reported by Bowden et al (1980) and Yoshikawa et al (1992), respectively 
(Table 3.3).143,145 Bowden et al (1980) and Kitagawa et al (1986) also isolated germacrene C (3.14) 
from the same source and suggested that 3.14 was the likely precursor of 3.17. Notably, both groups 
reported the optical rotation of 3.17 as ± 0o.129,143A similar result was also achieved in this work.  
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Table 3.3. Comparison of the 13C NMR data of 3.17 with those published in the literature 
C 3.17a Bowden et al (1980)b,c Yoshikawa et al (1992)d,e 
1 55.0 54.9 55.8 
2 24.9 24.8 25.7 
3 40.3 40.2 40.7 
4 80.8 80.5 81.0 
5 47.4 47.2 48.9 
6 121.5 121.4 123.2 
7 149.8 149.5 150.3 
8 30.1 30.0 31.0 
9 37.2 37.0 38.2 
10 154.0 153.7 155.2 
11 37.5 37.4 38.7 
12 21.6 21.5 21.7 
13 21.4 21.3 22.0 
14 106.6 106.4 107.0 
15 24.1 24.1 24.1 
aCDCl3 (125 MHz); bCCl4 (15 MHz); cSee ref. 143; dCD3OD (67.5 MHz); eSee ref. 26 
 
 
 
A guaiane sesquiterpene bearing a diacetate moiety (3.26) was isolated from fraction 5 of the 
NP flash chromatography. The 1H NMR spectra of 3.26 were similar to that of 3.16, except that there 
were an extra methyl signal at δH 1.52 (3H, s, H-15) as well as two acetate signals at δH 1.96 (3H, s) 
and δH 2.00 (3H, s). The presence of two acetate moieties (118 amu) was confirmed by HRESIMS 
analysis that gave a sodiated molecular ion peak at m/z 345.2047 [M+Na]+ (calcd for C19H30O4Na, 
345.2036). The allylic methine at δH 2.49 (1H, br d, 11.3, H-5) appeared as a broad doublet in the 1H 
NMR spectrum and showed a large vicinal coupling to H-1 at δH 2.33 (1H, d, 11.3), suggesting that 
3.26 possesses a 1,5-trans-linkage. Further 2D-NOESY experiments revealed cross-peaks between 
H-1/Me-15 and H-5/Me-14 that confirmed the trans linkage between H-1 and H-5. Terpene 3.26 has 
never been reported as a natural product; however, it has been prepared by the acetylation of a guaiane 
diol (formerly identified as alismoxide) (3.18).145 These authors reported a 3JH-5/H-6 of 3 Hz which is 
in agreement with our data (JH-5/H-6 2.4 Hz).  
To establish its absolute configuration, terpene 3.26 was recrystallized from isopropanol to 
obtain colorless crystals. The X-ray crystallographic analysis of 3.26 revealed an equatorial position 
for both acetate moieties. The ORTEP3 diagram (Figure 3.4) also revealed the absolute configuration 
of the chiral centers as 1R, 4S, 5S, 10R and confirmed the relative configuration of 3.26 deduced by 
NMR.  
3.26
AcO H
H OAc
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Figure 3.4. The ORTEP3 view of 3.26 
 
The last compound that was isolated from the soft coral extract was 3.27. The LRESIMS of 
3.27 gave a sodiated molecular ion peak at m/z 449 [M+Na]+. This molecular weight suggested a 
molecular formula of C30H50O with six degrees of unsaturation. The 1H NMR spectra of 3.27 
indicated the presence of a Δ5-sterol by the distinctive occurrence of an sp2 methine at δH 5.36 (1H, 
m, H-5) and an oxygenated methine at δH 3.52 (1H, m, H-3). The 1H NMR data revealed seven methyl 
signals between δH 0.60 and 1.00, as opposed to the five methyls that are usually associated with the 
cholesterol skeleton. The spectra also showed distinct upfield signals at δH  0.45 (1H, dd, 5.9, 4.4, H-
30b), 0.24 (1H, m), 0.15 (1H, m, H-22) and -0.13 (1H, dd, 5.9, 4.4, H-30a). These 1H NMR data 
matched well with those of gorgosterol, a cyclopropyl-containing side chain marine sterol. The [α]D 
value of 3.27 of -40 was comparable to that published in the literature (-45).146 Gorgosterol (3.27) 
was originally isolated from the gorgonian Plexaura flexuosa,147 then again from a coelenterate148 
and from the zoanthid Palythoa tuberculosa.149 The complete characterization of 3.27 was first 
reported by the Scheuer group146 and its absolute configuration was later secured by X-ray 
crystallography.150 
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3.2.2.!Secondary metabolites from P. lizardense  
3.2.2.1.!Sesquiterpenes from the first batch of P. lizardense specimens 
Four individuals of P. lizardense were collected at a dive site near Lizard Island, QLD in June 
2014. Analysis of an extract prepared from the P. lizardense cerata was carried out using similar 
methods to those described previously (Scheme 3.4). This method led to the re-isolation of 
germacrenes 3.14 and 3.16 as well as guaianes 3.17 and 3.26. Additionally, a germacrene derivative 
(3.28), muurolenes (3.2, 3.3 and 3.31) and a cubebol (3.37) were also isolated.  
 
 
Scheme 3.4. Isolation process of sesquiterpenes from P. lizardense batch one 
 
 
 
A new germacrene derivative 3.28 gave an ion cluster at m/z 243.1726 [M+Na]+ in the 
HRESIMS for a molecular formula of C15H24O. This molecular mass was two mass unit less than that 
of 3.14, indicating an additional degree of unsaturation. Comparison of the 1H NMR data of 3.28 to 
P. lizardense cerata batch one
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those of 3.14 revealed the presence of an extra double bond from signals for an exomethylene at δH 
5.22 (br t, 1.3) and 5.01 (s). The position of the exomethylene was assigned at C-15 based on the 
HMBC cross peaks from the exomethylene signals at δH 5.22 (1H, s, H-15a) and δH 5.01 (1H, s, H-
15b) to the neighboring carbons at δC 36.9 (C-3) and 70.7 (C-5). In the COSY spectrum, the alkene 
signal at δH 5.42 (1H, d, 9, H-6) was correlated to the oxygenated methine at δH 4.42 (1H, brd, J = 9 
Hz, H-5), thus providing a planar structure as depicted in Figure 3.5. 
 
 
Figure 3.5. Selected COSY and HMBC correlations of 3.28 
 
The 6E-configuration was apparent from the NOESY correlation between H-6 and the 
isopropyl methyls (Me-12 and Me-13). The same configuration was also deduced for the ∆1,10 double 
bond on the basis of NOESY correlation between Me-14 and the exomethylene (H-15a and H-15b), 
indicating that they are on the same face of the molecule. The chemical shift value of Me-14 at δC 
17.9 also corresponded well with that of 3.14 (δC 16.8) that established the same double bond 
configuration.  
The stereochemistry of the secondary alcohol at C-5 in 3.28 was deduced by comparison to 
that of germacrene diol (3.29) from the red algae Laurencia subopposita whose relative configuration 
was unequivocally determined by chemical derivatization studies.151 Wratten and Faulkner (1977) 
dehydrated the diol with phosgene in pyridine or Moffat oxidation conditions to generate a ketone 
(3.30). The formation of ketone (3.30) could only be achieved if the diol (3.29) has the shown 
configuration (Scheme 3.5). 
!  
Scheme 3.5. Proposed mechanism for the conversion of germacrene diol (3.29) to 8(15)-
dehydrooplopanone (3.30) by Wratten and Faulkner (1977)151 
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Two plausible diastereomers for 3.28 with different configurations at C-5 were then 
distinguished by NOESY data (Figure 3.6). Assuming a chair-chair conformation of the germacrene 
ring as shown previously in 3.29, Me-14 and the exomethylene H-15 should be in axial position, 
whereas the isopropyl group is equatorially orientated in both diastereomers. In diastereomer 3.28a, 
the –OH group is in a β-position and is equatorial; whereas in diastereomer 3.28b the same functional 
group is in an α-position and is axial. In the NOESY data, correlations between Me-14 and H-15 
were observed and were suitable for both diastereomers due to the axial-axial arrangement of these 
groups. However, H-5 showed correlations to H-1 and H-11 that suggested that H-5 was axially 
orientated as in diastereomer 3.28a. There was also W-coupling between H-5 and H-15a with a J 
value of 1.2 Hz that supported this argument. Based on these data, the -OH group should be in a β-
position relative to that at C-7 and so the relative configuration at C-5 was determined as S*. 
Germacrene 3.28 has no optical activity indicating that the compound may be obtained as a racemic 
mixture.  
 
!  
Figure 3.6. Plausible diastereomers for 3.28 with H-5 at axial (3.28a) and equatorial position (3.28b) 
showing observed NOESY correlations (plain arrow) and W-coupling (dashed arrow) 
 
 
Terpene 3.2 was obtained as a white solid by NP HPLC. A molecular formula of C15H24O for 
3.2 was inferred from a molecular ion peak at m/z 220 [M+] in the GC-MS. The 1H NMR of 3.2 
showed signals for two alkenes (δH 5.56 (1H, br s) and 5.44 (1H, br s)), an oxygenated methine (δH 
3.95, br s), four allylic protons (δH 1.77-2.12 (4H, m)), an isopropyl group (δH 2.04 (1H, m), 0.87 (3H, 
d, 7.0), 0.83 (3H, d, 7.0) and two vinyl methyls (δH 1.69 (3H, s) and 1.65 (3H, s)). These spectral 
features were in agreement with those reported for 3β-hydroxy-α-muurolene that was previously 
isolated from the same species of nudibranch.123 The equatorial position of H-3 was deduced from its 
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small vicinal coupling constant (J < 1 Hz) to H-2. Affeld and co-workers (2009) determined the 
relative and absolute configurations at the chiral centers by NOESY experiments and MPA ester (α-
methoxyphenylacetic acid) analysis, respectively. The absolute configuration of 3.2 was established 
as 1R, 3R, 6S, 7R. The [αD] value of 3.2 from the current work (+29, c 0.11) was comparable to that 
reported for the same compound by Affeld and co-workers (+131, c 1.67), suggesting that both 
compounds shared the same absolute configuration.  
The next muurolene derivative (3.3) was also obtained as a white solid by NP HPLC and gave 
a molecular ion peak at m/z 285 [M+Na]+ in the LRESIMS. This molecular mass was 42 mass units 
different from that of 3.2, denoting the presence of an acetate group. The 1H NMR data of 3.3 were 
similar to that of 3.2, except for the presence of an oxygenated methine at δH 5.20 (1H, t, 3.3, H-3) 
and an acetate signal at δH 2.10 (3H, s, -OCOCH3). The 1H NMR data and specific optical rotation of 
compound 3.3 (+95) corresponded well to those of 3β-acetoxy-α-muurolene (+122) from the same 
species of nudibranch. By using a similar method to that of 3.2, Affeld et al (2009) determined the 
absolute configuration of 3.3 as 1R, 3R, 6S, 7R.123 
Compound 3.31 was isolated as a colorless oil with a molecular formula of C15H24O based on 
the HRESIMS analysis, suggesting four double bond equivalents. The GC-MS fragmentation pattern 
of 3.31 showed peaks at m/z 204 [M-H2O]+, m/z 189 [M-H2O-Me]+ and m/z 161 [M-H2O-iPr]+, 
indicating the loss of H2O, a methyl and an isopropyl moiety, respectively. Comparison of the 1H 
NMR spectra of 3.31 and 3.2 showed observable differences. There were signals for an alkene (δH 
5.40 (1H, br s)), an oxygenated methine (δH 2.75 (1H, s)) and an epoxide methyl (δH 1.28 (3H, s)) in 
3.31, that were not observed in 3.2.  
Two candidate structures of 3.31 were then considered (Figure 3.7). The two plausible 
structures of 3.31 were differentiated by coupling constant analysis, COSY and HMBC correlations. 
The epoxide methine at δH 2.75 (s) showed a COSY correlation to the bridgehead methine at δH 2.24 
(t, 5.6) and an HMBC correlation to a methine at δC 41.6. There was also a COSY correlation from 
the alkene signal at δH 5.40 (br s) to that of the allylic methylene at δH 1.96 (br s). These spectral 
features suggested the epoxide position at C-4/C-5 that fitted structure 3.31a.  
 
 
Figure 3.7. Two plausible structures of 3.31 
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In the 1H NMR spectrum, a large JH-6/H-7 of 11 Hz indicated an axial-axial coupling between 
H-6 and H-7. The cis-junction between the two bridgehead protons (H-1 and H-6) were deduced from 
their JH-1/H-6 value of less than 1 Hz, as observed in 3.2 and 3.3. This hypothesis was supported by the 
observed NOESY correlations between the two protons. There were also NOESY correlations 
between H-5 and Me-15 that suggested both protons were cis-configured. These data led to the 
identification of two plausible diastereomers of 3.31a based on the orientation of the epoxide (3.31c 
and 3.31d) (Figure 3.8).  
 
 
Figure 3.8. Conformations of two diastereomers of 3.31 
 
The relative configuration of the epoxide was determined by comparison to the reported data 
of menthane derivatives (Figure 3.9). In their work, Gács"Baitz et al (1984) investigated the 
stereochemistry of the epoxide group at C-3 in relation to the 1H and 13C NMR data of 1,2-
epoxymenthanes.152 The six-membered menthane ring is expected to adopt half-chair conformation 
and that the configuration of the epoxide should dictate the coupling constants between H-2 and H-
3. A 3JH-2/H-3 < 1 Hz was observed in 1,2β-epoxide (3.32a), whereas 3JH-2/H-3 values of 2-2.5 Hz were 
observed in 1,2α-epoxide (3.32b). The observed 3JH-2/H-3 values were in agreement with the Dreiding 
models that showed a dihedral angle of approximately 90° and 30° between H-2 and H-3 in 3.32a 
and 3.32b, respectively. The configuration of the epoxides also affected the chemical shifts of the 
neighboring carbons due to the γ-gauche effect of the epoxide.152 In 3.32a, C-5 is on the same face as 
the epoxide and was shifted upfield (δC 16.2-16.4), compared to the same carbon (δC 20.2-20.6) in 
3.32b. A similar effect was also observed in C-4 in 3.32b (δC 38.8-42.9) vs C-4 in 3.32a (δC 43.9-
47.2). It is noteworthy that the effect of the epoxide configuration was also observed in other carbons, 
although to a lesser magnitude.  
By applying the same conformation for two diastereomers of 3.31 as shown in Figure 3.8, the 
3JH-5/H-6 value will depend on the orientation of the C-4/C-5 epoxy group. In 3.31c, the epoxide is in 
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a β-position, thus allowing a trans arrangement between H-5 and H-6. On the other hand, H-5 and 
H-6 are in cis relationship in 3.31d due to the α-position of the epoxide. By comparison to those of 
menthane derivatives, 3JH-5/H-6 values of < 1 Hz and 2-2.5 Hz would be observed in 3.31c and 3.31d, 
respectively. In the 1H NMR spectrum of 3.31, the signal for H-5 was observed as a singlet, indicating 
a JH-5/H-6 of < 1 Hz that corresponded to the cis arrangement between the two protons. Based on these 
data, the stereochemistry of the epoxide was established as 4R* and 5S* as depicted in 3.31c. 
Compound 3.31c gave an [αD]23 value of -21 (c 0.04, CHCl3), thus a trivial name of (-)-4,5-β-epoxy-
α-muurolene was proposed. This compound has been synthesized as part of a mixture resulting from 
the oxidation of α-muurolene (3.1),153 however, this is the first report of its isolation from nature. 
 
 
Figure 3.9. The conformations of the 1,2-epoxy-menthane derivatives showing the observed 3JH-2/H-3 
in 1,2β-epoxy-menthane (3.32a) and 1,2α-epoxy-menthane (3.32b) 
  
Bowden and co-workers (1986) also isolated muurolene epoxide 3.33 from the Australian soft 
corals Xenia spp. and with an absolute configuration established by chemical correlations with known 
muurolenes (Scheme 3.6).154 Reduction of epoxide in 3.33 afforded 3.34, which was further reacted 
with methanolic KOH to give 3.35. Further mesylation of the primary alcohol in 3.35 produced 3.36, 
which was reduced into α-muurolene (3.1) with known absolute configuration. The 1H NMR data of 
3.33 in C5D5N showed the H-5 signal as a singlet at δH 2.86, indicating a JH-5/H-6 of < 1 Hz as observed 
in 3.31c. These data thus further support the trans arrangement between H-5 and H-6 in 3.31c.  
 
 
Scheme 3.6. Chemical correlations of muurolene epoxide (3.33) into α-muurolene (3.1) by Bowden 
et al (1986)154 
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Cubebol (3.37) gave a molecular ion peak of m/z 222 [M+] in the GC-MS, suggesting a 
molecular formula of C15H26O with three degrees of unsaturation. The MS fragments of 3.37 were 
very similar to that of 3.31, showing m/z 204 [M-H2O]+, m/z 189 [M-H2O-CH3]+ and m/z 161 [M-
H2O-iPr]+. The 1H NMR spectrum of 3.37 was heavily congested in the aliphatic region, owing to the 
lack of alkene signals, thus indicating the compound was tricyclic. The 1H NMR spectrum of 3.37 
showed signals for a series of methylenes (δH 0.50, 0.80-1.00, 1.30-1.45, 1.50-1.70, 1.84), three 
methines (δH 0.80-1.00, 1.50-1.70) and four methyls (δH 0.80-1.00, 1.28). These spectral features 
were consistent with those reported for (-)-cubebol that was initially of plant origin.155 The 
enantiomer of (-)-cubebol has also been reported from a soft coral.156 
 
 
Table 3.4. Comparison of the 1H NMR data of 3.37 with (-)-cubebol and its epimers 
δH (multiplicity, J (Hz)) 
C 3.37a (-)-cubebolb,c 4-epi-cubebold,e 10-epi-cubebolf,g 
1 - - - - 
2 1.84 (ddd, 12.7, 11.5, 8.5) 1.82 (ddd, 12.6, 11.6, 8.6) 2.07 (m) 1.34 (m) 
 1.53 (m) 1.50 (ddd, 12.6, 8.6, 0.8) 1.38 (m) 1.20 (m) 
3 1.52 (m) 1.51 (ddt, 13.2, 8.8, 0.8) 1.45 (m) 1.73 (m) 
 1.36 (m) 1.33 (dddd, 13.2, 11.6, 8.6, 1.0) 1.14 (m) 1.53 (m) 
4 - - - - 
5 0.86 (d, 3.2) 0.84 (d, 3.2) 0.69 (d, 3.2) 1.07 (m) 
6 0.82 (dd, 3.2, 3.2) 0.80 (t, 3.2) 0.33 (dd, 3.2, 3.2) 0.77 (t, 3.0) 
7 0.99 (m) 0.97 (dddd, 12.4, 6.2, 4.4, 3.2) 0.88 (m) 0.92 (m) 
8 1.39 (m) 1.36 (ddt, 12.4, 4.4, 2.3) 1.30 (m) 1.20 (m) 
 0.81 (m) 0.79 (ddt, 13.6, 12.6, 2.2) 0.75 (m) 1.20 (m) 
9 1.60 (m) 1.57 (dddd, 13.6, 5.2, 4.6, 2.2) 1.50 (m) 1.53 (m) 
 0.51 (dddd, 15.4, 13.2, 11.5, 
2.2) 
0.49 (dddd, 13.6, 13.2, 11.1, 
2.0) 
0.45 (m) 1.34 (m) 
10 1.65 (m) 1.63 (dquint, 11.4, 6.2) 1.68 (m) 1.93 (m) 
11 1.62 (m) 1.60 (oct, 6.8) 1.45 (m) 1.64 (m) 
12 0.96 (d, 6.8) 0.94 (d, 6.7) 0.89 (d, 6.5) 0.95 (d, 6.5) 
13 0.92 (d, 6.8) 0.90 (d, 6.7) 0.92 (d, 6.5) 0.92 (d, 6.5) 
14 0.93 (d, 6.8) 0.91 (d, 6.4) 0.98 (d, 6.7) 0.98 (d, 7.0) 
15 1.28 (d, 1.1) 1.26 (d, 0.9) 1.33 (s) 1.27 (d, 1.0) 
aData obtained in CDCl3 at 500 MHz; bSynthetic product (CDCl3, 400 MHz); cSee ref.157; dNatural product (C6D6, 
500 MHz); eSee ref.158; fSynthetic product (CDCl3, 500 MHz); gSee ref.159  
 
Due to signal congestion, the relative configuration of the chiral centers was verified by NMR 
data comparison to those of previously reported cubebols,157–159 including C-4 and C-10 epimers of 
(-)-cubebol that have been isolated from algae158,160 and plant leaf oil,161 respectively. As shown in 
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Table 3.4, the NMR data of 3.31 were in agreement with those of (-)-cubebol that was synthesized 
by Furtsner and co-workers (2006)157, hence the same relative configuration was inferred for 3.31. 
In their paper, Cornwell and co-workers (2001) commented that 3.37 is a possible 
biosynthesis by-product of 3.16.138 This is due to the fact that 3.37 has the same relative configuration 
at C-4 as 3.16 that led us to assign the hydroxy group in the β-position. Compound 3.37 showed a 
specific optical rotation value of -190 that is comparable to that published in the literature (-51).157 
Various groups have reported the synthesis of 3.37 using different approaches. The 
Yoshikoshi group (1969) initially proposed the total synthesis of 3.37 from the dehydration of α- and 
β-cubebenes. The cyclopropanation was induced from an unsaturated α-diazoketone that furnished 
moderate yield and with poor diastereoselectivity.162,163 Fehr (2006) and Fürtsner (2006) groups 
synthesized 3.37 from R-carvone by using Pt and Au catalyzed cyclopropanation of propargylic 
esters.157,164,165 Meanwhile, Hodgson and colleagues (2010) stereoselectively prepared 3.37 through 
the formylation of (-)-menthone followed by the intramolecular cyclopropanation of a lithiated 
epoxide.166 
 
3.2.2.2.!Secondary metabolites from the second batch of P. lizardense specimens 
The second collection of P. lizardense secured five more individuals in February 2015. 
Separation and purification of the P. lizardense cerata extract yielded germacrenes (3.14, 3.16 and 
3.28), guaianes (3.16 and 3.26), muurolenes (3.2, 3.3, 3.38), cubebol (3.37) and gorgosterol (3.27). 
Three additional muurolenes (3.1, 3.5 and 3.38) were also isolated (Scheme 3.7).  
 
 
Scheme 3.7. Isolation process of sesquiterpenes from P. lizardense batch two 
P. lizardense cerata batch two
(1.3 g wet wt)
- Extracted with acetone (7 x 5 ml)
- Partitioned against Et2O (6 x 2 ml)
Et2O extract (116.4 mg)
6 fractions
Fraction CFraction A 
3.1, 3.14, 3.17
(49.5 mg)
NP HPLC (10% EtOAc/hexanes)
3.16 and 3.26
(0.4 mg)
3.27 (0.4 mg)
21 fractions
Fraction C-7
3.17 and 3.37
(1.8 mg)
Fraction 
C-15, C-16, C-17
3.2, 3.17, 3.28
(4.0 mg)
Fraction 
C-18 and C-19
Fraction C-21
3.3 (1.4 mg) 
3.31 (0.4 mg)
Fraction C-3
3.38 (0.2 mg)
Fraction 
C-5 and C-6
3.5 (0.2 mg)
Fraction 
C-10 and C-11
NP HPLC
(5% EtOAc/hexanes)
NP HPLC
(3.5% EtOAc/hexanes)
NP HPLC
(5% EtOAc/hexanes)
- NP flash chromatography (100%
hexanes ! 100% DCM)
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NP flash chromatography of the diethyl ether extract of P. lizardense cerata batch two yielded 
six fractions. The first flash chromatography fraction contained germacrene-C (3.14), together with 
an additional hydrocarbon (3.1). Considering the instability of 3.14, it was initially assumed that 3.1 
might be a cyclization product. Attempts to separate the two compounds by RP-HPLC were 
unsuccessful. The use of NP HPLC was avoided to minimize the contact of 3.14 with silica which 
presumably triggers cyclization of 3.14 due to its acidity. The molecular formula of 3.1 was 
determined as C15H24 by the molecular ion peak at m/z 204 [M+] in the GC-MS, thus denoting four 
double bond equivalents. Again, the MS fragmentation pattern was identical to those of muurolenes, 
showing m/z 189 [M-Me]+ and 161 [M-iPr]+. The NMR data acquisition of 3.1 was conducted on the 
mixture in benzene-d6 (C6D6) to give a better dispersion of proton signals. The 1H NMR spectrum of 
3.1 showed two alkene signals at δH 5.56 (1H, br s) and δH 5.44 (1H, br s), six allylic protons between 
δH 1.80-3.15 (6H, m) and two vinyl methyl signals at δH 1.69 (3H, s) and δH 1.65 (3H, s). The 
remaining signals were attributed to the isopropyl group, containing two doublet methyls at δH 0.83 
(3H, d, 7) and δH 0.87 (3H, d, 7) that were coupled to a common methine at δH 2.04 (1H, m). Despite 
the use of C6D6, the aliphatic signals still appeared congested, which complicated the determination 
of coupling constants. The 1H and 13C NMR data of 3.1 in C6D6 were in good agreement with α-
muurolene reported by Hirota and colleagues (1996).167 As seen in other muurolenes, the two 
bridgehead protons at δH 1.98 (1H, m, H-1) and δH 2.12 (1H, m, H-6) appeared as multiplet signals 
with 3JH-1/H-6 < 3 Hz that indicated a cis-junction. The optical rotation measurement of 3.1, however, 
was impeded due to its presence as an inseparable mixture with 3.14 and the instability of these 
compounds. 
Terpene 3.1 has been reported from gorgonians,168 the soft coral Heteroxenia sp.124,125 and 
from the sponge Acanthella cavernosa.167 Interestingly, compound 3.1 was not observed in the soft 
coral extract on which the Phyllodesmium mollusk had been collected. Our finding is in contrast with 
previous literature that reported compound 3.1 from the soft coral diet of P. lizardense.124,125  
The GC-MS analysis of terpene 3.5 revealed a molecular ion peak of m/z 220 [M]+ that was 
compatible with a molecular formula of C15H24O, indicating the presence of a hydroxy group. 
3.1 R1 = R2 = H
3.5 R1 = OH; R2 = H 
3.38 R1 = H; R2 = OH
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Comparison of the 1H NMR spectra of 3.1 and 3.5 showed similarities, except the absence of H-7 
that suggested a substitution at C-7. The assignment of a hydroxy group at C-7 was deduced from the 
downfield shift of the allylic methine signal at δH 2.43 (1H, br s, H-6) (+0.31 ppm), as well as the 
neighboring methylene signals at δH 2.05 (1H, br s, H-8a) (+0.21 ppm) and δH 1.97 (1H, br s, H-8b) 
(+0.13 ppm) in 3.5, compared to those in 3.1. The relative configuration at C-7 was determined from 
data comparison with those of literature.124 Terpene 3.5 was identified as 7α-hydroxy-α-muurolene, 
initially reported from the soft coral Heteroxenia fuscescens.124 Terpene 3.5 decomposed before the 
optical measurement could be measured.   
The final compound 3.38 had the same molecular formula of C15H24O determined by 
HRESIMS.  This molecular formula is identical to that of 3.5, indicated the presence of a hydroxy 
group in the molecule. The 1H NMR data of 3.38 were in agreement with those reported for 3.1, 
except for the replacement of the H-11 signal in 3.1 with an oxygenated carbon at δC 73.9. These data 
indicated a substitution at C-11 by a hydroxy group. Due to the deshielding effect of the hydroxy 
group, the isopropyl methyl signals in 3.38 were shifted downfield to δH 1.24 (3H, s, H-12) (+0.37 
ppm) and δH 1.17 (3H, s, H-13) (+0.34 ppm), compared to those of 3.1. The position of the hydroxy 
group at C-11 was confirmed by the HMBC correlation from the hydroxy group (δH 2.39) to C-13 (δC 
25.0) (Figure 3.10). Since the specific optical rotation of 3.38 showed a value of [αD]23 -10 (c 0.04, 
CHCl3), we propose to name compound 3.38 as (-)-11β-hydroxy-α-muurolene. 
 
 
Figure 3.10. Selected COSY and HMBC correlations of 3.38 
 
Table 3.5 presents the GC-MS retention times for sesquiterpenes with a molecular weight of 
less than 300 amu reported in this chapter. As shown below, α-muurolene (3.1) was eluted first, 
followed by cubebol (3.37) at just under 7 minutes. Germacrenes (3.14 and 3.28), guaiane (3.17), 
muurolene alcohols (3.5 and 3.38) and muurolene epoxide (3.31) were subsequently eluted between 
7-8 minutes. Lastly, muurolene acetate (3.3) was eluted after 8 minutes. Due to the similarity in the 
molecular weight of germacrene, guaiane and muurolene alcohols, data on their GC-MS retention 
times would be useful as an identification tool.   
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Table 3.5. GC-MSa retention times of sesquiterpenes based on the order of elution 
Compound  Retention time (mins) Molecular mass (m/z) 
germacrene C (3.14) n/ab n/ab 
α-muurolene (3.1) 6.65 204 
cubebol (3.37) 6.85 222 
germacra-1(10),5-dien-4β-ol (3.16) 7.30 220 
4,5−β-epoxy-α-muurolene (3.31) 7.34 220 
guaiane alcohol (3.17) 7.70 220 
7α-hydroxy-α-muurolene (3.5) 7.72 220 
11β-hydroxy-α-muurolene (3.38) 7.77 220 
germacra-1(10),4,6(7)-trien-5α-ol (3.28) 7.96 220 
3β-hydroxy-α−muurolene (3.2) 8.04 220 
3β-acetoxy-α−muurolene (3.3) 8.94 262 
aStandard program: ZB-5MS column, split mode, flow 1.5 mL/min; initial oven temperature 100 °C (isothermal for 3 
min), ramp 16 °C/min to 250 °C held for 10 min; injection temperature 250 °C, total time 40 min.; bNot available 
 
3.2.3.!Proposed biosynthetic pathways of guaianes and muurolenes 
!
  
 
 
 
 
The first germacrane sesquiterpene, namely germacrone (3.39) was discovered in 1957 from 
the Bulgarian Zdravets oil Geranium macrorrhizum.169 Due to their abundance in nature, germacranes 
have been considered as the biosynthetic intermediates in the formation of various sesquiterpenes 
from farnesyl pyrophosphate (FPP) or neryl pyrophosphate (NPP) (Scheme 3.8). Germacranyl cations 
A and B are geometrical isomers possessing E, E- and E, Z- configurations, respectively. 
Transannular cyclizations and Cope rearrangements of these cations may lead to the production of 
various sesquiterpenes, such as guaianes, elemanes, eremophilanes, cadinanes, amorphanes, 
muurolanes and copaanes. Additionally, isogermacranyl cation C, a regioisomer of E, E-germacrane 
with an isopropyl group at C-6 has been proposed as the precursor of rare gorgonanes and zieranes.170 
 
O
3.39
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!  
Scheme 3.8. Proposed biosynthetic pathways of sesquiterpenes from farnesyl pyrophosphate (FPP) 
and neryl pyrophosphate (NPP) via germacranyl cations (A, B, C).170 Bold texts indicate 
sesquiterpenes isolated in this work. 
 
The cyclodecadiene system of germacranes is built from three isoprenes that are connected 
from head to tail. As a result, germacranes comprise two methyls at C-4 and C-10, an isopropyl at C-
7 and two endocyclic double bonds at C-1/C-10 and C-4/C-5. These endocyclic alkenes may adopt 
cis- and trans-configurations to yield four possible geometrical isomers, i.e. E,E-, E,Z-, Z,E- and Z,Z-
isomers (Figure 3.11). The E,E-isomers are the most predominant with Z,Z-isomers being the least 
common in nature.141 Based on the E-configurations of C-1/C-10 and C-4/C-5, it can be concluded 
that 3.14 is derived from E,E-germacrane.  
 
 
Figure 3.11. Geometrical isomers of germacranes141 
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Germacrenes comprise a cyclodecatriene system and are classified based on the position of 
their double bonds. Germacrenes A-E (3.14, 3.40-3.43) are widespread in nature, however, only few 
of them are readily available in pure form. Germacrene C (3.14) and germacrene E (3.43), for 
example, undergo spontaneous cyclization in slightly acidic or elevated thermal conditions. 
Consequently, attempts on determining their molecular mass by GC analysis have been unsuccessful. 
This difficulty is confirmed by the absence of their GC-MS retention indices in the MassFinder library 
as shown in Table 3.6.171 In the current study, the same problem was encountered for germacrene C 
(3.14) as described in Section 3.2.1. 
 
 
Table 3.6. The GC-MS retention indices of germacrenes in non-polar CPSil5-column171 
Compound Retention indices 
Germacrene A (3.40) 1503 
Germacrene B (3.41) 1552 
Germacrene C (3.14) n/d 
Germacrene D (3.42) 1479 
Germacrene E (3.43) n/d 
n/d not detected.  
 
The cyclization of E,E-germacrane conformers may lead to the production of cis/trans-
guaianes (five, seven-membered system) and cis/trans-eudesmanes (six, six-membered system) 
(Scheme 3.9), as suggested by Tashkhodzhaev and co-workers (1997).141 The structure of the bicyclic 
products and the configuration of their chiral centers depend on the conformation of the germacranes. 
Therefore, the conformation of the precursor can be determined by analyzing the configurations of 
the final products. In guaianes and eudesmanes, the configurations of H-1 and H-5, as well as, the 
orientation of Me-14 and Me-15 are the anchor points to determine the conformation of germacranes. 
The orientations of the chiral centers in both guaianes and eudesmanes are determined relative to the 
constantly α−oriented H-7. 
The structural classes of potential products from the cyclization of E,E-germacranes are 
presented in Scheme 3.9. Germacranes with chair-chair (UU) conformation are responsible for the 
formation of 1α,5α-cis-guaianes and 5α,14β-trans-eudesmanes. Germacranes with boat-boat (DU) 
conformation may yield 1β,5α-trans-guaianes and 5α,14α-cis-eudesmanes. Cis-guaianes with 
1β,5β-orientations and 5β,14α-trans-eudesmanes are formed from germacranes with chair-boat (DD) 
3.423.40 3.143.41 3.43
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conformation. The least common germacranes with boat-boat (UD) conformation may produce 
1α,5β-trans-guaianes and 5β,14β-cis-eudesmanes.141   
 
 
Scheme 3.9. Structural types of guaianes and eudesmanes from the cyclization of four conformers of 
E,E-germacrane precursor 
 
The proposed biosynthesis of guaiane and muurolene sesquiterpenes is presented in Scheme 
3.10. Germacrene C (3.14) is the proposed precursor of the isolated germacrene alcohols (3.16, ent-
3.16 and 3.28). The loss of the hydroxy group in 3.16 generates a carbocation at C-4 that initiates C-
1/C-6 ring closure. The carbocation at C-10 may then produce a cadinene skeleton, that is oxidized 
into 3.31 and 3.37. Similarly, the loss of the hydroxy group in ent-3.16 also triggers the formation of 
a decalin framework, however, reduction of the carbocation at C-10 produces a muurolene skeleton. 
The muurolene hydrocarbon can be further oxidized to produce alcohol derivatives (3.2, 3.5, 3.38).  
The formation of the guaiane skeleton is initiated from the loss of a hydroxy group in 3.28. A 
carbocation at C-5 subsequently prompts the C-1/C-5 ring closure. Furthermore, the guaiane 
hydrocarbon may undergo addition of water across the double bond at C-4, together with loss of H+ 
from the carbocation at C-10, thus leading to 3.17.     
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Scheme 3.10. Proposed biosynthesis of guaianes and muurolenes from germacrene C (3.14)  
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3.2.4.!Secondary metabolites from P. poindimiei 
 Eleven specimens of P. poindimiei were collected in Nelson Bay, NSW in November 2013. 
The extraction of the cerata of P. poindimiei was carried out based on the methods described 
previously. Further separation and purification of the P. poindimiei extract yielded three pregnane 
steroids (3.44, 3.45, 3.47) and two punaglandins (3.53 and 3.54) (Scheme 3.11).  
 
 
Scheme 3.11. Isolation procedure of pregnane steroids and punaglandins from P. poindimiei  
 
 
  
 Pregna-1,4,20-trien-3-one (3.44) was isolated as a colorless oil from NP HPLC. In the 
LRESIMS, 3.44 displayed a sodiated molecular ion peak at m/z 319.2 [M+Na]+ for a molecular 
formula of C21H28O. The 1H NMR data of 3.44 showed signals for six alkenes (δH 4.96, 5.00, 5.75, 
6.07, 6.23, 7.07), three allylic protons (δH 1.90, 2.36, 2.48) and two methyls (δH 0.67 and 1.24). These 
NMR features were consistent with those reported for pregna-1,4,20-trien-3-one from soft corals. 
Compound 3.44 was reported by the Faulkner group as a minor compound in a mixture from an 
unidentified octocoral collected near Canton Island.172 Independently, the Kingston group isolated 
the same compound from the sea raspberry Gersemia rubiformis and confirmed the structure by 
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chemical synthesis.173 Later, 3.44 was also found in various soft corals, such as Carijoa sp.,174–177 
Cladiella sp.,178–180 Sinularia papillosa,181 Spongodes sp.,182–184 Scleronephtya sp.,185,186 Nephthea 
sp.187 and Subergorgia rubra.188 The specific rotation of 3.44 (+8, c 0.15, CHCl3) from P. poindimiei 
was comparable to that reported for pregna-1,4,20-trien-3-one from Nephthea sp. (+35, c 0.37, 
CHCl3), 187 thus the same absolute configuration was inferred.  
 18-Acetoxy-pregna-1,4,20-trien-3-one (3.45) displayed a molecular ion peak at m/z 377.2 
[M+Na]+ in the mass spectrum. This molecular mass was 58 mass units different to that of 3.44, 
suggesting the presence of an additional acetate group. The 1H NMR data of 3.45 consisted of signals 
for six alkenes (δH 4.94-7.04), an AB methylene (δH 4.09, d, 12.0; δH 4.04, d, 12.0), three allylic 
protons (δH 1.70-2.48), a series of methylenes (δH 1.00-2.00), an -OCOMe (δH 2.05) and a methyl 
group (δH 1.24). Dereplication analysis of 3.45 led to the identification of 18-acetoxy-pregna-1,4,20-
trien-3-one that is prolific in the octocoral Carijoa sp.174,175,177,189–191 The -OCOMe group was 
positioned at C-13 due to the absence of a typical angular methyl (Me-18) signal in the high field 
regions of the 1H NMR. The absolute configuration of 3.45 was defined by derivatization to yield 
3.46 of known configuration.172 The specific rotation value of +33 (c 0.7, CHCl3) was reported for 
18-acetoxy-pregna-1,4,20-trien-3-one from Indopacific Carijoa sp.175 In comparison, 3.45 gave a 
value of +23 (c 0.1, CHCl3), suggesting that 3.45 shared the same relative and absolute configurations 
as those reported for 18-acetoxy-pregna-1,4,20-trien-3-one from Carijoa sp.175  
 A molecular formula of C21H28O for 3.47 was inferred from a molecular ion peak at m/z 323.2 
[M+Na]+ in the LRESIMS. In the 1H NMR, 3.47 displayed signals for four alkenes (δH 4.96-5.35), an 
oxymethine (δH 3.52), three allylic protons (δH 1.90-2.30), a series of methylenes (δH 1.00-1.90) and 
two methyls (δH 0.61-1.02). These NMR data were consistent with those of 3β-pregna-5,20-dien-3-
ol that was first reported by Krubiner and colleagues (1969) as a synthesis product from pregnenolone 
(3.57).192 Two years later, Bose and Steinberg (1970) also prepared 3.47 from steroid 
hydroxyketones.193 The first isolation of 3.47 from natural sources was  reported by the Scheuer group 
from the sponge Damiriana hawaiiana.194 Diterpene 3.47 was later also reported from various 
octocorals, such as G. rubiformis,195 Muricea fruticosa,196 Pieterfaura unilobata,197 Carijoa riisei,174 
Eunicella cavolini 198 and Schleronephtya sp.186 The specific rotation measurement of 3.47 gave a 
value of -20 (c 0.05, CHCl3) that was comparable to that of 3β-pregna-5,20-dien-3-ol from P. 
unilobata (-58, c 0.05, CHCl3).197 
  
Chapter 3: Chemical analysis of cryptic nudibranchs from the genus Phyllodesmium  
 
! 61!
 
 
In addition to pregnane steroids, the cerata extract of P. poindimiei also contained two 
chlorinated prostanoids of the punaglandin series. Punaglandins 1-8 have been reported by Baker and 
co-workers (1985 and 1994) from the octocoral Telesto (= Carijoa) riisei.199,200 The punaglandins 
e.g. PUG-1 (3.48), typically contain five contiguous stereocenters at C-5, C-6, C-7, C-8 and C-12. In 
their work on PUG-1 (3.48), Baker et al (1985) determined the relative configurations at C-8 and C-
12 as trans based on the NOESY correlation between H-8 and H-13. The relationship between H-7 
and H-8 was established by coupling constant analysis and chemical derivatization studies. PUG-1 
(3.48) was treated with base to produce PUG-3 (3.49) and its Z isomer (3.50) in a ratio of 1:3 upon 
elimination of HOAc. Isomer 3.50 could only be produced if H-8 and the 7-OAc were trans to each 
other and hence H-7 and H-8 were gauche-configured (Figure 3.12). The JH-7/H-8 value of 4.2 Hz also 
supported their argument.200  
 
 
Figure 3.12. Partial structure of 3.48 showing gauche-configuration between H-7 and H-8 
!
Table 3.7 provides a summary of vicinal coupling constants for H-5 to H-8 in a series of 
punaglandins. The 3JH-5/H-6, 3JH-6/H-7 and 3JH-7/H-8 values in punaglandins show a common trend with J 
values of 1-4 Hz or 6-10 Hz for a threo or erythro configuration, respectively. The exception to this 
trend was reported for the successive threo configurations between H-5/H-6 and H-6/H-7 in 
punaglandins where the 3JH-5/H-6  and 3JH-6/H-7 of 5.3 Hz were observed.200 Another special case was 
observed for the derivative of prostaglandin-A2 (PGA2) (3.56), in which the 3JH-6/H-7 showed an 
atypical value of 6.3 Hz. A molecular modeling study of the PGA2 analogue (3.56) revealed that this 
unusual value was caused by the intramolecular hydrogen bonding between the cyclopentenone 
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carbonyl and the hydroxy group at C-6 that caused the molecule to adopt a seven-membered ring 
conformation.201  
 
 
 
Table 3.7. Observed coupling constants (in Hz) for known punaglandins and related prostanoids  
Compound JH-5/H-6  JH-6/H-7  JH-7/H-8  Compound JH-5/H-6 JH-6/H-7 JH-7/H-8  
Punaglandin 1a,b 5.3  5.3  4.2 Z-Punaglandin 4a,b 3.6  7.8 n/ag 
Punaglandin 1-OAca,b n/rh  n/rh  n/rh  Z-Punaglandin 4-OAca,b 3.9  7.8 n/ag 
Punaglandin 2a,b 4.3  5.3 4.2 Punaglandin 3 epoxidea,b 4.2  9.0 n/ag 
Punaglandin 2-OAca,b 1.1  7.8 1.7 Punaglandin 4 epoxidea,b 4.4  8.9 n/ag 
Punaglandin 3a,b 4.3  9.1 n/ag Punaglandin 5a,b 3.4  n/rh  7.7, 7.8 
Punaglandin 3-OAca,b 4.1  9.1 n/ag Punaglandin 5-OAca,b n/rh n/rh  n/rh 
Punaglandin 4a,b  4.3  9.1 n/ag Punaglandin 6a,b 3.4  n/rh 4.5, 8.4 
Punaglandin 4-OAca,b 4.1  9.2 n/ag Bromopunaglandin 1c,d 5.3  5.3 4.2 
Z-Punaglandin 3a,b 3.5  7.7 n/ag 5-epi-bromo-Z-
punaglandin 3c,d 
4.1  9.2 n/ag 
Z-Punaglandin 3-OAca,b 3.4  7.7 n/ag Prostaglandin-A2 
analoguee,f 
5.3  6.3, 6.3 n/ag 
aCDCl3, 300 MHz; bSee ref. 200; cCDCl3/MeOD (4:1), 500 MHz; dSee ref. 202; eCDCl3, 500 MHz; fSee ref. 201; gn/a 
not applicable; hn/r not reported  
 
Punaglandin 1  R1 = R2 = R3 = Ac, R4 = H, X = Cl
Punaglandin 1-OAc  R1 = R2 = R3 = R4 = Ac, X = Cl
Punaglandin 2 R1 = R2 = R3 = Ac, R4 = H, X = Cl; 17,18-dihydro
Punaglandin 2-OAc R1 = R2 = R3 = R4 = Ac, X = Cl; 17,18-dihydro
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The absolute configurations of the punaglandins were initially assumed to be the same as that 
of clavulone (3.52), a prostanoid previously isolated from the Okinawan octocoral, Clavularia viridis 
and of known absolute configuration.203,204 Baker and co-workers re-evaluated the absolute 
configurations of punaglandins after the Kitagawa group (1982) isolated chloroclavulones 
(claviridenones) from the Japanese C. viridis205 and revealed that claviridenones possess an opposite 
absolute configuration at C-12 to that of clavulones.206 Eventually, the absolute configuration of 
punaglandins was independently confirmed as shown for 3.48 by enantioselective synthesis of PUG-
3 (3.49) and PUG-4 (3.51).207–209  
The first punaglandin from P. poindimiei was punaglandin-8 (3.53). Compound 3.53 showed 
a cluster of molecular ion peaks at m/z 463.2/465.2 [M+Na]+ in a ratio of 3:1 in the LRESIMS for a 
molecular formula of C23H33ClO6. The 1H NMR spectrum of 3.53 displayed signals for five alkenes 
(δH 5.34-7.33), an oxymethine (δH 5.96), a methyl ester (δH 3.68), an acetate (δH 2.01), a series of 
allylic protons (δH 2.00-2.68) and methylenes (δH 1.20-1.72) as well as a methyl (δH 0.88). These 
spectral features were identical to those of punaglandin-8 from C. riisei.200 Punaglandin-8 (3.53) has 
also been reported from C. viridis.210  
 
 
 
Baker et al (1994) determined the Z-geometries of the double bonds at C-5/C-6 and C-14/C-
15 in 3.53 from the JH-5/H-6 (10.8 Hz) and JH-14/H-15 (11.0 Hz) values as well as the 13C chemical shifts 
of the allylic carbons at C-4 (δC 27.0) and C-16 (δC 27.5). These authors established the relationship 
between H-7 and H-8 as gauche-configured due to 3JH-7/H-8 of 3.4 Hz. They also determined the trans-
configuration between C-8 and C-12 from the NOESY correlations between H-8 and H2-13.200 The 
specific rotation of 3.53 from P. poindimiei gave a value of +30 (c 0.03, CHCl3), that was consistent 
with that reported for punaglandin-8 (+44, c 0.04, CHCl3) from C. viridis,210 therefore the same 
absolute configuration was deduced.  
The second punaglandin isolated from P. poindimiei was a new 5,6-epoxy-punaglandin-8 
(3.54). This compound displayed a molecular ion peak at m/z 479.1807 [M+Na]+ (calcd. 479.1857) 
in the HRESIMS for a molecular formula of C23H33ClO7. The molecular mass of 3.54 was 16 mass 
units larger than that of 3.53, indicating an additional oxygen substituent in the molecule. As shown 
in Table 3.8, the 1H NMR data of 3.54 showed the signals for two side chain alkenes at δH 5.32 (ddd, 
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11.1, 8.8, 7.3) and δH 5.63 (dt, 7.0, 11.1) and two epoxide methines at δH 3.09 (m) and δH 3.68 (m), 
that were not observed in 3.53. The two alkene signals of 3.54 were assigned at C-14/C-15 by 
comparison to those of 3.53. The epoxide methines were assigned as H-5 and H-6, based on the COSY 
correlation between H-6 and the oxymethine H-7.  
 
 
Table 3.8. The NMR data for 3.54 
H δHa δCb HMBC NOESY 
1 - 174.0 - - 
2 2.41 (m) 33.3 OCOMe H-3, H-8, H-13a 
 2.41 (m)    
3 1.85 (m) 22.1 n/dc H-2  
 1.85 (m)    
4 1.74 (m) 27.6 n/dc H-4b, H-7 
 1.55 (m)  C-6 H-4a, H-7, H-5 
5 3.09 (m) 56.6 n/dc H-4a, H-6 
6 3.68 (m) 56.0 n/dc H-5, H-8 
7 5.06 (dd, 9, 1.5) 70.9 C-6, C-9, C-12, OCOMe  H-4a, H-4b, H-8, -OH  
8 2.71 (d, 1.5) 56.0 C-6, C-9, C-13 H-2, H-4a, H-6, H-13a, H-7, H-14 
9 - 196.0 - - 
10 - n/d - - 
11 7.34 (s) 159.2 C-6, C-9 H-13a, H-13b, H-14, -OH  
12 - 76.0 - - 
13 2.51 (m) 39.6 C-12, C-14, C-15 H-2, H-11, H-14 
 2.40 (m)   H-11, H-14 
14 5.32 (dt, 11.1, 7.0) 121.2 n/dc H-8, H-13a, H-13b, H-15, H-11 
15 5.63 (ddd, 11.1, 8.8, 7.3) 136.0 n/dc H-14, H-16 
16 1.98 (m) 27.4 C-14, C-15, C-17, C-18 H-2, H-13a, H-15, H-17 
 1.98 (m)    
17 1.34 (m) 29.1 C-15, C-16, C-18 H-16 
18 1.27 (m) 31.5 n/dc n/dc 
19 1.30 (m) 22.5 C-18 H-20 
20 0.88 (t, 6.8) 14.0 C-18, C-19 H-19 
COOMe 3.67 (s) 51.7 COOMe n/dc 
COOMe - 174.0 - n/dc 
OCOMe 2.04 (s) 21.0 OCOMe n/dc 
OCOMe - 172.5 - - 
OH 4.21 (s) - C-11, C-12, C-13 H-7, H-13a, H-11 
aChemical shifts (ppm) referenced to CHCl3 (δH 7.26) in 500 MHz; bChemicals shifts (ppm) from 2D spectra referenced 
to CHCl3 (δC 77.16) in 125 MHz; cn/d not detected 
  
The relative configuration of the double bond and the chiral centers in 3.54 was then 
investigated. The 14Z configuration of the disubstituted double bond in 3.54 was established from the 
3JH-14/H-15 value of 11.1 Hz and the chemical shift of the allylic carbon (C-16) at δC 27.5 as observed 
previously in 3.53. The relative configurations of stereocenters at C-5, C-6, C-7, C-8, and C-12 in 
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3.54 were determined by employing J-based analysis and NOESY correlations. The trans relationship 
between H-8 and 12-OH across the cyclopentenone ring was supported by NOESY correlations 
between H-8 and H-13 as well as between H-7 and the hydroxy group at C-12. The relationship 
between H-7 and H-8 was determined as gauche due to the 3JH-7/H-8 of 1.5 Hz. The difference in the 
order of magnitude of 3JH-7/H-8 in 3.54 and that of 3.53 (3.4 Hz) may be due to the different substituents 
at C-5/C-6.  
The stereochemical determination of chiral centers for the epoxide at C-5 and C-6 of 3.54 was 
carried out on the basis of spin-coupling constants (3JH,H) analysis between adjacent stereocenters that 
are directly correlated to the Karplus equation.211,212 This method was developed based on the 
conformational arrangements of stereocenters that are characterized by staggered rotamers derived 
from threo and erythro configurations. The relative stereochemistry of the asymmetric centers was 
assigned from the 3JH,H values that correspond to the predominant staggered rotamer(s).  
The cis-configuration between H-5 and H-6 in 3.54 was concluded from their coupling 
constant value of 4.4 Hz.  The same value has also been reported for a cis-epoxide in a prostaglandin-
A2 analogue.201 There was also a NOESY correlation between H-5 and H-6 that supported this 
argument. In a trans-configured epoxide, a 3JH-5/H-6 value of 3.1 Hz would be expected134 and no 
NOESY correlation would be observed. Based on this data, two diastereomers of 3.54 were proposed 
corresponding to erythro- (3.54a) and threo-configurations (3.54b) between H-6 and H-7 (Figure 
3.13). In the 1H NMR spectra of 3.54, a 3JH-6/H-7 value of of 9.0 Hz between H-6 and H-7 indicated an 
erythro relationship.200,213 To verify this assignment, a J-based analysis of the C-6/C-7 bond was 
carried out. Three staggered rotamers for erythro and threo configuration were drawn and the 
magnitude of the dihedral angle dependent-coupling constants for each rotamer was estimated (Figure 
3.13). 
The conformation of H-6 and H-7 was determined as anti on the basis of a 3J value of 9.0 Hz. 
This conformation was suitable for conformers E1 (erythro) and T2 (threo). According to Matsumori 
et al. (1999), in a rotamer with anti-configured protons and gauche-configured carbons such as in T2 
(threo), a long range NOESY correlation between H-5 to H-8 should be anticipated.211 However, no 
such correlation was seen in the NOESY data collected on 3.54. Although the NOESY data should 
be interpreted with care, the lack of correlation between H-5 and H-8 supports the conformer E1 over 
T2. Hence the diastereomer 3.54a was further investigated.  
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Figure 3.13. J-based analysis: estimated coupling constant patterns corresponding to the 
conformational arrangement along the C-6/C-7 bond of 3.54 (Blue color indicates 
plausible conformers; plain arrow indicates anticipated NOESY correlations). For 
ease of modeling, the alkyl substituents were replaced by methyls. 
 
In an attempt to prepare a boronate or an acetate derivative, the epoxide ring in 3.54a was 
then opened to give a diol product. Compound 3.54a underwent an acid-catalyzed hydrolysis to 
generate a mixture of trans diols, 3.55a and 3.55b in a ratio of 3:1 (Scheme 3.12).201 In an acid-
catalyzed epoxide ring opening, the nucleophile usually attacks the less hindered carbon following 
an SN2 reaction mechanism.214 In the case of the hydrolysis of 3.54a, the production of 3.55a as the 
major component was thus anticipated. Due to the limited amount of the hydrolysis product, only the 
relative configuration determination of the major component will be discussed.  
 
 
Scheme 3.12. The acid-catalysis hydrolysis of 3.54a 
 
The 1H NMR data of the major diol product showed a vicinal coupling constant of 2.8 Hz 
between H-6/H-7 and 3.7 Hz between H-5/H-6 (Table 3.9). The stereochemical assignments at C-5 
and C-6 of the major diol product were then analyzed by employing a J-based analysis, combined 
with NOESY data (Figure 3.14). 
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Table 3.9. Selected 1H NMR and NOESY data for the major diol product 
H δHa NOESY 
4 1.92 (m) H-5, H-7 
 1.45 (m) H-5, H-7 
5 3.54 (m) H-4b, H-6, H-7 
6 4.07 (br dd, 2.8, 3.7) H-5, H-7 
7 5.26 (dd, 2.8, 1.9) H-5, H-6, H-8  
8 2.96 (d, 1.9) H-7, H-13a, H-13b 
13 2.73 (dd) H-8, H-16 
 2.64 (dd) H-8, H-16 
14 5.33 (m) H-8, H-13a, H-13b, H-15 
15 5.62 (m) H-14, H-16, H-17 
16 2.05 (m) H-13a, H-13b, H-15, H-17 
 2.05 (m)  
COOMe 3.66 (s) n/db 
OCOMe 2.04 (s) n/db 
aChemicals shifts (ppm) referenced to CHCl3 (δH 7.26) in 700 MHz; 
bn/d not detected 
 
 
Figure 3.14. J-based analysis: estimated coupling constant patterns corresponding to the 
conformational arrangement along the C-6/C-7 bond of 3.55 (Blue color indicates 
plausible conformer; plain arrow indicates NOESY correlations; dashed arrow 
indicates anticipated intramolecular hydrogen bonding). For ease of modeling, the 
alkyl substituents were replaced by methyls. 
 
Figure 3.15 shows three possible staggered isomers with the expected 3JH,H and 3JC,H that 
correspond to either erythro or threo configurations between H-6/H-7 in 3.55.211,212 In the 1H NMR 
spectra, a small 3JH-6/H-7 value of 2.8 Hz was appropriate for a gauche conformation between the two 
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protons; and so fitted conformers E2 (erythro), E3 (erythro), T1 (threo) and T3 (threo). The 
anticipated intramolecular hydrogen bonding between 6-OH and 7-OAc would require the two 
functional groups to be gauche-configured, thus conformer T3 was eliminated. Another important 
consideration is the expected intramolecular hydrogen bonding between the 5-OH and the oxygen 
from the cyclopentenone carbonyl, as previously observed in the derivative of prostaglandin A2 
(3.56).201 Consequently, C-5 and C-9 should also have a gauche configuration as expected in 
conformer E2. The relative configuration at C-6 was thus suggested as S*.  
 
 
Figure 3.15. Partial structure of 3.55a showing threo-configuration between H-5 and H-6 
!
The expected intramolecular hydrogen bonding between 5-OH and 6-OH was also taken into 
account in the J-based analysis to determine the relative configuration at C-5. The observed 3JH-5/H-6 
of 3.7 Hz required gauche configuration between the two protons. The threo configuration between 
H-5 and H-6, as shown in Figure 3.15, was in agreement with the observed correlation between H-5 
and H-7 in the NOESY data. The relative configuration at C-5 was thus suggested as R*, as 
anticipated for the trans nucleophilic addition in 3.55a.  The relative configuration of the major diol 
3.55a was then provisionally assigned as 5R*, 6S*, 7R*, 8R* and 12S*. An attempt to derivatize the 
hydrolysis product 3.55a into its boronate derivative was unsuccessful, possibly due to the hydrogen 
bonding effects between the hydroxy groups in 3.55a that caused the compound to be less reactive 
than expected. 
 
 
 
The atypical 3JH-6/H-7 value of 2.8 Hz for the erythro configuration between H-6 and H-7 
demonstrated that the characteristic vicinal coupling constant values previously observed for 
punaglandins as shown in Table 3.7 should be used with care for punaglandin polyols. The presence 
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of intramolecular hydrogen bonding in polyols should be taken into consideration during the 
stereochemistry determination of the stereocenters, as previously reported for the prostaglandin A2 
derivative (3.56).201 Interestingly, bromopunaglandin (3.57) showed identical vicinal coupling 
constant values to those of punaglandins (see Table 3.7), despite the 1H NMR data being collected 
from different solvents.202 We thus propose that the stereochemistry of 3.57 should be re-evaluated.  
 
3.2.5.!Proposed biosynthesis of pregnane steroids and chlorinated prostaglandins 
 Pregnane steroids from marine origin have been reported from a starfish,215–217 octocorals and 
sponges.218,219 According to Dorta and colleagues (2004), pregnane derivatives from starfish possess 
a ∆9(11)-nucleus with oxygen substituents at C-3, C-6 and C-20, whereas those from sponges usually 
have a ∆5(6)-nucleus. Moreover, pregnane derivatives from corals appear to have a typical 5α-
pregnane nucleus with a vinyl side chain. In particular, pregnane steroids from sponges and terrestrial 
plants always have a β-oriented hydroxy group at C-3. Meanwhile, those from octocorals may have 
an α- or β- oriented 3-OH.220  
 
 
Scheme 3.13. The conversion of cholesterol into pregnane steroids221 
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The biosynthesis of pregnane steroids (3.46) from cholesterol (3.58) requires the cytochrome 
P-450 (CYP) family of enzymes as catalysts in the cleavage process of the cholesterol side-chain 
(Scheme 3.13).222 The steroidogenesis of pregnane steroids from cholesterol involves the 
participation of at least six cytochrome P-450 enzymes. A single enzyme CYP11A1 plays a role in 
the cleavage of the cholesterol side chain, sequential hydroxylation and scission of C-20-C-22 
dihydroxylated bond to give pregnenolone (3.59).223 In scleractinian224 and alcyonacean corals,225 
cytochrome P-450 and other oxidase enzymes have been reported in relation to the metabolism of 
steroids. Seasonal changes in estrogen concentration226 and the biosynthesis of radiolabelled 
pregnenolone (3.59) into progesterone (3.61) via intermediate 3.60 in the scleractinian corals have 
been documented. It is indicated that the corals synthesize estrogen to regulate gametogenesis and 
spawning, suggesting that steroids play a role as bioregulators in the reproduction of corals.220    
Marine prostanoids, namely clavulones,205 have attracted continuous attention since their 
discovery from the soft coral C. viridis in 1982 due to their biological activities and unique 
biosynthetic pathway. The biosynthesis of clavulones from arachidonic acid (3.60) was proposed by 
Corey and co-workers (1987) via 8R-PETE (3.61), allene oxide (3.62), a pentadienyl cation (3.63) 
and preclavulone-A (3.64) as biosynthetic intermediates (Scheme 3.14).227–229 As described 
previously, punaglandins possess an opposite configuration at C-12 to that of clavulones. There are 
two proposed hypotheses that explain this difference: 1) halogenation at C-10 may occur after the 
formation of cyclopentenone ring that reverses the configuration via hydroxylation at C-12, 2) 
halogenation occurs in the acyclic precursor and the cyclization of the pentenone reverses the 
configuration at C-12.230 Due to the lack of biosynthetic data in halogenated prostanoids, the 
halogenation process and its stereochemical implications remain uncertain.  
 
 
Scheme 3.14. Biosynthesis pathway for clavulones proposed by Corey et al. (1987)227–229 
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3.2.6.!Isolation of cembranolides from P. longicirrum  
 An individual of P. longicirrum was collected at a dive site near Lizard Island in 2013. The 
cerata extract was prepared based on the methods described previously.  NP flash chromatography 
and NP HPLC of the cerata extract of P. longicirrum afforded a series of cembrane diterpenes, such 
as sarcophytonin A (3.67), sarcophytoxide (3.69), ent-sarcophine (3.72), 7,8-epoxy-isoneocembrene 
A (3.74), isosarcophytoxide (3.76), 11,12-epoxy-isoneocembrene A (3.78) and 
bisepoxysarcophytoxide (3.89). Additionally, new cembranolides bearing dihydrofuranol and 
dihydrofuranone moieties were also isolated, i. e. phyllodesmolide A (3.83), phyllodesmolide B 
(3.84), phyllodesmolide C (3.88), phyllodesmolide D (3.90) and phyllodesmolide E (3.91) (Scheme 
3.15).  
 
 
Scheme 3.15. Isolation procedure of P. longicirrum extract  
!
!
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A molecular formula of C20H30O was inferred for sarcophytonin A (3.67) (αD -32, c 0.04) 
from a molecular ion peak of m/z 309.2 [M+Na]+ in the mass spectrum. The 1H NMR data of 3.67 
revealed signals for a dihydrofuran methine at δH 5.52 (1H, m), three alkenes at δH 5.08 (1H, d, 10.7), 
5.00 (1H, t, 6.6) and 4.86 (1H, dd, 8.2, 3.8), a dihydrofuran methylene at δH 4.49 (2H, m) and four 
vinyl methyls at δH 1.58-1.69 (12H, s). Dereplication analysis of 3.67 led to the identification of 
sarcophytonin A. Kobayashi et al (1979) isolated sarcophytonin A for the first time from the extract 
of the soft coral Sarcophyton glaucum collected near Ishigaki Island, Japan.231 Recently, the same 
compound has been re-isolated from an Egyptian Sarcophyton sp.232 In both works, the relative 
configuration of 3.67 was unresolved due to its presence as a highly unstable oil231 and its isolation 
as a racemate.232 Bowden and colleagues (1987) differentiated 2R-sarcophytonin A (3.67) (αD -113.5, 
c 2.3) and 2S-sarcophytonin A (3.68) (αD +239, c 0.1) by their optical rotations.233 The specific 
rotation of sarcophytonin A from P. longicirrum gave an [αD] value of -32 (c 0.04). Although the 
sign of rotation agreed with that of 2R-sarcophytonin, the size of rotation did not match well. A 1H 
NMR check of 3.67 indicated that the compound had decomposed on storage, hence no further 
analysis was possible.  
 
 
 
Sarcophytoxide (3.69) was isolated as a mixture with phyllodesmolides D (3.90) and E (3.91) 
and gave a sodiated molecular ion peak at m/z 325.2 [M+Na]+, 16 amu different from that of 3.67 that 
indicated an extra oxygen in the molecule. Comparison of the 1H NMR spectrum of 3.67 and 3.69 
showed similarities, except for the presence of two alkenes (δH 5.22 (1H, d, 10.2); 5.09 (1H, dd, 10.8, 
5.1) and an epoxy methine (δH 2.71 (t, 4.1)) in 3.69, as opposed to three alkenes as in 3.67. The 
position of the epoxy group was assigned at C-7/C-8 based on data comparison with those from 
previous literature.233 Kashman et al (1974) initially isolated (2S,7S,8S)-sarcophytoxide (αD +40) 
(3.70) from S. glaucum.234 The enantiomer of (2S,7S,8S)-sarcophytoxide (3.69) (αD -137) was then 
isolated by Tursch et al (1976).235 The Faulkner group (1980) established the absolute configuration 
of (2S,7S,8S)-sarcophytoxide (3.70) by derivatizing it into (2S,7S,8S)-sarcophine (3.73) (Scheme 
3.16), whose relative and absolute configurations were already known by X-ray crystallography and 
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CD spectra, respectively.236 Three years later, Kobayashi et al (1983) defined the absolute 
configuration of (2S,7S,8S)-sarcophytoxide (3.70) by X-ray structure determination.237  
 
 
Scheme 3.16. Chemical correlations of 3.70 and 3.73 by the Faulkner group (1980)236 
 
Bowden and colleagues (1987) re-isolated (2R,7R,8R)-sarcophytoxide (3.69) and (2R,7S,8S)-
sarcophytoxide (3.71) from the soft coral Lobophytum pauciflorum and established their absolute 
configurations by converting them into 2R-sarcophytonin (3.67) (Scheme 3.17).233 The result 
indicated that the diastereomers 3.69 and 3.71 have the same absolute configuration at C-2 but 
differed in the configuration at C-7/C-8.  The specific rotation of sarcophytoxide from P. longicirrum 
was not carried out due to its presence as a mixture. The 1H NMR data of sarcophytoxide from P. 
longicirrum was compared to those of (2R,7R,8R)-sarcophytoxide (3.69) and (2R,7S,8S)-
sarcophytoxide (3.70) from L. pauciflorum and suggested that 3.69 possesses the same relative 
configuration as that described for (2R, 7R, 8R)-sarcophytoxide (Table 3.10). 
 
 
Scheme 3.17. Chemical correlations of sarcophytonins (3.67, 3.68), sarcophytoxides (3.69, 3.71) and 
isosarcophytoxides (3.76, 3.77) by Bowden et al (1987) 233 
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Table 3.10. 1H NMR data comparison of the diastereomers of sarcophytoxide 
H 3.69a (2R, 7R, 8R)-sarcophytoxideb,c (2R, 7S, 8S)-sarcophytoxideb,c 
2 5.53 (m) 5.53 (m) 5.30 (m) 
3 5.22 (d, 10.2) 5.22 (d, 10.2) 5.17 (d, 9.8) 
7 2.71 (t, 4.1) 2.71 (t, 4.1) 2.60 (t, 5.6) 
16 4.49 (br s) 4.49 (br s) 4.43 (dd, 11.7, 5) 
 4.49 (br s) 4.49 (br s) 4.37 (m) 
19 1.27 (s) 1.28 (s) 1.17 (s) 
aReferenced to CHCl3 at δH 7.26 (700 MHz); bData taken in CHCl3 (300 MHz); cSee ref.233  
 
 
 
Ent-Sarcophine (3.72) (αD -94, c 0.03) was purified by NP HPLC as a colorless oil. The 
LRESIMS analysis of 3.72 showed a sodiated molecular ion peak at m/z 339.2 [M+Na]+ for a 
molecular formula of C20H28O3. This molecular formula indicated an extra oxygen in the molecule 
compared to that of 3.69. The position of the oxygen was assigned at C-16 based on the loss of signals 
for a dihydrofuran methylene in the 1H NMR data of 3.72 with respect to those of 3.69. These 1H 
NMR data were comparable to those of sarcophine (3.73) (αD +92, c 0.1, CHCl3) from S. glaucum, 
whose relative and absolute configurations were established by X-ray crystallographic analysis and 
CD studies, respectively.238 Recently, Gross et al (2004) established the absolute configuration of 
sarcophine (3.73) as 2S, 7S, 8S by CD measurement, in comparison to that of sarcoglaucol-16-one 
(3.74) whose absolute configuration was defined by Mosher’s method.239 The [αD] measurement of 
3.72 gave an opposite sign to that of sarcophine (3.73) from soft corals, indicating an absolute 
configuration of 2R, 7R, 8R.  
 7,8-Epoxyisoneocembrene A (3.75) gave a molecular ion peak at m/z 311.2 [M+Na]+, 
corresponding to a molecular formula of C20H32O. The 1H NMR data of 3.75 compared to those of 
3.72 suggested observable differences. There were signals of an isopropyl group (δH 1.06 (3H, d, 7), 
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1.05 (3H, d, 7), 2.00-2.40 (1H, m)) as well as a conjugated diene (δH 6.04 (1H, d, 10.8); 5.97 (1H, d, 
10.4)), as opposed to a carbonyl group in 3.72. Dereplication analysis of 3.75 led to the identification 
of 7,8-epoxy-isoneocembrene A. Cembrane 3.75 has been isolated from the soft corals Sarcophyton 
sp.,240,241 Lobophytum sp.242 and Eunicea sp.243 The enantioselective synthesis of 3.75 revealed its 
absolute stereochemistry as 7R, 8R (αD -25, c 0.21, CHCl3).244 The optical rotation of 3.75 was not 
measured due to its presence as a minor component in the P. longicirrum extract.  
 
 
 
 (2R,11R,12R)-Isosarcophytoxide (3.76) was isolated as the major compound of the cerata 
extract of P. longicirrum. In the mass spectrum, 3.76 showed an adduct molecular ion peak at m/z 
325.2 [M+Na]+ for a molecular formula of C20H30O2. Comparison of the 1H NMR data of 3.76 to 
those of 3.69 revealed the presence of an epoxide methine that resonated at δH 2.74 (1H, dd, 9.1, 3.4) 
as opposed to δH 2.71 (1H, t, 4.1) in 3.69. These spectral features indicated that 3.76 and 3.69 were 
positional isomers. The position of the epoxy methine at C-11/C-12 was assigned based on data 
comparison with those of literature. The 1H NMR data of 3.76 were identical to those of 
isosarcophytoxide from the soft coral Sarcophyton birklandi that was reported by Bowden and co-
workers (1987) along with its C-2 epimer (3.77).233 In their work, the relative configuration of 3.77 
was established by X-ray crystallographic analysis that also permitted the assignment of the 
diastereomer 3.76. The absolute configurations of both isosarcophytoxides were then defined by the 
reductive elimination with a Zn/Cu couple to produce 2R-sarcophytonin A (3.67) (αD -113.5, c 2.3) 
and 2S-sarcophytonin A (3.68) (αD +239, c 0.1) (Scheme 3.17). The specific rotation of 3.76 (αD -
81, c 0.47) was comparable to that of (2R,11R,12R)-isosarcophytoxide (-128, CHCl3, concentration 
not reported) from the soft coral.233 Hence, we propose that 3.76 shared the same absolute 
configuration as that reported by Bowden and colleagues (1987).  
The purification of fractions 2 and 3 using NP HPLC (1% EtOAc/hexanes) yielded 11,12-
epoxyisoneocembrene A (3.78) as a colorless oil. The LRESIMS of 3.78 indicated a molecular 
formula of C20H32O that was identical to that of 3.75. Comparison of the 1H NMR data of 3.78 showed 
an epoxide methine at δH 2.88 (1H, dd, 7.0, 5.2), as opposed to δH 2.85 (1H, t, 5.4) in 3.75. These 1H 
NMR data of 3.78 were identical to those reported for 11,12-epoxyisoneocembrene A from Sinularia 
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grayi ([αD] +117),245 as well as from the soft corals Lobophytum sp.,246,247 Sclerophytum sp.,248 
Eunicea sp.,243 Sinularia sp.249,250 and Sarcophyton sp.251 The absolute configuration at C-11/C-12 
was proposed as 11S, 12S by Bowden et al (1983)246 using the Horeau technique, an empirical method 
for the correlation of configuration of secondary alcohols based on the principle of kinetic 
resolution.252  
Bowden et al (1983) observed that 3.78 stereospecifically afforded 3.79 when left exposed to 
air at ambient conditions, thus raising the hypothesis that the additional oxygen was directed both 
regio- and stereospecifically by the epoxide in the molecule (Scheme 3.18). Further direct epoxidation 
of 3.78 using one equivalent of m-chloroperoxybenzoic acid, indeed yielded a pure diastereomer 3.79. 
The reduction of 3.79 then produced two diols, 3.80 and 3.81. The diol 3.80 ([αD] +41) was 
hydrogenated to give a symmetrical diol 3.82 that was optically inactive, suggesting that the epoxides 
in 3.79 were on the same face of the molecule. Moreover, the Horeau determination of 3.81 indicated 
the absolute configuration of 11S, 12S for 3.78 and 3.79.246 The enantioselective synthesis of 3.78 
was reported by Li and co-workers (2000), confirming the absolute configuration proposed by 
Bowden and colleagues (1983).253 The isolation of 3.78 from P. longicirrum as a minor component 
prevented the determination of its optical rotation. 
 
 
Scheme 3.18. Chemical correlations of 3.78 by Bowden et al (1983)246 
 
Phyllodesmolide A (3.83) (αD -65, c 0.19) showed a molecular formula of C20H28O4 from the 
molecular ion peak at m/z 355.1880 [M+Na]+ (calcd. for m/z 355.1880) in the HRESIMS analysis. 
3.78
(S)
(S)O
H
(S)
(S)
(S)
(S)O
H
O
H
3.79
(R)
(S)
HO
OH
(R)
(S)
(S)HO
HO
3.80
3.81
[O]
2H2
+H2
+H2 -H2
(S)
(R)
HO
HO
3.82
1
7
18
17
20
19
16
4
Chapter 3: Chemical analysis of cryptic nudibranchs from the genus Phyllodesmium  
 
! 77!
This molecular formula indicated the presence of an extra oxygen in the molecule with respect to that 
of (2R,11R,12R)-isosarcophytoxide (3.76). The 1H NMR data of 3.83 compared to those of 3.76 
revealed the absence of the dihydrofuran methylene and the presence of an extra epoxide methine at 
δH 2.71 (d, 8.2). The presence of a dihydrofuranone was deduced from the carbonyl signal at δC 174.1 
in the 13C NMR data, that explained the loss of the dihydrofuran methylene signal. There was also a 
5J coupling (1.5 Hz) between H-2 and Me-17 due to the homoallylic coupling across the 
dihydrofuranone ring. The chemical shift of the carbonyl signal and the value of 5JH-2/H-17 were 
consistent with those reported for sarcophine (3.73).238 The epoxide methine at δH 2.71 (d, 8.2) was 
coupled to the allylic dihydrofuran signal at δH 4.56 (dd, 8.2, 1.5) and so was assigned at H-3. The 
HMBC correlations from H-3 to C-1, C-2 and C-4 supported this argument. The other epoxide 
methine at δH 2.67 (dd, 9.6, 3.7) was assigned at H-11 based on data comparison to 3.76 (δH 2.74 (dd, 
9.1, 3.4)) and by the observed HMBC correlations from H-11 to C-9, C-10, C-12 and C-13. The 
alkene proton at δH 5.15 (t, 5.3) showed a COSY correlation to H-6 and was assigned at C-7/C-8.  
 
 
 
The relative configuration of 3.83 was then investigated on the basis of chemical shift and 
coupling constant analyses, in conjunction with NOESY correlations. The 7E-configuration was 
deduced from the chemical shift of the allylic carbon C-6 at δC 23.8, as observed previously in 3.67, 
3.76 and 3.78. The relative configuration at stereocenters C-11/C-12 (11R*, 12R*) were proposed to 
be the same as those in (2R,11R,12R)-isosarcophytoxide (3.76), due to similar coupling constant 
values at H-11 (δH 2.67 (dd, 9.6, 3.7)) in 3.83 and that of 3.76 (δH 2.74 (1H, dd, 9.1, 3.4)). In the 
NOESY data, H-11 showed correlation to Me-18 that indicated they were on the same face of the 
molecule. A correlation between Me-18 and H-2 was also observed in the NOESY spectrum. The 1H 
NMR data of 3.83 also showed a 3JH-2/H-3 value of 8.2 Hz that indicated that the anti-configuration of 
the two protons.  
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Figure 3.16. Molecular modeling of 3.83 showing selected NOESY correlations 
 
The molecular modeling of phyllodesmolide A (3.83) using ChemBio3D Ultra Cambridge 
15.0 (RMS to 0.1) is shown in Figure 3.16. Me-18/H-2 and Me-18/H-11 were estimated to be 2.0 Å 
and 2.3 Å apart, respectively in agreement with the observed NOESY correlations. H-2 and H-3 were 
also predicted to form a dihedral angle of 175° that corresponded well with the observed 3J value of 
8.2 Hz. The relative configuration of phyllodesmolide A (3.83) therefore was established as 2R*, 3S*, 
4S*, 11R*, 12R*. In the antimalarial assay, 3.83 showed a modest activity by inhibiting 34% of the 
chloroquine-sensitive parasite Plasmodium falciparum (3D7 cells) at 10 µM.  
 
 
 
Phyllodesmolide B (3.84) (αD -20, c 0.04) was isolated as plate crystals by NP HPLC. The 
HRESIMS spectrum of 3.84 indicated a molecular formula of C20H28O4 from a molecular ion peak at 
m/z 355.1902 [M+Na]+. However, the 13C NMR data revealed a molecular formula of C20H30O4 from 
the signals of four alkenes (δC 125.2-137.5); an acetal (δC 114.0); five oxygenated carbons (δC 59.4-
82.2); six methylenes (δC 19.1-37.5) and four methyls (δC 9.6-18.3). The 1H NMR data comparison 
of 3.84 and those of 3.83 showed extra hydroxy and acetal protons at δH 9.60 (s) and δH 5.85 (br s), 
respectively. Furthermore, the 13C NMR data showed the absence of a carbonyl signal at δC 174.1. 
These data thus suggested a dihydrofuranol moiety in 3.84, as opposed to a dihydrofuranone. The 
epoxide methine at δH 2.93 (d, 4.7) was coupled to the dihydrofuran proton at δH 4.58 (br d, 4.7) and 
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showed HMBC correlations to C-1 and C-4, so was assigned at H-3. The other epoxide methine at δH 
2.76 (dd, 7.7, 4.8) in 3.84 was diagnostic for an epoxide at C-11/C-12. The planar structure of 3.84 
thus was established as a bisepoxydihydrofuranol cembranolide. 
The 7E-geometry in 3.84 was deduced from the upfield 13C chemical shift of the vinyl methyl 
(δC 15.1) as observed in other cembranolides.233,245,254 The coupling constant values of H-11 in 3.84 
(δH 2.76, dd, 7.7, 4.8) were similar to those of H-11 in 11S,12S-epoxyisoneocembrene A (3.78) (δH 
2.77, dd, 7.0, 5.2) whose absolute configuration has been secured by the Horeau technique.246 Thus, 
3.82 should possess the same configuration at C-11 and C-12 (11S, 12S). There were NOESY 
correlations observed between H-3/H-11 and H-2/Me-18, that indicated H-2 and H-3 were anti-
configured. However, the JH-2/H-3 value of 4.7 Hz in 3.84 was different from that observed in 3.83 (JH-
2/H-3 8.7 Hz).  Furthermore, there were also NOESY correlations between H-2 and H-3 that were not 
seen in 3.83. The ambiguity of the relative configuration at C-3 was solved by determining the relative 
configuration at C-2 and C-16 first. The relative configuration of the latter was determined on the 
basis of a long range coupling and the observed NOESY correlations. A coupling constant value of 
< 1 Hz between H-2 and H-16 in 3.84 indicated the presence of a homoallylic coupling in a 
dihydrofuran ring. The assignment of the configuration of the dihydrofuranol moiety was challenging 
due to the varied magnitude of the homoallylic coupling constant values in the literature (Table 3.13).  
Barfield and colleagues (1971) observed the inequality of long range coupling constants in cis 
and trans-2,5-dihydrofurans even in planar systems.255 They proposed that the sensitivity of long 
range coupling constant in 2,5-dihydrofuran and phthalan systems was correlated with the 
conformations of the five-membered ring.256 To test this hypothesis, Barfield et al (1975) then 
compared the homoallylic coupling constants in synthesized 2,5-dihydrofuran (A) and phthalan 
derivatives (B) with the calculated data.256 A comparison of homoallylic coupling constant values of 
2,5-dihydrofuran and phthalan systems is presented in Table 3.11. 
From the empirical data, the relative configuration of H-5α and H-5β in A was determined 
from the value of 5J2,5, but could not be determined by NOESY. In contrast, the relative assignment 
of H-3α and H-3β in B was unambiguously resolved by the NOESY data. Calculation of homoallylic 
coupling constants in the 2,5-dihydrofuran system with varying degree of ring puckering showed that 
the 5J2,5 values of the trans isomers were larger than those of cis isomers due to substituent and ring 
puckering effects. In particular, the presence of –OMe and –OAc groups that are attached to C2 and/or 
C5 in 2,5-dihydrofuran derivatives significantly decreases the 5J2,5 values with the cis coupling 
becoming very small. The combination of empirical and calculated data thus demonstrated that there 
is no simple universal trend in the magnitudes of homoallylic coupling constants in 2,5-dihydrofurans 
and phthalans.256  
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Table 3.11. 5J couplings across 2,5-dihydrofuran and phthalan systems in synthetic products 
Compound J value (Hz) NOESY Compound J value (Hz) NOESY 
A1a J2,5 (cis) 3.2e/3.3f/3.4g n/rh B6a J1,3 (cis) 1.2d/1.4e/1.2f Yes 
 J2,5 (trans) 6.4e/6.5f/6.3g n/rh  J1,3 (trans) 3.4d/3.4e/3.4f No 
A2a J2,5 (cis) 3.2f/3.3g n/rh C1b J2,5 (trans) 3.6d n/rh 
 J2,5  (trans) 5.9f/5.7g n/rh C2b J2,5 (cis) 0.2d n/rh 
B1a |J1,3 (cis) + J1,3 (trans)| = 4.3d n/rf D1c J2,5 (cis) 0.0d n/r 
B2a J1,3 (cis) n/rh n/rh D2c J2,5 (cis) 0.0d n/rh 
 J1,3  (trans) n/rh n/rh D3c J2,5 (cis) 0.0d n/rh 
B3a J1,3  (cis) n/rh n/rh D4c J2,5 (cis) 0.0d n/rh 
 J1,3  (trans) n/rh n/rh D5c J2,5 (cis) 0.0d n/rh 
B4a J1,3 (cis) 1.1d/1.2e/1.2f Yes D6c J2,5 (trans) 4.0d n/rh 
 J1,3 (trans) 3.0d/3.1e/3.0f No D7c J2,5 (trans) 4.0d n/rh 
B5a J1,3 (cis) 2.2d/2.1f n/rh D8c J2,5 (trans) 4.0d n/rh 
 J1,3  (trans) 3.0d/3.0f n/rh D9c J2,5 (trans) 4.0d n/rh 
aSee ref. 256; bSee ref. 257; cSee ref. 258,259; dCDCl3; 
eCCl4; fC6D6; gDMSO-d6; hnot reported 
D10c J2,5 (trans) 4.0d n/rh 
 
Independently, Jacobsen and co-workers (1971) reported that the homoallylic coupling in a 
trans 2,5-diacetoxy-dihydrofuran (J = 3.6 Hz) was larger than that of a cis isomer (J = 0.2 Hz) (C).257 
Comparable coupling constant values in cis- (J = 0 Hz) and trans-configured (J = 4.0 Hz) 3-vinyl-
2,5-dihydrofurans (D) were also observed in their synthesis work.258,259  
In a series of natural products containing phthalan systems (Table 3.12), a consistent pattern 
of the coupling constant values in cis and trans isomers was observed due to the rigidity of the 
structure. Compounds with a phthalan moiety such as aplysulfurin,260,261 ST-1,262 
phthalideisoquinolines,263–268 sesquiterpene lactone269 and angucyclines270,271  showed a 5J value of 
1.9-2.3 Hz for the trans isomers and 0 Hz for the cis isomers; except for the trans-configured 
dihydrofuran in membranolides C and D272,273 that showed a 5J value of 0 Hz. The relative and 
absolute configurations of aplysulfurin, egenine, corytensine and narcotine hemiacetal have been 
secured by X-ray crystallography. In xenicanes,274–276 the cis-configured 2,5-dihydrofuran found in 
novaxenicin A, B, and xenicane also showed a 5J value of 0 Hz, whereas helioxenicin C with trans-
configured  2,5-dihydrofuran gave a coupling constant value of < 1 Hz.  
O
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Table 3.12. 5J couplings across phthalan systems in natural products 
Compound J value (Hz) NOESY Compound J value (Hz) NOESY 
Aplysulfurina,b J15,16 (trans) 1.9k No Angucycline 1i J1,3 (cis) 0.0k No 
Membranolide Cc J15,16 (trans) 0.0k No Angucycline 2i J1,3 (trans) 2.2k No 
Membranolide Dc J15,16 (trans) 0.0l  Yes Angucycline 3j J7,12 (trans) 2.2m No 
ST-1d J1,3 (cis) 0.0m  Yes Angucycline 4 j J7,12 (cis) 0.0m No 
ST-1d J1,3 (trans) 2.3m No Angucycline 5 j J7,12 (trans) 2.3m No 
Egeninea,e J7’,9 (cis) 0.0k n/ro Angucycline 6 j J7,12 (cis) 0.0m No 
Corytensinea,f J7’,9 (cis) 0.0k n/ro Angucycline 7 j J7,12 (trans) 2.2m No 
Narcotinehemiacetala,g J7’,9 (cis) 0.0k n/ro Angucycline 8 j J7,12 (cis) 0.0m No 
Chlorajapolide Bh J6,15 (cis) 0.0l Yes Angucycline 9 j J7,12 (cis) 0.0m No 
aBlue color indicates known relative and/or absolute configurations by X-ray analysis; bSee ref. 259, 260; cSee ref. 
272; dSee ref. 262; eSee ref. 262, 267; fSee ref. 267; gSee ref. 263, 264; hSee ref. 269; iSee ref. 271; jSee ref. 270; 
kCDCl3; lC6D6; mMeOD; npyridine-d5; onot reported. 
 
Other compounds with a 2,5-dihydrofuran system attached to an acyclic chain or large-
membered rings showed varying values of coupling constants, owing to the flexibility of the molecule 
(Table 3.13). In terpenoids, such as thujuoric acids,277 the cis- and trans-configured dihydrofurans 
gave a value of < 1 and 2.5 Hz, respectively, that were in agreement with the previous data. A cis-
configured dihydrofuran that attached to an eight-membered ring in crenulacetals A and C showed a 
5J value of < 1 Hz and 0 Hz, respectively, as well as NOE correlations between two acetal protons. 
A larger homoallylic coupling constant value of 3.5 Hz and NOE correlations between the acetal and 
the methoxy protons were reported for crenulacetal B that possesses a trans-isomer dihydrofuran ring. 
In crenulacetal D, both acetal protons appeared as singlets due to their isochronous signals, hence the 
stereochemistry of the dihydrofuran ring was deduced from the NOE experiment only.278  
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Table 3.13. 5J couplings across 2,5-dihydrofuran systems in natural products 
Compound J value (Hz) NOESY Compound J value (Hz) NOESY 
Novaxenicin Aa,b J3,13 (cis) 0.0k Yes Orthopapolide 1g J2,15 (cis) < 1k n/ro 
Novaxenicin Bb J3,13 (cis) 0.0n n/ro Orthopapolide 2 g J2,15 (cis) < 1k Yes 
Helioxenicin Cc J3,13 (trans) < 1k No Orthopapolide 3 g J2,15 (cis) < 1k No 
Xenicaned J3,13 (cis) 0.0k Yes Thujuoric acid Ah J15,16 (cis) < 1k Yes 
Crenulacetal Ae J18,19 (cis) < 1k n/ro Thujuoric acid Bh J15,16 (trans) 2.5k No 
Crenulacetal Be J18,19 (trans) 3.5k n/ro Thujuoric acid Ch J15,16 (cis) < 1k Yes 
Crenulacetal Ce J18,19 (cis) 0.0k n/ro Yunnanolide Ai J21,23 (trans) 0.0n No 
Crenulacetal De J18,19 (trans) 0.0k n/ro Walsogyne Dj J21,23 (cis) 0.0m Yes 
Tomenphantopin Af J2,15 (trans) 0.0l n/ro Walsogyne Ej J21,23 (cis) 0.0m Yes 
Tomenphantopin Ba,f J2,15 (trans) 0.0l n/ro     
aBlue color indicates known relative and/or absolute configurations by X-ray analysis; bSee ref. 274; cSee ref. 275; 
dSee ref. 276; eSee ref. 278; fSee ref. 279; gSee ref. 280; hSee ref. 277; iSee ref. 281; jSee ref. 282; kCDCl3; lMeOD; 
mDMSO-d6; nC6D6; onot reported. 
 
In limonoids, i.e. yunnanolide A281 (trans) and walsogyne D-E282 (cis), both dihydrofuran 
isomers showed an identical value of 0 Hz. The absence of homoallylic coupling in a trans-configured 
dihydrofuran was also observed in germacranolides, such as tomenphantopin B, whose absolute 
configuration has been determined by single crystal X-ray analysis.279  
Based on the coupling constant value of JH-2/H-16 < 1 Hz and the presence of NOE correlations 
between the two acetal protons, four diastereomers of 3.84 each with a cis-configured dihydrofuran 
moiety were considered (3.84a-3.84d). Each diastereomer was then modelled by ChemBio3D Ultra 
(Cambridge) 15.0 with an RMS to 0.1 (Figure 3.17). NOESY correlations were then used to predict 
the most plausible diasteromer.  
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Figure 3.17. Molecular modeling for candidate structures 3.84a-3.84d 
 
The observed NOESY correlation between H-2 and Me-18 was in agreement with 3.84a (inter 
proton distance 2.1 Å), 3.84b (inter proton distance 2.9 Å) and 3.84d (inter proton distance 2.4 Å), 
but less consistent with 3.84c (inter proton distance 3.5 Å). The observed NOESY correlations 
between H-2/H-3 as well as H-3/ H-11 were plausible in diastereomers 3.84a, 3.84b and 3.84d due 
to the predicted inter proton distances of ≤ 3 Å. The three diastereomers 3.84a, 3.84b and 3.84d were 
then differentiated by determining the dihedral angle between H-2 and H-3 to match with the observed 
3JH-2/H-3 of 4.7 Hz. In diastereomer 3.84a, 3.84b and 3.84d, the dihedral angles of H-2/H-3 were 
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predicted to be 165°, 82° and 138°, respectively. Consequently, the 3JH-2/H-3 would be anticipated to 
be ~8.0 Hz in diastereomer 3.84a and < 1 Hz in diastereomer 3.84b. The observed vicinal coupling 
constant between H-2 and H-3 of 4.7 Hz was appropriate for diastereomer 3.84d. Based on these data, 
the relative configuration of 3.84d was suggested as 2S*, 3S*, 4S*, 11S*, 12S*, 16R*. The molecular 
modeling and selected NOESY correlations of 3.84d is shown in Figure 3.18.! 
 
 
Figure 3.18. Molecular modeling of 3.84d showing selected NOESY correlations 
!
To provide an unequivocal elucidation, phyllodesmolide B (3.84) was crystallized from 
EtOAc/hexanes solution to afford crystalline plates. Surprisingly, the X-ray crystallography image of 
the resulting structure revealed an acetal 3.85 that was not detected in the 1H NMR. An X-ray 
crystallographic analysis of 3.85 established its absolute configuration as 2S, 3R, 4R, 11R, 12R, 16R, 
that was different from that of the lactol 3.84 (Figure 3.19). 
!
 
Figure 3.19. The ORTEP view of the acetal 3.85 
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The crystal 3.85 represents the minor component in the sample containing phyllodesmolide B 
(3.84) due to the reactivity of the dihydrofuranol ring in the molecule (Scheme 3.19). The 
dihydrofuranol ring in 3.84 may undergo ring opening to give a hydroxyaldehyde (3.86), oxidation 
to form a dihydrofuranone (3.87) and reaction with methanol (solvent used for mass measurement in 
this work) to form an acetal (3.85). The presence of a dihydrofuranone 3.87 also explained the 
observed molecular ion peaks in the HRESIMS. Under electrospray condition, dihydrofuranone 3.87 
may be ionizing more easily than the lactol 3.82, causing it to be the predominant species detected in 
the mass spectrum.  
 
 
Scheme 3.19. The chemical reactivity of 3.84 
 
The HRESIMS measurement of phyllodesmolide C (3.88) (αD -51, c 0.08) indicated the same 
molecular formula of C20H28O4 (m/z 355.1880 [M+Na]+, calcd. for m/z 355.1880) as those of 
phyllodesmolides A (3.83) and B (3.84). In constrast to the MS data, the 13C NMR spectrum of 3.88 
suggested a molecular formula of C20H30O4. As described previously for phyllodesmolide B (3.84), 
the discrepancy between the 1H NMR and the mass spectrum of 3.88 may be due to the presence of 
a dihydrofuranone as a minor component. The 1H NMR data of 3.88 and 3.84 showed similarities, 
except for the coupling constant values of H-2 (δH 4.62 (d, 8.7)), H-3 (δH 2.67 (d, 8.7)) and H-11 (δH 
2.71 (dd, 10.0, 3.2)). Also different was the chemical shift and multiplicity of the acetal proton H-16 
at δH 5.96 (br d, 3.6) that was shifted slightly downfield (∆ 0.11 ppm) compared to that of 3.84. The 
presence of the acetal proton along with a hydroxy signal at δH 8.45 (s) suggested that 3.88 contained 
a dihydrofuranol motif. These spectral features also indicated that 3.88 was the diastereomer of 3.84.  
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The 7E-configuration and the transoid arrangement of the epoxides were deduced from the 
chemical shift of the vinyl methyls between δC 9.6-18.3. The coupling constant values of the 
trisubstituted H-11 (δH 2.71 (dd, 10.0, 3.2)) were different from those of phyllodesmolide B (3.84) at 
δH 2.76 (dd, 7.7, 4.8), suggesting an alternative configuration at C-11/C-12 (11R*, 12R*). There was 
also a 5J coupling of 3.6 Hz between H-2 and H-16 across the dihydrofuran ring that was suitable for 
a trans relationship between the two protons.257 By using the same approach as described previously 
for phyllodesmolide B (3.84), four diastereomers of phyllodesmolide C (3.88) were investigated by 
molecular modeling (Figure 3.20).  
 
 
 
 
Figure 3.20. Molecular modeling of candidate structures 3.88a-3.88d 
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In the NOESY experiment, there was a correlation between H-11 and Me-18 that was 
consistent with diastereomers 3.88b and 3.88d based on the estimated inter-proton distance of 2.8 Å 
and 2.3 Å, respectively. In contrast, the inter-proton distance of H-11 and Me-18 was predicted to be 
5.5 Å in each of diastereomers 3.88a and 3.88c. The possibility of diastereomer 3.88b was then 
eliminated on the basis of the observed NOESY correlation between H-2 and Me-18. In diastereomer 
3.88b, the two protons were estimated to be 3.8 Å apart, whereas in diastereomer 3.88d their distance 
was found to be 2.1 Å. The dihedral angle between H-2 and H-3 in diastereomer 3.88d was predicted 
to be 177° that was in agreement with the observed 3J value of 8.7 Hz between the two protons. Thus, 
diastereomer 3.88d was suggested to be the most plausible candidate structure for phyllodesmolide 
C with the relative configuration of 2R*, 3S*, 4S*, 11R*, 12R*, 16R* (Figure 3.21).   Phyllodesmolide 
C (3.88) was tested in an antimalarial assay and showed 36% inhibition against the chloroquine-
sensitive parasites P. falciparum (3D7 cells) at 10 µM.  
!
 
Figure 3.21. Molecular modeling of 3.88d showing selected NOESY correlations 
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9.9, 3.4) and δH 2.73 (d, 8.1) were diagnostic for epoxides at C-3/C-4 and C-11/C-12, as observed in 
phyllodesmolides A-C (3.83-3.84, 3.88). The alkene signal at δH 5.15 (m) was then assigned at C-
7/C-8. The 1H NMR data of 3.89 matched well with those of bisepoxysarcophytoxide that was 
initially reported from Sarcophyton sp. collected from North Queensland.283  
Bisepoxysarcophytoxide isolated by Bowden et al (1979) was reduced with Zn/Cu couple to 
afford isosarcophytoxide (3.76) and sarcophytonin A (3.67) (Scheme 3.20).283 The specific rotation 
value of the isosarcophytoxide product was -174 that was comparable to that of (11R,12R)-
isosarcophytoxide (3.76) (-166). Meanwhile, the sarcophytonin A product from 
bisepoxysarcophytoxide (3.89) showed an [αD] value of -243 that was different from that of 2R-
sarcophytonin A (3.67) product from the conversion of sarcophytoxide (3.69) (-72) and 
isosarcophytoxide (3.69) (-35). Bowden and colleagues (1979) suggested that the racemization may 
had occurred during the derivatization process.283 The complete stereochemistry of 
bisepoxysarcophytoxide isolated by Bowden et al. (1979) thus remained unresolved. 
 
 
Scheme 3.20. Chemical correlations of 3.89 by Bowden et al (1979)283 
 
Having knowledge of the data of various epoxy cembranolides isolated in this work, the 
determination of the relative configuration of 3.89 was then attempted by data comparison. The E-
geometry of the double bond and the transoid configuration of the epoxides in 3.89 were deduced 
from the chemical shift of the vinyl methyls between δH 10.2-18.4. The configuration of the epoxide 
carbons at C-11 and C-12 was determined as R* and R* based on the similar chemical shift and 
coupling constant values of H-12 (δH 2.77 (dd, 9.9, 3.3)) with those observed previously in 
isosarcophytoxide (3.76) (δH 2.74 (dd, 9.1, 3.4)), phyllodesmolide A (3.83) (δH 2.70 (d, 8.2)) and 
phyllodesmolide C (3.88) (δH 2.67 (dd, 9.6, 3.7)). The configurations at C-3 and C-4 were determined 
as S* and S* based on the 1H NMR data of H-3 at δH 2.73 (d, 8.1), that were comparable to those of 
phyllodesmolide A (3.83) (δH 2.70 (d, 8.2)) and phyllodesmolide C (3.88) (δH 2.67 (d, 8.7)). The 
vicinal coupling constant value of 8.1 Hz between H-2 and H-3, suggested that both protons were 
anti-configured and thus C-2 should have an R* configuration. The relative configuration of 3.89 was 
thus established as 2R*, 3S*, 4S*, 11R*, 12R*. The specific rotation value of 3.89 from P. 
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longicirrum (αD -140, c 0.21) was comparable to that reported in the literature  ([αD] -47 (c 0.09, 
CHCl3).283  
 
 
 
The mass spectra of phyllodesmolide D (3.90) (αD -83, c 0.04) displayed an adduct ion at m/z 
339.1931 [M+Na]+ for a molecular formula of C20H28O3. The 13C NMR data of 3.90 displayed signals 
for six alkenes (δC 123.5-140.8), an acetal methine (δC 113.6), three oxygenated carbons (δC 59.2-
82.4), six methylenes (δC 22.6-39.1) and four methyls (δC 9.6-16.7). These data suggested a molecular 
formula of C20H30O3. By comparison to those of phyllodesmolides B and C (3.84, 3.88), this 
molecular formula suggested the loss of an oxygen atom in the molecule. The 1H NMR spectrum of 
3.90 revealed the presence of a hydroxy group (δH 8.22, s) and an acetal proton (δH 5.89, br s) that 
indicated the signals for a dihydrofuranol motif. There was an epoxide methine at δH 2.68 (t, 4.1) that 
was typical for H-7, as observed previously in (2R,7R,8R)-sarcophytoxide (3.69) (δH 2.71 (t, 4.1)), 
(2R,7R,8R)-sarcophine (3.72) (δH 2.67 (t, 4.5)). The two alkenes at δH 5.23 (dd, 10.1, 0.9) and 
5.09 (dd, 10.1, 5.2) were assigned at H-3 and H-11 on the basis of HMBC correlations from H-3 to 
C-5 as well as from H-11 to C-10 and C-13, respectively. The planar structure of 3.90 was established 
as 7,8-epoxydihydrofuranol-cembranolide.  
The relative configuration of 3.90 was deduced based on 1H NMR data comparison with those 
of the sarcophytoxide diastereomers (3.69-3.70) and the sarcophine diastereomers (3.72 and 3.73) 
(Table 3.15) whose relative and absolute configuration have been described.233,239 The E-geometries 
of the alkenes at C-3/C-4 and C-11/C-12 in 3.90 were deduced from the 13C NMR chemical shifts of 
the vinyl methyls between δC 9.6-16.7. The relative configurations at C-2, C-7 and C-8 were 
suggested to be 2R*,7R*, 8R* due to the similarity of the chemical shifts and coupling constant values 
of the stereocenters and the surrounding vinyl methyls in 3.90 to those of (2R,7R,8R)-sarcophytoxide 
(3.69) and (2R,7R,8R)-sarcophine (3.72) (Table 3.14). The small 5J coupling (J < 1 Hz) between H-
2 and H-16 indicated the cis configuration between the two protons, as observed previously in 
phyllodesmolide B (3.84). This was confirmed by the observed NOESY correlations between the H-
2 and H-16.  
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Table 3.14. 1H NMR data comparison of 7,8 epoxy-furanocembranolides 
H 3.90a 3.91a 3.69a 3.70b,c 3.72a 3.73d,e 
2 5.46 (d, 10.2) 5.66 (br d, 10.2) 5.53 (m) 5.30 (m) 5.56 (dd, 9.8, 
1.4) 
5.34 (d, 9.5) 
3 5.23 (dd, 10.2, 
0.9) 
5.11 (m) 5.22 (d, 10.2) 5.17 (d, 9.8) 5.04 (dd, 9.8, 
1.1) 
4.94 (d, 9.5) 
7 2.68 (t, 4.1) 2.69 (t, 4.3) 2.71 (t, 4.1) 2.60 (t, 5.6) 2.67 (t, 4.5) 2.50 (t, 5) 
16 5.89 (s) 5.96 (d, 2.6) 4.49 (br s) 4.43 (dd, 11, 
7.5) 
- - 
 - - 4.49 (br s) 4.37 (m) - - 
18 1.84 (d, 0.9) 1.84 (s) 1.81 (s) 1.76 (s) 1.89 (br d, 1.1) 1.93 (d, 1) 
19 1.26 (s) 1.28 (s) 1.26 (s) 1.17 (s) 1.28 (s) 1.21 (s) 
aReferenced to CHCl3 at δH 7.26 (700 MHz); bData taken in CHCl3 (300 MHz); cSee ref.233; Data taken in CCl4 (100 
MHz); cSee ref.234 
 
A molecular modeling of 3.90 was carried out according to the method described previously 
(Figure 3.22). The observed NOESY correlations between H-2/Me-18 and H-3/H-7 were consistent 
with the predicted inter-proton distances of 2.0 and 2.4 Å, respectively. Additional observed NOESY 
correlations such as between H-3 and Me-20 may be due to the flexibility of the cembrane ring. The 
experimental 3JH-2/H-3 value of 10.2 Hz also fitted with the estimated dihedral angle of 168°. Based on 
these data, the relative configuration of 3.90 was proposed as 2R*,7R*, 8R*, 16R*. 
 
 
Figure 3.22. Molecular modeling of 3.90 showing selected NOESY correlations 
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In the HRESIMS, phyllodesmolide E (3.91) (αD -100, c 0.03) showed two molecular ion peaks 
at m/z 339.1933 [M+Na]+ and 341.2088 [M+Na]+. The first and the latter molecular ion peaks were 
assumed to be corresponding to the dihydrofuranone cembranolide (C20H28O3) and its lactol form 
(C20H30O3), respectively, based on the mass spectrometry data observed previously in other 
phyllodesmolides. The 1H NMR data comparison of phyllodesmolide D (3.90) and E (3.91) showed 
a slight difference in the 1H NMR spectrum (Table 3.14). The observable difference was the 
appearance of H-16 as a doublet (J = 2.6 Hz) that suggested a trans configuration across the 
dihydrofuranol ring as seen before in phyllodesmolide C (3.88). The trans configuration between H-
2 and H-16 may have occurred due to the epimerization of H-16 during the opening and the closing 
of the lactol ring.  
 
 
Figure 3.23. Molecular modeling of 3.91 showing selected NOESY correlation 
 
A molecular modeling of 3.91 (Figure 3.23) showed a dihedral angle of 168° that was in 
agreement with the observed mutual coupling constant between H-2 and H-3 of 10.2 Hz. NOESY 
correlations between H-2/Me-18 and H-6/Me-19 were also consistent with the predicted inter-proton 
distances of 2.1 Å for each pair. The relative configuration of 3.91 thus was suggested as 2R*,7R*, 
8R*, 16S*. 
 
3.2.7.!Proposed biosynthesis of cembranes 
 The cembranoid skeleton consists of 4 isoprenes that are connected in a head to tail manner 
to form a ten-membered ring with an isopropyl sidechain. The diversity of cembranes in nature is the 
result of further cyclization and the attachment of various functional groups, such as lactone, epoxide, 
furan, ester, ether, hydroxyl, aldehyde and carboxylic moieties.284  
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Scheme 3.21. The proposed biosynthetic pathway of isopropyl cembranes and furanocembranolides 
!
Cembrane diterpene (3.93) has been proposed to be derived from the cyclization of 
geranylgeranyl pyrophosphate (3.92) (Scheme 3.21). The oxidation of isopropyl cembrane 3.93 
generate isoneocembrenes (3.75, 3.78). Further oxidation and cyclization of 3.93 also yield 
sarcophytonin A 3.67 via diol 3.94, whereas dihydrofuranol cembrane 3.96 and dihydrofuranone 
cembrane 3.97 can be formed from hydroxyaldehyde 3.95 as the biosynthetic intermediate. 
!
3.2.8.!Chemical ecology of secondary metabolites from Phyllodesmium spp.  
The crude cerata extracts of P. lizardense and P. poindimiei were tested in preliminary 
unpalatability assays by members of the Cheney group at the School of Biological Sciences, UQ. A 
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two-fold serial dilution of the extract was prepared from natural concentration as the stock solution. 
The natural concentration (mg/mL) indicates the weight of tissue extract per volume of the tissue.  
The cerata extracts of P. lizardense and P. poindimiei were unpalatable against the rock-pool 
shrimp Palaemon serenus with ED50 values of 25 mg/mL (natural concentration 82 mg/mL) and 4 
mg/mL (natural concentration 12 mg/mL), respectively. A more comprehensive assay was conducted 
by the author on the cerata extract of P. longicirrum. The results showed that the P. longicirrum 
extract was strongly rejected by P. serenus with an ED50 value of 0.6 mg/mL (natural concentration 
of 400 mg/mL) (Figure 3.24).  
 
 
Figure 3.24. Rejection of pellets (ED50) by the shrimp Palaemon serenus for crude cerata extract of 
P. longicirrum  
!
Previous studies on P. lizardense (= lizardensis) from the Great Barrier Reef by the König 
group (2009) reported the isolation of α-muurolene (3.1), 3β-hydroxy- α-muurolene (3.2) and 3β-
acetoxy-α-muurolene (3.3). König et al (2009) suggested that P. lizardense feeds exclusively on the 
soft coral Heteroxenia sp., rather than the sympatric coral, Xenia sp. This hypothesis was based on 
the GC-MS analysis of the extract of Heteroxenia sp. that contained muurolenes 3.2 and 3.3, whereas 
that of Xenia sp. lacked these compounds.123 This argument was supported by earlier studies that 
reported the muurolene chemistry of Heteroxenia spp.124,125 König et al (2009) also observed that P. 
lizardense preferred to sit on Heteroxenia sp., even though the Xenia colonies were abundant in the 
natural habitat.123   
Comparison of the secondary metabolites in the cerata extract of P. lizardense and those in 
the soft coral in the current project showed that both species shared the same components., i.e. 
germacrene C (3.14), guaiane alcohol (3.16), guaiane diacetate (3.17) and gorgosterol (3.27). In 
contrast to the König’s report, the soft coral substrate of P. lizardense from our current work did not 
contain any trace of muurolenes. This result suggested that the soft coral substrate that was collected 
along with P. lizardense is probably a Xenia sp. A previous report by Kitagawa et al (1986) 
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demonstrated that Xenia sp. contained germacrene C (3.14), guaiane alcohol (3.17) and gorgosterol 
(3.27) that is in agreement with our finding.129 Due to the limited amount of material, a proper 
taxonomic identification of the soft coral was not possible. However, Kashman et al (1980) suggested 
that the sesquiterpene composition in soft corals is species specific and thus can be used as a chemical 
marker to aid the identification of soft corals. 
Additional muurolenes and a cubebane that were found in the P. lizardense extract in our 
study, but were not observed in the soft coral substrate, may indicate that the nudibranch also has 
been feeding on Heteroxenia sp. The postulation of the feeding preference of P. lizardense for 
Heteroxenia sp. over Xenia sp. that suggested by König et al (2009) therefore needs to be re-
evaluated. This suggestion was drawn based on the observation and collection of the nudibranch at 
one period of time only (July 2006). While the GC-MS analysis that was used by the König group to 
compare the secondary metabolites in the extracts of Heteroxenia sp. and P. lizardense might be 
useful, it is not unequivocal for the identification of sesquiterpenes. This practice should have been 
coupled with other techniques, such as NMR and HPLC to secure the validation of the result. 
Sesquiterpenes, such as germacrene C (3.14) often change rapidly over time as described previously 
in this chapter due to the unstable nature of the compound. Notably, the König group analyzed the 
specimens after they had been stored in methanol over a long period of time that potentially caused 
the derivatization of the sesquiterpenes.  
Ecological experiments on P. lizardense and Xenia sp. are rare in the literature. Our 
preliminary work thus highlights the feeding deterrent activity of germacrene C (3.14) as the major 
component in P. lizardense and the soft coral substrate.  A noteworthy ecological assay by Coll et al. 
(1982) demonstrated that the extracts of xeniid corals were weakly toxic against the common 
mosquito fish Gambusia affinis.40 Further investigation by Sammarco et al. (1987) correlated the low 
toxicity of xeniid corals to their soft, fleshy and weakly mineralized morphology.285 Another 
important study was performed by Cierezko and co-workers (1977) that proposed the function of 
gorgosterol (3.27) as a kairomone, in which it is used as a diagnostic chemical marker in the 
identification of food sources.286 This finding was consistent with the earlier report of the detection 
of gorgosterol (3.27) in Xenia sp. and its predator, the crab Caphyra laevis by Gillet (1968).287  
Our work also represents the first report of chemical sequestration in P. poindimiei. The cerata 
extract of P. poindimiei was found to contain the same pregnane steroids as previously reported for 
the extract of Carijoa riisei,189,199,200 in addition to punaglandins as the minor metabolites. Our 
preliminary unpalatability assay results are in agreement with a previous report that demonstrated the 
distastefulness of P. poindimiei extract to fish species such as Chaetodon miliaris, Lutjanus kasmira, 
Thalassoma duperrey, Forciper longrinostris and F. flavissimus.288 Since pregnane steroids were 
suggested to play a role as a pheromone, where they contribute to the reproduction of corals;220 the 
Chapter 3: Chemical analysis of cryptic nudibranchs from the genus Phyllodesmium  
 
! 95!
allomone (defense) function of P. poindimiei thus may be associated with punaglandins. This 
hypothesis is reasonable considering that closely related compounds to punaglandins, for example 
prostaglandin 15R-PGA2 (1.28) has been shown to deter fish feeding.38,39   
As reported by the Scheuer group, the 1976 collection of C. riisei from Enewetak atoll in the 
Pacific yielded two pregnane steroids,189 whereas the collections of C. riisei from Oahu in 1985 
produced punaglandins 1 and 3 without pregnane steroids.199 Subsequent collections of C. riisei in 
Hawaii resulted in a total of 19 punaglandins, although not all of them were present in each 
collection.200 Punaglandins were later found in the extract of Indian Carijoa sp. along with pregnane 
steroids.175 The octocoral Carijoa multiflora collected from the Pacific176,220 and Carijoa sp. from the 
South China Sea177 also contained pregnane steroids. The variation of punaglandin content in C. riisei 
indicated that it is probably affected by geographical location. In our current work, pregnane steroids 
(3.44, 3.45, 3.47) were isolated as the major component, whereas punaglandins (3.53-3.54) were 
obtained as the minor metabolites. Traces of additional punaglandins were observed in other fractions 
by NMR, but the amounts were insufficient for further analysis. The isolation of pregnane steroids 
and punaglandins in P. poindimiei indicated that this nudibranch is presumably feeding on the soft 
coral Carijoa sp. 
Compared to the other two species, P. longicirrum exhibited the strongest unpalatability 
toward P. serenus, that is probably associated with the cembranolide content in the extract. Cembrane 
diterpenes such as sarcophine (3.73) from Sarcophyton glaucum have been reported to be toxic 
against G. affinis (LD50 3 mg/L).289 Sarcophine (3.73) was used by Coll and co-workers (1983) as a 
standard compound to test the antifeedant properties of furanocembranoids in the soft coral-feeding 
mollusk Ovula ovum. Coll and colleagues (1983) observed the ingestion and transformation of 
sarcophytoxide (3.69) (half as toxic as sarcophine (3.73)) into the less toxic sarcophytonin A (3.67) 
(one tenth as toxic as sarcophine (3.73)) by the mollusk.290 In general, cembrane diterpenes have been 
associated with the ichthyotoxicity of soft corals against G. affinis between 5-20 ppm.43    
Cembranes from the P. longicirrum extract that were isolated in our current study are different 
from those reported in the earlier study conducted by Coll et al (1985). P. longicirrum from the 
Orpheus Island, Townsville, QLD was collected while feeding on the soft coral S. trocheliophorum. 
It was reported that isopropyl cembranes, such as thunbergol (3.7), epoxythunbergol (3.8) and 
trocheliophorol (3.9) were the main metabolites in the P. longicirrum (= longicirra) cerata.126 This 
finding was in agreement with the chemistry of S. trocheliophorum that  has been known to contain 
isopropyl cembranes,291–294 isoprenyl cembranes295,296 and furanocembranoids.293,297,298  None of the 
isopropyl cembranes reported by Coll and colleagues (1985) were collected from this work.  A recent 
report by the König group on the chemical analysis of P. longicirrum from the Great Barrier Reef 
using UPLC-HRMS also did not yield thunbergol (3.7), epoxythunbergol (3.8) and trocheliophorol 
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(3.9). Dereplication analysis of the observed molecular masses suggested the presence of 
sarcophytonin A (3.67), B (3.96) and sarcophine (3.72) although the complete identification of these 
cembranes was never pursued.120 Interestingly, the same group isolated cembrane-derived polycyclic 
diterpenes during re-investigation of the chemistry of P. longicirrum from the same location.127 The 
discrepancy of the isolated secondary metabolites from P. longicirrum reported by the König group 
probably resulted from the lengthy storage of the specimen in ethanol. These chatancin-like 
diterpenes were probably artefacts, rather than natural products. 
Most coelenterates contain symbiotic zooxanthellae that have been reported to be the actual 
producer of secondary metabolites. The production of gorgosterol (3.27) by zooxanthellae was 
initially proposed by Ciereszko and co-workers (1968).148 In an independent study, Kokke et al (1981) 
found that the sterol composition in three Caribbean gorgonians was different from those observed in 
the symbiotic zooxanthellae. The latter contained gorgosterol (3.27), but the first did not. Hence, 
Kokke and colleagues (1981) proposed that the sterol composition in each zooxanthella is chemically 
unique and that the symbiosis relationships may be species specific.299 Later study by Wither and co-
workers (1982) provided answers for this ambiguity by finding that the symbiotic zooxanthellae from 
the sea anemone Aiptasia pulchella can certainly synthesize gorgosterol and its dimethyl 
derivative.300 Recently, gorgosterol (3.27) and its derivatives have also been reported in various 
marine diatoms.301,302 
In contrast to gorgosterol (3.27), sesquiterpenes, diterpenes and punaglandins are produced 
by the soft corals. Kashman et al (1980) observed the sesquiterpene composition in several soft corals 
in a preliminary analysis using gas-liquid chromatography fingerprinting and found that the 
sesquiterpene composition remained constant throughout the year. Based on these chemical 
fingerprints, the authors suggested that the sesquiterpenes found in soft corals were produced by 
themselves, instead of by their symbionts.303 The Djerassi group (1984) also investigated the origin 
of terpene in three gorgonian isolates using radiolabelled isotopes. They found that the cultures of 
zooxanthellae do not produce terpenes nor triterpene sterols, but do so in symbiosis with their host.304 
Recently, a study of the diversity and chemotypes of Sarcophyton spp. in relation to the symbiotic 
zooxanthellae revealed that there was no correlation between the two species. It is suggested that the 
symbiotic zooxanthellae are unlikely to be involved in the biosynthesis of cembrane diterpenes found 
in soft corals.305 This hypothesis was supported by the isolation of diterpenes in azooxanthellae soft 
coral, Dendronephthya sp.306 Similarly, punaglandins found in C. riisei should be produced by the 
animal itself, since the octocoral also lacks symbiotic algae. 199 
 
Chapter 3: Chemical analysis of cryptic nudibranchs from the genus Phyllodesmium  
 
! 97!
3.3.!Conclusions 
Three Phyllodesmium spp. that were investigated in our current work sequester secondary 
metabolites from their host corals. The cerata extracts of P. lizardense, P. poindimiei and P. 
longicirrum were unpalatable to the shrimp P. serenus. Based on the chemical analysis, it is proposed 
that P. lizardense might have been feeding on both Xenia sp. and Heteroxenia sp., rather than 
exclusively on Heteroxenia sp. only as suggested by König et al (2009). The unpalatability of P. 
poindimiei may be associated with the punaglandin content, since pregnane steroids have been 
hypothesized to be involved in the reproduction of corals by Dorta and colleagues (2004). The extract 
of P. longicirrum strongly repelled P. serenus, owing to the presence of cembranes. Future studies 
on Phyllodesmium spp. should assess the taxonomic identification of the soft coral diet of P. 
lizardense. Further ecological assays on punaglandins and cembranes should also be carried out to 
validate the unpalatability of these compounds and their structure activity relationships.  
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CHAPTER 4! 
Secondary metabolites from Chromodorid nudibranchs 
 
4.1.!Introduction 
 This chapter reports the investigation of secondary metabolites from Chromodorid 
nudibranchs, i.e. Goniobranchus coi, Ardeadoris egretta, Miamira magnifica and Miamira 
miamirana. Sections 4.1.1. and 4.1.2. in this chapter review the sponge-nudibranch association and 
reported secondary metabolites from Chromodorid nudibranchs, respectively. The isolation of 
rearranged diterpenes from G. coi is described in Section 4.2.1., whereas diterpenes from A. egretta 
are presented in Section 4.2.2. Oxygenated polybrominated diphenyl ethers obtained from Miamira 
spp. are discussed separately in Section 4.2.3.1. for M. magnifica and Section 4.2.3.2. for M. 
miamirana. 
 
4.1.1.!Sponge-nudibranch association 
 The first formal study of sponge-nudibranch interactions was carried out by Burreson et al 
(1975), when these authors isolated 9-isocyanopupukeanane (4.1) from the nudibranch Phyllidia 
varicosa and its dietary sponge, Hymeniacidon sp.307 Recently, in a study of the predator-prey 
relationships using the nudibranch Hypselodoris cantabrica and the sponge prey Dysidea fragilis, 
Cruz et al (2012) found that the predator is chemically better protected than its prey, suggesting that 
the acquisition of chemical defense is a form of defensive escalation.308  
   
 
  
In nudibranchs, loss of the shell is compensated by the acquisition of chemical defenses from 
the food source as a result of adaptation. Nudibranchs gradually elaborate the chemicals, make them 
more effective, even biosynthesize them (de novo), independent of diet. The distastefulness of 
nudibranchs is usually correlated with their conspicuousness (aposematism) as in the case of dorid 
nudibranchs.309 Nudibranchs from the family of Chromodorididae often accumulate their defensive 
metabolites in anatomical compartments called mantle dermal formations (MDFs), while protecting 
vital organs such as the head, rhinophores and gills. The chemical analysis of MDFs from 
O
OCN
4.1 4.2
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Hypselodoris webbi revealed the presence of high concentrations of longifolin (4.2), indicating the 
putative role of this compound as a chemical defense.310  
 
4.1.2.!Selected diterpenes from Chromodorid nudibranchs 
 Nudibranchs of the genus Chromodoris have been studied extensively. They have been 
reported to feed on diverse marine sponges of the genus Aplysilla, Dendrilla, Dysidea and 
Spongionella.311 Recently, some of the members of Chromodoris sp. have been reclassified to 
Felimida sp., Goniobranchus sp., Doriprismatica sp. and Glossodoris sp.,75 thanks to advances in 
genetic analysis. Previously known Chromodoris spp. have been found to contain 
furanosesquiterpenes,312,313 norditerpenes,314–317 diterpenes,315,317–333 sesterterpenes334,335 and rarely 
macrolides.336 In this chapter, only norditerpenes and diterpenes from Chromodorid nudibranchs will 
be discussed.  
 
 
 
The first report of an oxygenated diterpene from a Chromodoris sp. was the isolation of 
norrisolide (4.3) from C. norrisi in 1983, whose structure was determined by X-ray 
crystallography.318 A cytotoxic and an antimicrobial agent, chromodorolide A (4.4) was then reported 
from the skin of C. cavae, along with chromodrolide B (4.5) whose bioactivity was not tested due to 
the limited amount of material.322,325 In 1986, Molinski and Faulkner isolated macfarlandins A-E (4.6-
4.10) from C.  macfarlandi, that was sustained on Aplysilla sulphurea.314 Both norrisolide (4.3) and 
macfarlandin E (4.10) were reisolated from C. norrisi, along with shahamin C (4.12) and polyrhaphin 
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A (4.13). The same four compounds were also isolated from the Californian sponge Aplysilla 
polyharphis, suggesting the dietary origin in C. norrisi.321 Norrisolide (4.3) and macfarlandin E (4.10) 
have been reported to exhibit antitumor activity by acting as Golgi-vesiculating agents.337,338 The 
Cimino group reported the isolation of an ichtyotoxic diterpene closely related to macfarlandin A 
(4.6), luteorosin (4.11), from C.  luteorosea in 1990. The ichthyotoxicity of 4.11 implied its possible 
role as a defense allomone.323,326  
 
 
 
A wide range of norditerpenes and diterpenes has also been reported from the nudibranchs, 
Goniobranchus spp. A plethora of compounds (4.14-4.28) with the dendrillol/aplyroseol skeleton has 
been isolated from G. tasmaniensis320 and G. epicurius (previously identified as Ceratosoma 
brevicaudatum).319 Some of these compounds, aplyroseols 1-6 (4.14-4.19) were originally isolated 
from the sponge Aplysilla rosea.320  
Our group has investigated aplyroseol-type compounds (4.29-4.33) from Chromodoris sp. 
and G. reticulata collected from a dive site in Mooloolaba.330,332 The latter also yielded 
chromoculatimine A (4.34) and B (4.35) as well as a spongian-16-one derivative (4.36).332 Further 
investigation of the extract of G. albopunctata and D. atromarginata has afforded more spongian 
diterpenes (4.37-4.50),317,329,333 whereas analysis of the extracts of G. verreri and G. splendidus has 
produced a diverse array of norditerpenes and diterpenes bearing gracilane skeletons (4.51-
4.57).315,316  
A recent investigation of the dorid nudibranch, C. hamiltoni from South Africa has led to the 
isolation of unusual halogenated homo-diterpenes namely hamiltonins A-D (4.58-4.61). Hamiltonins 
A and B (4.58-4.59) were tested in antimicrobial and cytotoxicity assays, however, they did not 
display any significant activity.327 
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To the best of our knowledge, chemical analysis of Chromodorid nudibranchs from the genus 
Ardeadoris and Miamira has not been reported elsewhere. In this chapter, investigation of the 
chemistry of A. egretta, M. magnifica and M. miamirana will be described for the first time. 
 
 
 
4.2.!Results and discussion 
4.2.1.!Rearranged spongian diterpenes from Goniobranchus coi 
Two individuals of Goniobranchus coi from Lizard Island (#47) and Mackay (#1095) were 
dissected before chemical analysis.  The mantle and gut tissues of G. coi (#47) were extracted with 
acetone separately. The acetone extracts were subsequently partitioned with Et2O to yield 2.3 mg of 
brownish yellow oil from the mantle and 7.6 mg of pale yellow oil from the gut. NP HPLC (20% 
EtOAc/hexanes) of both the mantle and gut extracts of G. coi (#47) gave norrisolide (4.3) as the major 
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compound, in addition to macfarlandin C (4.8), cheloviolene C (4.65) and dendrillolide A (4.66) 
(Scheme 4.1). Using similar methods, the same four compounds were obtained from G. coi (#1095) 
mantle and gut extracts, along with chromolactol (4.62) as a minor component (Scheme 4.2).   
 
 
Scheme 4.1. Isolation process of rearranged spongian diterpenes from G. coi batch one 
 
 
Scheme 4.2. Isolation process of rearranged spongian diterpenes from G. coi batch two 
 
Norrisolide (4.3) was isolated as colorless crystals and gave a molecular ion peak at m/z 399 
[M+Na]+ by mass spectrometry for a molecular formula of C22H32O5. The 1H and 13C NMR of 
norrisolide (4.3) showed the signals for two acetal methines at δH 6.44 (1H, d, 3.4, H-15) and δH 6.14 
(1H, d, 6.0, H-16), a γ-lactone carbonyl at δC 174.5 (C-11) and an acetate group (δC 169.4, δH 2.07) 
from the [3.3.0]-dioxabicyclooctane ring. The perhydroindane system was assigned from the presence 
of two sp3 methines at δH 2.14 (1H, t, 9.2, H-8) and δH 1.15 (1H, dd, 13.2, 6.8, H-5), a series of 
methylenes at δH 1.07-1.72 (10H) and three methyl singlets at δH 0.66-0.86 (9H). There were also a 
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pair of exomethylene signals at δH 5.16 (1H, s) and δH 5.08 (1H, s) observed in the 1H NMR spectra. 
These spectral features were consistent with those of norrisolide that was first reported by Hochlowski 
and coworkers (1983).318  
 
 
 
Norrisolide (4.3) was stereoselectively synthesized by the Theodorakis group to establish its 
absolute configuration as 5S, 8R, 9S, 13R, 14R, 15R and 16R.339–341 In our current work, 4.3 was 
recrystallized from ethyl acetate/hexane (1:4) solution to yield colorless crystals. Our collaborator, 
Dr. Jack K. Clegg (School of Chemistry and Molecular Biosciences, UQ) subsequently performed an 
X-ray crystallographic analysis to establish the same absolute configuration of 4.3 as previously 
reported by Theodorakis et al. (Figure 4.1). Furthermore, the specific rotation of 4.3 from G. coi gave 
a value of +9 (c 0.20, CHCl3) that was comparable to the value of +3.5 (c 0.13, CH2Cl2) reported by 
Theodorakis and co-workers (2004).340  
 
Figure 4.1. ORTEP view of norrisolide (4.3) 
 
Macfarlandin C (4.8) was obtained as small needles and showed an adduct ion at m/z 399 
[M+Na]+ by mass spectrometry, suggesting the same molecular formula as norrisolide (4.3). The 
presence of two acetal protons at δH 6.53 (1H, d, 6.9, H-15) and δH 6.04 (1H, d, 4.1, H-16); γ-lactone 
carbon at δC 176.0 (C-11) as well as an acetate group at δC 170.0 and δH 2.10 (s) that were diagnostic 
for the [3.3.0]-dioxabicyclooctane system as seen in norrisolide (4.3). The difference in the 3JH-13/H-
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16 value in 4.8 (4.1 Hz) and that of 4.3 (6.2 Hz) is caused by the different conformation of the 
tetrahydrofuran ring, despite identical relative configuration of the [3.3.0]-dioxabicyclooctane ring 
system.342  
 
 
 
The decalin system involving the C14H23 fragment in macfarlandin C (4.8) was assigned based 
on the presence of a trisubstituted olefinic proton at δH 5.31 (1H, br t, 3.9, H-1), an sp3 methine at δH 
1.39 (1H, br d, 13.3), a series of methylenes at δH 1.16- δH 2.02 (8H), one methyl doublet at δH 1.00 
(3H, d, 7, Me-18) and three methyl singlets at δH 0.82 (s, Me-17), δH 0.83 (s, Me-18) and δH 0.87 (s, 
Me-20). The 1H and 13C NMR data of 4.8 were identical to those reported by Molinski and Faulkner 
(1986).342 The specific rotation value of -8 (c 0.18, CHCl3) for 4.8 from current work was comparable 
to that of the same compound from C. macfarlandi (-29, c 0.75, CHCl3).342 In the current study, an 
X-ray crystallographic analysis of 4.8 was attempted with the intention of establishing its absolute 
configuration, however the quality of the crystals was inferior even after several attempts at 
recrystallization, hence further analysis could not be pursued.  
 
 
 
Chromolactol (4.62) was isolated as a colorless oil from NP HPLC. The molecular formula 
of C20H30O4 was indicated by high-resolution mass measurement of the molecular ion peak at m/z 
333.2075 [M-H]- (calcd. for 333.2071). This molecular mass is closely related to those of 
cheloviolenes A (4.63) and B (4.64).343 The 1H NMR of chromolactol (4.62) showed signals for two 
acetal protons at δH 6.18 and δH 5.54; an exomethylene at δH 4.92 and δH 4.88; two sp3 methine protons 
at δH 3.01 and δH 1.26; four allylic protons at δH 2.06-2.86; a series of methylenes between δH 1.07-
O
O
AcO
H
H O
H
H
1
8
11
13
15
18 19
20
17
4.8
O
OH
HO
H
H
O
H
H
1
8
17
18
20
19
11
13
15
10
4.62
O
O
H
AcO H
H
O
H
H
4.66
O
O
H
HO H
H
O
H
H
1
8
17
18
11
15
4.63
13
20
19
O
O
H
HO H
H
O
H
H 11
4.64
Chapter 4: Secondary metabolites from Chromodorid nudibranchs  
!
! 105!
1.72; followed by three methyls at δH 0.67-0.86. The HMBC spectrum revealed signals for two 
quaternary carbons at δC 33.4 and δC 44.0; a trisubstituted alkene at δC 148.2 and a lactone carbonyl 
at δC 175.4. Since the exomethylene and the lactone carbonyl contributed to two out of six double 
bond equivalents required for the system, therefore the compound should be tetracyclic.  
In rearranged spongian diterpenes, the A/B ring system may present as a decalin as in 
macfarlandin C (4.8), a perhydroazulene as in dendrillolide A (4.66) or a perhydroindane system as 
in norrisolide (4.3) and cheloviolene C (4.65). The absence of an alkene signal in the 1H NMR 
eliminated the possibility for a decalin system. Accordingly, the perhydroazulene and perhydroindane 
skeletons were considered for the A/B ring system of chromolactol (4.62). 
 
 
Figure 4.2. Selected COSY and HMBC correlations for the A/B ring system of 4.62!
 
The A ring of chromolactol (4.62) was established based on the COSY correlations from H-
1b (δH 1.10, m) to H-2b (δH 1.52, m), that was further coupled to H-3b (δH 1.07, m). HMBC 
correlations from Me-18 and Me-19 (δH 0.86, s, overlap) to C-3 (δC 41.6) suggested the attachment 
of both methyls to ring A. The COSY spectrum also displayed the connectivity of H-5/H-6/H-7/H-8. 
The linkage between the two rings was evident from the HMBC correlations from Me-20 (δH 0.67, s) 
to C-1 (δC 39.9), C-5 (δC 58.7) and C-8 (δC 58.8). Both gem-dimethyl signals (Me-18 and Me-19) also 
displayed three-bond correlations to C-5 that further supported the connection between ring A and B. 
The elucidation of the A/B ring system of chromolactol (4.62) was thus established as a 
perhydroindane system (Figure 4.2).  
 
 
Figure 4.3. Molecular modelling for the perhydroindane system in 4.62 showing selected NOESY 
correlations. For simplicity, the alkyl substituent was replaced by a methyl. 
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Table 4.1. Comparison of 1H NMR data of a perhydroazulene system (A) in 4.66 and a 
perhydroindane (B) system in 4.3, 4.62 and 4.65 
 
H Dendrillolide A (4.66) a,b Norrisolide (4.3) c,d Chromolactol (4.62) c,e Cheloviolene C (4.65) c,d 
1 2.28 (m) 1.63 (m) 1.67 (m) 1.56 (m) 
 1.73 (m) 1.01 (dt, 12.7, 4.5) 1.10 (m) 1.15 (td, 12.5, 4.6) 
2 1.62 (m) 1.55 (m) 1.59 (m) 1.53 (m) 
 1.26 (m) 1.55 (m) 1.52 (m) 1.53 (m) 
3 1.60 (m) 1.46 (m) 1.45 (m) 1.44 (dt, 12.5, 3.1) 
 1.30 (m) 1.06 (dt, 13.3, 4.5) 1.07 (m) 1.06 (td, 12.5, 4.6) 
4 - - - - 
5 1.65 (m) 1.15 (dd, 13.2, 6.8) 1.26 (m) 1.28 (m) 
6 1.58 (br) 1.68 (m) 1.65 (m) 1.61 (m) 
  1.46 (m) 1.43 (m) 1.61 (m) 
7 1.48 (m) 1.66 (m) 1.72 (m) 1.66 (m) 
 1.16 (m) 1.66 (m) 1.65 (m) 1.66 (m) 
8 - 2.14 (t, 9.2) 2.06 (m) 2.04 (m) 
9 2.52 (m) - - - 
10 - n/af n/af n/af 
17 4.60 (d, 2.3) n/af n/af n/af 
 4.46 (d, 2.3)    
18 0.91 (s) 0.86 (s) 0.86 (s) 0.86 (s) 
19 0.93 (s) 0.86 (s) 0.86 (s) 0.86 (s) 
20 0.76 (s) 0.66 (s) 0.67 (s) 0.67 (s) 
aData was acquired in 20% C6D6 in CCl4 at 200 MHz; bSee ref. 344; cChemical shifts (ppm) referenced to CHCl3 (δH 
7.26); dAt 500 MHz; eAt 700 MHz; fNot applicable 
 
 
Table 4.2. Comparison of 13C NMR data of a perhydroazulene system (A) in 4.66 and a 
perhydroindane (B) system in 4.3, 4.62 and 4.65 
 
C Dendrillolide A (4.66) a,b Norrisolide (4.3) c,e Chromolactol (4.62) c,d Cheloviolene C (4.65) c,e 
1 37.8 38.8 39.9 40.2 
2 28.8 19.7 19.9 19.8 
3 38.1 41.7 41.6 41.3 
4 36.2 33.2 33.5 33.3 
5 54.5 58.1 58.7 58.9 
6 27.2 21.2 20.8 20.0 
7 38.3 24.5 24.8 26.1 
8 47.0 59.2 58.8 57.4 
9 56.0 45.1 44.0 43.5 
10 153.6 n/af n/af n/af 
17 114.7 n/af n/af n/af 
18 34.7 33.4 33.4 33.0 
19 26.0 20.7 20.7 20.5 
20 24.3 14.2 14.2 13.7 
aData was acquired in 20% C6D6 in CCl4 at 200 MHz; bSee ref. 344; cChemical shifts (ppm) referenced to CHCl3 (δC 
77.16); dAt 500 MHz; eAt 700 MHz; fNot applicable 
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If the A/B ring system in chromolactol (4.62) was a perhydroazulene, HMBC correlations 
from H-1 and H-9 to the trisubstituted alkene C-10 and the exomethylene carbon C-17 would be 
anticipated. By comparison, the 1H and 13C NMR data for the A/B ring system of chromolactol (4.62) 
matched closely those of norrisolide (4.3) and cheloviolene C (4.65), but were different to those of 
dendrillolide A (4.66) as presented in Table 4.1 and Table 4.2. These similarities also suggested that 
the perhydroindane system of chromolactol (4.62) possesses the same relative configurations at C-5, 
C-8 and C-9 as those in norrisolide (4.3) and cheloviolene C (4.65). The NOESY correlations between 
H-8 and H-5 as well as between Me-18 and Me-20 further supported this hypothesis (Figure 4.3). 
The same NOESY correlations were also observed for norrisolide (4.3). 
The remainder of the molecule consisted of a bicyclo ring portion and an exomethylene that 
together corresponded to four double bond equivalents. The elucidation of ring D was permitted from 
the COSY correlations of H-12/H-13/H-16. Similarly, the C ring of chromolactol (4.62) was deduced 
from a COSY correlation between H-14 (δH 2.76, br s) and H-15 (δH 5.54, br s). The connectivity 
between rings C and D was drawn from the HMBC correlations of H-14 and H-15 to C-13. The 
elucidation of ring C and D thus provided the planar structure of a [3.3.0]-dioxabicyclooctane ring 
system (Figure 4.4). The HMBC spectrum revealed the correlation from the exomethylene protons 
H-17a (δH 4.92, s) and H-17b (δH 4.88, s) to C-14 (δC 58.5), providing the linkage between the 
exomethylene (H-17) and ring C. HMBC correlations from H-17a and H-17b to C-8 also linked the 
perhydroindane system and [3.3.0]-dioxabicyclooctane ring in 4.62. 
 
 
Figure 4.4. Selected COSY and HMBC correlations for the dioxabicyclooctane ring system of 4.62!
 
Rearranged spongian diterpenes often contain either [3.3.0]- or [3.2.1]-dioxabicylooctane ring 
systems (Figure 4.5). The difference between the two structures lies in the presence of a γ−lactone 
(A) or a δ−lactone ring (B). If a [3.3.0]-dioxabicylooctane ring system were present, the γ−lactone 
carbonyl would have a chemical shift of δC 168-178 as reported in norrisolide (4.3),318 macfarlandin 
C (4.8),342 cheloviolenes A-C (4.63-4.65)343 and dendrillolide A (4.66).344 On the contrary, a 13C 
chemical shift at δC 165-168 would be present for the δ−lactone carbonyl as observed in 
macfarlandins D and E (4.9-4.10).342 In addition, a long range W-coupling would be observed 
between H-13 and H-15 in a [3.2.1]-dioxabicylooctane ring system that is typical of coplanar 
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bridgehead protons. In macfarlandins D (4.9) and E (4.10), long range 4JH-13/H-15 values of 1.2 Hz and 
0.8 Hz were reported, respectively.342  The presence of a lactone carbonyl at δC 175.4 (C-11) and the 
absence of W-coupling between H-13 and H-15 in chromolactol (4.62) thus indicated the presence of 
a [3.3.0]-dioxabicylooctane ring system. 
 
 
Figure 4.5. Bicyclo ring systems of rearranged spongian diterpenes: [3.3.0]-dioxabicylooctane ring 
system (a) and [3.2.1]-dioxabicylooctane ring system (b) 
 
 
The stereochemical analysis of the dioxabicyclooctane ring of chromolactol (4.62) was next 
considered, focusing on the relative configurations at C-13, C-14, C-15 and C-16 by comparison to 
those of norrisolide (4.3), macfarlandin C (4.8), dendrillolide A (4.66), cheloviolenes A (4.63) and B 
(4.64) (Table 4.3 and Table 4.4). The relative configuration of cheloviolene A (4.63) has  been 
established by X-ray crystallography,40 whereas the absolute configuration of norrisolide (4.3) has 
been determined by enantioselective syntheses.340,341 Cheloviolenes A (4.63) and B (4.64) are rare 
examples of rearranged spongian diterpenes with a [3.3.0]-dioxabicylooctane ring system that 
possesses a trans configuration between H-13 and H-14. Cheloviolene A (4.63) is distinguished from 
cheloviolene B (4.64) based on the configuration at C-15. In cheloviolene A (4.63), H-14 is trans to 
H-15, whereas in cheloviolene B (4.64), it is cis.343  In comparison to the [3.3.0]-dioxabicylooctane 
ring system in norrisolide (4.3), macfarlandin C (4.8) and dendrillolide A (4.66), each has a cis 
configuration between H-13/H-14 and a trans configuration between H-14/H-15. 
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Table 4.3. Comparison of 1H NMR data for [3.3.0]-dioxabicyclooctane ring system for selected rearranged diterpenes 
H Norrisolide (4.3)a,b Macfarlandin C (4.8) a,b Dendrillolide A (4.66)d,e Cheloviolene A (4.63)f  Cheloviolene B (4.64)f  Chromolactol (4.62)a,c 
10 - n/ag n/ag n/ag n/ag - 
11 - - - - - - 
12 2.55 (d, 7.2) 2.74 (dd, 17.4, 10.4) 2.34 (dd, 17.5, 10.1) 2.94 (dd, 18.4, 11) 2.96 (ddd, 18.1, 3.6, 0.5) 2.86 (dd,18.6, 11.4) 
 2.55 (d, 7.2) 2.55 (dd, 17.4, 8.9) 2.09 (dd, 17.5, 9.3) 2.73 (ddd, 18.4, 3.9, 0.5) 2.61 (ddd, 18.1, 3.6, 0.5) 2.75 (dd, 18.6, 5.3) 
13 3.36 (m) 3.03 (dddd, 10.4, 8.9, 6.9, 4.1) 2.60 (m) 3.10 (dddd, 11, 6.2, 3.9, 2.2) 3.10 (dddd, 11, 6.2, 3.6, 2.6) 3.01 (ddd, 11.4, 6.2, 5.3) 
14 3.07 (dd, 9.4, 3.4) 2.80 (t, 6.9) 2.40 (dd, 6.6, 6.2) 2.25 (br d, 2.2) 2.25 (ddd, 2.6, 1, 0.5) 2.76 (br s) 
15 6.44 (d, 3.4) 6.53 (d, 6.9) 6.33 (d, 6.2) 5.52 (br s) 5.61 (d, 1) 5.54 (s) 
16 6.14 (d, 6) 6.04 (d, 4.1) 5.73 (d, 4.4) 6.07 (d, 6.2) 6.06 (d, 6.2) 6.18 (d, 6.2) 
17 5.16 (s) n/ag n/ag n/ag n/ag 4.92 (s) 
 5.09 (s) n/ag n/ag n/ag n/ag 4.88 (s) 
OH n/ag n/ag n/ag 3.07 (s) 2.85 (s) not detected 
OCOCH3 2.07 (s) 2.10 (s) 1.92 (s) n/ag n/ag n/ag 
OCOCH3 n/ag - - n/ag n/ag n/ag 
aChemical shifts (ppm) referenced to CHCl3 (δH 7.26); bAt 500 MHz; cAt 700 MHz; dData was acquired in 20% C6D6 in CCl4 at 200 MHz; eSee ref. 344; fSee ref. 343; gNot applicable 
 
Table 4.4. Comparison of 13C NMR data for [3.3.0]-dioxabicyclooctane ring system for selected rearranged diterpenes 
H Norrisolide (4.3)a,b Macfarlandin C (4.8) a,b Dendrillolide A (4.66)d,e Cheloviolene A (4.63)f  Cheloviolene B (4.64)f  Chromolactol (4.62)a,c 
10 143.0 n/ag n/ag n/ag n/ag 148.2 
11 174.5 176.0 175.1 168.8 177.7 175.4 
12 30.9 30.0 28.9 29.7 28.5 35.8 
13 40.6 42.0 42.0 40.2 40.8 45.2 
14 49.8 51.6 54.8 66.1 68.5 58.5 
15 101.8 96.1 97.0 103.2 105.6 104.1 
16 107.4 104.7 105.0 109.5 112.1 108.9 
17 117.2 n/ag n/ag n/ag n/ag 111.5 
OCOCH3 21.1 21.1 21.2 n/ag n/ag n/ag 
OCOCH3 169.4 170.0 168.9 n/ag n/ag n/ag 
aChemical shifts (ppm) referenced to CHCl3 (δH 7.26); bAt 125 MHz; cAt 175 MHz; dData was acquired in 20% C6D6 in CCl4 at 200 MHz; eSee ref. 344; fSee ref. 343; gNot applicable 
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The relationship between H-13 and H-16 in chromolactol (4.62) was determined on the basis 
of the 3JH-13/H-16 value and the NOESY data. In chromolactol (4.62), a 3J value of 6.2 Hz between H-
13 and H-16 was observed and there was a NOESY correlation between the two protons, indicating 
that H-13 and H-16 were cis-configured. An identical 3JH-13/H-16 value has been reported in norrisolide 
(4.3),318 cheloviolenes A (4.63)343 and B (4.64),343 but slightly different to that of macfarlandin C 
(4.8) whose 3JH-13/H-16 value was reported as 4.1 Hz.342 In their paper, Molinski and Faulkner (1986) 
argued that the different coupling constant values between H-13 and H-16 arise from the different 
conformation of the C ring.342 They commented that “In norrisolide (4.3), the C ring adopts an 
“envelope” conformation with oxygen being the flap; whereas in macfarlandin C (4.8), the C ring has 
a “skew” or two-fold conformation. The small change in the conformation of the tetrahydrofuran ring 
causes a significant change to the coupling constants between protons in this ring”.342  
The relative configuration at C-14 of chromolactol (4.62) was investigated next. H-14 
appeared as a broad singlet, revealing a 3JH-13/H-14 of less than 1 Hz. Additionally, no NOESY 
correlation was observed between H-13 and H-14. The small coupling constant between H-13 and H-
14 matched closely to that of cheloviolenes A (4.63) and B (4.64) with 3JH-13/H-14 of 2.2 Hz and 2.6 
Hz, respectively. Similarly, in each of cheloviolenes A (4.63) and B (4.64), a NOESY correlation 
between H-13 and H-14 was absent.343 Based on this similarity, the relationship between H-13 and 
H-14 was established as trans. If H-13 and H-14 were cis-configured, a 3JH-13/H-14 of 6-10 Hz would 
be observed, as found in norrisolide (4.3) (3JH-13/H-14 9.4 Hz),318 macfarlandin C (4.8) (3JH-13/H-14 6.9 
Hz)342 and dendrillolide A (4.66) (3JH-13/H-14 6.6 Hz).344,345 Furthermore, in macfarlandin C (4.8), 
irradiation of the H-16 signal enhanced the signals of H-13 and H-14 in the NOESY experiment.342  
The configuration between H-14 and H-15 was determined from the 3JH-14/H-15 value and the 
NOESY data. In chromolactol (4.62), the 3JH-14/H-15 value of less than 1 Hz matched closely to those 
of cheloviolenes A (4.63) and B (4.64), providing an ambiguous relative configuration at C-15. Lower 
values of 3JH-14/H-15 have been reported for cheloviolenes A (4.63) (< 1 Hz) and B (4.64) (1 Hz).343 A 
comparison of the chemical shift of C-15 between chromolactol (4.62) (δC 104.1) and cheloviolenes 
A (4.63) (δC 103.2) and B (4.64) (δC 105.6) to distinguish the relative configuration at C-15 was also 
uninformative since the values are so similar. In chromolactol (4.62), there was a NOESY correlation 
between H-14 and H-15 (Figure 4.6). The same NOESY correlation was also reported in cheloviolene 
A (4.63), but was absent in cheloviolene B (4.64).343 Therefore, the relative configuration between 
H-14 and H-15 in chromolactol (4.62) was suggested as trans. Ideally, a NOESY correlation between 
H-14 (δH 2.76) and H-12b (δH 2.74) would be useful to support this argument. However, the NOESY 
correlation between the two protons could not be determined due to overlapping signals. According 
to Bobzin and Faulkner (1991), the small coupling constants between H-13/H-14 and H-14/H-15 are 
due to the conformation of [3.3.0]-dioxabicyclooctane ring with a hydrogen bond between the 
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hydroxy group and the lactone.346 This conformation caused the torsional angles of H-14-C-14-C-13-
H-13 and H-14-C-14-C-15-H-15 to be close to perpendicular, in line with the observed coupling 
constant. 
The trans-configuration of H-14 and H-15 has been reported for compounds 4.3, 4.8, 4.63, 
4.64 and 4.66, despite strikingly different coupling constants between H-14 and H-15 among this 
series of compounds. In norrisolide (4.3),318 macfarlandin C (4.8)342 and dendrillolide A (4.66),344,345 
the 3JH-14/H-15 values of 3.4 Hz, 6.9 Hz and 6.2 Hz have been observed respectively. 
 
 
Figure 4.6. Molecular modelling for the [3.3.0]-dioxabicyclooctane ring of 4.62 showing selected 
NOESY correlations. For ease of modeling, the alkyl substituent has been replaced by a 
methyl.  
 
Two possible diastereomers of chromolactol (4.62) were considered based on the partial 
relative stereochemistry so far determined (Figure 4.7). In the NOESY data, there were correlations 
between H-13/H-16, H-14/H-15 and H-14/Me-20. To investigate the plausible diastereomer of 
chromolactol, both diastereomers of chromolactol (4.62) were modelled by ChemBio3D Ultra 
(Cambridge) applying energy minimization to an RMS gradient of 0.1. A single conformer that 
corresponds to each plausible diastereomer (4.62a and 4.62b) is presented in Figure 4.7. Both 
diastereomers adopt an envelope conformation for ring C of the dioxabicyclooctane ring, supporting 
the observed mutual coupling constant between H-13 and H-16 of 6.2 Hz. They also displayed 
estimated dihedral angles of close to 90° for H-13-C-13-C-14-H-14 and H-14-C-14-C-15-H-15, that 
were consistent with the observed 3JH-13/H-14 and 3JH-14/H-15 of less than 1 Hz.  
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Figure 4.7. Molecular modelling for two candidate diastereomers of chromolactol (4.62) showing 
selected NOESY correlations. A key difference in the predicted NOESY correlations of 
diastereomers 4.62a and 4.62b is highlighted in blue. 
 
The observed NOESY correlations between H-13/H-16, H-14/H-15 and H-14/Me-20 were in 
agreement with the predicted inter proton distances of < 3 Å in diastereomers 4.62a and 4.62b. The 
key difference between the two diastereomers shown above is the predicted NOESY correlations 
between Me-20/H-15 in diastereomer 4.62a and those between Me-20/H-14 in diastereomer 4.62b 
(Figure 4.7). Although the observed NOESY correlation between H-14 and Me-20 suggested the 
preference of 4.62b over 4.62a, these NOESY data were inconclusive to distinguish the two 
diastereomers. This is due to the rotational mobility of the C-8/C-14 bond resulting in a number of 
conformers that may cause additional NOESY correlations for either diastereomer.  
The proposed biosynthesis of chromolactol (4.62) was then considered, focusing on the 
stereochemical implications to guide which diastereomer might be the most plausible (Figure 4.8). 
The biosynthesis of the norrisane skeleton from a spongian diterpene precursor (4.67) was proposed 
by Hochlowski et al (1983) and Keyzers et al (2006).318,347 The enantiomer shown for the spongian 
diterpene framework (4.67) is based on the absolute configuration established by the synthetic study 
of spongian-16-one.348 Compound 4.67 undergoes opening of ring C, followed by contraction of ring 
B to yield the norrisane skeleton (4.68). Oxidation of the tetrahydrofuran ring, followed by lactone 
ring closing generates 4.69. The opening of the lactol ring allows the epimerization at C-14 due to its 
α position  to the aldehyde. Consequently, the cis configuration of H-13/H-14 is changed to trans 
across the tetrahydrofuran ring. The final step of the biosynthesis involved the closing of ring D to 
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produce chromolactol (4.62b) with the relative configuration shown. Additional epimerization may 
also occur at C-15 to yield 15-epi-chromolactol (4.62c).  
 
 
Figure 4.8. Proposed biosynthetic pathway of 4.62b showing relative configurational outcomes 
 
In order to further confirm the stereochemistry of the dioxabicyclooctane ring in 4.62b, a 
Monte Carlo conformational search using the Monte Carlo Multiple Minimum (MCMM) and the 
program Macromodel (Schrodinger Inc.)349 was performed by Dr. Gregory K. Pierens (Center of 
Advanced Imaging, UQ) for the diastereomer 4.62b. The lowest energy conformations < 3 kcal/mol 
were optimized in Gaussian350 providing 22 conformers. All conformers were then refined by DFT 
(density functional theory) calculations using B3LYP/6-31+G(d,p) converging to 4 conformers for 
4.62b. The energies were used to calculate the Boltzmann-weighted 1H and 13C NMR chemical shifts 
in chloroform solvent. The mean absolute error (MAE) for the 1H and 13C NMR chemical shifts were 
0.14 ppm and 2.00 ppm, respectively, that indicated a good match with the experimental results as 
shown in Table 4.5.  
 
Table 4.5. Experimental vs theoretical 1H and 13C NMR chemical shifts (ppm) in chloroform  solvent 
for the diastereomer 4.62b 
Position 
1H 13C 
Experimentala DFT calculations Experimentalb DFT calculations 
11 n/ac n/ac 175.4 177.3 
12 n/ac n/ac 35.8 37.0 
13 3.01 2.86 45.2 47.4 
14 2.76 2.71 58.5 60.1 
15 5.54 5.46 104.1 104.1 
16 6.18 5.92 108.9 109.1 
 MAE 0.14 MAE 2.00 
a700 MHz, b175 MHz, cNot applicable 
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Cheloviolene C (4.65) was isolated as a colorless oil from NP HPLC (20% EtOAc/hexanes). 
In the mass spectrum, 4.65 showed a sodiated molecular ion peak at m/z 385 [M+Na]+, 16 mass units 
less than that of norrisolide (4.3). The NMR data of the A/B ring system of 4.65 revealed comparable 
features to those of norrisolide (4.3) and chromolactol (4.62) as presented in Table 4.1 and Table 4.2, 
indicating the presence of a perhydroindane system. The rest of the molecule was a C10H14O4 
fragment containing an exomethylene (δH 5.04 (1H, s) and δH 5.03 (1H, s); δC 117.8), γ-lactone (δC 
176.8) and an acetate group (δH 2.04 (s); δC 176.8). The proton connectivity of the fragment was 
established from the coupling constant analysis and the COSY data (Figure 4.9). Methylene signals 
at δH 4.04 (1H, dd, 11.6, 3.7, H-15a) and δH 3.97 (1H, dd, 11.6, 6.6, H-15b) were coupled to an allylic 
methine at δH 2.24 (1H, ddd, 10.4, 6.6, 3.7, H-14), that was further coupled to the lactone methine at 
δH 2.91 (1H, dddd, 10.4, 9.4, 8.4, 7.8, H-13). There were also COSY cross peaks detected between 
H-13 and the neighboring methylenes assigned as H-12 (δH 2.73 (1H, dd, 17.5, 8.4); δH 2.35 (1H, dd, 
17.5, 10.3) as well as between H-13 and H-16 (δH 4.46 (1H, dd, 9.4, 7.8); δH 3.87 (1H, t, 9.4). 
Cheloviolene C (4.65) was isolated by Bergquist et al (1991), however, the relative configuration at 
C-13 and C-14 was not established.343 Therefore, the relative configurations at these stereocenters 
were next investigated. 
 
 
Figure 4.9. Selected COSY correlations of 4.65  
 
The configuration assignment of the acyclic subunit of cheloviolene C (4.65) was determined 
by employing J-based configurational analysis, in conjunction with NOESY correlations. There are 
two possible diastereomers of cheloviolene C (4.65), possessing erythro (4.65a) or threo (4.65b) 
relationships between H-13 and H-14 (Figure 4.10), respectively. Three staggered rotamers for each 
configuration and the dihedral angle-dependent 3JH,H values are presented in Figure 4.11. Among six 
possible rotamers, T1 and E2 satisfied the observed 3JH-13/H-14 value of 10.4 Hz. In the case of two 
protons with an anti conformation, long range NOESY between H-1 and H-4 should be observed.211 
Therefore, a NOESY correlation between H-12 and H-15 would be expected in E2, whereas that 
between H-15 and H-16 would be anticipated in T1.  
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Figure 4.10. Possible relative configuration of 4.65 at C-13/C-14: erythro (a) and threo (b) 
 
 
Figure 4.11. J-based analysis: coupling constant patterns corresponding to the conformational 
arrangement along the C-13/C-14 bond of 4.65. Plausible conformers are highlighted in 
blue. The plain arrow indicates anticipated NOESY correlations.  
 
 
 
Figure 4.12. Molecular modelling for 4.65b showing selected NOESY correlations (A) and with 
hydrogen atoms omitted from the model for clarity (B) 
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In the NOESY experiments, there were correlations between H-15 and H-12 that suggested a 
threo configuration between H-13 and H-14 in cheloviolene C as shown for the diastereomer 4.65b 
(Figure 4.12). There were also NOESY correlations between H-5/H-9, H-5/Me-19 and H-9/H-14, 
indicating that they are on the same face of the molecule. NOESY correlations were also seen between 
H-12/H-15, H-12/H-14, H-13/H-15, H-14/H-16 and Me-18/Me-20. Additional NOESY cross-peaks 
from H-17 to H-7, H-13, H-14, H-15, H-16 and Me-20 indicated rotational mobility along the C-9/C-
13 bond.  
 
 
 
Figure 4.13. Proposed biosynthesis of norrisolide (4.3) and cheloviolene C (4.65b) showing plausible 
diastereomers  
 
Similar to that of chromolactol (4.62), the biosynthesis of cheloviolene C may start from a 
spongian diterpene precursor (4.67) that undergoes rearrangement to yield the norrisane skeleton 
(4.68) (Figure 4.13). Oxidation and lactone ring closing then generates norrisolide (4.3). The opening 
of the hemiacetal ring produces cheloviolene C with the relative configuration shown (4.65b). On the 
basis of the J-based analysis, biosynthesis and molecular modelling, therefore we propose that 4.65b 
is the likely diastereomer of cheloviolene C. 
Dendrillolide A (4.66) was isolated as a colorless oil from NP HPLC (20% EtOAc/hexanes). 
The LRESIMS of 4.66 showed a sodiated molecular ion peak at m/z 399 [M+Na]+ that indicated the 
same molecular formula as that of norrisolide (4.3) and macfarlandin C (4.8). Similar features of the 
[3.3.0]-dioxabicyclooctane ring as seen in norrisolide (4.3) and macfarlandin C (4.8) were observed 
in the 1H NMR spectrum of 4.66. These features include two acetal protons at δH 6.45 (1H, d, 6.2, H-
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15) and δH 6.05 (1H, d, 4.4, H-16), two tetrahydrofuran methines at δH 3.14 (1H, m, H-13) and δH 
2.67 (1H, m, H-14) as well as a furanone methylene at δH 2.72 (1H, dd, 18.0, 9.9, H-12a) and δH 2.53 
(1H, dd, 18.0, 9.6, H-12b). 
Terpene 4.66 also contains a perhydroazulene ring system that is composed of an 
exomethylene at δH 4.83 (1H, d, 2.3, H-17a) and δH 4.56 (1H, d, 2.3, H-17b), two allylic protons at 
δH 2.67 (1H, m, 2.3, H-9) and δH 2.37 (1H, dd, 12.5, 5.5, H-1a), a series of methylenes at δH 1.20-
1.90 (10H) and three methyl singlets at δH 0.93-0.97 (9H). The 1H NMR data of 4.66 in CDCl3 are 
identical to those of dendrillolide A from the Australian nudibranch, Goniobranchus albonares.351 
The specific rotation value of 4.66 of +9 (c 0.04, CHCl3) was also comparable to that obtained from 
G. albonares (+18, c 0.01, CHCl3),351 suggesting that the two samples shared the same configuration.  
 
 
 
The initial structure of dendrillolide A from the sponge Dendrilla sp. was assigned incorrectly. 
The Faulkner group (1984) elucidated dendrillolide A with a perhydroazulene system and [3.2.1]-
dioxabicyclooctane ring as depicted in 4.70.345 They were required to reexamine the structure of 
dendrillolides A and B, when they isolated macfarlandins D (4.9) and E (4.10) from the nudibranch 
Choromodoris macfarlandi.342 The spectral data of both dendrillolides were inconsistent despite the 
structure similarities. At the same time, Hambley and coworkers (1986) reported the crystal structure 
of aplyviolene from the sponge Chelonaplysilla violacea with the same structure and relative 
configuration as those of dendrillolide A initially proposed by Faulkner et al.352 Moreover, Hambley 
et al. also isolated aplyviolacene that has the same structure and relative configuration as those of 
macfarlandin E (4.10).352 Faulkner and co-workers then revised the name of dendrillolide B to 
dendrillolide A (4.66). The structure of dendrillolide B remains unknown to date and the structure of 
dendrillolide C (4.71) is unchanged.342 
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4.2.2.!Spongian diterpenes from Ardeadoris egretta 
 A specimen of A. egretta (#63) from Lizard Island (QLD) (2008) was dissected into mantle 
and gut tissues prior to extraction. The preparation of mantle and gut extracts was carried out based 
on the methods described previously (Scheme 4.3). Similarly, two other specimens of A. egretta that 
were re-collected from the same location in October 2012 (#371) and also from Mooloolaba (QLD) 
in March 2013 (#480) were also dissected, then extracted using the same method.  
 
 
Scheme 4.3. Extraction procedure of A. egretta batch one (#63) and two (#371, #480) 
 
The various mantle extracts from A. egretta were combined based on the similar 1H NMR 
spectra before chemical analysis. NP flash chromatography (hexanes/DCM/EtOAc), followed by NP 
HPLC (hexanes/EtOAc) of the combined mantle extracts yielded aplyroseol-2 (4.15) as the major 
compound (Scheme 4.4). Following the same method, the purification of the combined gut extracts 
also afforded aplyroseol-2 (4.15), along with dendrillol-1 (4.20), methyl 7α-acetoxy-8β,14β-
diformylpodocarpanae-13β-carboxylate (4.32), aplyroseol-9 (4.72), isoagatholactone (4.74), ent-
spongian-16-one (4.75), dendrillol-3 (4.76) and the new 7α-hydroxydendrillol-3 (4.77) (Scheme 
4.5.).  
 
Ardeadoris egretta #371, #480
- Extracted with acetone (7 x 10 mL)
- Partitioned against Et2O (4 x 5 mL)
Et2O extract (233 mg)
- Dissected
Mantle (8.5 g) 
Gut (4.5 g) Et2O extract (49 mg)
- Extracted with acetone (5 x 3 mL) 
-Partitioned against Et2O (3 x 3 mL)
Ardeadoris egretta #63
- Extracted with acetone (4 x 10 mL)
- Partitioned against Et2O (4 x 5 mL)
Et2O extract (57 mg)
- Dissected
Mantle (4.9 g) 
Gut (1.2 g) Et2O extract (8 mg)
- Extracted with acetone (6 x 5 mL) 
-Partitioned against Et2O (6 x 3 mL)
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Scheme 4.4. Isolation procedure of mantle extract from A. egretta   
 
 
 
Scheme 4.5. Isolation procedure of gut extract from A. egretta  
 
 
  
Ent-spongian-16-one (4.75) was isolated as a white solid from NP HPLC and gave a 
molecular ion peak of m/z 327.2 [M+Na]+ in the LRESIMS. The 1H NMR data of 4.75 showed signals 
for a γ-lactone unit (δH 4.21; δH 4.10; δH 2.52; δH 2.08) and four methyls (δH 0.80- δH 0.86). These data 
matched closely with those of spongian-16-one reported by Kernan et al (1990) from the New Zealand 
sponge Dictyodendrilla cavernosa.353 Bergquist and colleagues (1993) also reported the isolation of 
the same terpene from another New Zealand sponge, Chelonaplysilla violacea.343 The relative 
Combined mantle extract (290 mg)
NP HPLC (10% EtOAc/hexanes)
Fraction E
Fraction F
7 fractions
4.15 (18.0 mg)
Bioassay
Mantle extract (60 mg)
Fraction B
4.72 and 4.32 (mixture) (1.0 mg)
5 fractions
4.73 (0.9 mg), 4.74 (0.1 mg), 4.75 (0.2 mg), 4.76 (0.2 mg)Fraction 2
NP flash chromatography (100% hexanes ! 100% EtOAc)
NP flash chromatography 
(100% hexanes ! 100% EtOAc)
Combined gut extract (57 mg)
NP HPLC (25% EtOAc/hexanes)
Fraction E
7 fractions
4.15 (2.3 mg)
Bioassay
Gut extract (12 mg)
NP flash chromatography (100% hexanes 
! 100% EtOAc)
Fraction D
4.15 (0.1 mg)
4.20 (0.1 mg)
4.72 (0.7 mg)
4.76 (0.3 mg)
4.77 (0.1 mg)
4.75
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O
OHH
H
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configuration of spongian-16-one from D. cavernosa was established based on proton coupling 
constant analysis, molecular modeling and by comparison to aplyroseol-3 (4.16).353 H-13 was 
established as equatorially orientated based on the JH-12ax/H-13 value of 6.0 Hz that was comparable to 
the JH-12ax/H-13 value of 7.0 Hz in 4.16. Furthermore, the relationship between H-13α and H-14α was 
defined as cis-configured due to the JH-13/H-14 value of 8.0 Hz, in comparison to that of 7.0 Hz found 
in 4.16. Pattenden and Roberts (1996) demonstrated the concise synthesis of ± spongian-16-one via 
complex polycycle construction.348,354 The specific rotation of 4.75 from the current work gave an 
opposite sign (-32) to that isolated from D. cavernosa (+53),353 suggesting that 4.75 is the enantiomer 
of spongian-16-one reported from marine sponges.  
 
 
 
Isoagatholactone (4.74) was obtained as a colorless oil from NP HPLC. The LRESIMS of 
4.74 showed a sodiated molecular ion peak at m/z 325.1 [M+Na]+, that was 2 mass units different 
from that of 4.75. Comparison of the 1H NMR data of 4.74 and 4.75 showed similar features, except 
for the presence of an alkene signal at δH 6.87 (dd, 7.0, 3.5) that was assigned as H-12. These NMR 
data were comparable to those of isoagatholactone reported by Cimino and co-workers (1974) from 
the sponge Spongia officinalis.355 The stereoselective syntheses of 4.74 have been reported 
extensively by various groups.356–359 The specific rotation of 4.74 (+2) was comparable to that of 
isoagatholactone from S. officinalis (+6).355 Imamura et al (1981) and Abad et al (1996) synthesized 
(+)-isoagatholactone and reported the specific rotation value as +7 (the concentration and solvent 
used were not reported)356 or +8 (c 1.6, CHCl3),358 respectively. Meanwhile, De Miranda and 
colleagues (1981) synthesized ent-isoagatholactone that gave an [α]D value of -11 (c 0.6, CHCl3).359 
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Methyl 7α-acetoxy-8β,14β-diformylpodocarpane-13β-carboxylate (4.32) was isolated as a 
mixture with aplyroseol-9 (4.72) from the NP flash chromatography. The 1H NMR data of 4.32 
showed signals for two aldehydes (δH 9.98; δH 9.70), a methyl ester (δH 3.67), an acetate (δH 2.08) 
and three methyls (δH 0.75-0.79). These NMR features were consistent with those of a diterpene 
isolated from Chromodoris sp. (possibly G. reticulata).330 Yong and co-workers (2008) suggested the 
equatorial position of H-7 and hence the α-orientation of the acetate group at C-7 on the basis of the 
small coupling constant of 3 Hz between H-7 and H2-6.330 Both aldehyde groups were suggested to 
be β-orientated as indicated by NOESY correlations from 15-CHO to H-7β as well as from 17-CHO 
to H-6β, H-7β and Me-20. Consequently, H-14 was assigned as α-orientated. Moreover, the observed 
NOESY correlations between H-13 to H-14 indicated the α-orientation of H-13.330 Two closely 
related metabolites, 4.78 and 4.79 have been reported as the key intermediates in the biosynthesis of 
dendrillol-type diterpenes.360,361 The measurement of the specific rotation of 4.32 was not carried out 
due to its presence as a mixture.  
 
 
Dendrillol-3 (4.76) was obtained as a white solid from NP HPLC and showed an adduct ion 
of m/z 371.2 [M+Na]+ in the LRESIMS. The 1H NMR spectra of 4.76 showed signals for 
oxymethylenes (δH 4.24; δH 4.10), a methyl ester (δH 3.73) and three methyls (δH 0.75-0.87). 
Dereplication analysis of 4.76 led to the identification of dendrillol-3 that was first reported by Karuso 
and colleagues (1986) from the sponge Dendrilla rosea.362  
7α-Acetoxydendrillol-3 (= aplyroseol-9, 4.72) was isolated as a mixture with methyl 7α-
acetoxy-8β,14β-diformylpodocarpane-13β-carboxylate (4.32) from the NP flash chromatography of 
the mantle extract of A. egretta. Compound 4.72 has also been isolated from NP HPLC of the gut 
extract as a colorless oil. The LRESIMS of 4.72 gave a molecular ion peak of m/z 429.1 [M+Na]+, 
58 mass units larger than that of 4.76. The NMR features of 4.72 were comparable to those of 4.76 
based on the presence of signals for oxymethylenes (δH 4.36; δH 4.01), a methyl ester (δH 3.73) and 
three methyls (δH 0.77-0.80). Additionally, there was an acetate (δH 2.13), together with an 
oxymethine (δH 4.82) in 4.72 which replaced the methylene group at C-7 in 4.76. These NMR data 
were consistent with those reported for 7α-acetoxydendrillol-3 from Chromodoris obsoleta.328 7α-
Acetoxydendrillol-3 has also been isolated from the sponge Aplysilla rosea, but was named 
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aplyroseol-9.363 The relative configuration of aplyroseol-9 was determined by comparison to that of 
aplyroseol-8 (4.80) from the same sponge as well as by NOESY data. Ring C in 4.80 was suggested 
to adopt a boat conformation, where H-13 was α-orientated since it showed axial-axial coupling (11.4 
Hz) to H-12β and axial-equatorial coupling (4.1 Hz) to H-12α. Accordingly, H-14 in 4.80 was 
determined as α-orientated showing axial-equatorial coupling (6.7 Hz) to H-13 and W-coupling (1.5 
Hz) to H-12α. NOESY correlations were also observed between H-7β/H-14 and H-7β/H-17β, 
implying the axial orientation of the butyrate group.363 The sample of 4.72 gave an [α]D value of -20 
that was comparable to that reported for aplyroseol-9 (-6) from A. rosea.363 
7α-Hydroxydendrillol-3 (4.77) was isolated as a colorless oil from NP HPLC. The molecular 
formula of 4.77 was determined as C21H32O5 from the HRESIMS analysis that gave an adduct ion at 
m/z 387.2142 [M+Na]+ (calcd. for C21H32O5, 387.2147). Comparison of the molecular mass of 4.77 
to that of 4.76 showed 18 mass units different that indicated an additional hydroxy group. Inspection 
of the 1H and 13C NMR data of 4.77 showed the presence of an oxymethylene group (δH 4.32; δH 3.95; 
δC 73.1), an oxygenated methine (δH 3.74; δC 71.5), a methyl ester group (δH 3.73; δC 174.4), four sp3 
methines (δH 3.46; δH 2.89; δH 1.68; δH 1.48), a series of methylenes (δH 0.96 - δH 1.89) and three 
methyls (δH 0.75, δH 0.83; δH 0.87).  
The γ-lactone unit in 4.77 was indicated by an HMBC correlation from H-17a (δH 4.32, d, 9.9) 
to a carbonyl (C-15) at δC 178.1. The hydroxy group was assigned based on the 1H NMR data 
comparison of 4.72, 4.76, and 4.77 (Table 4.6). The difference between the 1H NMR data of 4.76 and 
4.77 was the signal of H-7 that resonated at δH 3.74 (CH) in 4.77, whereas H-7 in 4.76 were observed 
at δH 1.96 and 1.28 (CH2), indicating a hydroxy group substitution at C-7 in 4.77. There was also a 
gCOSY correlation between H-6 (δH 1.74, m) and H-7 (δH 3.74, m) that supported this argument. The 
presence of 7-OH also shifted the signals of H-5 (∆ 0.55 ppm), H-6 (∆ 0.10-0.37 ppm), H-9 (∆ 0.55 
ppm) and H-14 (∆ 0.91 ppm) in 4.77 further downfield, compared to those in 4.76. Similar downfield 
shifts were also observed in 4.72 due to -OAc substitution at C-7.363  
The relative configuration of 4.77 was next investigated, in comparison to those of dendrillol-
3 (4.76) and aplyroseol-9 (4.72) (Table 4.6). A boat conformation was inferred for ring C based on 
the large coupling constant (11.0 Hz) between H-12α and H-13α as well as a medium J value of 7.3 
Hz between H-13α and H-14. A large axial-axial coupling constant between H-12α and H-13α has 
also been reported for dendrillol-3 (4.76) (10.5 Hz)330,362 and aplyroseol-9 (4.72) (11.5 Hz).363 
Moreover, the medium size coupling constant between H-13α and H-14 was comparable to those of 
dendrillol-3 (4.76) (7.7 Hz)330,362 and aplyroseol-9 (4.72) (6.8 Hz).363 There was also a W-coupling 
between H-12α and H-14 with a J value of 1.1 Hz. By comparison, a W coupling was also observed 
in dendrillol-3 (4.76) (JH-12/H-14 1.0 Hz)330,362 and aplyroseol-9 (4.72) (JH-12/H-14 1.6 Hz).363 The 
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presence of NOESY correlations between H-9/H-13α also supported the boat conformation in ring 
C. The alternative conformation of ring C would require H-13 in an equatorial position. 
Consequently, a smaller JH-12/H-13 would be observed due to axial-equatorial coupling between the 
two protons. Also, no W-coupling between H-12α and H-14 nor NOESY correlation between H-9/H-
13α would be expected (Figure 4.14). NOESY correlations were also observed between H-7β/H-17b 
and H-7β/H-14, indicating the α-position of the hydroxy group (Figure 4.15). The same NOESY 
correlations were reported for aplyroseol-9 (4.72).363 Additional NOESY correlations were observed 
for H-17a/Me-20 and H-17b/Me-20 in 4.77. 
 
 
Table 4.6. Comparison of 1H NMR data of 4.72, 4.76 and 4.77  
H 4.72a 4.76b 4.77c 
1 1.40-1.78 (m) 1.57 (m) 1.58 (m) 
 0.94 (m) 0.87 (m) 0.96 (m) 
2 1.40-1.78 (m) 1.53 (m) 1.56 (m) 
 1.40-1.78 (m) 1.42 (m) 1.46 (m) 
3 1.40-1.78 (m) 1.39 (m) 1.44 (m) 
 1.17 (dt, 13.2, 4.2) 1.13 (td, 13.1, 4.2) 1.20 (ddd, 13.4, 13.4, 4.4) 
4 - - - 
5 1.29 (dd, 13.2, 2.8) 0.93 (dd, 11.8, 2.3) 1.48 (dd, 11.4, 3.5) 
6 1.96 (td, 15.4, 2.8) 1.64 (m) 1.74 (m) 
 1.40-1.78 (m) 1.37 (m) 1.74 (m) 
7 4.81 (dd, 3.0, 2.8) 1.96 (td, 13.0, 3.0) 3.74 (m) 
  1.28 (ddt, 13.0, 3.8, 1.8)  
8 - - - 
9 1.40-1.78 (m) 1.33 (m) 1.68 (m) 
10 - - - 
11 1.40-1.78 (m) 1.64 (m) 1.68 (m) 
 1.40-1.78 (m) 1.51 (m) 1.48 (m) 
12 1.90 (m) 1.85 (m) 1.89 (m) 
 1.40-1.78 (m) 1.64 (m) 1.62 (m) 
13 2.85 (ddd, 11.0, 6.8, 4.2) 2.89 (ddd, 10.8, 7.5, 3.7) 2.89 (ddd, 11.2, 7.3, 4.2) 
14 2.95 (dd, 6.8, 1.6) 2.55 (dd, 7.5, 1.0) 3.46 (dd, 7.3, 1.1) 
15 - - - 
16 - - - 
17 4.36 (d, 10.1) 4.22 (dd, 9.4, 1.8) 4.32 (d, 9.9) 
 4.01 (d, 10.1) 4.08 (d, 9.4) 3.95 (d, 9.9) 
18 0.80 (s) 0.86 (s) 0.87 (s) 
19 0.79 (s) 0.81 (s) 0.83 (s) 
20 0.77 (s) 0.73 (s) 0.75 (s) 
OAc 2.13 (s) - - 
COOMe 3.73 (s) 3.70 (s) 3.73 (s) 
aSee ref. 363; bSee ref. 331, 361; cChemical shifts (ppm) referenced to CHCl3 (δH 7.26) at 500 MHz 
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Figure 4.14. Diterpene 4.77 with a boat (A) and a chair conformation (B) for ring C 
 
Diterpene 4.77 was then modelled by ChemBio3D Ultra 15.0 (Cambridge) by applying energy 
minimization to an RMS gradient of 0.1 (Figure 4.15). The boat conformation for ring C was 
preferred, placing the methyl ester group in the equatorial position. NOESY correlations between H-
7β/H-17b and H-7β/H-14 were in agreement with the predicted inter-proton distances of 2.3 Å and 
2.5 Å, respectively. Similarly, NOESY correlations for H-17a/Me-18 and H-17b/Me-18 were 
consistent with the estimated inter proton distances of 2.6 Å between H-17a/Me-18 and 2.3 Å between 
H-17b/Me-18. 
 
 
Figure 4.15. Molecular modelling for 4.77 showing key NOESY correlations (A) and with hydrogen 
atoms omitted from the model for clarity (B) 
 
An unusual dendrillol-sterol conjugate (4.73) was isolated as a colorless oil from NP HPLC. 
In the HRESIMS, 4.73 showed a sodiated molecular ion peak at m/z 815.5796 [M+Na]+ (calcd. for 
C50H80O7, 815.5774) for a molecular formula of C50H80O7 with 11 double bond equivalents. The 1H 
and 13C NMR data of 4.73 showed the signals for two acetal methines (δH 5.71; δH 5.12), an alkene 
(δH 5.34), two oxygenated methines (δH 5.25; δC 75.4 and δH 3.50; δC 77.0), a methyl ester group (δH 
3.68; δC 175.3), an acetate group (δH 2.10; δC 170.1) and seven methyls (δH 0.67-0.98).  
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Table 4.7. Comparison of 1H NMR data of the dendrillol portion of 4.73 and 4.28 
H 4.73a 4.28b,c 
1 1.67 (m) n/rd 
 0.90 (m) n/rd 
2 1.62 (m) n/rd 
 1.45 (m) n/rd 
3 1.41 (m) n/rd 
 1.16 (m) n/rd 
4 - - 
5 1.29 (m) 0.95 (dd, 13.0, 3.5) 
6 1.92 (m) 1.58 (m) 
 1.72 (m) 1.26 (dq, 13.0, 4.5) 
7 5.25 (m) 2.54 (dt, 13.0, 4.0) 
  1.39 (dt, 13.0, 4.0) 
8 - - 
9 1.64 (m) n/rd 
10 - - 
11 1.61 (m) 1.50 (m) 
 1.32 (m) 1.46 (m) 
12 1.80 (m) 1.85 (br d, 13.0) 
 1.71 (m) 1.71 (m) 
13 2.76 (m) 2.82 (ddd, 13.5, 6, 4.5) 
14 2.54 (br d, 4.4) 2.50 (br d, 6.0) 
15 5.12 (br s) 6.07 (s) 
16 - - 
17 5.71 (d, 8.5) 6.44 (s) 
18 0.76 (s) 0.79 (s) 
19 0.79 (s) 0.86 (s) 
20 0.93 (s) 0.79 (s) 
OH 3.04 (d, 8.5) - 
OAc 2.10 (s) 2.13 (s) 
COOMe 3.68 (s) 3.73 (s) 
aChemical shifts (ppm) referenced to CHCl3 (δH 7.26) at 500 MHz; bData were acquired 
in CDCl3 at 300 MHz; cSee ref. 16; dn/r  not reported 
 
The NMR features of the diterpene portion of 4.73 were comparable to those of diterpene 4.28 
that was reported from a Chromodoris sp. (formerly identified as Ceratosoma brevicaudatum)311 
(Table 4.7). However, there was an additional oxygenated methine in 4.73 at δH 5.25 (m). This proton 
was assigned as H-7 based on the gCOSY correlation to H2-6 at δH 1.92 (m) and δH 1.72 (m), as well 
as HMBC correlation to an -OCOMe at δC 170.1. By comparison, H-17 in 4.73 was shifted upfield 
(∆ 0.73 ppm) relative to that in 4.28, suggesting a different substituent group at C-17. Indeed, H-17 
appeared as a doublet (J = 8.5 Hz) and was mutually coupled to a hydroxy group at δH 3.04 (d, 8.5). 
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A similar upfield shift (∆ 0.95 ppm) was also observed for H-15 in 4.73. An HMBC correlation from 
H-15 to C-23 (δC 77.0) provided the linkage between the dendrillol and the sterol fragments.    
 
 
Table 4.8. Comparison of 1H NMR data of the sterol portion of 4.73 and cholesterol364 
C 4.73a Cholesterolb,c C 4.73a Cholesterolb,c 
21 1.83 (m) 1.71 34 0.98 (m) 1.02d  
 1.05 (m) 0.98 35 1.56 (m) 1.46 
22 1.81 (m) 1.76  1.06 (m) 1.46 
 1.53 (m) 1.45 36 1.83 (m) 1.80 
23 3.50 (m) 3.37  1.25 (m) 1.20 
24 2.26 (m) 2.22 37 1.09 (m) 1.04d 
 2.12 (m) 2.22 38 0.67 (s) 0.67 
25 - - 39 0.98 (s) 0.97 
26 5.34 (br s) 5.21 40 1.37 (m) 1.26 
27 1.95 (m) 1.89 41 0.91 (d) 0.90 
 1.52 (m) 1.41 42 1.33 (m) 1.26 
28 1.43 (m) 1.41  0.99 (m) 0.85 
29 0.90 (m) 0.88 43 1.33 (m) 1.31 
30 - -  1.14 (m) 1.05 
31 1.50 (m) 1.46 44 1.13 (m) 1.03 
 1.40 (m) 1.46 45 1.51 (m) 1.40 
32 1.99 (m) 1.96 46 0.86 (d, 7) 0.71 
 1.99 (m) 1.16 47 0.86 (d, 7) 0.71 
33 - -    
aChemical shifts (ppm) referenced to CDCl3 (δH 77.16) at 500 MHz; bData were acquired in CDCl3 at 500 MHz at 
313±2 K referenced to TMS, proton multiplicities were not reported; c See ref. 364; dInterchangeable 
 
The steroid fragment of 4.73 was identified based on 1H NMR data comparison to those of 
cholesterol (Table 4.8). There were signals for an alkene at δH 5.34 (br s, H-26), an oxygenated 
methine at δH 3.50 (m, H-23), two angular methyls at δH 0.67 (s, Me-38) and δH 0.98 (s, Me-39) as 
well as three methyl doublets at δH 0.91 (d, 6.6 Hz, Me-41) and δH 0.86 (d, 7.0 Hz, overlap Me-46 
and Me-47) that are typical for a cholesterol nucleus.364 
The relative configuration of 4.73 was considered by comparison to those of 4.28 and 4.77. 
An axial-equatorial coupling between H-13α and H-14 (4.2 Hz) in 4.73 was diagnostic for a boat 
conformation in ring C. The appearance of H-14 as a broad doublet indicated the presence of small 
W-coupling (J < 1 Hz) to H-12α. A gCOSY correlation between H-12α/H-14 further supported this 
interpretation. In keeping with the boat conformation, a NOESY correlation between H-9 and H-13 
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was also observed. The α-position of the acetoxy group at C-7 was established on the basis of NOESY 
correlations between H-7β/OH and H-7β/H-14. Furthermore, the α-position of the hydroxy group at 
C-17 was suggested by the NOESY correlations between H-7β/ΟΗ and between H-17/H-11b. The 
downfield shift of H-7 at δH 5.25 was diagnostic for an α-orientated 17-OH.330 In contrast, a slightly 
upfield signal for H-7 has been reported at δH 4.73 for diterpenes with a β-orientated 17-OH.110 H-15 
was established as α-orientated based on the NOESY correlations between H-14/H-15 and H-12β/Η-
15. If H-15 were β-orientated, a larger JH-14/H-15 value would be anticipated due to their cis-
configuration. Moreover, the presence of W-coupling (J < 1 Hz) between H-15 and H-17 and their 
gCOSY correlation were all consistent with the predicted relative configurations. The presence of 
NOESY correlations from H-15 to H-23 and to H-24a indicated that these protons were in close 
proximity. However, the relationship between H-15 and H-23 could not be determined due to the free 
rotation along the C-O bonds. Finally, the relative configuration of the sterol portion of 4.73 
wasinferred by comparison with published 1H NMR data of cholesterol (Table 4.8). 364  
Molecular modeling showing the relative configuration and NOESY correlations for 4.73 is 
depicted in Figure 4.16.  All observed NOESY correlations were in agreement with the inter proton 
distances being less than 3 Å. The predicted α-orientation of H-15 and β-orientation of H-17 were 
consistent with the observed W-coupling (J < 1 Hz) between the two protons. The estimated dihedral 
angle of H-14-C-14-C-15-H-15 of 100° was also consistent with the small coupling constant between 
H-14 and H-15 (J < 1 Hz).   
 
 
Figure 4.16. Molecular modeling for 4.73 showing key NOESY correlations  
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Figure 4.17. The 1H NMR spectra comparison of the mantle extract (A), the first NP flash 
chromatography fraction (B), the second NP flash chromatography fraction (C) of A. 
egretta and 4.73 (D) 
 
 
Figure 4.18. Lactone-hemiacetal formation from the parent dialdehyde 4.78 by Arnó et al (2003)360,361 
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The isolation of a mixed diterpene-sterol structure has not been reported elsewhere. The acetal 
formation between the two compounds may result due to contact with silica during NP flash 
chromatography (Figure 4.17), therefore 4.73 was considered as an artefact. In the crude extract and 
the first NP flash chromatography fraction, there were dialdehyde signals that possibly originated 
from the diterpene intermediate (4.32). During purification of the secondary metabolites from A. 
egretta, the parent aldehyde 4.32 formed an acetal with the 3-OH group of the sterol to give 4.73. In 
a synthetic study by Arnó and colleagues to study the reduction of 4.78, it was shown that the cyclic 
hemiacetal 4.82 was more stable and the ring-opened 4.81 was not detected in the 1H NMR spectra 
(Figure 4.18). Another synthetic study has also shown that the lactone-hemiacetal formation from 
dialdehydes readily occurs due to the higher stability of cyclic hemiacetals.360,361 
 
 
Figure 4.19. Acetal formation from dialdehyde 4.32 upon exposure to MeOH-d4 
 
Our group has also reported the facile conversion of diterpene 4.32 to cyclic hemiacetals 4.83 
and 4.84 upon exposure to methanol-d4, a reaction that mimics chemical conversions that may occur 
during the isolation of diterpenes from sponges and mollusks (Figure 4.19).330  When 4.32 was 
exposed to MeOH-d4 in an NMR tube, the 1H NMR spectrum showed evidence of cyclization to 
acetal products. Subsequent purification led to the isolation of two deuterated compounds (4.83 and 
4.84).330 
 
 
 
Dendrillol-1 (4.20) was obtained as a colorless oil from NP HPLC. The LRESIMS of 4.20 
showed a molecular ion peak at m/z 357.2 [M+Na]+ for a molecular formula of C20H30O4. The 1H 
NMR spectra of 4.20 revealed signals for two acetal methines (δH 6.10; δH 5.49) and three methyls 
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(δH 0.83-0.91). These 1H NMR data were comparable to those of dendrillol-1 isolated from the sponge 
D. rosea.362 The relative configuration of dendrillol-1 has been established by single crystal X-ray 
determination.362 Comparison of the specific rotation value of 4.20 (-53) and that of dendrillol-1 (-
32)362 were comparable, thus the same relative configuration was inferred.  
 Aplyroseol-2 (4.15) was the major compound found in the mantle and gut extracts of A. 
egretta. The molecular formula of C22H32O6 of 4.15 was indicated by the sodiated molecular ion peak 
at m/z 415.2 [M+Na]+. The 58 mass units different between the molecular mass of 4.15 and that of 
4.20 suggested the presence of an –OAc substituent. Comparison of the 1H NMR data of 4.15 to those 
of 4.20, revealed the signals for an oxymethine at δH 4.75 (t, 7.5) and an acetate at δH 2.13 (s) which 
replaced the methylene group (H-7) in 4.20. Diterpene 4.15 was identified as aplyroseol-2 based on 
dereplication analysis. Aplyroseol-2 was initially isolated from the sponge Igernella notabilis and 
was named 7α,7β-dihydroxy-15,17-oxidospongian-16-one-7-acetate.110 The same compound was re-
isolated from Aplysilla rosea and was named aplyroseol-2.365 The relative configuration of 
aplyroseol-2 was inferred by data comparison to that of aplyroseol-1 (4.14) from the same sponge. 
The relative configuration of 4.14 was determined by presumed biogenesis from a spongian diterpene 
precursor, in conjunction with J value analysis and NOESY data. The C-7 butyrate ester was 
suggested to be axially orientated based on the mutual coupling constant of 3.5 Hz between H-6eq 
and H-7.365 
 
4.2.3.!Oxygenated polybrominated diphenyl ethers (O-PBDEs) from Miamira spp. 
4.2.3.1.!Hydroxy polybrominated diphenyl ethers (OH-PBDEs) from Miamira magnifica 
 An individual of Miamira magnifica (#955) was collected from a dive site near North 
Stradbroke Island in November 2013. The mantle and gut extracts of M. magnifica were prepared 
based on the methods described previously. The separation of hydroxy polybrominated diphenyl 
ethers (OH-PBDEs) was carried out by NP flash chromatography (hexanes/DCM/EtOAc/MeOH). 
Further purification of OH-PBDEs was performed by NP HPLC (hexanes/EtOAc) or RP HPLC 
(MeCN/water with 0.1% TFA). 1-Hydroxy-3,5,2’,4’-tetrabromo-diphenylether (4.86) was isolated as 
the major compound in both mantle and gut extracts of M. magnifica. Five known OH-PBDEs were 
also obtained (4.85, 4.88, 4.89, 4.90, 4.91), along with a new compound (4.87). The isolation scheme 
for OH-PBDEs from M. magnifica is presented in Scheme 4.6. 
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Scheme 4.6. Isolation scheme for OH-PBDEs from M. magnifica  
 
 
 
1-Hydroxy-3,6,2’,4’-tetrabromodiphenyl ether (4.86) was isolated as a white solid from NP-
HPLC of the mantle extract and RP HPLC of the gut extract. Compound 4.86 showed the typical 
cluster of five molecular ion peaks, corresponding to the presence of four bromine substituents. A 
molecular formula of C12H5Br4O2 was inferred corresponding to a cluster of molecular mass of m/z 
496.7/498.7/500.7/502.7/503.7 [M-H]-. Inspection of the 1H NMR data of 4.86 revealed the presence 
of meta-coupled aromatic protons at δH 7.78 (1H, d, 2.2, H-3’) and δH 7.29 (1H, dd, 8.8, 2.2, H-5’) 
as well as at δH 7.34 (1H, d, 2.2, H-4) and δH 7.21 (1H, d, 2.2, H-6). Additionally, there was an upfield 
aromatic proton at δH 6.43 (1H, d, 8.8, H-6’) and a broad singlet at δH 5.54 that was typical for a 
phenolic hydroxy group.134 Dereplication analysis of 4.86 led to the identification of 1-hydroxy-
3,6,2’,4’-tetrabromodiphenyl ether that was initially reported from an Australian marine sponge. The 
structure of 1-hydroxy-3,6,2’,4’-tetrabromodiphenyl ether was secured by X-ray crystallographic 
analysis.366  
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Fraction A
-Extracted with acetone (4 x 5 mL)
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Gut (0.90 g wet wt.)
-Extracted with acetone (5 x 5 mL)
-Partitioned against Et2O (5 x 5 mL)
Et2O extract (28.0 mg) Et2O extract (17.8 mg)
- NP flash chromatography (100% 
hexanes ! 20% EtOAc/hexanes)
Fraction 3 Fraction 4
4.85 (0.1 mg)
4.86 (0.2 mg)
4.85 (1.5 mg)
4.86 (3.0 mg)
4.87 (0.2 mg)
4.87 (2.0 mg)
- NP flash chromatography (50% 
hexane/DCM ! 100% MeOH)
NP HPLC (5% 
EtOAc/hexanes)
4.89 (0.1 mg)
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- RP HPLC (80% MeCN/water + 0.1% TFA)
4.85, 4.88, 4.89 
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4.86 (2.0 mg)
4.91 (0.1 mg)
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(0.5 mg)
NP HPLC (5% 
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Dorsal horn (0.09 g wet wt. )
-Extracted with acetone (3 x 5 mL)
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Et2O extract (2.3 mg) 4.85, 4.86, 4.87 (2.3 mg)
Br
Br
O
OH
BrBr
4.86
2' 1
3 54'
Chapter 4: Secondary metabolites from Chromodorid nudibranchs  
!
! 132!
 The new compound 4.87 was obtained as a colorless oil from NP flash chromatography of the 
mantle extract. A molecular formula of C12H579Br4O2 was deduced from the ion peak at m/z 496.7028 
(calcd. for m/z 496.7042) in the HRESIMS. There were four phenyl protons (δH 6.40-7.79) and a 
hydroxy proton (δH 5.70) in the 1H NMR data. The 1H NMR data of 4.86 and 4.87 showed similarities. 
The most upfield proton at δH 6.40 (1H, d, 8.8) was diagnostic for H-6’ in ring A.367 The chemical 
shift of H-6’ between δH 6.40-6.50 is indicative of the presence of a cross ring effect due to the 
presence of a bromine substituent at C-3 that acts as an electron donating group and is shielding H-
6’. If C-3 were protonated, the signal for H-6’ would be expected between δH 6.80-7.00.367,368 In the 
COSY spectrum, the signal for H-6’ was coupled to the signal at δH 7.29 (1H, dd, 8.8, 2.2, H-5’) that 
was further meta-coupled to the signal at δH 7.79 (1H, d,  2.2, H-3’). These spectral features indicated 
that 4.87 has the same dibrominated substitution pattern in ring A as that observed in 4.86. The 
remaining two ortho-coupled aromatic protons at δH 7.47 (1H, d, 8.8) and δH 6.97 (1H, d, 8.8)  plus 
two bromine substituents therefore belonged to ring B.  
 
 
Figure 4.20. Two candidate structures of 4.87 
 
Two plausible structures of 4.87 with different substitution patterns in ring B were considered 
(Figure 4.20). As described above, one of the two bromine substituents was assigned to C-3 based on 
the chemical shift of H-6’ at δH 6.40. Therefore, the other bromine may be positioned at C-4 or C-6. 
There were HMBC correlations observed from the signal at δH 7.47 (1H, d, 8.8) to the carbons at δC 
149.1, 116.0 and 120.0 as well as from the signal at δH 6.97 (1H, d, 8.8) to the carbons at δC 149.1, 
120.0 and 116.0. These HMBC data, however, were ambiguous and did not differentiate the two 
candidate structures.  
 The structures of 4.87a and 4.87b were then compared to those of 4.92 and 4.93, respectively. 
Compound 4.92 exemplifies a 3,4-dibromination pattern in ring B that is identical to the bromine 
substitution pattern in 4.87a and was isolated from a sponge of the genus Phyllospongia collected 
from the Solomon Islands.369 Compound 4.93 was reported from the Indonesian marine sponge 
Lamellodysidea herbacea370 and possesses a 3,6-dibromination pattern that is identical to that of 
4.87b. The 1H and 13C NMR data for ring B in each of 4.92 and 4.93 are presented in Table 4.9. The 
13C NMR data of both compounds were also compared to the the calculated 13C NMR values for 
Br
Br
O
OH
Br
Br
4.87a
Br
Br
O
OH
Br
Br
4.87b
2' 1
3
44'
A B
Chapter 4: Secondary metabolites from Chromodorid nudibranchs  
!
! 133!
multi-substituted aromatics to verify the published structural assignments.134 As noted below, the 13C 
NMR data of 4.93 matched closely with the calculated values (∆ δC < 5). However, the 13C NMR data 
of 4.92, especially for C-2, C-3 and C-6, were inconsistent with the predicted data (∆ δC ≥ 5) and led 
us to hypothesize that the assignment of the 13C NMR data provided by Segraves and co-workers 
(2004) were incorrect.369  
 
 
Table 4.9. 1H and 13C NMR data for ring B in 4.92 and 4.93 
Position 
δH  δC 
4.92a,b 4.93c,d 4.92a,b Est.e,f 4.93c,d Est. e,f 
1 - - 149.3 147.3 150.2 151.6 
2 - - 140.6 148.8g 140.6 148.8 g 
3 - - 110.4 116.6 g 116.7 112.3 
4 - 7.17 (d, 9.0) 115.8 118.7 125.2 126.3 
5 7.34 (d, 9.0) 7.45 (d, 9.0) 130.2 128.5 131.9 128.5 
6 7.07 (d, 9.0) - 124.0 116.6 g 111.6 109.0 
aNMR in MeOH-d4 at 500 MHz (1H) and 125 MHz (13C); bSee ref. 368; cNMR in acetone-d6 at 
500 MHz (1H) and 125 MHz (13C); dSee ref. 369; eSee ref. 132; fEst.= estimated; gBold values 
indicate ∆ δC ≥ 5 
 
To validate the estimated 13C NMR values for OH-PBDEs, a comparison between the 
experimental and predicted 13C NMR data of ring B of known OH-PBDEs from M. magnifica is 
presented in Table 4.10. From six compounds (4.85-4.86, 4.88-4.91) that were evaluated, the 
predicted 13C NMR values were consistent with the experimental data independent of the solvent. The 
calculated 13C NMR data were proven useful to guide the assignment of OH-PBDEs.  
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Table 4.10. Comparison of experimental 13C NMR data and the predicted values for ring B of known PBDEs from M. magnifica 
C 4.85 4.86 4.88 4.89 4.90 4.91 Exp.a,b,i Est.c,j Exp.d,e,i  Est. c Exp. a,b,i Est. c Exp.a,f,i Est. c Exp. d,e,i Est. c Exp. g,h,i Est. c 
1 146.4 150.6 152.1 150.5 148.9 149.5 148.1 153.8k 150.2 150.6 148.8 152.8 
2 140.5 146.0k 138.4 145.6k 139.9 147.8k 138.7 147.8k 143.8 146.7 139.8 150.0k 
3 120.1 115.6 118.7 115.5 113.6 118.8k 116.7 114.5 122.1 123.2 117.2 117.8 
4 116.1 120.9 125.1 127.4 119.3 122.0 128.0 129.6 121.8 120.9 125.2 124.2 
5 132.8 131.8 118.0 119.8 122.9 123.1 122.2 123.1 121.8 124.2 119.8 126.4k 
6 110.1 111.2 119.6 117.7 120.8 119.9 113.4 112.3 116.5 115.5 115.8 114.5 
aCDCl3, 75 MHz; bSee ref. 371; cSee ref. 372; dDMSO-d6, 125 MHz; eSee ref. 373; fSee ref. 374; gDMSO-d6 (NMR field strength was not reported); 
hSee ref. 375; iExp. = experimental; jEst. = estimated; kBold values indicate ∆ δC ≥ 5 
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The 13C NMR data for ring B in 4.87 were then compared to the calculated values for 4.87a 
and 4.87b (Table 4.11). Notably, the empirical 13C NMR data were comparable to the predicted values 
for 4.87a, suggesting that the metabolite had a 3,4-dibromination pattern rather than the alternative 
3,6-dibromination pattern.  
 
Table 4.11. Comparison of 13C NMR data for ring B in 4.87 and the calculated values for 4.87a and 
4.87b  
 
C 4.87a 4.87ab 4.87bb 
1 149.1 147.3 151.6 
2 140.3 148.8 148.8 
3 120.0 116.6 112.3 
4 116.0 118.7 126.3 
5 131.2 128.5 128.5 
6 117.1 116.6 109.0 
aCDCl3, 125 MHz; bCalculated values134; Bold values indicate ∆ δC ≥ 5 
 
A 1D NOESY experiment was then undertaken to confirm this hypothesis (Figure 4.21). 
Irradiation of the signal of 1-OH (δH 5.54) enhanced the aromatic proton signal H-6 (δH 6.97), 
indicating their proximity in the molecule. Additional NOE enhancements were observed for the 
signals of H-5, H-5’ and H-6’ that suggested a rotation around the ether bond. The signal enhancement 
of the 1-OH was not observed upon irradiation of the signal of H-6, presumably due to the broadness 
of the 1-OH signal.  Thus, to provide unambiguous assignment of 4.87, the phenol group was reacted 
with methyl iodide to yield a methyl ether analogue (4.94) (Scheme 4.7).  
 
 
Figure 4.21. 1D NOESY experiment with irradiation of the –OH signal in 4.87  
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Scheme 4.7. The methylation reaction of 4.87 
 
Two separate 1D NOESY experiments were then carried out by irradiating signals of the 
methyl ether group (δH 3.77) (Figure 4.22) or of H-6 (δH 6.88) (Figure 4.23). Consistent with previous 
experiment, irradiation of the methyl ether enhanced the signal of H-6, while irradiation of the H-6 
signal sharpened the signals of H-5 and of the methoxy substituent. These NOESY data further 
confirmed the bromination pattern at C-3 and C-4 in 4.87. Thus, compound 4.87 was proposed as 1-
hydroxy-3,4,2’,4’-tetrabromodiphenyl ether. Comparison of the 1H NMR data for OH- and OMe-
tetrabromo diphenyl ethers is presented in Table 4.12. 
 
 
Figure 4.22. NOE enhancement of H-5 and -OMe due to irradiation of H-6 signal in 4.94  
 
 
Figure 4.23. NOE enhancement of H-6 due to irradiation of -OMe signal in 4.94 
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Table 4.12. Comparison of the 1H NMR data of OH- and OMe-tetrabromo diphenyl ethers in CDCl3 
(500 MHz) 
 
C  4.87 4.94 
1  - - 
2  - - 
3  - - 
4  - - 
5  7.47 (d, 8.8) 7.52 (d, 8.9) 
6  6.97 (d, 8.8) 6.88 (d, 8.8) 
1'  - - 
2'  - - 
3'  7.79 (d, 2.2) 7.75 (d, 2.4) 
4'  - - 
5'  7.29 (dd, 8.8, 2.2) 7.22 (dd, 8.8, 2.4) 
6'  6.40 (d, 8.8) 6.30 (d, 8.9) 
-OH  5.70 (s) - 
-OMe  - 3.77 (s) 
 
A series of pentabromodiphenyl ethers (4.85, 4.88, 4.89, 4.90) was also obtained from the 
mantle and gut extracts of M. magnifica. The four compounds showed similarities in the LRESIMS 
by displaying a cluster of molecular ion peaks at m/z 575, 577, 579, 581, 583, 585 [M-H]-. Compounds 
4.85, 4.88 and 4.89 also revealed identical substitution patterns in ring A by showing the presence of 
two meta-coupled protons at δH 7.78 ± 0.01 (d, 2.2, H-3’) and δH 7.29 ± 0.01 (dd, 8.8, 2.2, H-5’). 
Additionally, there was an aromatic proton at δH 6.40 ± 0.01 (d, 8.8) that was diagnostic for H-6’ in 
OH-PBDEs with bromine substitution at C-3.367  
The bromination pattern of ring B in 4.85, 4.88 and 4.89 was distinguished by the chemical 
shift of the aromatic proton singlet at δH 7.46 (s), 7.55 (s) and 7.78 (s), respectively as shown in  
Table 4.13. By comparison with the literature data,367 it is known that an aromatic proton that 
is located either at C-3 and C-6 adjacent to an oxygen atom would be more shielded than the one that 
is positioned at C-4 and C-5 next to a bromine substituent. Following dereplication analysis, the 
aromatic proton singlet was assigned to H-5 (δH 7.74) in 4.85, H-6 (δH 7.46) in 4.88 and H-4 (δH 7.55) 
in 4.89. All three compounds have been isolated from the sponge Dysidea (=Lamellodysidea) 
herbacea.372–374  
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Table 4.13.  Comparison of the 1H NMR data of OH-pentabromo diphenyl ethers isolated in this study 
 
C 4.85a,b 4.88a,c 4.89a,d 4.90a,e 
1 - - - - 
2 - - - - 
3 - - - 7.01 (s) 
4 - - 7.55 (s) - 
5 7.74 (s) - - - 
6 - 7.46 (s) - - 
1' - - - - 
2' - - - - 
3' 7.78 (d,  2.2) 7.78 (d, 8.8) 7.77 (d, 2.2) 7.79 (d, 2.2) 
4' - - - - 
5' 7.30 (dd, 8.8, 2.2) 7.30 (dd, 8.8, 2.2) 7.30 (dd, 8.8, 2.2) 7.45 (dd, 8.8, 2.2) 
6' 6.39 (d,  8.8) 6.40 (d, 8.8) 6.41 (d, 8.8) 6.88 (d, 8.8) 
OH 5.54 (s) n/df 5.91 n/df 
aCDCl3, 500 MHz; bSee ref. 374; cSee ref. 373; dSee ref. 372; eSee ref. 368; fn/d not detected 
 
The synthesis of 4.85 has been reported by Marsh and co-workers (2003) by the coupling of 
2,2’,4,4’-tetrabromodiphenyliodonium chloride (4.95) with a brominated 2-hydroxybenzaldehyde 
(4.96), followed by Baeyer-Villiger oxidation and acid-catalyzed hydrolysis (Scheme 4.8).375 
Moreover, the structures of 4.88 from D. fragilis376 and 4.89 from D. herbacea372 were established 
by X-ray crystallography.  
 
 
Scheme 4.8. The synthesis of 4.85 and 4.91 from the coupling of 2,2’,4,4’-
tetrabromodiphenyliodonium chloride (4.95) with brominated 2-
hydroxybenzaldehyde (4.96-4.97) by Marsh and co-workers (2003)375 
 
 Compound 4.90 was isolated as a mixture with 4.85 and 4.89 from the RP-HPLC and further 
purification was prevented by the limited amount of material. The identification of 4.90 was thus 
carried out by 1H NMR data comparison to those of 4.85, 4.88 and 4.89, revealing the downfield shift 
of H-5’ (+ 0.16 ppm) and of H-6’ (+ 0.48 ppm) in 4.90 (Table 4.13). Two meta-coupled protons at δH 
7.79 (d, 2.2, H-3’) and δH 7.45 (dd, 8.8, 2.2, H-5’) were observed in the 1H NMR spectrum. An 
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aromatic proton at δH 6.88 (d, 8.8) was diagnostic for H-6’ with C-3 being occupied by a proton, as 
opposed to a bromine.367 Consequently, a proton singlet at δH 7.01 (s) was assigned as H-3. Compound 
4.90 was identified as 1-hydroxy-4,5,6,2’,4’-pentabromodiphenyl ether, that was initially reported 
from D. herbacea.368 Marsh and colleague (2003) synthesized 4.90 via coupling of 2,4-
dibromophenol (4.100) with fluorobenzaldehyde (4.101) (Scheme 4.9).   
 
 
Scheme 4.9. The synthesis of 4.90 from the coupling of 2,4-dibromophenol (4.100) with 
bromofluorobenzaldehyde (4.101) by Marsh and co-workers (2003) 375 
 
 
The LRESIMS of 4.91 showed a cluster of molecular ion peaks at m/z 653, 655, 657, 659, 
661, 663, 665 [M-H]-  that was diagnostic for the presence of six bromine substituents. Accordingly, 
the 1H NMR spectrum of 4.91 consisted of three aromatic protons only. The occurrence of a 2’,4’-
dibrominated phenyl moiety in ring A was apparent from the presence of two meta-coupled protons 
at δH 7.78 (d, 2.2, H-3’) and δH 7.30 (dd, 8.8, 2.2, H-5’), while a doublet proton at δH 6.39 (d, 8.8) was 
attributed to H-6’. Compound 4.91 was identified as 1-hydroxy-3,4,5,6,2’,4’-hexabromodiphenyl 
ether, that was first reported from Dysidea sp.377 The Radchenko group (1993) synthesized 4.91 by 
reacting brominated diphenyl iodonium salts (4.103) and brominated guaiacol (4.104) (Scheme 
4.10).378 Recent synthesis work of 4.91 was carried out by Marsh et al (2003) using the same 
procedure as that described for 4.85 (Scheme 4.8).375 
 
 
Scheme 4.10.  The synthesis of 4.91 by reacting a brominated diphenyl iodonium salt with brominated 
guaiacol378 
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It is worth noting that during the isolation of OH-PBDEs from M. magnifica, two HPLC 
methods were used for purification. Guided by previous literature, the first attempt of purification 
was carried out by RP-HPLC (80% MeCN/water + 0.1% TFA) to separate a fraction containing OH-
PBDEs. This method successfully separated tetrabromodiphenyl ethers; however, even with these 
conditions the pentabromodiphenyl ethers were still eluted as a mixture. The second purification 
attempt employed NP-HPLC (5% EtOAc/hexanes) to purify the mantle extract of M. magnifica. This 
method was effective to separate tetrabromo- and pentabromodiphenyl ethers. Notably, the degree of 
bromination and the location of individual bromines significantly contributed to the lipophilicity of 
OH-PBDEs. In particular, bromine substituents at C-5 and/or C-6 appeared to “conceal” the polarity 
of the neighboring hydroxy group. In a mixture containing OH-PBDEs, 4.89 was eluted first followed 
by 4.85, 4.86 and 4.87 according to their increasing polarity. Interestingly, the tetrabromodiphenyl 
ether that lacked bromine substituents at C-5 and C-6 (4.87) was eluted 20 minutes later than that 
with bromine substituents at C-5 only (4.86) (Figure 4.24). 
 
Figure 4.24. NP HPLC separation of OH-PBDEs from the mantle extract of M. magnifica 
 
The lipophilicity of halogenated aromatics has been extensively examined in ecological 
studies, due to their presence as environmental contaminants. Studies on the structure of halogenated 
aromatics have been crucial to predicting the disposition of these toxins in humans. Generally, 
increasing the ring complexity in halogenated aromatics as well as the size and number of halogens 
contribute to the increase in lipophilicity.379  
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4.2.3.2.!Methoxy polybrominated diphenyl ethers (OMe-PBDEs) from Miamira miamirana 
A specimen of Miamira miamirana was supplied by Cairns Marine in June 2016 and dissected 
into mantle (including dorsal horn) and gut tissues before extraction. The mantle and gut extracts of 
M. miamirana were prepared based on previous methods (Scheme 4.11). The mantle extract was 
separated by NP flash chromatography using a gradient of hexanes/EtOAc as eluent. Fractions 2-4 of 
the mantle extract were found to contain tribromomethoxy diphenyl ether 4.105 as the major 
component, along with tetrabromomethoxy diphenyl ethers 4.106-4.107. The same compounds were 
also collected from the gut extract.  
 
 
Scheme 4.11. Isolation scheme for OMe-PBDEs from M. miamirana  
 
Compound 4.105 was obtained as a mixture with 4.106 from fraction 3 of the NP flash 
chromatography of the mantle extract. The LRESIMS of 4.105 showed a cluster of four molecular 
ion peaks at m/z 449/451/453/455 [M-H]-, that is typical for the presence of three bromine 
substituents. In the 1H NMR spectrum of 4.105, there were five aromatic protons between δH 6.78-
7.49 and a methoxy signal at δH 3.88 (3H, s). The assignment of OMe-PBDEs could not utilize the 
NMR trends that were previously observed in OH-PBDEs due to the unpredictable effect of the 
methoxy group on the proton and carbon chemical shifts.367 The aromatic protons were therefore 
assigned on the basis of the COSY data. A doublet proton at δH 7.49 (1H, d, 2.3, H-5) was meta-
coupled to another doublet proton at δH 7.02 (1H, d, 2.3, H-3). An additional pair of meta-coupled 
protons were observed at δH 7.22 (1H, d, 2.3, H-3’) and δH 6.99 (1H, dd, 8.5, 2.3, H-5’). The latter 
was further ortho-coupled to a proton at δH 6.78 (1H, d, 8.5, H-6’). The 1H NMR data of 4.105 were 
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identical to those of 1-methoxy-2’-hydroxy-4,6,4’-tribromodiphenyl ether from the Palauan sponge 
Phyllospongia dendyi.380 
The LRESIMS of 4.106 showed molecular ion peaks at m/z 527/529/531/533/535 [M-H]-, 
indicating the presence of four bromine substituents. The 1H NMR data of 4.106 displayed two pairs 
of aromatic meta-coupled aromatic protons between δH 6.72-7.41 and also a methoxy proton at δH 
4.02 (s). By data comparison to those of 4.105, the aromatic protons at δH 7.41 (1H, d, 2.2) and δH 
6.72 (1H, d, 2.2) were assigned as H-5 and H-3, respectively. The aromatic signal at δH 7.22 (1H, 
overlap) was assigned as H-3’ based on the identical chemical shift to that of 4.105.  The COSY data 
showed a cross peak between H-3’ and the remaining aromatic proton signal at δH 7.31 (1H, d, 2.2) 
that was subsequently assigned as H-5’. Dereplication analysis of these data led to the identification 
of 1-methoxy-2’-hydroxy-4,6,4’,6’-tetrabromodiphenyl ether that was initially isolated from L. 
herbacea.370,381–383 The same compound has also been reported from the marine sponges Dysidea 
fragilis371 and Phyllospongia dendyi.380  
     
 
Table 4.14. Comparison of 1H NMR data of OMe-PBDEs 
C 4.105a,b 4.106a,c 4.107a,d 
1 - - - 
2 - - - 
3 7.02 (d, 2.3) 6.72 (d, 2.2) 6.45 (d, 2.2) 
4 - - - 
5 7.49 (d, 2.3) 7.41 (d, 2.2) 7.35 (d, 2.2) 
6 - - - 
1' - - - 
2' - - - 
3' 7.22 (d, 2.3) 7.22 (overlap) 7.09 (d, 2.2) 
4' - - - 
5' 6.99 (dd, 8.5, 2.3) 7.31 (d, 2.2) 7.41 (d, 2.2) 
6' 6.78 (d,  8.5) - - 
-OH n/de n/de - 
-OMe 3.88 (s) 4.02 (s) 3.99 (s) 
-OMe - - 3.76 (s) 
aCDCl3, 500 MHz; bSee ref. 380; cSee ref. 68; dSee ref. 368; en/d not detected 
 
Tetrabromodiphenyl ether 4.107 was isolated as a minor component in the mantle and gut 
extracts of M. miamirana and was purified by NP flash chromatography. The presence of four 
bromine substituents was indicated by the LRESIMS data that showed molecular ion peaks at m/z 
541/543/545/547/549 [M-H]-. The 1H NMR data of 4.107 showed two pairs of meta-coupled aromatic 
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protons at δH 7.41 (1H, d, 2.2, H-5’), 7.35 (1H, d, 2.2, H-5), 7.09 (1H, d, 2.2, H-3’) and 6.45 (1H, d, 
2.2, H-3), along with two methoxy signals at δH 3.76 (3H, s) and 3.99 (3H, s). The identification of 
4.107 was carried out by data comparison to those of previous literature (Table 4.14). 1,2’-
Dimethoxy-4,6,4’,6’-tetrabromodiphenyl ether (4.107) was reported for the first time from the sponge 
Phyllospongia foliascens by the Faulkner group.368 Other groups also obtained the same compound 
from L. herbacea,370,381 Dysidea sp.,384 Dysidea dendyi 385 and P. dendyi.386     
 
4.2.3.3.!Anatomical distribution of O-PBDEs in M. magnifica and M. miamirana tissues  
O-PBDEs are prolific in nature with extensive biological activities. Natural O-PBDEs from 
marine invertebrates have been typically reported from sponges of the genus Dysidea,64,69,72-73,75–79  
Phyllospongia368,380,386 and occasionally from mollusks.390–392 The sponge Dysidea sp. also contains 
sesquiterpenes384,393–410 and polychlorinated peptide derivatives.411–415 The bioaccummulation of O-
PBDEs at ppm levels has been reported in marine mammals, suggesting the persistent nature of O-
PBDEs in the environment.416 The origin of OH- and OMe-PBDEs has been much debated due to 
their structural similarities to industrial flame retardants.417 Biosynthetic studies via 14C 
measurements indicated that OMe-PBDEs (4.108-4.109)418 as well as OH-PBDEs (4.85, 4.110-
4.112)419 can be of natural origin. OH-PBDEs were initially indicated as the product of the symbiotic 
sponge-associated cyanobacteria, but the definite genetic basis for algal biosynthesis of OH-PBDEs 
has not been established.420 Recent studies, however, have revealed that O-PBDEs are biosynthesized 
by marine bacteria.85  
 
 
 
In the case of M. magnifica, there are two issues of note. The first being that OH-PBDEs were 
found in the mantle, dorsal horn and digestive tissues (Table 4.15). In particular, only tetra- and 
pentabrominated OH-PBDEs were distributed in the mantle and dorsal horn. Secondly, the isolated 
OH-PBDEs displayed an identical 2,4-dibromination pattern relative to the diphenyl ether bond in 
ring A. Moreover, they also showed identical ortho-hydroxylation relative to the ether linkage in ring 
B with varying bromination pattern at C-3, C-4, C-5, and C-6. The second batch of M. magnifica 
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(#1252-3) from Moololaba was dissected into mantle and viscera tissues before chemical analysis. 
By dereplication analysis, each mantle and viscera extracts were found to have the same composition 
of OH-PBDEs as those observed in M. magnifica (#955) from North Stradbroke Island.  
 
Table 4.15. The anatomical distribution and ratio of OH-PBDEs in M. magnifica  
OH-PBDEs Mantle % w/wa,b Gut % w/w Horn % w/w
b 
Tetrabromodiphenyl ether 4.86 X 45% X 60% X 62% 
 4.87 X 31% X 6% X 18% 
Pentabromodiphenyl ether 4.85 X 22% X 18% X 18% 
 4.88 - - X 5% - - 
 4.89 trace 2% X 7% - - 
 4.90 - - trace 1% - - 
Hexabromodiphenyl ether 4.91 - - trace 3% - - 
a% weight of compound/total weight of isolated OH-PBDEs; bCalculated based on peak integration in the 1H NMR 
spectrum 
 
In contrast to those of M. magnifica, OMe-PBDEs from M. miamirana contained an identical 
4,6-dibromination pattern in ring B and displayed ortho-hydroxylation and/or ortho-methoxylation 
relative to the ether linkage in rings A and B. Due to its small size, M. miamirana was dissected into 
mantle and gut only. As shown in Table 4.16, OMe-PBDEs 4.105-4.107 were found in the mantle 
and gut tissues of M. miamirana. The ratio of OMe-PBDEs in M. miamirana was determined by 
careful integration of proton signals in the 1H NMR spectrum because of the limitation of material. 
In the mantle extract, tribromodiphenyl ether 4.105 appeared as the major component. In contrast, 
tetrabromodiphenyl ethers 4.106-4.107 were predominant in the gut tissue. Consistent with the 
anatomical distribution of OH-PBDEs in M. magnifica (Table 4.15), these data indicated the 
preference of the accumulation of O-PBDEs with a fewer number of bromines in the mantle tissue of 
M. miamirana. However, since only one specimen of M. miamirana was collected during this 
research, this speculation needs to be further tested with a larger number of samples.   
 
Table 4.16. The distribution and ratio of OMe-PBDEs in M. miamirana 
OMe-PBDEs Mantle % w/wa,b Gut % w/wb 
Tribromodiphenyl ether 4.105 X 70% X 16% 
Tetrabromodiphenyl ether 4.106 X 25% X 42% 
 4.107 X 5% X 42% 
a% weight of compound/total weight of isolated OMe-PBDEs; bCalculated based on peak 
integration in the 1H NMR spectrum 
 
The detection of O-PBDEs in the digestive tissues of M. magnifica and M. miamirana 
indicated that the chemicals were sequestered from the food source. The identification of six known 
OH-PBDEs in M. magnifica led to the speculation that the preferred sponge diet might be the sponge 
L. herbacea (see Table 4.17). Generally, L. herbacea occurs in two chemotypes: the first one produces 
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sesquiterpenes and polychlorinated amino acid derivatives, whereas the second one only produces 
OH-PBDEs.421 Notably, the OH-PBDEs reported from L. herbacea are tetra- and pentabromo 
diphenyl ethers with ortho-hydroxylation in ring B.372,374 This is consistent with our findings in M. 
magnifica (4.85, 4.88-4.90). The tribromo- and tetrabromo diphenyl ethers 4.105-4.107 obtained from 
M. miamirana have been reported from various genera of sponges. However, the three compounds 
have been exclusively found in the sponge of the genus Phyllospongia (see Table 4.17).368,380,386 
Therefore, it is reasonable to propose that M. miamirana is may be feeding on this sponge.  
 
Table 4.17. O-PBDEs isolated in this study and previously reported from marine sponges 
Compound/ 
Species 4.85 4.86 4.88 4.89 4.90 4.91 4.105 4.106 4.107 
L. herbacea X374  X373,374 X372,374 X368,374 X388  X370,381–383 X370,381 
D. fragilis   X371   X371  X371  
D. dendyi         X385 
D. granulosa  X367 X367 X367      
Dysidea sp. X422 X387,389 X387 X422 X387 X422   X384 
P. dendyi       X380 X380 X380 
P. foliascens         X368 
Callyspongiidae a,b  X366        
Psammocinia sp. X369     X369    
aSpecies was not identified; bNeeds to be re-examined (see ref. 367) 
 
The occurrence of O-PBDEs in nudibranchs has been reported by Faulkner and Clardy390 as 
well as the Garson group.391 Faulkner and Clardy (1986) observed the presence of O-PBDEs (4.88 
and 4.110) and furanosesquiterpenes in the methanol extract of Chromodoris funerea (= lineolata) 
collected in Iwayama Bay, Palau.390 In contrast, the acetone extract of C. funerea collected in 
Kaibakku Lake (adjacent to Iwayama Bay) contained sesterterpenes only and was lacking 
sesquiterpenes and O-PBDEs.423  
 
 
 
The Paul group observed the sequestration of OH-PBDEs in the extracts of the gastropterid 
mollusks (Order Cephalaspidea), Sagaminopteron psychedelicum and Sagaminopteron 
nigropunctatum that were found feeding on Dysidea granulosa in Guam. The difference between the 
two mollusks lies on their defense strategies, in which S. psychedelicum has a bright coloration, 
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whereas S. nigropunctatum is cryptic. Paul et al (2006) reported that both species incorporate 
tetrabromo diphenyl ether 4.86 as the major component in the mantle, parapodia and mucus. The 
concentration of 4.86, however, was distributed differently between body parts. Compound 4.86 was 
accumulated in the mantle of S. psychedelicum (4.03%) and S. nigropunctatum (2.37%) at 
approximately the same concentration found in the sponge extract. The same metabolite was 
concentrated at twice the concentration in the parapodia of S. psychedelicum (7.97%) and S. 
nigropunctatum (10.10%). In the mucus of S. psychedelicum, 4.86 was detected in trace amounts; 
whereas in the mucus (1.84%) and egg masses (2.22%) of S. nigropunctatum, the level of 4.86 was 
quite significant.392 
In a geographical study of secondary metabolites from a Discodorid nudibranch, Asteronotus 
cespitosus, collected from Western Australia, the Great Barrier Reef and the Philippines, our group 
reported that OH- and OMe-PBDEs (4.91, 4.113-4.116) were detected in all specimens. 
Sesquiterpenes were also isolated from both mantle and digestive tissues of specimens collected from 
the Great Barrier Reef and the Philippines, but were absent in the specimen from Western Australia. 
Since only sesquiterpenes were found in the mantle tissues, Fahey and Garson (2002) suggested that 
A. cespitosus selectively incorporate these secondary metabolites from their food source (possibly L. 
herbacea) as defensive chemicals. They also hypothesized that OH- and OMe-PBDEs were 
eliminated as they were either too toxic to be integrated into the body tissue, or not as effective as 
defensive weapons.391 Unfortunately, the bioactivity of these metabolites was not assessed.  
In various ecological experiments, tetrabromo diphenyl ether 4.86 has been reported to show 
antifeedant activity against tropical reef fish,424 the gastropod Stylocheilus longicauda,425 the 
pufferfish Canthigaster solandri392 and two species of crabs Leptodius spp.,392,426 highlighting its 
significant predator deterrent activity. On the other hand, Handayani and co-workers (1997) reported 
that hexabromodiphenyl ether 4.91 with full bromination in ring B displayed the most potent toxicity 
against the brine shrimp Artemia salina (LC50 < 1µg/mL), compared to those of tetrabromo hydroxy 
diphenyl ethers (LC50 3.30-8.66µg/mL). Moreover, methylation of the hydroxy group in OH-PBDEs 
significantly reduced the toxicity of these compounds in the brine shrimp assay (LC50 26.25 µg/mL). 
These authors therefore hypothesized that the toxicity level of OH-PBDEs against the brine shrimp 
is directly proportional to the number of bromine substituents.388  
In the current study, our collaborators from the School of Biological Sciences tested the 
combined mantle and viscera extracts of M. magnifica (#1252-3) from Mooloolaba in the brine 
shrimp assay and found that it exhibited an LC50 of 58 µg/mL (natural concentration 1.03 mg/mL). 
The extracts of M. miamirana could not be tested in the same assay due to the limited amount of 
sample. Consequently, direct comparison of the toxicity between the two species could not be drawn. 
However, we propose that the preferential sequestration of OH- and OMe-PBDEs with fewer number 
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of bromines in the mantle and dorsal horn of M. magnifica and M. miamirana may be due to the 
significant deterrent properties and low toxicity level of the selected compounds. This is also 
indicated that the sequestered O-PBDEs may play a putative role as defensive metabolites. 
 
4.3.!Conclusions 
Chromodorid nudibranchs typically sequester diterpene metabolites from their sponge preys. 
The analysis of secondary metabolites from G. coi and A. egretta that were collected along the coast 
of Queensland and New South Wales has yielded a range of spongian diterpenes. A new rearranged 
diterpene, chromolactol (4.62), possessing an unusual stereochemistry of the dioxabicyclooctane ring, 
was obtained from the mantle extract of G. coi. The relative configuration of the [3.3.0]-
dioxabicyclooctane ring in 4.62 is similar to that observed in cheloviolene A (4.63) from the sponge 
Chelonaplysilla violacea. Hence, we propose that G. coi is probably feeding on this sponge. Another 
new diterpene, 7α-hydroxy-dendrillol-3 (4.77) was isolated from the gut extract of A. egretta. The 
relative configuration of 4.77 was determined by coupling constant analysis that indicated a boat 
conformation of ring C, as previously observed in dendrillol-3 (4.76).   
To date, Miamira is the only genus of Chromodorid nudibranchs that sequesters O-PBDEs, 
rather than terpenes, from their food source. M. magnifica and M. miamirana were found to sequester 
OH-PBDEs and OMe-PBDEs, respectively. The anatomical distribution analysis of O-PBDEs in 
Miamira spp. suggested that these nudibranchs selectively accumulate O-PBDEs with fewer number 
of bromines in the mantle tissues. We hypothesize that this is probably due to the significant deterrent 
activity and low toxicity of the selected O-PBDEs.  Compared to other dorid nudibranchs, M. 
magnifica and M. miamirana may also have developed adaptive digestive systems that enable them 
to consume O-PBDEs without damaging their internal organs. However, further research would be 
needed to be undertaken to test this hypothesis. 
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CHAPTER 5! 
Sesquiterpenes from Chromodorid and Dendrodorid nudibranchs 
 
5.1.!Introduction 
 This chapter covers the isolation of furanosesquiterpenes from two species of Chromodorid 
nudibranchs, Ceratosoma trilobatum and Ceratosoma brevicaudatum as well as from two species of 
Dendrodorid nudibranchs, Dendrodoris krusensternii and Dendrodoris nigra. Eleven 
monofuranosesquiterpenes were obtained from the mantle and viscera extracts of C. trilobatum and 
C. brevicaudatum, such as dendrolasin (5.1), 6E,8Z,10E-dehydrodendrolasin (5.2), 6E,8E,10E- 
dehydrodendrolasin (5.3), furodysinin (5.8), furodysin (5.14), pallescensin A (5.16), euryfuran (5.17), 
nakafuran-9 (5.21), pallescensin B (5.23), agassizin (5.26) and dihydropallescensin-2 (5.31). A series 
of drimane esters 5.33 containing fatty acyl residues was also isolated from the extracts of D. 
krusensternii and D. nigra. The fatty acid components of the drimane esters were identified by fatty 
acid methyl ether (FAME) analysis.  
 Sections 5.1.1.-5.1.2. in this chapter review the reported sesquiterpenes from selected 
Chromodorid and Dendrodorid nudibranchs. The isolation and identification of furanosesquiterpenes 
from C. trilobatum and C. brevicaudatum are presented in sections 5.2.1.1. and 5.2.1.2., respectively. 
The anatomical distribution of furanosesquiterpenes in Ceratosoma spp. is described in section 
5.2.1.3. Sections 5.2.1.1. and 5.2.1.2. highlight the fatty acid compositions of drimane esters from the 
extracts of D. krusenternii and D. nigra. Furthermore, the antifeedant properties of these extracts is  
discussed in section 5.2.3.  
 
5.1.1.!Furanosesquiterpenes from selected Chromodorid nudibranchs  
In addition to diterpenes (see Chapter 4), Chromodorid nudibranchs may also acquire 
sesquiterpene metabolites from their dietary sponges. Chromodorid nudibranchs, such as Ceratosoma 
spp., Chromodoris spp., and Hypselodoris spp. have been reported to contain furanosesquiterpenes. 
The simplest forms of furanosesquiterpene isolated from nudibranchs are composed of a furan ring 
with an alkenyl side chain as exemplified by dendrolasin (5.1), that was originally isolated as the 
odorous substance of the ant Dendrolasius fuliginosus.427 Terpene 5.1 is commonly found in various 
species of Hypselodoris nudibranchs,428,429 and occasionally reported from other species such as 
Chromodoris lochi430 and Tyrinna nobilis (= delicata).431 Terpene 5.1 was found to be inactive in a 
toxicity assay against the mosquitofish Gambusia affinis.3 The derivatives of 5.1, i.e. 
dehydrodendrolasins (5.2-5.3) and 5-OAc-dendrolasin (5.4) have been observed from C. 
brevicaudatum432 and H. jacksoni,433 respectively. Further analysis of the extracts of C. 
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brevicaudatum432 and H. cantabrica3 yielded linear bisfuranosesquiterpenes, such as 
dehydrolasiosperman (5.5) and tavacfuran (5.6). Investigation of the anatomical distribution of 
furanosesquiterpenes in H. webbi led to the isolation of longifolin (5.7) from the mantle dermal 
formations (MDFs) that indicated its potential role as a chemical defense.310  
 
 
 
Tricyclic furanosesquiterpenes containing a decalin system are also common metabolites in 
Chromodorid nudibranchs. Furodysinin (5.8) has been isolated from the nudibranchs C. funerea (= 
lineolata)390 and Hypselodoris spp.351,428 Both enantiomers of furodysinin (5.8) were ichtyotoxic 
against G. affinis.429,434 The extracts of C. brevicaudatum contain unusual sulfur-containing 
furodysinins (5.9-5.11);432 whereas those of H. lajensis435 and C. funerea (= lineolata) contain 
furodysinin lactones (5.12-5.13).390 Chemical analysis of H. californiensis,428 H. porterae,428 H. 
webbi436 and H. zebra437 yielded additional tricyclic furanosesquiterpenes, such as furodysin (5.14), 
microcionin-1 (5.15), pallescensin A (5.16) and euryfuran (5.17). (+)-Pallescensin A (5.16) was 
unpalatable to the sculpin Clinocottus analis.28  
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 Hypselodoris nudibranchs have been rigorously studied due to their chemical diversity. 
Furanosesquiterpenes with a furan ring attached to a bridged bicyclo system, such as nakafuran-8 
(5.18) and nakafuran-9 (5.21) have been detected in H. godeffroyana and Chromodoris (= 
Hypselodoris) maridadilus, respectively.438 Terpene 5.21 has also been detected in various species of 
Hypselodoris nudibranchs404,428,429 and was distasteful to G. affinis429 and the common reef fishes 
Chaetodon spp.438 The isomer of 5.21, isonakafuran-9 (5.22) was first found in the extracts of H. 
villafranca, H. cantabrica and H. tricolor from the Cantabrian sea.439 The latter also sequesters 
spiniferin-1 (5.24) from its sponge prey.440 Additional nakafurans (5.19-5.20) were isolated from the 
extract of H. zebra.437 Moreover, the isomer of 5.18, pallescensin-B (5.23), was accumulated in the 
mantle of the Indopacific nudibranchs, Ceratosoma trilobatum and Ceratosoma gracilimum.434  
 
 
 
Hypselodoris nudibranchs from various geographical locations selectively prey upon sponges 
containing furanosesquiterpenes. The Mediterranean H. tricolor436 and the Hawaiian H. daniellae313 
sequester the tricyclic furanosesquiterpene, spiniferin-2 (5.25), from their diet. Meanwhile, agassizin 
(5.26) was present in the Mexican H. agassizi,428 the Mediterranean H. cantabrica429 and the 
Australian H. jacksoni.433 The latter also contained a furanosesquiterpene with a monocyclic farnesyl 
moiety, namely pallescensone (5.27) and a unique dihydrofuran with an esterified spirolactol 
skeleton, dehydroherbadysidolide (5.32).433 Based on an experiment in an aquarium, the Spanish H. 
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webbi accumulates microcionins 1-4 (5.15, 5.28-5.31) from the sponge Microciona toxystila in the 
MDFs.440 Furthermore, the isomer of 5.30, dihydropallescensin-2 (5.31) was obtained from T. nobilis 
collected from Argentina.431  
 
5.1.2.!Drimane sesquiterpenes from selected Dendrodorid nudibranchs  
 In contrast to other families of nudibranchs, dorid nudibranchs elaborate defense strategies 
involving de novo biosynthesis, independent of their diet.309,441 The biosynthetic origin of drimane 
sesquiterpenes in Dendrodorid nudibranchs has been rigorously studied441–445 and will be discussed 
at the end of this chapter.  
Cimino and co-workers (1981) investigated the digestive gland extract of Dendrodoris 
limbata and isolated drimane esters (5.33).446 One year later, the same group re-investigated 
additional specimens and found that the digestive gland contained 5.33 and the mantle extract 
accumulated polygodial (5.34).447 The ecological data showed that 5.33 was inactive as an 
antifeedant, whereas 5.34 was immediately rejected by the marine fish Chromis chromis.447  
 
 
 
Olepupuane (5.35) was isolated as a mixture with polygodial (5.34) from a series of non-
dissected Dendrodoris nudibranchs, such as D. nigra, D. tuberculosa and D. krebsi collected from 
Oahu. Olepupuane (5.35) and drimane esters (5.33) were also obtained from Doriopsilla albopunctata 
collected from Baja, California and Doriopsilla janaina collected from Bahia de los Angeles, Mexico. 
The composition of drimane sesquiterpenes in D. albopunctata varied according to the collection 
sites. D. albopunctata from La Jolla, California contained only polygodial (5.34), whereas those from 
Sunset Cliffs, California contained only methoxy acetal 5.36. Olepupuane (5.35) exhibited 
antifeedant activity against the Pacific damsel fish Dascyllus aruanus with an ED50 value of 15-20 
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µg/mg of pellet.448 The acetoxy derivative of 5.35 (5.37) was obtained from the mantle extract of 
Dendrodoris grandiflora. The digestive gland extract of the same species yielded 5.33, along with 
various furanosesquiterpenes that appeared to be of dietary origin.442 The Cimino group further 
investigated the anatomical distribution of drimane sesquiterpenes in the Mediterranean D. limbata 
and D. grandiflora and isolated 7-deacetoxy-olepupuane (5.38) in the mantle tissue of both species.449  
 
 
 
Originally reported from the bark of Cinnamosma fragrans,450,451 cinnamolide (5.39) has been 
commonly isolated from terrestrial plants451–458 but only rarely found in a marine organism. Grkovic 
et al (2005) reported the detection of 5.39 from D. krusensternii collected in New Zealand. 
Cinnamolide 5.39 was isolated in significantly higher concentration (3 mg/g dry weight) from the 
external organs (skin and mantle) compared to that from the digestive glands (1 mg/g dry weight). 
These results indicated the use of 5.39 as a predator deterrent,459 although the ecological data of 5.39 
has not been established to date.  Additionally, a series of cytotoxic drimane sesquiterpenes, namely 
dendocarbins A-N (5.40-5.53), were isolated from the Japanese Dendrodoris carbunculosa along 
with isodrimeninol (5.54) and 11-epivaldiviolide (5.55). The major component of the animal 5.54 
was found to have a sharp peppery taste.460  
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5.2.!Results and discussion 
5.2.1.!Secondary metabolites from Ceratosoma spp. 
5.2.1.1.!Furanosesquiterpenes from Ceratosoma trilobatum  
 Three specimens of Ceratosoma trilobatum (#1017, #1031-2) were collected at a dive site 
near Amity Point, Moreton Bay, QLD in June and July 2014. The purification of the mantle and gut 
extracts was carried out by NP flash chromatography and NP HPLC to yield dendrolasin (5.1), 
furodysinin (5.8), furodysin (5.14), pallescensin A (5.16), euryfuran (5.17), agassizin (5.26) and 
dihydropallescensin-2 (5.31) (Scheme 5.1). The identification of these compounds was conducted by 
dereplication analysis using in-house and third party (Marinlit, Scifinder Scholar and Reaxys) 
databases. 
 
 
Scheme 5.1. Isolation procedure of furanosesquiterpenes from C. trilobatum 
 
Dendrolasin (5.1) was found as the major component in the gut and the minor component in 
the mantle extracts of C. trilobatum. Terpene 5.1 showed a molecular ion peak at m/z 218 [M]+ in the 
GC-MS. In the 1H NMR data, the furan protons were diagnostic from three signals that resonated 
between δH 6.00-7.50, in which the α-furan protons at δH 7.34 (br t, 1.6) and at δH 7.21 (br s) are more 
downfield than that of the β-furan proton at δH 6.28 (br s).351 There were also two alkene signals at 
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δH 5.17 (t, 7.0) and δH 5.08 (t, 6.7) as well as three vinyl methyls at δH 1.68 (br d, 0.8), 1.60 (br s) and 
1.59 (br s). These 1H NMR data were consistent with those reported by our group.351 
The planar structure of dendrolasin from Dendrolasius fuliginosus was determined by Quilico 
and co-workers (1957) by chemical derivatization studies,427 but the stereochemistry of the double 
bond and the assignment of the methyls were not established. Numerous isolation and synthesis 
studies also did not provide the characterization of 5.1. Our group recently characterized the E-
geometry of C-7/C-8 double bond by a NOE experiment where the signal of H2-9 was increased upon 
irradiation of H-7. Furthermore, irradiation of H-11 sharpened the signal of Me-14, indicating that 
the two protons were on the same side of the double bond (Figure 5.1).351  
 
 
Figure 5.1. Selected NOESY correlations of 5.1351 
 
Furodysinin (5.8) ([α]D -5, c 0.05, CHCl3) was predominant in the mantle extract of C. 
trilobatum and was isolated as the minor compound in the gut tissue. Terpene 5.8 displayed an m/z 
216 [M]+ in the GC-MS, two mass units difference from that of 5.1. The α- and β-furan protons were 
observed at δH 7.21 (br s) and 6.24 (d, 1.9), respectively. The alkene signal was seen at δH 5.62 (br s), 
whereas the methyl signals were detected at δH 1.66 (br s), 1.20 (s) and 1.18 (s). These 1H NMR data 
matched closely with those of synthetic (-)-furodysinin whose absolute configuration has been 
established as 5S, 10R.461 In addition to Hypselodoris spp,428,433,436 (-)-furodysinin has also been 
isolated from Dysidea sponges,462–464 whereas its enantiomer has been reported from the dorid 
nudibranch Hexabranchus sanguineus (Spanish dancer).465  
 Furodysin (5.14) ([α]D -13, c 0.01, CHCl3) was isolated in the gut extract of C. trilobatum as 
the minor metabolite and showed an identical molecular ion peak to that of 5.8 in the GC-MS. The 
1H NMR spectrum of 5.14 was similar to that of 5.8, except that the proton chemical shifts were 
slightly shifted upfield, suggesting that 5.8 and 5.14 were positional isomers. There were signals at 
δH 7.23 (d, 1.9) and 6.14 (d, 1.9) that corresponded to the furan protons. The alkene was observed at 
δH 5.28 (br s), along with three methyl signals at δH 1.69 (br s), 1.29 (s) and 1.07 (s). The 1H NMR 
data of 5.14 were in agreement with those of (-)-furodysin that was synthesized by Vaillancourt and 
co-workers (1991). In their work, the absolute configuration of (-)-furodysin was established as 5S, 
10R.461 The difference of the chemical shifts of the respective protons in 5.14 and 5.8 is caused by 
the position of oxygen in the furan ring. In 5.14, the oxygen is adjacent to the gem-dimethyl group, 
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whereas in 5.8 the oxygen is next to the allylic protons. In nature, 5.14 usually co-occurs with 5.8 in 
sponges390,462 and nudibranchs,390,436,466 suggesting that they share a common biogenetic origin.  
 Pallescensin A (5.16) was isolated as a mixture with dihydropallescensin-2 (5.31) from the 
gut extract. In the GC-MS, 5.16 showed a molecular ion peak at m/z 218 [M]+. The 1H spectrum of 
5.16 showed signals at δH 7.18 (d, 1.8) and 6.11 (d, 1.8) that were appropriate for α- and β-furan 
protons as well as three methyl signals at δH 1.19 (s), 0.93 (s) and 0.90 (s). These 1H NMR data 
corresponded well with those reported for synthetic (+)-pallescensin A by Smith and Mewshaw 
(1984).467 The absolute configuration of (+)-pallescensin A as 5S, 10S was established by Matsumoto 
and Usui (1978) via chemical synthesis.468 Recent synthesis work on (±)-pallescensin A was also 
reported by the Banwell group.469 Ent-Pallescensin A has been reported from the Portuguese sponge 
Fasciospongia sp.470  
 Euryfuran (5.17) was obtained along with furodysin (5.14) from the gut extract of C. 
trilobatum. The GC-MS profile of 5.17 showed an identical molecular ion peak to that of 5.16. The 
furan protons resonated at δH 7.08 (br d, 1.4) and 7.05 (br d, 1.4), whereas three methyl signals were 
detected at δH 1.20 (s), 0.94 (s) and 0.90 (s). These data were in agreement with those of (-)-euryfuran 
from Euryspongia sp. where it was originally isolated from.471 Cortes and co-workers reported the 
absolute configuration of (-)-euryfuran in 1987.471 The positive enantiomer of euryfuran has been 
isolated from an Australian sponge Dysidea sp.472 and the Portuguese nudibranch Doriopsilla 
pelseneeri.473  
 Agassizin (5.26) ([α]D +25, c 0.01, CHCl3) was isolated as the minor component in the mantle 
and gut extracts of C. trilobatum, displaying a molecular ion peak of m/z 214 [M]+ in the GC-MS. 
The 1H NMR spectrum of 5.26 contained signals for two furan protons at δH 7.16 (br s) and 6.11 (br 
s); three alkenes at δH 5.80 (ddd, 9.0, 5.0, 2.8), 5.67 (d, 5.0), 5.47 (dd, 9.0, 2.8); a bis-allylic methylene 
at δH 3.61 (d, 15.4), 3.25 (d, 15.4); and two methyls at δH 1.00 (d, 7.2) and 0.87 (s). These 1H NMR 
data were consistent with (-)-agassizin from H. agassizi.428 The enantiomer of agassizin has been 
reported by our group from H. jacksoni.433  
 
 
  
Hochlowski et al (1982) established the relative configuration of (-)-agassizin by NOE 
correlations, coupling constant analysis and comparison of 1H NMR data to those of pallescensin G 
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(5.58). Irradiation of the H-4 signal resulted in the sharpening of the H-2 signal. The small coupling 
constant (J = 2.5 Hz) between H-3 and H-4, as well as the presence of allylic coupling between H-2 
and H-4 requires C-4 to be orthogonal to the diene system. Accordingly, the methyl groups should be 
cis to one another.428  
In the current work, we determined the absolute configuration of 5.26 by measuring the 
electronic circular dichroism (ECD) profile of (+)-agassizin (5.26). ECD is a powerful tool to 
determine the absolute configuration of a natural product based on the presence of chromophore in 
the molecule. In (-)-agassizin, the presence of a furan moiety and a conjugated s-cis diene contributed 
to π ! π* transition that gives rise to UV maxima at 225 (ε 9250) and 266 nm (ε 3470), 
respectively.428  
 
 
Scheme 5.2. i) Diene conformation and helicity; ii) s-cis-diene helicity rule (R = rotatory power)474 
 
As shown in Scheme 5.2, a diene chromophore may exist in either planar or skewed 
conformations. The latter can occur with either P helicity (torsional angle θ > 0) or M helicity 
(torsional angle θ < 0). Consequently, optical activity of the diene chromophore can be measured in 
relation to helicity that represents the skew angle θ of the π-electron system. The constant property 
of an optically active molecule is defined as a specific rotatory power.475 The rotational power of a 
skewed diene should be large, in comparison to that of a planar diene.474 Moscowitz et al (1961) 
postulated a positive rotatory power for P helicity and a negative rotatory power for M helicity in s-
cis dienes based on the empirical data of various s-cis terpenes and steroid dienes.476  
The measurement of (+)-agassizin by ECD spectroscopy showed a positive Cotton effect at 
266 nm that indicated a P helicity of the s-cis diene (Figure 5.2). These ECD results were then 
compared to those of compounds containing s-cis diene systems, i.e. sterols whose absolute 
configurations have been determined by X-ray crystallography (Figure 5.3).  
P helicity
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M helicity
R < 0
s-cis s-trans
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Figure 5.2. ECD profile of (+)-agassizin (5.26) in MeOH solution at ambient temperature  
 
 
Figure 5.3. Sterols containing an s-cis diene system477–480 
 
Figure 5.3 shows the application of the diene helicity rule to a series of Δ5,7-sterols containing 
a 2,4-diene system similar to that in 5.26. Ergosterol showed a negative Cotton effect at 269 nm as a 
result of the M helicity of the diene. On the other hand, isopyrocalciferol, pyrocalciferol and 
lumisterol showed positive Cotton effects that corresponded to the P helicity of the diene. These 
results suggested that the diene helicity rule predicts the ECD data correctly for this group of 
compounds.  
To predict the helicity of the s-cis dienes in 5.26, two candidate enantiomers was modeled by 
ChemBio 3D Ultra (Cambridge) with energy minimization at the MM2 level to an RMS gradient of 
0.1. As shown in Figure 5.4, the s-cis diene of the cyclohexadiene ring adopts a skewed conformation. 
The methyl at C-4 was shown in equatorial position and that at C-5 was axially orientated. For 4R,5S-
agassizin (5.26a), the skewed s-cis diene was predicted to adopt P helicity, whereas that of 4S,5R-
agassizin (5.26b) was estimated to adopt M helicity. Since the predicted helicity for 4R,5S-agassizin 
(5.26a) was in agreement with the empirical data, the absolute configuration of (+)-agassizin was thus 
determined as 4R, 5S. 
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Figure 5.4. Chem3D molecular models of (+)-4R,5S-agassizin (5.26a) and (+)-4S,5R-agassizin 
(5.26b) with hydrogen atoms omitted from the models for clarity. The skewed s-cis diene 
for each model is highlighted in yellow. 
 
Dihydropallescensin-2 (5.31) was obtained as a mixture with pallescensin A (5.16) from the 
gut tissue of C. trilobatum and showed a molecular ion peak at m/z 218 [M]+ in the GC-MS. The 1H 
NMR data showed signals for three furan protons at δH 7.34 (br t, 1.7), 7.20 (br s), 6.26 (br s); an 
exomethylene at δH 4.80 (br s) and 4.58 (br s); and two methyls at δH 0.91 (s) and 0.84 (s). These data 
were consistent with those of synthetic (+)-dihydropallescensin-2 whose absolute configuration was 
determined as 1’S by Kurth and Soares (1987).481 Terpene 5.31 was initially isolated from the 
nudibranch Cadlina luteomarginata.28 Later, the same compound was obtained from the sponges 
Dysidea fragilis482 and Dysidea septosa.403  
 
5.2.1.2.!Furanosesquiterpenes from Ceratosoma brevicaudatum  
 A specimen of C. brevicaudatum (#1180) was collected at a dive site near Coffs Harbour, 
NSW in October 2014 and subsequently dissected into three parts: mantle, gut and dorsal horn before 
extraction. Each body part extract was subsequently purified to obtain dendrolasin (5.1), 6E,8Z,10E-
dehydrodendrolasin (5.2), 6E,8E,10E-dehydrodendrolasin (5.3), furodysinin (5.8), euryfuran (5.17), 
nakafuran-9 (5.21) and pallescensin B (5.23) (Scheme 5.3).  
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Scheme 5.3. Isolation procedure of furanosesquiterpenes from C. brevicaudatum 
 
6E, 8Z, 10E-Dehydrodendrolasin (5.2) was obtained as a mixture with dendrolasin (5.1) in 
the mantle and gut extracts of C. brevicaudatum, displaying a molecular ion peak at m/z 216 [M]+ in 
the GC-MS. The furan protons were observed at δH 7.37 (br t, 1.7), 7.28 (m) and 6.29 (br s), whereas 
five alkenes were detected at δH 6.70 (d, 16.0), 6.42 (dd, 15.0, 1.3), 5.88 (d, 11.0), 5.78 (dt, 15.5, 6.9), 
and 5.62 (dd, 15.0, 6.9). There were also signals for a bis-allylic methylene at δH 3.30 (d, 6.9), a vinyl 
methyl at δH 1.85 (s) and two overlap doublet methyls at δH 1.02 (d, 6.6) in the 1H NMR spectrum. 
These data were identical to those reported for the same metabolite from the South Australian C. 
brevicaudatum. Ksebati and Schmitz (1988) determined the stereochemistry of the double bonds by 
NOE correlations, coupling constant analysis and the chemical shift of the vinyl methyl.432  
6E, 8E, 10E-Dehydrodendrolasin (5.3) was isolated from the mantle and gut extracts of C. 
brevicaudatum. Terpene 5.3 showed an identical molecular ion peak to that of 5.2. The 1H NMR data 
of 5.3 was also similar to those of 5.2, except that H-7 was shifted upfield from δH 6.70 (d, 16.0) in 
5.2 to 6.15 (d, 16.0) in 5.3, indicating a trans configuration in the adjacent double bond. The 1H NMR 
data of 5.3 were also consistent to those of Ksebati and Schmitz’s (1988). They conclusively 
established the E-configuration for the C-8/C-9 double bond from the upfield 13C chemical shift of 
the vinyl methyl.432 The Cimino group isolated 5.3 from the sponge Pleraplysilla spinifera and 
determined the stereochemistry of the double bond by NOE correlations and coupling constant 
analysis.483 Terpene 5.3 has also been detected in Australian sponges Euryspongia spp. 
(Dysideidae).484,485  
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5.8 (0.5 mg)
5.17 and 5.23 (0.2 mg)
5.21 (0.1 mg)
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  Nakafuran-9 (5.21) ([α]D +29, c 0.01, CHCl3) was detected in the mantle and gut extracts of 
C. brevicaudatum and gave a molecular ion peak at m/z 216 [M]+ in the GC-MS. The 1H NMR 
features of 5.21 contained signals for two furan protons at δH 7.11 (br d, 1.6) and 6.06 (br d, 1.6); an 
allylic methine at δH 3.17 (br s); two vinyl methyls at δH 1.59 (s) and 1.58 (s) and a methyl at δH 1.07 
(s). The 1H NMR data of 5.21 were in agreement with those reported for (-)-nakafuran-9 from H. 
infucata.486 This is the first report of the isolation of (+)-nakafuran-9 from nature.  
Pallescensin-B (5.23) was observed as a mixture with euryfuran (5.17) in the mantle and gut 
extracts of C. brevicaudatum. Terpene 5.23 displayed an identical molecular ion peak in the GC-MS 
profile to that of 5.21. There were signals for furan protons at δH 7.09 (br d, 1.8) and 6.05 (br d, 1.8); 
an alkene at δH 5.83 (dd, 7.5, 1.4); an allylic methine at δH 3.45 (td, 7.3, 2.3); a vinyl methyl at δH 1.81 
(d, 1.8) and two methyls at δH 0.94 (s) and 0.79 (s) in the 1H NMR spectrum. The featured signals of 
5.23 were identical to those of synthetic (±)-pallescensin B reported by Liu and Liao (1999).487  
 
5.2.1.3.!Anatomical distribution and antifeedant properties of furanosesquiterpenes 
 Chemical investigation of the extracts of C. trilobatum and C. brevicaudatum suggested that 
both species accumulated secondary metabolites previously obtained from sponges of the family 
Dysideidae (Table 5.1). In C. trilobatum, dendrolasin (5.1) was found as the major component in the 
gut extract, whereas furodysinin (5.8) was predominant in the mantle (Table 5.1). Our collaborators 
at the School of Biological Sciences tested the extract of C. trilobatum in toxicity and palatability 
assays. It was found that the extract of C. trilobatum was toxic against brine shrimp (LD50 5.1 mg/mL, 
natural concentration 7.5 mg/mL) and was distasteful to the Palaemon shrimp at natural 
concentration. 
To investigate the accumulation of certain furanosesquiterpenes as defensive allomones, C. 
brevicaudatum was dissected into mantle, gut and dorsal horn. In contrast to those of C. trilobatum, 
the mantle and gut extracts of C. brevicaudatum had the same chemical composition (Table 5.1). A 
distinctive chemical distribution was observed in the dorsal horn with furodysinin (5.8) as the major 
component. The extract of C. brevicaudatum exhibited similar activities to those of C. trilobatum. 
The extract of C. brevicaudatum was toxic against brine shrimp (LD50 4.4 mg/mL, natural 
concentration 6.1 mg/mL) as well as distasteful to the Palaemon shrimp and the common toadfish at 
a natural concentration in the bioassays conducted by our collaborators. 
The anatomical distribution of furanosesquiterpenes in C. trilobatum and C. brevicaudatum 
indicated the selective sequestration of furodysinin (5.8) in the mantle and dorsal horn, suggesting its 
function as a chemical defense. The exclusive incorporation of 5.8 in the mantle tissue of the 
Indopacific C. trilobatum and the dorsal horn of C. gracilimum has also been reported by the Cimino 
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group.434 Furodysinin 5.8 repelled the shrimp Palaemon elegans at a concentration of 1 mg/mL.488 
The bioactivities of the extracts of C. trilobatum and C. brevicaudatum in the current work may have 
been underestimated, due to the volatile nature of furanosesquiterpenes and thus they were easily 
evaporated during the extract preparation. Furthermore, the presence of other furanosesquiterpenes 
in the extracts of C. trilobatum and C. brevicaudatum may also have obscured the activity of 
furodysinin (5.8) in the bioassays.   
 
Table 5.1. Anatomical distribution of furanosesquiterpenes in C. trilobatum and C. brevicaudatum 
Compounds Sponge origin C. trilobatum C. brevicaudatum Ma Gb M G Hc 
Dendrolasin (5.1) C. mycofijiensis430 
Dictyodendrilla sp.489 
F. rimosa490 
++ +++ + ++ + 
6E,8Z,10E-Dehydrodendrolasin (5.2) n/ad - - + + - 
6E,8E,10E-Dehydrodendrolasin (5.3) P. spinifera483 
Euryspongia sp.484 
E. deliculata485 
- - + + - 
Furodysinin (5.8) Dysidea sp.462 
D.herbacea463 
Dysidea sp.464 
+++ ++ +++ + ++ 
Furodysin (5.14) Dysidea sp.390,462 -  - - - 
Pallescensin A (5.16) D. pallescens491 
Fasciospongia sp.470 
- + - - - 
Euryfuran (5.17) Euryspongia sp.471 
Dysidea sp.472 
- + + + + 
Nakafuran-9 (5.21) D. fragilis438 - - + + - 
Pallescensin B (5.23) D. pallescens491 - - + + + 
Agassizin (5.26) n/ad + + - - - 
Dihydropallescensin-2 (5.31) D. fragilis482 
D. septosa403 
- + - - - 
amantle; bgut; chorn; dNot available   
 
The accumulation of dendrolasin (5.1) in the gut extracts of C. brevicaudatum and C. 
trilobatum indicated its role as the precursor for other furanosesquiterpenes. Schulte and co-workers 
(1980) proposed the generation of nakafuran and pallescensin terpenes from dendrolasin (5.1) by 
transannular carbocation cyclization and cationic rearrangement (Scheme 5.4). The production of 
nakafuran-9 (5.21) from nakafuran-8 (5.18) involves a Wagner-Meerwein like rearrangement and 
hydrogen migration to the adjacent carbon.438 Kazlauskas and colleagues (1978) suggested that 
dendrolasin (5.1) may be converted into furodysinin (5.8) and furodysin (5.14) via spirodysin (5.59) 
as the intermediate.462,492  
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Scheme 5.4. Proposed biogenetic pathway of furanosesquiterpenes isolated in this study438 
 
5.2.2.!Secondary metabolites from Dendrodoris spp. 
5.2.2.1.!Fatty acid composition of drimane esters from Dendrodoris krusensternii  
 An individual of D. krusensternii (#110) was collected in Moreton Bay, QLD in September 
2012 and was dissected into mantle and gut tissues. The 1H NMR profiles for each of the mantle and 
gut extract were recorded before bioassay and chemical analysis. A portion of the combined extract 
was used for bioassay and the remaining was separated by NP flash chromatography, followed by RP 
HPLC (100% MeOH) to afford a mixture of 5.33 containing fatty acid side chains and cinnamolide 
(5.39) (Scheme 5.5). 
Cinnamolide (5.39) ([α]D -5, c 0.16, CHCl3) was detected in the mantle extract of D. 
krusensternii and displayed a molecular ion peak at m/z 234 [M]+ in the GC-MS. The 1H NMR spectra 
of 5.39 showed signals for an alkene from an α,β-unsaturated lactone at δH 6.83 (q, 3.4), an AB 
methylene at δH 4.42 (t, 9.2) and 4.08 (t, 9.2, H-11b), an allylic methine at δH 2.90 (ddddd, 9.2, 9.2, 
5.1, 3.6, 3.6), an allylic methylene at δH 2.45 (ddd, 20.4, 4.2, 4.2) and 2.17 (dddd, 20.4, 4.9, 5.0, 3.3) 
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and three methyl signals at δH 0.97 (s, Me-12), 0.93 (s, Me-13) and 0.83 (s, Me-14). These data were 
in agreement with those reported for (-)-cinnamolide from the stem bark of Warburgia spp.493 The 
absolute configuration of (-)-cinnamolide has been established as 5S, 9S, 10R450 by chemical 
correlations to polygodial (5.34).494  
 
 
Scheme 5.5. Isolation procedure of drimane esters from D. krusensternii  
   
A mixture of drimane esters (5.33) was collected from RP HPLC (100% MeOH) and 
identified based on the diagnostic furan signals at δH 6.32 (d, 2, H-11) and 6.05 (t, 2, H-12) as well 
as three methyl signals at δH 0.88 (s, Me-15), 0.83 (s, Me-14) and 0.81 (s, Me-13) that matched closely 
to those of drimane esters from D. limbata.446 The presence of polyunsaturated fatty acids was evident 
from the intense signal of alkene protons at δH 5.36 (m) and an alkyl chain at δH 1.26 (m). Cimino et 
al (1981) reported that the heating of 5.33 in n-hexane solution in silica gel for a few minutes, 
followed by filtration resulted in the elimination of the fatty acyl residues to give 5.56 (Scheme 
5.6).446 
 
Dendrodoris krusensternii #110
Mantle (12.0 g wet wt.) 
- NP flash chromatography (100% 
hexanes ! 100% DCM)
Fraction 1
-Extracted with acetone (7 x 25 mL)
-Partitioned against Et2O (3 x 10 mL)
- dissected
Gut (9.5 g wet wt.)
-Extracted with acetone (7 x 10 mL)
-Partitioned against Et2O (5 x 5 mL)
Et2O extract (34 mg) Et2O extract (126 mg)bioassay
A mixture of 5.33 (13.0 mg)
- RP HPLC (100% MeOH)
5.39 (1.6 mg)
- RP HPLC (100% MeOH)
Fractions A-O
- Reacted with 0.12 M HCl/MeOH
- Refluxed at 60 oC for 1 hour
FAME derivatives
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Scheme 5.6. The elimination of fatty acyl residue in 5.33 by heating in n–hexane solution446 
 
Various studies have reported the isolation of natural products with fatty acid chains from 
marine sponges.495 Our group has also investigated the fatty acid composition in the sponges 
Amphimedon terpenensis,496 Coscinoderma matthewsi497 and Aplysinella strongylata.498 The isolated 
fatty acid fragments may have a linear or branched chain with iso and anteiso arrangement of the 
terminal methyls. The most common method to determine the composition of fatty acid is by using 
fatty acid methyl ester (FAME) analysis. This technique involves the methylation of the fatty acid 
components by an acid catalyst under mild temperature condition.499 The ester products can then be 
readily analyzed by GC-MS to determine the length of the fatty acids and the type of the terminal 
methyls. The latter can also be ascertained by 1H NMR analysis.  
In the GC-MS, the presence of a methyl ester can be identified based on a distinctive base 
peak at m/z 74 that corresponds to the McLafferty rearrangement ion (Scheme 5.7).500 Often a 
molecular ion peak of [M-31]+ that represents the loss of a methyl ester can also be seen. A linear 
saturated fatty acid chain is commonly featured by the presence of a homologue series with 14 amu 
difference in the GC-MS profile.501 However, this feature alone can overlap with that of branched 
fatty acids.  
 
 
Scheme 5.7. The McLafferty rearrangement  
 
The location of the methyl branch may be distinguished by the fragmentation pattern of the 
FAME that has methyl branching in the chain (Figure 5.5). The diagnostic fragmentation peaks are 
generated by simple cleavage or expulsion of hydrocarbon moieties from within the chain. A primary 
ion (a) is formed when the cleavage occurs on the ester side of the methyl branch to yield CH3-O-
CO-(CH2)n+ ion. If the cleavage occurs on the other end of the chain as to include the methyl branch, 
a secondary ion (b) (CH3-O-CO-(CH2)n-CH+-CH3) would be generated. The c ion results from the 
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loss of CH3OH from the b ion. The d ion is formed when the c ion loses H2O. Sometimes c+1 and 
d+1 ions can also have diagnostic values. The iso branched chain is characterized by the presence of 
the d ion ([M-65]+) and the b ion at m/z 43. Meanwhile, the anteiso branched chain yields prominent 
b ions ([M-29]+ and [M-57]+), a c+1 ion ([M-61]+) and a d ion ([M-79]+). Additionally, the loss of 
tert-butyl group also yields a secondary ion peak at m/z 57.502 The position of the methyl branch in a 
FAME can also be determined based on the GC retention behavior, that is presented as an equivalent 
chain length (ECL) value.502 In the GC-MS, an iso type fatty acid is usually eluted first followed by 
anteiso and linear fatty acids.501  
 
 
Figure 5.5. GC-MS fragmentation pattern of iso-, anteiso- and linear FAME from D. krusensternii 
 
The 1H NMR spectra can also be used to distinguish the type of terminal methyls in fatty acids 
by observing the multiplicity pattern of the terminal methyls. A triplet methyl signal (J = 6-7 Hz) is 
diagnostic for a linear fatty acid. The methyl signals of an iso derivative are observed as an overlapped 
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doublet (J = 6-7 Hz), whereas those of an anteiso chain appear as a triplet (J = 6-7 Hz) and a doublet 
(J = 6-7 Hz).351 
 
 
Scheme 5.8. Preparation of FAME derivatives 
 
In the current work, 5.33 containing a mixture of drimane esters was subjected to RP HPLC 
(100% MeOH) using two C18 columns in series to give nine fractions. The FAME derivatives were 
then prepared by reacting each fraction with 0.12 M HCl/MeOH solution, followed by reflux at 60° 
C for an hour (Scheme 5.8). The resulting products were then analyzed by GC-MS, LRESIMS and 
1H NMR.  
 
Table 5.2. Fatty acid composition of drimane esters (5.33) from D. krusensternii 
Fraction Sub-fraction GC-MS
a Fatty acid Retention time (min) m/z 
A A1  9.7 268 [M]+ Anteiso-16:1 
 A2 9.8 270 [M]+ 16:0 
 A3 11.1 298 [M]+ 18:0 
B B1 8.9 256 [M]+ Anteiso-15:0 
 B2 11.1 298 [M]+ 18:0 
C - 9.1 256 [M]+ 15:0 
D - n/db 282 [M]+ 17:1n-7c 
E E1 9.6d 270 [M]+ Iso-16:0 
 E2  9.6d 270 [M]+ Anteiso-16:0 
 E3 9.8 270 [M]+ 16:0 
 E4 10.5 284 [M]+ 17:0 
 E5 11.1 298 [M]+ 18:0 
F - 9.8 270 [M]+ 16:0 
G G1 10.9 296 [M]+ 18:1 
 G2 11.1 298 [M]+ 18:0 
H - 10.4 284 [M]+ 17:0 
I I1 9.8 270 [M]+ 16:0 
 I2 10.9 298 [M]+ Anteiso-18:0 
 I3 11.1 298 [M]+ 18:0 
 I4  11.6 n/db 19:1n-9c 
a.!Standard program: ZB-5MS column, split mode, flow 1.5 mL/min; initial oven temperature 100 °C (isothermal for 
3 min), ramp 16 °C/min to 250 °C held for 10 min; injection temperature 250 °C, total time 40 min.  
b.!n/d - Not detected  
c.! Identified by data comparison to fatty acid standards (Nu-Chek-Prep, Minnesota, USA) on DB-23 column, split 
mode, flow 1.5 mL/min; initial oven temperature 100 °C (isothermal for 2 min), ramp 6 °C/min to 220 °C then 3 
°C/min to 250 °C; injection temperature 250 °C, total time 30 min. 
d.!Overlapping peaks 
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Fraction A of the RP HPLC contained a major component (A1) and two minor components 
(A2-A3). In the GC-MS spectrum, the major component (A1) was eluted at 9.7 min and showed a 
parent ion at m/z 268 with fragmentation at m/z 236 [M-32]+ (loss of methanol from the ester moiety); 
m/z 194 [M-74]+ (rearrangement of the ester moiety); m/z 74 (McLafferty) that are typical for fatty 
acid chain.501 The 1H NMR spectra of fraction A showed two methyl signals at δH 0.89 (t, 6.5) and 
0.86 (d, 6.5) that are diagnostic for an anteiso derivative. The fatty acid was thus identified as anteiso-
16:1 (A1). The first minor component was eluted at 9.8 min and showed molecular ion peaks at m/z 
270 [M]+; m/z 239 [M-31]+; m/z 227 [M-43]+; a series of homologue from m/z 115-199 and m/z 74 
(McLafferty). This fragmentation pattern is typical for a linear hexadecanoic acid (n-16:0) side chain 
(A2). The second minor component was eluted at 11.1 min and displayed a parent ion at m/z 298 with 
fragmentation peaks at m/z 267 [M-31]+; m/z 255 [M-43]+; m/z 241 [M-57]+; a series of homologue 
from m/z 87-199 and m/z 74 (McLafferty). These features were identified as linear octadecanoic acid 
(n-18:0) side chain (A3). The 1H NMR profile of the last two components overlapped with that of the 
major component. Accordingly, the multiplicity of the terminal methyls could not be determined. 
Following the same procedure above, fatty acid methyl esters in fractions B-I of the RP HPLC were 
identified as shown in Table 5.2. Fatty acids that were available as trace amounts were identified by 
data comparison to those of standards. 
 
5.2.2.2.!Fatty acid composition of drimane esters from Dendrodoris nigra 
 Four individuals of D. nigra (#1046-8, 1064) were collected at a dive site near Cleveland 
Point, QLD in August 2014. All individuals were combined without dissection and extracted 
following the method described previously (Scheme 5.9). Each HPLC fraction was subsequently 
derivatized to generate FAME products. Due to the small amount of material, identification of some 
fatty acids was carried out by data comparison to those of standards (Table 5.3).  
  
 
Scheme 5.9. Isolation procedure of drimane esters from D. nigra  
Dendrodoris nigra #1046-1048, 1064
(2.6 g wet wt.)
- NP flash chromatography 
(100% hexanes – 100% DCM)
Fraction 2 and 3 (combined)
-Extracted with acetone (3 x 5 mL)
-Partitioned against Et2O (3 x 5 mL)
Et2O extract (18.5 mg)
A mixture of 5.33 (2.1 mg)
- RP HPLC (100% MeOH)
- RP HPLC (100% MeOH)
Fractions A-O
- Reacted with 0.12 M HCl/MeOH
- Refluxed at 60 oC for 1 hour
FAME derivatives
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 Table 5.3. Fatty acid composition of drimane esters (5.33) from D. nigra 
Fraction Sub-fraction GC-MS
a Fatty acid Retention time (min) m/z 
A A1  9.8 270 [M]+ 16:0 
 A2 11.1 298 [M]+ 18:0 
B - 9.6 268 [M]+ 18:1 
C - 9.0 256 [M]+ Anteiso-15:0 
D - 10.9 294 [M]+ 18:2 
E E1 9.2 256 [M]+ Anteiso-15:0 
 E2  11.1 298 [M]+ 18:0 
F - 10.3 n/db Anteiso-17:1c 
G G1 9.6 270 [M]+ Iso-16:0 
 G2 9.7 270 [M]+ Anteiso-16:0 
H - 9.9 n/db 19:2c 
I - 9.8 270 [M]+ 16:0 
J - 10.9 296 [M]+ 18:1 
K K1 10.2 284 [M]+ Iso-17:0 
 K2 10.3 284 [M]+ Anteiso-17:0 
 K3 10.4 284 [M]+ 17:0 
 K4 10.9d 270 [M]+ 18:1 
 K5 10.9d 298 [M]+ Anteiso-18:0 
 K6 12.0 322 [M]+ Anteiso-20:2 
 K7 12.1 322 [M]+ 20:2 
L - 10.5 284 [M]+ 17:0 
M M1 10.9 298 [M]+ Anteiso-18:0 
 M2 11.1 298 [M]+ 18:0 
 M3 11.6 n/db 19:1n-9c 
N - 11.1 298 [M]+ 18:0 
O O1 11.1 298 [M]+ 18:0 
 O2 12.1 324 [M]+ Anteiso-20:1 
 O3 12.2 324 [M]+ 20:1 
a.!Standard program: ZB-5MS column, split mode, flow 1.5 mL/min; initial oven temperature 100 °C (isothermal for 
3 min), ramp 16 °C/min to 250 °C held for 10 min; injection temperature 250 °C, total time 40 min.  
b.!n/d not detected  
c.!Identified by data comparison to fatty acid standards (Nu-Chek-Prep, Minnesota, USA) on DB-23 column, split 
mode, flow 1.5 mL/min; initial oven temperature 100 °C (isothermal for 2 min), ramp 6 °C/min to 220 °C then 3 
°C/min to 250 °C; injection temperature 250 °C, total time 30 min. 
d.!Overlapping signals 
  
5.2.2.3.!The antifeedant properties of Dendrodoris extracts 
In the bioassays conducted by our collaborators, the extracts of D. krusensternii and D. nigra 
were inactive in the brine shrimp toxicity assay and were palatable to the common toadfish T. 
hamiltoni. The extract of D. krusensternii was also palatable to the shrimp P. serenus, whereas the 
extract of D. nigra was not tested in the same experiment due to the small amount of material. The 
lack of antifeedant activity of drimane esters (5.33) as the major component in D. krusensternii and 
D. nigra, suggested different physiological functions of this compound in the mollusks.444 
The Cimino group reported the high distribution of drimane esters (5.33) in the digestive 
glands and the absence of the same compound in the mantle of D. limbata, indicating that drimane 
esters (5.33) do not play a role as defensive metabolites. On the contrary, polygodial (5.34) was 
predominant in the mantle and was highly toxic, even to the animal itself.447 The contrasting 
biological activity of drimane esters (5.33) and polygodial (5.34) raised a speculation that polygodial 
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(5.34) may be synthesized and stored in the skin gland or polygodial (5.34) may be biotransformed 
to drimane esters (5.33) before being transported through the digestive tracts.443 Further biosynthetic 
experiment revealed that 7-deacetoxy-olepupuane (5.38) was, in fact, the precursor of co-occurring 
drimane sesquiterpenes in dorid nudibranchs.   
In the current study, neither D. krusensternii nor D. nigra contained polygodial (5.34) and 
olepupuanes (5.35-5.38). This is contradictory to previous findings where this group of compounds 
has been consistently reported from other dorid nudibranchs collected from Italy,23 Mediterranean,25 
Hawaii,27 California29 and New Zealand.40 Instead, the extract of D. krusensternii contained 
cinnamolide (5.39) as the minor component in the mantle. The same compound was isolated as the 
major compound from D. krusensternii collected from New Zealand.459 The distinct presence of 
cinnamolide (5.39) in D. krusensternii from Australia and New Zealand indicated that the 
composition of drimane sesquiterpenes in dorid nudibranchs is affected by geographical location.    
The predominant occurrence of drimane esters (5.33) in both species of Dendrodoris 
nudibranchs used in this study is probably also influenced by seasonal factors. During the biosynthetic 
experiment, Cimino et al (1985) observed that the specific radioactivity ratio of polygodial (5.34) vs 
drimane esters (5.33) in the Italian D. limbata was reversed from April to May 1984. They speculated 
that the changing ratio of these drimanes was due to the difference in the metabolic rates that resulted 
from the seasonal development of the nudibranch.443 A recent five-year survey that investigated the 
seasonal abundance of dorid nudibranchs in West Portugal further revealed the migration behavior of 
these nudibranchs in the intertidal zone. D. herytra and D. grandiflora started to emerge from March 
(spring), peaked between April-May (spring) and disappeared in July (summer). The migration 
behavior of mature Dendrodoris nudibranchs was found to be affected mainly by the turbidity of 
seawater due to the increased phytoplankton biomass that provided food source and camouflage to 
avoid predators.503 The use of camouflage, rather than allomones, as the defense strategy of D. 
krusensternii and D. tuberculosa was also proposed by Cheney et al (2014) based on the close 
phylogenetic relationships of these species to cryptic nudibranchs.504    
In our current work, specimens of D. krusensternii and D. nigra were collected from southern 
Queensland between July and August (subtropical winter). Assuming that D. krusensternii and D. 
nigra adopt the same migration behavior as seen previously in D. herytra and D. grandiflora, it is 
reasonable to suggest that these species probably emerged to reproduce. Based on field observation, 
mature D. krusensternii (85 mm) and D. nigra (20-35 mm) used in this study were caught during 
mating and some of them were even spawning. In separate fieldwork (August 2013), the egg masses 
of D. nigra (#743) were collected at a dive site near  Stradbroke Island, QLD. Based on the 1H NMR 
data comparison, it was found that the egg masses extract of D. nigra (#743) contained drimane esters 
(5.33) and olepupuane (5.35) in a 5:1 ratio. This is in agreement with the observation of the egg 
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masses of D. limbata that also accumulated drimane esters (5.33) as the major component, indicating 
their putative role during the reproductive cycle.449  
As shown in Tables 5.2 and 5.3, the extracts of D. krusensternii and D. nigra contained 
drimane esters with diverse fatty acyl residues bearing saturated, unsaturated, linear, branched (iso- 
and anteiso-), odd and even carbon chains. D. krusensternii contained drimane esters with 
octadecanoic acid (18:0) as the major component; whereas, hexadecanoic acid (16:0) was found as 
the major fatty acyl residue in D. nigra. The ECL (equivalent chain length) values of fatty acids from 
D. krusensternii and D. nigra are presented in Appendix 85. 
The presence of odd and branched fatty acids (OBFA) in both extracts indicated that they are 
of bacterial origin.505 The vestibular glands (female reproduction) and egg masses of D. nigra from 
Dingo Beach, QLD and Cockle Bay, NSW were found to contain symbiotic bacteria that may play a 
role in the reproductive system of this species. It was hypothesized that the reproductive function of 
these bacteria was to breakdown the mucous layer and the egg capsule during intracapsular 
development to ensure the release of veliger (planktonic larva). In the egg masses, these bacteria may 
be beneficial to protect the embryos, to provide food source for the larvae or to be passed to the next 
generation.506  
 
5.3.!Conclusions 
The investigation of secondary metabolites from the Australian C. trilobatum and C. 
brevicaudatum has yielded a series of furanosesquiterpenes. Furodysinin (5.8) was accumulated 
exclusively in the mantle parts of both nudibranchs, whereas dendrolasin (5.1) was contained in the 
gut tissues. The extracts of Ceratosoma spp. were toxic against brine shrimp and were repelled by the 
shrimp P. serenus, owing to the presence of furodysinin (5.8) as a putative chemical defense. Study 
of the chemistry of D. krusensternii and D. nigra led to the isolation of drimane esters (5.33) as the 
major component in all body parts and cinnamolide (5.39) as the minor metabolite in the mantle 
tissues. The analysis of the fatty acid composition of drimane esters (5.33) from both Dendrodoris 
nudibranchs yielded various fatty acids containing C15-C20 chain lengths. The extracts of Dendrodoris 
spp. were inactive in the toxicity and unpalatability assays, thus drimane esters (5.33) may serve an 
alternative ecological function, such as during reproduction. A more comprehensive study to confirm 
this hypothesis would need to be undertaken. 
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CHAPTER 6! 
Experimental  
 
6.1.!General experimental procedures 
6.1.1.!Solvents 
Distillation of analytical grade solvents was performed prior to extractions, partitions and 
flash chromatography. HPLC grade solvents were used for normal phase and reversed phase HPLC. 
MiliQ water was used for both partition and RP HPLC. MS grade methanol was used for low 
resolution and high resolution MS analyses. Proteo and deuterated chloroform were passed through 
basic and neutral alumina (1:1 ratio) prior to use.  
 
6.1.2.!Normal phase (NP) and reversed phase (RP) thin layer chromatography (TLC) 
NP TLC was performed on silica gel pre-coated with alumimium-backed plates (Kieselgel 60 
F254, Merck), whereas RP TLC was conducted on C-18 modified silica pre-coated with aluminium-
backed plates (RP-18 F254, Merck). TLC was performed by spotting the analyte solution onto the TLC 
plate using a capillary pipette. The TLC plate was then developed in a sealed chamber using a pre-
mixed mobile phase. Once developed, the TLC plate was removed from the chamber and air-dried 
before being visualized under UV light (254 nm and 366 nm). The analyte spots that were UV active 
were marked. To visualize analyte spots invisible under UV light, the TLC plate was stained using 
reagents, i.e.: vanillin (general purpose) and Dragendorff (alkaloids). The vanillin reagent was 
prepared by dissolving 6 g of vanillin in 95 mL of 96% ethanol and 1.5 mL of concentrated sulfuric 
acid. The Dragendorff reagent was created by mixing two solutions. The first solution was generated 
by dissolving 1.7 g of bismuth subnitrate in 40 mL of glacial acetic acid. The second one was prepared 
by dissolving 8 g of potassium iodide in 20 mL of water. The stained TLC was heated using a heat 
gun until visible spots appeared. All analyte spots were then marked. 
 
6.1.3.!Normal phase (NP) and reversed phase (RP) flash chromatography 
Normal phase flash chromatography was performed by using dry-packed Kieselgel 60 (0.040-
0.063 mm, Merck). The silica-based stationary phase for reversed phase flash chromatography was 
prepared by following literature methods.507 The C18-bonded silica was generated by mixing 
trichlorooctadecylsilane (40.6 mL) and DCM (1000 mL) with 500 g of Kieselgel 60 (0.0040-0.063 
mm, Merck) to create a suspension. The silica gel slurry was stirred at room temperature for two 
hours, then filtered off on a Buchner funnel with DCM (3 x 500 mL), dry MeOH (2 x 500 mL) and 
again with DCM (2 x 500 mL). Another mixture of trimethylchlorooctadecylsilane (46.7 mL) in DCM 
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(1000 mL) was added to the bonded silica and left to react at room temperature for two hours. The 
suspension was filtered and washed with DCM (4 x 500 mL) and dried overnight in the fume 
cupboard.  
NP and RP flash chromatography were performed under the pressure of compressed air in a 
glass column with a diameter of 0.5 cm-5 cm containing a glass frit or plugged cotton wool. The flash 
chromatography fractions collected were monitored by TLC before combining. 
 
6.1.4.!Normal phase high performance liquid chromatography (NP HPLC) 
NP HPLC was carried out using a Waters 515 pump connected to a Gilson 132 series 
refractive index detector with a Waters µPorasil (10 µm, 7.8 x 300 mm) or a Phenomenex Luna (5 
µm, 10 x 250 mm) column. Separations were performed with isocratic elution conditions using 
premixed, filtered and degassed mobile phases at a flow rate of 2 mL/minute. All HPLC fractions 
were collected manually.  
 
6.1.5.!Reversed phase high performance liquid chromatography (RP HPLC) 
RP HPLC was conducted on an Agilent 1100 series with in-line vacuum degassing unit, an 
Agilent D1311A quaternary pump, a variable wavelength UV and/or a refractive index detector. 
Columns used in the RP-HPLC were Phenomenex Gemini (5 µm, 10 x 250 mm) (semipreparative) 
or Phenomenex Gemini (5 µm, 4.6 x 250 mm) (analytical). Separations were performed either using 
isocratic or a gradient of eluent conditions using filtered and degassed mobile phases at a flow rate of 
1.5 mL/minute. All HPLC fractions were collected manually.  
 
6.1.6.!Mass spectrometry (MS) 
Low resolution electrospray ion mass spectra (LRESIMS) were measured using a Bruker 
Daltonics Esquire High Capacity Trap (HCT) with orthogonal eloctrospray ionization (ESI) source. 
High resolution electrospray ion mass spectra (HRESIMS) were measured using a Bruker Daltonics 
MicroTof-Q (Quadrupole Time of Flight), Apollo II ESI source with ion funnel and time-of-flight 
mass analyzer with orthogonal ion mounted source. Samples for MS measurement were prepared in 
MS grade solvents with a concentration between 100 nM-10 µM.  
 
6.1.7.!Gas chromatography-mass spectrometry (GC-MS) 
GC-MS analyses were performed on a Shimadzu GCMS QP-2010 Plus with a ZB-5MS 
column (30 m, internal diameter 0.25 mm, Phenomenex); program rate: split mode; column flow 2.5 
mL/min; total flow 76.9 mL/min; column temperature held at 100° C for 3 minutes; 100-250° C at 
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16° C/min then held at 250° C for 10 minutes; injection temperature 250° C; total program time: 40 
minutes. Samples were prepared in n-hexane or DCM (1 mg/mL). 
 
6.1.8.!Optical rotations 
Optical rotation measurements were carried out on a Jasco P-1010 polarimeter at 589 nm at 
ambient temperature with a 10-cm quartz-cell for solutions in chloroform. Samples were dissolved in 
1 mL of distilled chloroform before measurement.  
 
6.1.9.!Nuclear magnetic resonances (NMR) 
Proton (1H) NMR spectra were recorded on a Bruker Avance 500 MHz with a 5 mm SEI 
probe or a Bruker Avance III HD 700 MHz with 5 mm TCI cryoprobe. Solvents used for NMR 
measurements were CDCl3 (referenced at δH 7.26, δC 77.16), CD3OD (referenced at δH 3.31, δC 
49.00), C6D6 (referenced at δH 7.16, δC 128.06), (CD3)CO (referenced at δH 2.05, δC 29.84) and 
(CD3)SO (referenced at δH 2.50). Chemical shifts were recorded in parts per million (ppm) and 
coupling constant (J values) were measured in Hertz (Hz). 2H NMR spectra were recorded on a 
Bruker Avance 400 spectrometer.  
The selective gradient 1D NOESY NMR spectra were recorded on a Bruker Avance 500 MHz 
or a Bruker Avance III HD 700 MHz. The irradiated signal was selected using gradient pulses of 1 
millisecond and a refocussing 180 Gaussian pulse of 50 milliseconds. 1D TOCSY NMR spectra were 
acquired on a Bruker Avance 500 with mixing time of 20-100 milliseconds.  
Two dimensional (2D) NMR data were acquired from a Bruker Avance 500 MHz or a Bruker 
Avance III HD 700 MHz using a 2 K x 256 or 2 K x 412 complex data matrix, which was zero filled 
once in each dimension, then a π/2 shifted sine-squared bell curve window function was applied in 
both dimensions before Fourier transformation. Gradient enhanced HMBC (geHMBC) and HSQC 
(geHSQC) NMR spectra were acquired with 32 or 64 transients per increment. The evolution delay 
was set for nJH-C 4 or 8 Hz for geHMBC and 1JH-C 135 or 145 Hz for geHSQC. Double Quantum 
Filtered COSY (DQFCOSY) or gradient COSY (gCOSY) spectra were obtained with 24-64 transients 
per increment and a pulse delay of 2 seconds. 2D NOESY spectra were recorded with 32-64 transients 
per increment, a recycle time between scans of 3.4 seconds and mixing time of 400-600 milliseconds.  
 
6.1.10.!Electronic circular dichroism (ECD) 
 ECD measurement were performed on a Jasco-710 spectropolarimeter using a 1 mm path 
length cuvette, with following parameter setting: ambient temperature, wavelength scans 190-400 
nm, bandwith 1 nm, response 2 sec, scanning speed 100 nm/min, accumulation value 3, HT values < 
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600 V. Samples were prepared in MeOH HPLC grade with a concentration of 1 mg/mL and were 
measured in a sample volume of 250 µL. 
 
6.2.!Bioassays 
6.2.1.!Unpalatability assay 
The unpalatability assays against the shrimp Palaemon serenus were performed by following 
methods described elsewhere.35,488,508 The unpalatability assays were conducted by members of the 
Cheney research group (School of Biological Sciences, UQ). The shrimp P. serenus were collected 
along the intertidal area of Caloundra, SE Queensland by hand nets. The collected shrimp were 
transferred into aquaria at the School of Biological Sciences, UQ and allowed to acclimatize for at 
least 3 days. The shrimp were fed with ample food (Ocean Nutrition, Formula 2) prior to use. Shrimp 
were selected randomly from the aquaria and transferred individually into small compartments (135 
mm x 98 mm x 90 mm) with sufficient aeration and water flow. Shrimp were initially fed with fish 
flakes (Ocean Nutrition, Formula 2) and then were starved for 2 days before use in assays.  
The nudibranch extracts were prepared based on the method described above. A stock solution 
was created based on the natural concentration (weight of extract per volume of the body tissue) of 
each species. A two-fold serial dilution of the extract was produced from the stock solution using 
DCM as a solvent. The artificial pellet was prepared based on literature methods508 by mixing 25 mg 
of freeze-dried squid mantle, 15 mg of alginic acid, 15 mg of purified sea sand and 250 µL of extracts 
(treatment pellets) or 250 µL of DCM (control pellets). These mixtures were allowed to dry under a 
Nederman arm for at least 15 minutes to evaporate the organic solvent. The dried mixtures were 
reconstituted by adding 250 µL of distilled water and a drop of red food coloring before being blended 
evenly. The pellets were then inserted into a 1 mL syringe, exuded into a CaCl2 solution and rinsed 
with distilled water. The pellets were offered to shrimp using tweezers until they were grasped by the 
appendages of the shrimp. After 60 minutes, shrimp were checked for a red spot in the gastric mill. 
Acceptance of pellets was indicated by the presence of a red spot, whereas rejection of pellets was 
indicated otherwise. Shrimp that rejected the pellets were offered control pellets after the treatment 
pellets were removed, then these shrimp were re-observed for 30 minutes. Shrimp that did not accept 
the control pellets were removed from analysis as this suggested that the shrimp were molting or 
about to expire. Percent of rejection was calculated as the number of shrimp that rejected the pellets 
per the number of total shrimp. Percent of rejection was interpolated into a standard curve, either 
sigmoidal or hyperbola, that was fitted using least squares method509 based on R2 values. ED50 values 
were calculated as interpolated x values (concentration of extract as mg/mL). Calculations were 
conducted using Graphpad Prism 7 software.  
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6.2.2.!Toxicity assay 
 The toxicity assay was conducted against the brine shrimp Artemia salina by members of the 
Cheney research group (School of Biological Sciences, UQ) and using literature methods.35,510 
Extracts were prepared by diluting the stock solution (natural concentration (NC)) in DCM. Four 
different doses were created: NC, 0.5 NC, 0.1 NC, 0.01 NC in triplicate. Blank DCM was used as a 
control. Approximately 250 µL of each dose was added onto microfiber filter papers (Whatman GF/C, 
47 mm diameter) that were placed in a 20 ml vial. The filter papers containing extract solutions were 
then dried under a stream of N2. Ten recently hatched brine shrimp in 250 µL of salt water were added 
into each vial and were left at room temperature for 24 hours. The natural deaths were taken into 
account based on the control treatments by following Abbott’s formula:511 
 %"Deaths = " (test − control)(100 − control) 
 
Percent death was determined from the interpolation of the concentration of extract into the 
standard curve, either a line or hyperbola, that was fitted using least squares method509 based on R2 
values. The LD50 values of the crude extracts were calculated as interpolated x values (concentration 
of extract as mg/mL). Calculations were conducted using Graphpad Prism 7 software. 
 
6.2.3.!Cytotoxicity assay 
The cytotoxicity assay of A. ingens and S. carteri extracts was conducted by Nurrahmi D. 
Fajarningsih (Agency of Marine and Fisheries Research, Indonesia) by means of MTT assay at a 
concentration of 30 µg/mL in triplicate.512 Extracts (100 µL) were inserted into microplate wells 
containing 104 of HeLa cells and incubated for 48 h in a CO2 incubator. The MTT reagent (10 µL, 
concentration 5 mg mL-1) was then added to the microplate wells prior to re-incubation for 4 h. The 
reaction was stopped by adding 100 mL of 10% sodium dedocyl sulfate (SDS) solution. Tested 
samples were subsequently incubated for 12 h in a dark room at room temperature, followed by the 
measurement of absorbance at 570 nm. Determination of cell mortality percentage was calculated 
based on the obtained absorbance value relative to the control. 
 
6.2.4.!Antimalarial assay 
The antimalarial assay for acanthocyclamine A (2.45) was performed by Dr. Tina Skinner-
Adams (Eskitis Institute, Griffith University). The same assay for phyllodesmolides D (3.90) and E 
(3.91) was performed by the author under the supervision of Mary Clarke and A/Prof. Katherine 
Andrews (Eskitis Institute, Griffith University) based on methods described elsewhere.513–515 P. 
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falciparum 3D7 infected O+ erythrocytes (Australian Red Cross Blood Service) were cultured in 
RPMI 1640 media (Gibco, USA) supplemented with 10% heat-inactivated pooled human sera 
(Australian Red Cross Blood Service) and 0.05% 10 mg/ml gentamycin (Gibco, USA). Cultures were 
maintained at 0.1 – 10% parasitemia, 5% haematocrit, and were incubated at 37 oC in an atmosphere 
of 5% O2, 5% CO2, and 90% N2. Culture parasitemia was determined manually using bright field 
microscopy on the Quick dip (POCD Health Care, Australia) stained thin blood smears. Selected 
compounds were screened at 10 µM for antimalarial activity against P. falciparum 3D7 (chloroquine 
sensitive) using tritiated hypoxanthine incorporation. This method provides a quantitative 
measurement of compound activity based on the uptake of the radiolabelled nucleic acid precursor 
by the parasite. Phosphate buffered saline (PBS), experimental controls (media with and without 
vehicle and chloroquinone), test compounds (1 µL of 2 mM stock in DMSO) were prepared in 
triplicate in 96-well tissue culture plates (3596 Costar®, Corning, USA) for a final volume of 100 uL 
per well. Non-synchronous P. falciparum parasites (1% parasitemia and 1% final haematocrit) and 
uninfected erythrocyte controls (1% final haematocrit) were added into the designated wells for a 
final volume of 200 µL per well. [3H]-hypoxanthine (PerkinElmer®, USA) was added to each well 
(0.5 µCi/well) before being incubated under the previously described conditions. The assays were 
terminated after 48 h by freezing the plates overnight at -80 oC and then thawing at room temperature 
to lyse the erythrocytes. The contents of each well were harvested onto 1450 MicroBeta filter mats 
(Wallac, USA) using FilterMate™ Universal Harvester (PerkinElmer, USA). The mats were left to 
dry before sealing in sample bags with betaplate scint (PerkinElmer®, USA), a scintillation fluid. 
Hypoxanthine incorporation was determined using 1450 MicroBeta® TriLux Liquid Scintillation and 
Luminescence Counter (PerkinElmer®, USA). Percentage growth inhibition was calculated using 
negative controls (infected erythrocytes with vehicle) as 100% growth while IC50 values were 
calculated using linear interpolation of inhibition curves. Each sample was tested in three independent 
assays. 
 
6.3.!Experimental for Chapter 2 
6.3.1.!Biological material of Acanthostrongylophora ingens 
The sponge sample (W-74-08) was provided by the Agency of Marine and Fisheries Research 
(Indonesia) and was obtained by SCUBA diving near Hoga Island, Wakatobi Marine National Park, 
Southeast Sulawesi in April 2008. The specimen was kept frozen until extraction. The sponge is a 
massive tubular form, with an osculum on the top of each tube and is of greenish brown color. The 
taxonomic description of A. ingens was provided by Tri A. Hadi (Indonesian Institute of Sciences) as 
follow: the sponge surface is uneven with a fragile texture. The spicules consist of slightly bent 
strongyles (approximately 110-150 µm long; 5-8 µm wide) and thin, slightly bent oxeas 
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(approximately 140 µm long; 2 µm wide). The ectosomal skeleton consists of irregularly positioned 
spicules, whereas the choanosomal skeleton is composed of multispicular tracts that are held together 
by a minimal amount of spongin. A voucher specimen (number SVP01/03/13) is deposited at the 
Research Center for Oceanography, Indonesian Institute of Sciences.  
 
6.3.2.!Extraction and isolation of alkaloids from Acanthostrongylophora ingens 
Frozen sponge (200 g wet wt) was exhaustively extracted with methanol (3 x 500 mL) at room 
temperature. The combined extracts were dried under vacuum to yield a 15 g dark brown gum, which 
was subsequently partitioned between hexanes (3 x 375 mL) and methanol (750 mL) to remove lipid. 
A portion of the resulting extract (2.5 g) was subjected to RP flash chromatography using a step 
gradient elution from 20% to 100% methanol in water + 0.1% TFA, followed by 100% isopropanol 
+ 0.1% TFA to yield nine fractions. The fourth fraction (100 mg), which gave a positive response to 
Dragendorff spray, was converted into its free base by passing through a strong cation ion exchange 
(SCX) cartridge (Phenomenex), eluting first with methanol then 5% NH4OH-methanol.516 The 
resulting free-base fraction (100 mg) was subjected to NP flash chromatography using 
hexanes/isopropanol/triethylamine (20:1:4) to yield three major fractions.  Acanthocyclamine A 
(2.45) was obtained from the first fraction as a colorless oil (28.5 mg).  Approximately 20 mg of 
acanthocyclamine A (2.45) was recrystallised from 250 µL hexanes/isopropanol mixture (24:1) at -4 
ºC using the vapor diffusion method prior to X-ray analysis. The third fraction of the NP flash 
chromatography (141 mg) was purified by repetitive RP HPLC using a gradient of 40-80% 
MeCN/H2O (0.1% TFA) and an isocratic 20% MeCN/H2O to obtain villagorgin A (2.52) (6 mg). 
 
6.3.3.!X-ray crystallography of acanthocyclamine A (2.45) 
The X-ray crystallographic analysis of acanthocyclamine A hydrate (2.45.H2O) was 
conducted by Prof. Paul V. Bernhardt (School of Chemistry and Molecular Biosciences, UQ) and 
gave the following data: C26H44N2.H2O, M 402.65, T 190 K, orthorhombic, space group P212121 (No. 
19), a 9.9146(1) Å, b 13.7764(2) Å, c 17.4873(2) Å; V 2388.55(5) Å3; Dc (Z=4) 1.120 g cm-3; F(000) 
896; µ(Cu-Kα) 0.505 mm-1; 36161 data (2θmax = 125°); 3817 unique data, Rint 0.0422, 3714 with I > 
2σ(I); R 0.0322 (obs. Data), wR2 0.0827 (all data), goodness of fit 1.041, CCDC number 988993.  
X-ray diffraction analysis was carried out on an Oxford Diffraction Gemini S Ultra CCD 
diffractometer by means of Cu-Kα radiation (λ=1.54180 Å) and data were collected within 4.09° < θ 
< 62.53° scan range. The crystal was preserved at a temperature of 190 K using an Oxford 
Cryosystems Desktop Cooler. Data reduction and semi-empirical absorption corrections were 
conducted with CrysAlisPro software package (version 171.38.28, Agilent). The structure was solved 
by direct methods and refined by full-matrix least-squares F2 with SHELXL517 within the WinGX 
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graphical user interface.518 ORTEP3 was used to produce thermal ellipsoid plot.519 The absolute 
structure was established from a statistical analysis of anomalous dispersion effects of 1633 Bijvoet 
pairs according to the method of Hooft et al.520 leading to a probability (P2) of the correct enantiomer 
being 1.00 (Hooft parameter -0.1(1), v = 10 using Student’s t-statistics). 
 
6.3.4.!Biological material of Stylissa carteri 
The sponge sample (W-73-08) was provided by the Agency of Marine and Fisheries Research 
(Indonesia) and was obtained by SCUBA diving near Hoga Island, Wakatobi Marine National Park, 
Southeast Sulawesi in April 2008. The specimen was kept frozen until extraction. The sponge is 
grayish yellow in its dry state with a tough texture. The taxonomic description of S. carteri was 
provided by Tri A. Hadi (Indonesian Institute of Sciences) as follow: S. carteri has an erect and 
lamellate growth form with the surface covered by conical spines and ridges. The spicules are styles, 
slightly bent (approximately 450 x 20 µm) and consist of a small number of strongyles. In addition, 
it also has a disorganized skeleton in cross section. A voucher specimen (number SVP02/03/13) is 
deposited at the Research Center for Oceanography, Indonesian Institute of Sciences. 
 
6.3.5.!Extraction and isolation of bromopyrroles from Stylissa carteri 
Frozen sponge (200 g, wet wt.) was exhaustively extracted with methanol (3 x 500 mL) at 
room temperature. The combined extracts were dried under vacuum to yield a 5 g (dry wt) crude 
extract. A portion of the resulting methanolic extract (4.1 g) was partitioned repetitively between 
water and ethyl acetate (5 x 10 mL). The combined ethyl acetate soluble material was dried to give a 
1.2 g of extract, which was further subjected to NP flash chromatography by employing step gradient 
solvent from 100% hexanes to 100% methanol to yield 13 fractions. The eighth fraction (41.2 mg) 
was further purified by means of semipreparative RP HPLC using an isocratic 30% acetonitrile/water 
for 50 min to yield 4-bromo-1H-pyrrole-3-carboxamide (2.55) (14.1 mg), 4-bromo-1H-pyrrole-3-(N-
hydroxymethyl) carboxamide (2.56) (4.2 mg), 4-bromo-1H-pyrrole-3-(N-methoxymethyl) 
carboxamide (2.57) (1.6 mg), 3,4-dibromo-1H-pyrrole-2-carboxamide (2.58) (3.9 mg) and 3-
bromoaldisin (2.60) (3.1 mg). The tenth fraction (16 mg, wet wt.) was also subjected to RP HPLC by 
using 20% acetonitrile/water to afford aldisin (2.59) (8.4 mg), 3-bromoaldisin (2.60) (2.9 mg) and 
mukanadin C (2.61) (2.9 mg). 
 
Acanthocyclamine A (2.45): crystals (20.0 mg); [α]25D -26.5 (c 0.073, CHCl3); 1H NMR (CDCl3, 
500 MHz) and 13C NMR (CDCl3, 125 MHz) see Table 2.1; (+)-HRESIMS m/z 385.8581 [M+H]+ 
(calcd. for 385.3577, C26H45N2). 
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Villagorgin A (2.52):96 brown gum (6.0 mg), isolated as a mixture with an unidentified alkaloid; 1H 
NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3, 125 MHz) see Table 2.2; (+)-HRESIMS m/z 
265.1449 [M+H]+ (calcd for 265.1448, C16H16N4); Deuterated villagorgin A (2.52) (+)-HRESIMS 
m/z 268.1645 [M+H]+ (calcd. for 268.1636, C16H14N42H3) 
 
4-bromo-1H-pyrrole-3-carboxamide (2.55):106 amorphous powder (14.1 mg); 1H NMR (CDCl3, 
500 MHz) δ 9.60 (1H, br s, NH-1), 6.95 (1H, dd, J = 2.9, 1.6, H-2), 6.60 (1H, dd, J = 2.9, 1.6, H-5), 
5.30 (2H, br s, -CONH2); (-)-LRESIMS m/z 187/189 [M-H]- 
 
4-bromo-1H-pyrrole-3-(N-hydroxymethyl) carboxamide (2.56): amorphous powder (4.2 mg); 1H 
NMR (CDCl3, 500 MHz) δ 9.40 (1H, br s, NH), 6.95 (1H, dd, J = 2.9, 1.6, H-2), 6.60 (1H, dd, J = 
2.9, 1.6, H-5); 5.35 (1H, br s, -OH), 4.91 (2H, d, J = 6.8, H-8); 13C NMR (CDCl3, 125 MHz, data 
from HSQC and HMBC) δ 161.1 (-CONH-), 125.1 (C-5), 121.8 (C-2), 111.8 (C-4), 97.4 (C-3); (-)-
HRESIMS m/z 216.9623 [M-H]- (calcd. for 216.9618, C6H6N2O279Br). 
 
4-bromo-1H-pyrrole-3-(N-methoxymethyl) carboxamide (2.57): amorphous powder (1.6 mg); 1H 
NMR (CDCl3, 500 MHz) δ 9.40 (1H, br s, NH-1), 6.95 (1H, dd, J = 2.9, 1.6, H-2), 6.59 (1H, dd, J = 
2.9, 1.6, H-5); 6.40 (1H, br s, NH-7), 4.85 (2H, d, J = 7.0, H-8), 3.38 (3H, s, -OMe); 13C NMR (CDCl3, 
125 MHz, data from HSQC and HMBC) δ 160.2 (-CONH-), 125.2 (C-3), 121.9 (C-2), 116.7 (C-5), 
111.8 (C-4), 71.2 (C-8), 56.0 (-OCH3); (-)-HRESIMS m/z 254.9741 [M-H]- (calcd. for 254.9740, 
C7H9N2NaO279Br). 
 
3,4-dibromo-1H-pyrrole-2-carboxamide (2.58):109 amorphous powder (3.9 mg); 1H NMR (CDCl3, 
500 MHz) δ 9.43 (1H, br s, NH-1), 6.60 (1H, dd, J = 2.9, 1.6, H-5), 5.50 (2H, br s, NH2); 13C NMR 
(CDCl3, 125 MHz, data from HSQC and HMBC) δ 125.9 (C-2), 113.1 (C-5), 106.2 (C-3); (-)-
LRESIMS m/z 265/267/269 [M-H]-.  
 
Aldisin (2.59):521 amorphous powder (8.4 mg); 1H NMR (CDCl3, 500 MHz) δ 7.86 (1H, br s, NH-
1), 6.99 (1H, d, J = 3, H-2), 6.71 (1H, d, J = 3, H-3), 3.49 (2H, m, H-6), 2.81 (2H, m, H-5); (-)-
LRESIMS m/z 187/189 [M+Na]+. 
 
3-Bromoaldisin (2.60): 106 amorphous powder (6.0 mg); 1H NMR (MeOH, 500 MHz) δ 6.80 (1H, s, 
H-2), 3.49 (2H, m, H-5), 2.81 (2H, m, H-6); (+)-LRESIMS m/z 241/243 [M+Na]+. 
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Mukanadin C (2.61): 112 amorphous powder (2.9 mg); [α]22D -1 (c 0.2, CHCl3); Lit. 112 [α]23D -6 (c 
0.083, MeOH); 1H NMR (MeOD, 500 MHz) δ 7.10 (1H, d, J = 1.8, H-5), 6.81 (1H, s, H-3), 5.63 (1H, 
t, J = 3.5, H-1’), 3.73 (1H, dd, J =13.5, 3.5, H-2’), 3.51 (1H, dd, J =13.5, 3.5, H-2’); (+)-LRESIMS 
m/z 253/255 [M+Na]+, (-)-LRESIMS m/z 229/231 [M-H]-. 
 
6.4.!Experimental for Chapter 3 
6.4.1.!Biological material of Phyllodesmium lizardense and its soft coral substrate 
Four individuals of P. lizardense (#1012-1015) and a sample of the soft coral substrate were 
collected at a dive site near Lizard Island, QLD in June 2014 and were kept frozen until extraction. 
Another five individuals of P. lizardense (#1240-1244) were collected at the same site in February 
2015.  
 
6.4.2.!Extraction and isolation of sesquiterpenes 
6.4.2.1.!Soft coral substrate of Phyllodesmium lizardense 
Extraction of 22.3 g wet weight of soft coral was carried out with acetone (7 x 50 mL) then 
partitioned against diethyl ether (3 x 15 mL) to yield a dark green oil (563 mg). Separation of the 
extract was carried out by NP flash chromatography with a gradient of hexanes/DCM with 25% 
increment of DCM. Twenty-four fractions were pooled into eight fractions based on their TLC 
pattern. Fraction A retained germacrene C (3.14) (236 mg) and guaiane alcohol (3.17) (1.2 mg). 
Fraction E contained germacra-1(10),5-dien-4β-ol (3.16) as a mixture with impurities (50 mg) and 
decomposed before purification. Fraction E was separated by NP flash chromatography with 10% 
increments of DCM in hexanes to obtain 8 sub-fractions. Guaiane diacetate (3.26) (1.5 mg) was eluted 
as the first sub-fraction. Sub-fraction 3 and 4 were purified by RP-HPLC with 100% methanol to 
yield gorgosterol (3.27) (2.2 mg). 
 
6.4.2.2.!Phyllodesmium lizardense batch one (#1012-1015) 
The cerata of P. lizardense were separated from the body tissues prior to extraction. The cerata 
were then extracted with acetone (7 x 5 mL) and sonicated for 4 minutes each time. The extract was 
allowed to settle and filtered through cotton wool. The combined extracts were evaporated under 
vacuum to remove the solvent. The extract was subsequently partitioned against diethyl ether (3 x 5 
mL). The diethyl ether extracts were combined and dried over sodium sulfate prior to drying to obtain 
200 mg of a dark green oil. This extract was fractionated by silica flash chromatography using a 
gradient of hexanes/DCM with 25% increment of DCM as eluent to give 18 fractions. These fractions 
were pooled into 7 fractions based on their TLC pattern.  
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Fraction A was obtained as a colorless oil that contained a mixture of α-muurolene (3.1), 
germacrene C (3.14) and guaiane alcohol (3.17) (51.1 mg). 3β-Acetoxy-muurolene (3.3) (1.3 mg), 
germacra-1(10),5-dien-4β-ol (3.16) (3.0 mg) and cubebol (3.37) (1.2 mg) were isolated from fraction 
D (11.5 mg) using NP HPLC with 5% EtOAc/hexanes as eluent. Fraction E (30 mg) was subjected 
to NP flash chromatography with a gradient of hexanes/DCM to yield 10 subfractions. Fraction E-4 
(2.5 mg) was separated by NP-HPLC with 7% EtOAc/hexanes to give 3β-hydroxy-α-muurolene (3.2) 
(0.1 mg), germacra-1(10),5-dien-4β-ol (3.16) (0.1 mg), guaiane alcohol (3.17) (0.2 mg) and cubebol 
(3.37) (0.1 mg). The purification of fraction E-5 (4.9 mg) by NP-HPLC (10% EtOAc/hexanes) 
afforded 3β-hydroxy-α-muurolene (3.2) (0.3 mg), guaiane alcohol (3.17) (1.3 mg), germacra-
1(10),4,6(7)-trien-5β-ol (3.28) (0.3 mg) and cubebol (3.37) (0.2 mg). Fraction E-6 (13.7 mg) was 
purified by NP HPLC to yield 3β-hydroxy-α-muurolene (3.2) (0.7 mg), guaiane alcohol (3.17) (2.7 
mg), guaiane diacetate (3.26) (0.5 mg), gorgosterol (3.27) (1.3 mg) and germacra-1(10),4,6(7)-trien-
5β-ol (3.28) (0.7 mg).  
 
6.4.2.3.!Phyllodesmium lizardense batch two (#1240-1244) 
Approximately 1.3 g of P. lizardense cerata was extracted exhaustively with acetone (7 x 5 
mL). The acetone extract was concentrated under vacuum, prior to partitioning with diethyl ether (6 
x 2 mL). The combined diethyl ether extracts were concentrated under N2 gas to afford 116 mg of a 
dark green oil. NP flash chromatography of the diethyl ether extract with a gradient of hexanes/DCM 
with 25% increment of DCM gave 14 fractions. These fractions were combined into 6 fractions based 
on their TLC pattern. Fraction A (49.5 mg) contained a mixture of α-muurolene (3.1), germacrene C 
(3.14) and guaiane alcohol (3.17). Other sesquiterpenes were retained in fraction C. Thus, NP HPLC 
of fraction C (40 mg) with 10% EtOAc/hexanes was carried out to yield 21 fractions.  
Fractions containing known compounds were identified based on data comparison with those 
from previous isolation. Fraction C-7 (0.4 mg) contained a mixture of germacra-1(10),5-dien-4β-ol 
(3.16) and guaiane diacetate (3.26). Fraction C-15 (0.1 mg), C-16 (0.6 mg) and C-17 (1.1 mg) 
contained a mixture of guaiane alcohol (3.17) and cubebol (3.37). 3β-Hydroxy-α-muurolene (3.2), 
guaiane alcohol (3.17) and germacra-1(10),4,6(7)-trien-5β-ol (3.28) were collected from fraction C-
18 (0.6 mg) and C-19 (3.4 mg). Fraction C-21 (0.4 mg) contained gorgosterol (3.27). 
Repetitive NP HPLC was employed to purify fractions containing new compounds. Fraction 
C-3 (2 mg) was purified with NP HPLC (5% EtOAc/hexanes) to obtain 3β-acetoxy-α-muurolene 
(3.3) (1.4 mg) and 4,5-β-epoxy-α-muurolene (3.31) (0.4 mg). Fraction C-5 and C-6 (1 mg) were 
combined and purified with NP HPLC (3.5% EtOAc/hexanes) to afford 7α-hydroxy-α-muurolene 
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(3.5) (0.2 mg). Purification of combined fraction C-10 and C-11 (0.7 mg) by NP HPLC (5% 
EtOAc/hexanes) gave 11β-hydroxy-α-muurolene (3.38) (0.2 mg).  
 
α-Muurolene (3.1)168 as a mixture with germacrene-C (3.14)128: colorless oil (100 mg); 1H NMR 
(C6D6, 500 MHz) δ 5.56 (1H, br s, H-5), 5.44 (1H, br s, H-9), 3.12 (1H, m, H-6), 2.04 (1H, m, H-11), 
1.98 (1H, m, H-1), 1.84 (2H, m, H-8), 1.83 (2H, m, H-3), 1.77 (1H, m, H-2a), 1.69 (3H, s, Me-14), 
1.65 (3H, s, Me-15), 1.50 (1H, m, H-7), 1.47 (1H, m, H-2b), 0.87 (3H, d, J = 7, Me-12), 0.83 (3H, d, 
J = 7, Me-13); 13C NMR (C6D6, 125 MHz, data from HSQC and HMBC), δ 136.0 (C-10), 134.0 (C-
4), 124.7 (C-5), 121.9 (C-9), 41.4 (C-7), δ 39.3 (C-1), 37.0 (C-6), 30.5 (C-3), 26.8 (C-11), 24.9 (C-
2), 24.7 (C-8), 23.9 (Me-15), 21.7 (Me-14), 21.4 (Me-12), 15.9 (Me-13); GC-MS m/z 204 [M]+. 
 
3β-Hydroxy-α-muurolene (3.2):123 white solid (1.1 mg); [α]25D +29 (c 0.11, CHCl3), Lit:123 +131 (c 
1.67, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.67 (1H, dd, J = 5, 1.4, H-5), 5.45 (1H, br s, H-9), 3.95 
(1H, br s, H-3), 2.22 (1H, br d, J = 11.5, H-1), 2.08 (1H, m, H-6), 1.95 (1H, dt, J = 14, 2.7, H-2a), 
1.92 (1H, m, H-11), 1.87 (1H, dt, J = 17.2, 4, H-8a), 1.81 (3H, d, J = 1.8, 1.4, Me-14), 1.78 (1H, m, 
H-8b), 1.70 (3H, dd, J = 1.6, 0.8, Me-15), 1.64 (2H, dd, J = 14, 4.1, H-2b), 1.44 (1H, m H-7), 0.89 
(3H, d, J = 7, Me-12); 0.84 (3H, d, J = 7, Me-13); GC-MS m/z 220 [M]+. 
 
3β-Acetoxy-α-muurolene (3.3):123 white solid (2.7 mg); [α]23D +95 (c 0.07, CHCl3), Lit:123 +122 (c 
0.38, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.81 (1H, dd, J = 4.8, 1.5, H-5), 5.43 (1H, br s, H-9), 
5.19 (1H, br t, J = 3.5, H-3), 2.22 (1H, br d, J = 11.7, H-1), 2.14 (1H, m H-6), 2.09 (3H, s, -OCOCH3), 
1.94 (1H, dt, J = 14.3, 2.8, H-2a), 1.91 (1H, m, H-11), 1.86 (1H, m, H-8a), 1.80 (1H, ddd, J = 10.3, 
4.5, 2.2, H-8b), 1.71 (3H, dd, J = 1.5, 1.1, Me-15), 1.66 (4H, m, Me-14 and H-2b), 1.44 (1H, m, H-
7); 0.90 (3H, d, J = 7, Me-12); 0.85 (3H, d, J =  7, Me-13);  (+)-LRESIMS m/z 285 [M+Na]+. 
 
7α-Hydroxy-α-muurolene (3.5):124 colorless oil (0.2 mg); compound decomposed prior to optical 
rotation measurement, Lit:124 -20 (concentration and solvent were not reported); 1H NMR (CDCl3, 
500 MHz) δ 5.51 (1H, br s, H-5), 5.32 (1H, br s, H-9), 2.44 (1H, br s, H-6), 2.12 (1H, m, H-1), 2.05 
(1H, m, H-8a), 1.97 (1H, m, H-8b), 1.92 (1H, m, H-11), 1.91 (2H, m, H-3), 1.77 (2H, m, H-2), 1.73 
(3H, s, Me-15), 1.69 (3H, s, Me-14), 0.92 (3H, d, J = 6.9, Me-12), 0.91 (3H, d, J = 6.9, Me-13); 13C 
NMR (CDCl3, 125 MHz, partial data from HSQC and HMBC), δ 119.5 (C-5), 119.4 (C-9), 39.3 (C-
6), 37.6 (C-1), 33.2 (C-11), 30.8 (C-8), 28.6 (C-3), 24.2 (Me-15), 24.1 (C-2), 21.2 (Me-14), 17.4 (Me-
13), 15.9 (Me-12). GC-MS m/z 220 [M]+. 
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Germacrene C (3.14):128 colorless oil (236 mg); 1H NMR (CDCl3, 500 MHz) δ 6.23 (1H, d, J = 9.4, 
H-6), 5.20 (1H, d, J = 9.4, H-5), 4.93 (1H, ddt, J = 11.6, 4.9, 1.3, H-1), 2.55 (1H, dddd, J = 12.8, 6.3, 
2.6, 1.3, H-9a), 2.39 (1H, m, H-8a), 2.38 (1H, m, H-11), 2.21 (1H, dt, J = 12.1, 3.4, H-3a), 3.16 (1H, 
dddd, J = 12.6, 8, 4.5, 4.5, H-2a), 2.10 (1H, ddd, J = 12.8, 4.9, 2.6, H-8b), 1.99 (1H, ddd, J = 23.6, 
12.6, 4.1, H-2b), 1.91 (1H, td, J = 12.8, 5.7, H-9b), 1.74 (1H, td, J = 12.1, 4.9, H-3b), 1.57 (3H, s, 
Me-15), 1.14 (3H, d, J = 1.6, Me-14), 1.09 (3H, d, J = 7, Me-12), 1.08 (3H, d, J = 7, Me-13); 13C 
NMR (CDCl3, 125 MHz, data from HSQC and HMBC), see Table 3.1.  
 
Germacra-1(10),5-dien-4β-ol (3.16):135 colorless oil (3.1 mg); [α]22D +50 (c 0.28, CHCl3), Lit:135 
+122 (c 1.22, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.25 (1H, d, J = 15.7, H-5), 5.19 (1H, dd, J = 
15.7, 9.5, H-6), 4.95 (1H, d, J = 11.6, H-1), 2.51 (1H, ddd, J = 25.7, 13.1, 3.4, H-2a), 2.26 (2H, m, 
H-9), 2.02 (1H, ddd, J = 14, 9.5, 5.7, H-7), 1.95 (1H, d, J = 13.1, H-2b), 1.64 (1H, dt, J = 14, 4, H-
3a), 1.54 (1H, t, J = 14, H-3b), 1.54 (3H, s, Me-14), 1.42 (1H, m, H-11), 1.38 (2H, m, H-8), 1.20 (3H, 
s, Me-15), 0.83 (3H, d, J = 6.7, Me-12), 0.79 (3H, d, J = 6.7, Me-13); 13C NMR (CDCl3, 125 MHz, 
data from HSQC and HMBC), see Table 3.2. GC-MS m/z 220 [M]+. 
 
Guaiane alcohol (3.17):143–145 white solid (5.4 mg); [α]22D +4 (c 0.01, CHCl3), Lit:144 +9 (c 0.29, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.54 (1H, br s, H-6), 4.74 (1H, br s, H-15a), 4.68 (1H, br s, 
H-15b), 2.49 (1H, dd, J = 13.2, 10.3, H-9a), 2.28 (1H, m, H-5), 2.28 (1H, m, H-1), 2.25 (1H, m, H-
11), 2.21 (1H, m, H-8a), 2.02 (1H, t, J = 13.2, H-9b), 1.99 (1H, m, H-8b), 1.89 (1H, m, H-2a), 1.74 
(2H, m, H-3), 1.73 (1H, m, H-2b), 1.23 (3H, s, Me-14), 0.98 (3H, d, J = 6.6, Me-12), 0.97 (3H, d, J 
= 6.7, Me-13); 13C NMR (CDCl3, 125 MHz, data from HSQC and HMBC), see Table 3.3; (+)-
LRESIMS m/z 243 [M+Na]+. 
 
Guaiane diacetate (3.26):145 colorless plates (2 mg); [α]24D +12 (c 0.07, CHCl3); Lit:145 0 (c 0.5, 
CHCl3);  1H NMR (CDCl3, 500 MHz); δ 5.49 (1H, d, J = 2.4, H-6), 2.49 (1H, br d, J = 11.3, H-5), 
2.33 (1H, m, H-1), 2.30 (1H, m, H-9a), 2.25 (1H, m, H-2a), 2.24 (1H, m, H-11), 2.22 (1H, dd, J = 
16.3, 9.3, H-8a), 2.00 (1H, m, H-9b), 1.99 (3H, s, -OCOCH3), 1.95 (3H, s, -OCOCH3), 1.91 (1H, dd, 
J = 16.3, 9.3, H-8b), 1.78 (2H, m, H-3), 1.77 (1H, m, H-2b), 1.52 (3H, s, Me-14), 1.41 (3H, s, Me-
15), 0.99 (3H, d, J = 6.8, Me-12), 0.98 (3H, d, J = 6.8, Me-13); 13C NMR (CDCl3, 125 MHz, data 
from HSQC and HMBC), δ 170.7 (2 x OCOCH3), 149.5 (C-7), 121.1 (C-6), 89.1 (C-4), 87.7 (C-10), 
48.4 (C-5), 47.0 (C-1), 37.4 (C-11), 36.9 (C-2), 36.6 (C-9), 24.6 (C-8), 22.6 (OCOCH3), 22.4 (C-3), 
22.2 (OCOCH3), 21.5 (Me-13), 21.2 (Me-12), 19.2 (Me-15), 18.9 (Me-14); (+)-LRESIMS m/z 345 
[M+Na]+; (+)-HRESIMS m/z 345.2047 (calcd for C19H30O4Na, 345.2036).    
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Gorgosterol (3.27):146,150 white solid (3.9 mg); [α]25D -40(c 0.14, CHCl3), Lit:146 -45 (concentration 
and solvent were not reported); 1H NMR (CDCl3, 500 MHz): δ 5.36 (1H, br s, H-6), 3.53 (1H, m, H-
3), 2.28 (1H, ddt, J = 12.2, 4.6, 2.1, H-4a), 2.23 (1H, tq, J = 12.2, 2.1, H-4b), 2.04 (1H, m, H-12a), 
2.02 (1H, m, H-16a), 1.98 (1H, m, H-7a), 1.84 (1H, m, H-1a), 1.83 (1H, m, H-2a), 1.60 (1H, m, H-
15a), 1.57 (1H, m, H-25), 1.50 (1H, m, H-7b), 1.50 (1H, m, H-2b), 1.46 (2H, m, H-11), 1.44 (1H, m, 
H-8), 1.33 (1H, m, H-16b), 1.24 (1H, m, H-17), 1.19 (1H, m, H-12b), 1.09 (1H, m, H-1b), 1.08 (1H, 
m, H-15b), 1.03 (1H, m, H-20), 1.01 (1H, m, H-14), 1.00 (6H, s, Me-19 and Me-21), 0.95 (3H, d, J 
= 6.5, Me-26), 0.94 (3H, d, J = 6.5, Me-28), 0.94 (1H, m, H-9), 0.90 (3H, s, Me-29), 0.85 (3H, d, J = 
6.9, Me-27), 0.66 (3H, s, Me-18), 0.45 (1H, dd, J = 8.8, 4.3, H-30a), 0.24 (1H, m, H-24), 0.18 (1H, 
m, H-22), -0.13 (1H, dd, J = 6.4, 4.3, H-30b); 13C NMR (CDCl3, 125 MHz, data from HSQC and 
HMBC), δ 140.8 (C-5), 121.8 (C-6), 71.9 (C-3), 58.1 (C-17), 56.6 (C-14), 50.9 (C-24), 50.3 (C-9), 
42.8 (C-13), 42.4 (C-4), 39.9 (C-12), 37.3 (C-1), 36.5 (C-10), 35.4 (C-20), 32.1 (C-25), 32.0 (C-22), 
32.0 (C-8), 31.8 (C-7), 31.6 (C-2), 28.3 (C-16), 25.8 (C-23), 24.7 (C-15), 22.3 (Me-26), 21.6 (Me-
27), 21.3 (C-30), 21.2 (Me-21), 21.0 (C-11), 19.4 (Me-19), 15.5 (Me-28), 14.4 (Me-29), 11.9 (Me-
18); (+)-LRESIMS m/z 449 [M+Na]+. 
 
Germacra-1(10),4,6(7)-trien-5β-ol (3.28): colorless oil (1 mg); [α]23D  0 (c 0.07, CHCl3); 1H NMR 
(CDCl3, 500 MHz): δ 5.41 (1H, d, J = 9, H-6), 5.22 (1H, br t, J = 1.4, H-15a), 5.01 (1H, br s, H-15b), 
4.95 (1H, br s, H-1), 4.42 (1H, br d, J = 9, H-5), 2.30 (2H, m, H-3), 2.22 (1H, m, H-11), 2.19 (1H, m, 
H-9a), 2.17 (2H, m, H-2), 2.10 (2H, ddd, J = 12.8, 4.7, 3, H-8); 1.78 (1H, t, J = 12.8, H-9b), 1.56 (3H, 
s, Me-14), 1.08 (3H, d, J = 6.9, Me-13), 1.06 (3H, d, J = 6.9, Me-12); 13C NMR (CDCl3, 125 MHz, 
data from HSQC and HMBC), δ 154.2 (C-4), 145.4 (C-7), 133.1 (C-10), 127.2 (C-1), 126.5 (C-6), 
112.5 (C-15), 70.7 (C-5), 36.9 (C-3), 36.6 (C-9), 34.4 (C-11), 29.0 (C-8), 28.8 (C-2), 22.9 (Me-12), 
21.8 (Me-13), 17.9 (Me-14); (+)-LRESIMS m/z 243 [M+Na]+; (+)-HRESIMS m/z 243.1726 (calcd 
for C15H24ONa, 243.1719).    
 
4,5-β-Epoxy-α-muurolene (3.31): colorless oil (1.6 mg); [α]23D -21 (c 0.04, CHCl3); 1H NMR 
(CDCl3, 500 MHz): δ 5.40 (1H, br s, H-9), 2.75 (1H, s, H-5), 2.24 (1H, t, J = 5.6, H-6), 2.02 (1H, br 
s, H-1), 1.96 (1H, br s, H-8), 1.75 (2H, m, H-3), 1.70 (1H, m, H-11), 1.60 (3H, br s, Me-15), 1.49 
(2H, m, H-2), 1.39 (1H, m, H-7), 1.28 (3H, s, Me-14), 0.94 (3H, d, J = 6.8, Me-12), 0.89 (3H, d, J = 
6.8, Me-13); 13C NMR (CDCl3, 125 MHz, data from HSQC and HMBC), δ 134.0 (C-10), 121.9 (C-
9), 64.2 (C-5), 58.0 (C-4), 41.6 (C-7), 39.8 (C-6), 32.0 (C-1), 28.9 (C-8), 26.7 (C-11), 26.3 (C-3), 
23.5 (Me-14), 21.2 (C-2), 21.0 (Me-15), 20.9 (Me-12), 19.7 (Me-13); (+)-LRESIMS m/z 243 
[M+Na]+; (+)-HRESIMS m/z 243.1716 (calcd for C15H24ONa, 243.1719).    
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Cubebol (3.37):155 colorless oil (0.3 mg); [α]25D -190 (c 0.02, CHCl3), Lit:157 -51 (c 1.0, CHCl3); 1H 
NMR (CDCl3, 500 MHz), see Table 3.4. GC-MS m/z 222 [M]+. 
 
11β-Hydroxy-α-muurolene (3.38): colorless oil (0.2 mg); [α]23D -10 (c 0.02, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 5.67 (1H, br d, J = 4, H-5), 5.37 (1H, br s, H-9), 2.39 (1H, s, OH), 2.20 (1H, m, 
H-6), 2.08 (1H, m, H-8a), 1.98 (1H, br s, H-1), 1.97 (2H, m, H-3), 1.86 (1H, m, H-2a), 1.78 (1H, m, 
H-8b), 1.70 (3H, s, Me-14), 1.64 (1H, m, H-7), 1.68 (3H, s, Me-15), 1.54 (1H, m, H-2b), 1.24 (3H, s, 
Me-12), 1.17 (3H, s, Me-13); 13C NMR (CDCl3, 125 MHz, data from HSQC and HMBC), δ 137.2 
(C-4), 136.8 (C-10), 123.9 (C-5), 121.1 (C-9), 73.9 (C-11), 47.4 (C-7), 39.8 (C-1), 36.5 (C-6), 30.2 
(C-3), 29.2 (Me-13), 28.9 (C-8), 25.0 (Me-12), 24.1 (C-2), 23.7 (Me-14), 21.3 (Me-15); (+)-
LRESIMS m/z 243 [M+Na]+; (+)-HRESIMS m/z 243.1717 (calcd. for C15H24ONa, 243.1719).    
 
6.4.3.!X-ray crystallography of guaiane diacetate (3.26) 
The X-ray crystallographic analysis of 3.26 was conducted by Dr. Jack Clegg (School of 
Chemistry and Molecular Biosciences, UQ). Diffraction from a colorless plate like crystal was 
collected on the MX1 beamline at the Australian Synchrotron,522 employing Si(111)-monochromated 
synchrotron radiation (λ = 0.7108 Å). Cell constants were obtained from a least squares refinement 
against 28984 reflections located between 3.37 to 55.80º 2θ. Data were collected at 100 K with phi 
scans to 55.80º 2θ and reduction and integration was carried out in XDS.523 Subsequent computations 
were carried out with the Olex2 graphical user interface.524 The structure was solved in the space 
group P212121 by direct methods with SHELXT525 and extended and refined with SHELXL.526 The 
non-hydrogen atoms in the asymmetric unit were modelled with anisotropic displacement 
parameters.  A riding atom model with group displacement parameters was used for the hydrogen 
atoms. The absolute structure was established with the Flack parameter33–36 refining to 0.1(9).     
  
6.4.4.!Biological material of Phyllodesmium poindimiei (#855-865) 
 Eleven individuals of P. poindimiei (#855-865) were collected in Nelson Bay, NSW in 
November 2013. The cerata of P. poindimiei were separated from their body tissues prior to 
extraction. 
 
6.4.5.!Extraction and isolation of pregnane steroids and punaglandins from Phyllodesmium 
poindimiei (#855-865) 
 The extraction procedure of the cerata of P. poindimiei (#855-865) (0.61 g) followed the 
protocol described previously to give 22 mg of bright orange oily extract. NP flash chromatography 
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of the cerata extract using a gradient of hexanes/DCM/EtOAc yielded five fractions. Fraction A of 
the NP flash chromatography contained pregnane steroids and was purified by NP HPLC (15% 
EtOAc/hexanes) to afford pregna-1,4,20-trien-3-one (3.44) (1.5 mg), 18-acetoxy-pregna-1,4,20-trien-
3-one (3.45) (1.0 mg) and 3β-pregna-5,20-dien-3-ol (3.47) (0.5 mg). Fraction B of the NP flash 
chromatography retained a mixture of punaglandins. Punaglandin-8 (3.53) (0.3 mg) was isolated from 
repetitive RP HPLC (90% MeOH/water), whereas 5,6-epoxy-punaglandin-8 (3.54) (0.2 mg) was 
collected from repetitive RP HPLC (100% MeCN/water) with two C-18 columns in series.   
 
6.4.6.!Hydrolysis of 5,6-α-epoxy-punaglandin-8 (3.54) 
Approximately 0.5 mg of 3.54 was dissolved in chloroform. Para toluene sulfonic acid (1 eq) was 
then added into the solution, along with a drop of water.  The mixture was shaken rigorously and 
stirred at room temperature. After 2 hours, the organic layer was collected and the remaining aqueous 
residue was partitioned with choloroform. The combined chloroform layer was concentrated under 
N2 stream prior to NMR analysis. 
 
Pregna-1,4,20-trien-3-one (3.44):172,173 colorless oil (1.5 mg); [α]23D +8 (c 0.15, CHCl3); Lit. [α]23D 
+35 (c 0.37, CHCl3);187 1H NMR (CDCl3, 500 MHz) δ 7.07 (1H, d, J=10.1, H-1), 6.23 (1H, dd, 
J=10.2, 1.8, H-2), 6.07 (1H, t, J=1.4, H-4),  5.75 (1H, ddd, J=16.9, 10.3, 7.8, H-20), 5.00 (1H, dd, 
J=16.9, 1.3, H-21a), 4.96 (1H, dd, J=10.3, 1.3, H-21b), 2.48 (1H, ddd, J=13.4, 5.1, 1.5, H-6a), 2.36 
(1H, ddd, J=13.4, 4.4, 2.6, H-6b), 1.24 (3H, s, Me-19), 0.67 (3H, s, Me-18); (+)-LRESIMS m/z 319 
[M+Na]+. 
 
18-Acetoxy-pregna-1,4,20-trien-3-one (3.45):189 colorless oil (1.0 mg); [α]23D +23 (c 0.1, CHCl3); 
Lit. [α]23D  +33 (c 0.7, CHCl3);175 1H NMR (CDCl3, 500 MHz) δ 7.04 (1H, d, J=10.1, H-1), 6.24 (1H, 
dd, J=10.2, 1.8, H-2), 6.08 (1H, t, J=1.5, H-4),  5.80 (1H, ddd, J=17.2, 10.1, 8.1, H-20), 4.96 (1H, dd, 
J=17.2, 2.0, H-21a), 4.94 (1H, dd, J=10.1, 2.0, H-21b), 4.09 (1H, d, J=12.0, H-18a), 4.04 (1H, d, 
J=12.0, H-18b), 2.48 (1H, ddd, J=13.6, 5.1, 1.6, H-6a), 2.38 (1H, ddd, J=13.5, 4.3, 2.6, H-6b), 1.24 
(3H, s, Me-19); (+)-LRESIMS m/z 377 [M+Na]+. 
 
3β-Pregna-5,20-dien-3-ol (3.47):194 colorless oil (0.5 mg); [α]23D -20 (c 0.05, CHCl3);  Lit. [α]23D -
58 (c 0.05, CHCl3);197 1H NMR (CDCl3, 500 MHz) δ 5.77 (1H, ddd, J=16.5, 10.9, 7.7, H-20), 5.35 
(1H, m, H-6), 4.99 (1H, m, H-21a), 4.96 (1H, m, H-21b), 3.52 (1H, m, H-3), 1.02 (3H, s, Me-19), 
0.61 (3H, s, Me-18); (+)-LRESIMS m/z 319.2 [M+Na]+. 
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Punaglandin-8 (3.53):200 colorless oil (0.3 mg); [α]23D +30 (c 0.03, CHCl3); Lit. [α]23D +44 (c 0.04, 
CHCl3);210 1H NMR (CDCl3, 500 MHz) δ 7.33 (1H, s, H-11), 5.96 (1H, dd, J=9.6, 3.4, H-7), 5.84 
(1H, t, J=10.3, H-6), 5.34 (1H, m, H-14), 3.68 (3H, s, -COOCH3), 3.19 (1H, s, OH), 2.68 (1H, d, 3.6, 
H-8), 2.55 (1H, dd, J=14.3, 7.0, H-13a), 2.40 (1H, dd, J=14.0, 8.0, H-13b), 2.33 (2H, t, J=7.3, H-2), 
2.21 (2H, ddd, J=7.7, 4.1, 1.2, H-4), 2.01 (3H, s, -OCOCH3), 2.00 (2H, m, H-16), 1.72 (1H, m, H-3), 
0.88 (3H, t, J=6.6, Me-20); (+)-LRESIMS m/z 463/465 [M+Na]+. 
 
5,6-α-Epoxy-punaglandin-8 (3.54): colorless oil (0.2 mg); [α]23D +12 (c 0.02, CHCl3); 1H and 13C 
NMR (CDCl3, 500 MHz) see Table 3.8; (+)-HRESIMS m/z 479.1807 [M+Na]+ (calcd. 479.1857, 
C23H3335ClO7Na). 
 
Punaglandin diol (3.55a): colorless oil (0.2 mg); 1H and 13C NMR (CDCl3, 500 MHz) see Table 3.9. 
 
6.4.7.!Biological material of Phyllodesmium longicirrum 
 An individual of P. longicirrum was collected at a dive site near Lizard Island in 2013. The 
cerata of P. longicirrum were separated from their body tissues prior to extraction. 
 
6.4.8.!Extraction and isolation of cembranolides from P. longicirrum 
 The extraction procedure of the cerata of P. longicirrum (12 g) followed the protocol 
described previously to give 4.0 g of dark green gum. NP flash chromatography of the cerata extract 
(1.0 g) using a gradient of hexanes/DCM yielded eight fractions. Fraction B and C of the NP flash 
chromatography was purified by second NP flash chromatography (a gradient of hexanes/DCM) and 
NP HPLC (1% EtOAc/hexanes) to afford sarcophytonin A (3.67) (9.5 mg), 7,8-epoxy-
isoneocembrene A (3.75) (0.2 mg) and 11,12-epoxy-isoneocembrene A (3.78) (0.5 mg). The major 
compound, isosarcophytoxide (3.76) (175 mg), was retained in fractions D and E. Fraction F of the 
NP flash chromatography was purified by NP flash chromatography (a gradient of hexanes/DCM) 
and NP HPLC (20-30% EtOAc/hexanes) to yield sarcophytoxide (3.69) (7.8 mg), ent-sarcophine 
(3.72) (0.3 mg), isosarcophytoxide (3.76) (2.1 mg), phyllodesmolides A (3.83) (1.0 mg), B (3.84) (1.4 
mg), C (3.88) (1.6 mg), D (3.90) (0.9 mg), E (3.91) (1.3 mg) and bisepoxysarcophytoxide (3.89) (0.5 
mg). The methoxy derivative of phyllodesmolide A (3.85) was recrystallized from 50% 
EtOAc/hexanes solution by using diffusion method.  
 
Sarcophytonin A (3.67):231 colorless oil (9.5 mg); [α]23D -32 (c 0.04, CHCl3); Lit. [α]23D -210 (c 0.1, 
CHCl3);283 1H NMR (CDCl3, 500 MHz) δ 5.52 (1H, m, H-2), 5.08 (1H, d, J=10.7, H-3), 5.00 (1H, t, 
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J=6.6, H-7), 4.86 (1H, dd, J=8.2, 3.8, H-11), 4.49 (2H, m, H-16), 1.69 (3H, s, Me-18), 1.64 (3H, s, 
Me-17), 1.60 (3H, s, Me-20), 1.58 (3H, s, Me-19); (+)-LRESIMS m/z 309 [M+Na]+. 
Sarcophytoxide (3.69),233 isolated as a mixture with phyllodesmolides D (3.90) and E (3.91), 
colorless oil (7.8 mg); 1H NMR (CDCl3, 500 MHz) δ 5.53 (1H, m, H-2), 5.22 (1H, d, J=10.2, H-3), 
5.09 (1H, dd, J=10.8, 5.1, H-11), 4.49 (1H, br s, H-16), 2.71 (1H, t, J=4.1, H-7), 1.82 (3H, s, Me-18), 
1.64 (3H, s, Me-17), 1.59 (3H, s, Me-20), 1.27 (3H, s, Me-19); (+)-LRESIMS m/z 325 [M+Na]+. 
 
Ent-Sarcophine (3.72):238 colorless oil (0.3 mg); [α]23D -94 (c 0.03, CHCl3); Lit. [α]23D +92 (c 1.0, 
CHCl3);238 1H NMR (CDCl3, 500 MHz) δ 5.56 (1H, dd, J = 9.8, 1.4, H-2), 5.15 (1H, dd, J=9.6, 5.4, 
H-11), 5.04 (1H, dd, J=9.8, 1.1, H-3), 2.74 (1H, ddd, J=14.3, 10.2, 8.3, H-14), 2.67 (1H, t, J=4.5, H-
7), 2.38 (2H, m, H-5), 2.25 (1H, m, H-10a), 2.19 (1H, m, H-13a), 2.10 (1H, m, H-9a), 2.09 (1H, m, 
H-14b), 2.03 (1H, m, H-13b), 1.93 (1H, m, H-10b), 1.89 (1H, m, H-6a), 1.89 (3H, br d, J=1.1, Me-
17), 1.85 (3H, br d, J = 1.4, Me-17), 1.69 (1H, m, H-6b), 1.62 (3H, s, Me-20), 1.28 (3H, s, Me-19), 
1.11 (1H, dt, J=13.0, 2.9, H-9b); (+)-LRESIMS m/z 339 [M+Na]+. 
 
7,8-Epoxy-isoneocembrene A (3.75):240 colorless oil (0.2 mg); compound decomposed prior to 
optical rotation analysis; Lit. [α]23D -22.5(c 0.19, CHCl3);1H NMR (CDCl3, 500 MHz) δ 6.04 (1H, d, 
J=10.8, H-2), 5.97 (1H, d, J=10.8, H-3), 5.07 (1H, br t, J=6.2, H-11), 2.85 (1H, t, J=5.4, H-7), 1.76 
(3H, s, Me-18), 1.61 (3H, s, Me-20), 1.27 (3H, s, Me-19), 1.06 (3H, s, Me-16), 1.05 (3H, s, Me-17); 
(+)-LRESIMS m/z 311 [M+Na]+. 
 
Isosarcophytoxide (3.76):233,283 colorless oil (175 mg); [α]23D -81 (c 0.47, CHCl3);  Lit.122 [α]23D  -
128 (concentration was not reported, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.32 (1H, m, H-2), 5.04 
(1H, d, J=9.9, H-3), 4.99 (1H, t, J=7.0, H-7), 4.40 (2H, m, H-16), 2.74 (1H, dd, J=9.1, 3.4, H-11), 
2.28 (1H, m, H-5a), 2.25 (1H, m, H-6a), 3.16 (2H, m, H-6a, H-9a), 2.06 (1H, m, H-9b), 2.04 (1H, m, 
H-5b), 1.92 (1H, m, H-13a), 1.90 (1H, m, H-14a), 1.85 (1H, m, H-10a), 1.82 (1H, m, H-14b), 1.70 
(3H, s, Me-18), 1.58 (3H, s, Me-17), 1.57 (3H, s, Me-19), 1.41 (1H, m, H-10b), 1.27 (1H, m, H-13b), 
1.17 (3H, s, Me-20); (+)-LRESIMS m/z 325.2 [M+Na]+. 
 
11,12-Epoxy-isoneocembrene A (3.78):129 colorless oil (0.2 mg); compound decomposed prior to 
optical rotation analysis; Lit. 245 [α]23D +117 (c 0.09, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.93 (1H, 
d, J=10.4, H-2), 5.85 (1H, dd, J=10.4, 1.0, H-3), 5.23 (1H, br t, J=6.3, H-7), 2.88 (1H, dd, J=7.0, 5.2, 
H-11), 1.72 (3H, br d, J=1.0, H-18), 1.60 (3H, s, Me-20), 1.26 (3H, s, Me-19), 1.04 (3H, d, J=6.9, 
Me-16), 1.02 (3H, d, J=6.9, Me-17); (+)-LRESIMS m/z 311 [M+Na]+. 
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Phyllodesmolide A (3.83): colorless oil (1.6 mg); [α]23D -65 (c 0.19, CHCl3); 1H NMR (CDCl3, 700 
MHz) δ 5.15 (1H, t, J=5.3, H-7), 4.56 (1H, dd, J=8.3, 1.5, H-2), 2.70 (1H, d, J=8.2, H-3), 2.67 (1H, 
dd, J=9.6, 3.7, H-11), 2.36 (1H, m, H2-14), 2.23 (1H, m, H2-6), 2.21 (2H, m, H2-9), 2.14 (1H, m, H-
5a), 2.01 (1H, m, H-10a), 2.09 (1H, m, H-13a), 1.89 (3H, d, J=1.5, Me-17), 1.81 (1H, ddd, J=14.0, 
10.4, 5.7, H-13b), 1.64 (3H, d, J=0.8, Me-19), 1.49 (5H, m, H-5b, H-10b, Me-18), 1.28 (3H, s, Me-
20); 13C NMR (CDCl3, 175 MHz, data from HSQC and HMBC), δ 174.1 (C-16), 157.4 (C-1), 135.3 
(C-8), 125.6 (C-7), 125.2 (C-15), 80.9 (C-2), 62.5 (C-3), 61.6 (C-11), 61.0 (C-4, C-12), 37.1 (C-5), 
36.6 (C-9), 34.0 (C-13), 24.2 (C-10), 23.8 (C-6, C-14), 18.4 (Me-18), 17.8 (Me-20), 15.7 (Me-19), 
9.3 (Me-17); (+)-HRESIMS m/z 355.1880 [M+Na]+ (calcd. for 355.1880, C20H28O4Na). 
 
Phyllodesmolide B (3.84): colorless oil (1.0 mg); [α]23D -20 (c 0.04, CHCl3); 1H NMR (CDCl3, 700 
MHz) δ 9.60 (1H, s, OH), 5.85 (1H, s, H-16), 5.16 (1H, t, J=6.7, H-7), 4.58 (1H, br d, J=4.7, H-2), 
2.93 (1H, d, J=4.7, H-3), 2.76 (1H, dd, J=7.7, 4.8, H-11), 2.25 (1H, m, H-9a), 2.20 (3H, m, H2-6, H-
14a), 2.15 (1H, m, H-9b), 2.10 (1H, m, H-5a), 2.05 (1H, m, H-14b), 1.92 (1H, m, H-10a), 1.87 (2H, 
m, H2-13), 1.74 (3H, br s, Me-17), 1.65 (3H, br d, J=0.8, Me-19), 1.56 (1H, m, H-10b), 1.53 (3H, s, 
Me-18), 1.42 (1H, m, H-5b), 1.27 (3H, s, Me-20); 13C NMR (CDCl3, 175 MHz, data from HSQC and 
HMBC), δ 137.5 (C-1), 134.5 (C-8), 127.3 (C-15), 125.2 (C-7), 114.0 (C-16), 82.2 (C-2), 62.8 (C-3), 
61.4 (C-4), 59.8 (C-12), 59.4 (C-11), 37.5 (C-5), 36.2 (C-9), 33.8 (C-13), 24.2 (C-10), 22.9 (C-6), 
19.1 (C-14), 18.3 (Me-20), 17.0 (Me-18), 15.1 (Me-19), 9.6 (Me-17); (+)-HRESIMS m/z 355.1902 
[M+Na]+ (calcd. for 355.1902, C20H28O4Na) for the lactone form. 
 
Phyllodesmolide C (3.88): colorless oil (1.4 mg); [α]23D -51 (c 0.08, CHCl3); 1H NMR (CDCl3, 700 
MHz) δ 8.45 (1H, s, OH), 5.96 (1H, br d, J=3.6, H-16), 5.13 (1H, t, J=5.7, H-7), 4.62 (1H, br d, J=8.7, 
H-2), 2.67 (1H, d, J=8.7, H-3), 2.71 (1H, dd, J=10.0, 3.2, H-11), 2.24 (1H, m, H-6a), 2.20 (1H, m, H-
6b), 2.19 (2H, m, H2-9), 2.15 (1H, m, H-14a), 2.14 (1H, m, H-5a), 2.06 (1H, m, H-14b), 2.01 (1H, m, 
H-10a), 1.96 (1H, m, H-13a), 1.76 (3H, s, Me-17), 1.67 (1H, ddd, J=13.6, 11.7, 4.8, H-13b), 1.62 
(3H, br d, J=1.1, Me-19), 1.46 (1H, m, H-10b), 1.43 (3H, s, Me-18), 1.42 (1H, m, H-5b), 1.23 (3H, 
s, Me-20); 13C NMR (CDCl3, 175 MHz, data from HSQC and HMBC), δ 137.2 (C-1), 134.3 (C-8), 
126.5 (C-15), 125.0 (C-7), 113.9 (C-16), 85.0 (C-2), 64.3 (C-3), 61.4 (C-11), 60.2 (C-4, C-12), 37.0 
(C-5), 36.3 (C-9), 33.8 (C-13), 23.7 (C-10), 23.5 (C-6), 21.3 (C-14), 17.8 (Me-18), 17.7 (Me-20), 
15.1 (Me-19), 9.9 (Me-17); (+)-HRESIMS m/z 355.1884 [M+Na]+ (calcd. for 355.1880, C20H28O4Na) 
for the lactone form. 
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Bisepoxysarcophytoxide (3.89):283 colorless oil (2.1 mg); [α]23D -140 (c 0.03, CHCl3); Lit. 283 [α]23D 
-46.7 (c 0.09, CHCl3); 1H NMR (CDCl3, 500 MHz) δ  5.15 (1H, m, H-7), 4.55 (1H, m, H-16a), 4.53 
(1H, m, H-2), 4.47 (1H, m, H-16b), 2.77 (1H, dd, J=9.9, 3.3, H-11), 2.73 (1H, d, J=8.1, H-3), 2.20 
(3H, m, H2-9, H-14a), 2.09 (2H, m, H-5a, H-6a), 2.04 (1H, m, H-14b), 1.99 (2H, m, H-6b, H-10a), 
1.91 (1H, m, H-13a), 1.66 (1H, m, H-13b), 1.65 (3H, s, Me-17), 1.61 (3H, br s, Me-19), 1.47 (1H, m, 
H-10b), 1.42 (4H, m, H-5b, Me-18), 1.24 (3H, s, Me-20); (+)-LRESIMS m/z 341.2 [M+Na]+. 
 
Phyllodesmolide D (3.90): colorless oil (0.9 mg); [α]23D -83 (c 0.04, CHCl3);  1H NMR (CDCl3, 700 
MHz) δ 8.22 (1H, s, OH), 5.89 (1H, s, H-16), 5.46 (1H, d, J=10.2, H-2), 5.23 (1H, dd, J=10.1, 0.9, 
H-3), 5.11 (1H, dd, J=10.1, 5.2, H-11), 2.68 (1H, t, J=4.1, H-7), 2.57 (1H, m, H-14a), 2.34 (2H, m, 
H2-5), 2.24 (1H, m, H-10a), 2.08 (1H, ddd, J=13.2, 5.4, 2.7, H-9a), 2.01 (1H, m, H-13a), 1.92 (1H, 
m, H-13b), 1.89 (1H, m, H-6a), 1.88 (1H, m, H-10b), 1.84 (3H, d, J=0.9, Me-18), 1.78 (1H, m, H-
14b), 1.71 (3H, s, Me-17), 1.64 (1H, m, H-6b), 1.58 (3H, s, Me-20), 1.26 (3H, br d, J=1.1, Me-19), 
1.01 (1H, dt, J=13.2, 2.7, H-9b); 13C NMR (CDCl3, 175 MHz, data from HSQC and HMBC), δ 140.8 
(C-1), 140.2 (C-4), 136.1 (C-12), 125.1 (C-15), 124.8 (C-3), 123.5 (C-11), 113.6 (C-16), 82.4 (C-2), 
61.0 (C-7), 59.2 (C-8), 39.1 (C-9), 36.9 (C-5), 36.0 (C-13), 25.7 (C-14), 24.8 (C-6), 22.9 (C-10), 16.7 
(Me-19), 15.0 (Me-18), 14.7 (Me-20), 9.6 (Me-17); (+)-HRESIMS m/z 339.1931 [M+Na]+ (calcd. 
for 339.1928, C20H28O3Na) for the lactone form.  
 
Phyllodesmolide E (3.91): colorless oil (1.3 mg); [α]23D -100 (c 0.03, CHCl3);  1H NMR (CDCl3, 700 
MHz) δ 8.40 (1H, s, OH), 5.96 (1H, d, J=2.6, H-16), 5.66 (1H, br d, J=10.2, H-2), 5.11 (2H, m, H-3, 
H-11), 2.69 (1H, t, J=4.3, H-7), 2.61 (1H, m, H-14a), 2.37 (2H, m, H2-5), 2.26 (1H, m, H-10a), 2.11 
(1H, ddd, J=13.2, 5.2, 2.5, H-9a), 2.01 (1H, m, H-13a), 1.91 (2H, m, H-6a, H-10b), 1.90 (1H, m, H-
13b), 1.84 (3H, d, J=0.9, Me-18), 1.75 (1H, m, H-14b), 1.74 (3H, s, Me-17), 1.65 (1H, m, H-6b), 1.60 
(3H, s, Me-20), 1.28 (3H, br d, J=1.1, Me-19), 1.01 (1H, dt, J=13.2, 2.9, H-9b); 13C NMR (CDCl3, 
175 MHz, data from HSQC and HMBC), δ 141.9 (C-1), 140.6 (C-4), 136.0 (C-12), 123.9 (C-15), 
123.8 (C-3, C-11), 113.7 (C-16), 82.1 (C-2), 61.1 (C-7), 59.4 (C-8), 39.2 (C-9), 37.2 (C-5), 36.0 (C-
13), 25.0 (C-6), 23.2 (C-10), 21.8 (C-14), 16.5 (Me-19), 15.1 (Me-18), 14.8 (Me-20), 9.5 (Me-17); 
(+)-HRESIMS m/z 339.1931 [M+Na]+ (calcd. for 339.1933, C20H28O3Na) for the lactone form and 
m/z 341.2087 [M+Na]+ (calcd. for 341.2088, C20H28O3Na) for the lactol form. 
 
6.4.9.!X-ray crystallography of the methoxy derivative of phyllodesmolide B (3.85) 
The X-ray crystallographic analysis of 3.85 was conducted by Aidan Brock (School of 
Chemistry and Molecular Biosciences, UQ). Diffraction from a colorless plate like crystal was 
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collected on the MX1 beamline at the Australian Synchrotron,522 employing Si(111)-monochromated 
synchrotron radiation (λ = 0.7108 Å). Cell constants were obtained from a least squares refinement 
against 29489 reflections located between 2.16 and 54.21º 2θ. Data were collected at 100 K with phi 
scans to 54.21º 2θ and reduction and integration was carried out in XDS.523 Subsequent computations 
were carried out with the Olex2 graphical user interface.524 The structure was solved in the space 
group P21 by direct methods with SHELXT525 and extended and refined with SHELXL.526 The non-
hydrogen atoms in the asymmetric unit were modelled with anisotropic displacement parameters.  A 
riding atom model with group displacement parameters was used for the hydrogen atoms. The 
absolute structure was established with the Flack parameter527–530 refining to -0.7(14).   
 
6.5.!Experimental for Chapter 4 
6.5.1.!Biological material of Goniobranchus coi 
An individual of G. coi (#47) was collected at a dive site near Lizard Island, QLD in 2009 and 
was kept frozen until extraction. Another individual of G. coi (#1095) was collected at a dive site 
near Mackay, NSW in October 2014. All individuals were dissected into mantle and gut tissues prior 
to extraction.  
 
6.5.2.!Extraction and isolation of rearranged diterpenes  
6.5.2.1.!Goniobranchus coi (#47) batch one 
Approximately 0.12 g of G. coi mantle was extracted with acetone (3 x 3 mL) then partitioned 
against Et2O (3 x 3 mL) to yield 2.3 mg of extract. NP HPLC of the mantle extract by using 20% 
EtOAc/hexanes afforded norrisolide (4.3) (0.7 mg), macfarlandin C (4.8) (0.1 mg) and dendrillolide 
A (4.66) (0.1 mg). 
The gut tissue of G. coi was exhaustively partitioned against Et2O (6 x 5 mL) to give 7.6 mg 
of extract. NP flash chromatography of the Et2O extract with a gradient of hexanes/DCM/EtOAc 
yielded 3 fractions. Fraction 2 (3.1 mg) was purified by NP HPLC with 20% EtOAc/hexanes to obtain 
norrisolide (4.3) (0.2 mg), macfarlandin C (4.8) (1.3 mg) and cheloviolene C (4.65) (0.2 mg). 
 
6.5.2.2.!Goniobranchus coi (#1095) batch two 
The extraction of 0.49 g of mantle of G. coi (#1095) was carried out by using acetone (7 x 3 
mL), followed by partition against Et2O (3 x 3 mL) to yield 5.3 mg of extract.  The purification of the 
mantle extract by NP HPLC (20% EtOAc/hexanes) afforded norrisolide (4.3) (1.3 mg), macfarlandin 
C (4.8) (1.3 mg), chromolactol (4.62) (0.2 mg), cheloviolene C (4.65) (0.2 mg) and dendrillolide A 
(4.66) (0.6 mg). A similar extraction method of the gut portion of G. coi (#1095) gave 5.2 mg of 
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extract. NP HPLC (20% EtOAc/hexanes) of the gut extract afforded norrisolide (4.3) (2.0 mg), 
macfarlandin C (4.8) (1.8 mg), cheloviolene C (4.65) (1.3 mg) and dendrillolide A (4.66) (0.1 mg). 
Norrisolide (4.3):318,340 colorless crystal (4.2 mg); [α]25D +9 (c 0.2, CHCl3), Lit:38 +3.5 (c 0.13, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.44 (1H, d, J = 3.4, H-15), 6.14 (1H, d, J = 6, H-16), 5.16 
(1H, s, H-17a), 5.09 (1H, s, H-17b), 3.36 (1H, m, H-13), 3.07 (1H, dd, J = 9.4, 3.4, H-14), 2.55 (2H, 
d, J = 7.2, H-12), 2.14 (1H, t, J =9.2, H-8), 2.07 (3H, s, -OCOCH3), 1.68 (1H, m, H-6a), 1.66 (2H, 
m, H-7), 1.63 (1H, m, H-1a), 1.55 (2H, m, H2-2), 1.46 (2H, m, H-3a, H-6b), 1.15 (1H, dd, J = 13.2, 
6.8, H-5), 1.06 (1H, dt, J =13.3, 4.5, H-3b), 1.01 (1H, dt, J = 12.7, 4.5, H-1b), 0.86 (6H, s, Me-19, 
Me-20), 0.66 (3H, s, Me-18); 13C NMR (CDCl3, 125 MHz, data from HSQC and HMBC and HMBC) 
δ 174.5 (C-11), 169.4 (-OCOCH3), 143.0 (C-10), 117.2 (C-17), 107.4 (C-16), 101.8 (C-15), 59.2 (C-
8), 58.1 (C-5), 49.8 (C-14), 45.1 (C-9), 41.7 (C-3), 40.6 (C-13), 38.8 (C-1), 33.4 (Me-20), 33.2 (C-
4), 30.9 (C-12), 24.5 (C-7), 21.2 (C-6), 21.1 (-OCOCH3), 20.7 (Me-19), 19.7 (C-2), 14.2 (Me-18); 
(+)-LRESIMS m/z 399 [M+Na]+. 
 
Macfarlandin C (4.8):342 needles (4.5 mg); [α]25D -8 (c 0.18, CHCl3), Lit:342 -29 (c 0.75, CHCl3); 1H 
NMR (CDCl3, 500 MHz) δ 6.53 (1H, d, J = 6.9, H-15), 6.04 (1H, d, J = 4.1, H-16), 5.31 (1H, br t, J 
= 3.9, H-1), 3.03 (1H, dddd, J = 10.4, 8.9, 6.9, 4.1, H-13), 2.80 (1H, t, J =6.9, H-14), 2.74 (1H, dd, J 
= 17.4, 10.4, H-12a), 2.55 (1H, dd, J = 17.4, 8.9, H-12b), 2.10 (3H, s, -OCOCH3), 2.02 (2H, br s, H-
2), 1.89 (1H, br q, J = 7, H-9), 1.73 (1H, dq, J = 12.6, 3.6, H-6a), 1.62 (1H, dd, J = 12.6, 4.2, H-7a), 
1.60 (1H, dt, J = 12.6, 3.6, H-7b), 1.39 (1H, br d, J = 13.3, H-5), 1.35 (1H, ddd, J = 12.7, 6.1, 2.4, H-
3a), 1.24 (1H, dd, J = 12.6, 4.2, H-6b), 1.15 (1H, dt, J = 12.7, 4.9, H-3b), 1.00 (3H, d, J = 7, Me-18), 
0.87 (3H, s, Me-20), 0.83 (3H, s, Me-19), 0.82 (3H, s, Me-17); 13C NMR (CDCl3, 125 MHz, data 
from HSQC and HMBC and HMBC) δ 176.0 (C-11), 170.0 (-OCOCH3), 140.0 (C-10), 118.4 (C-1), 
104.7 (C-16), 96.1 (C-15), 18.4 (Me-17), 51.6 (C-14), 48.5 (C-5), 44.2 (C-9), 42.0 (C-13), 40.0 (C-
8), 35.3 (C-7), 32.4 (C-3), 31.2 (C-4), 30.0 (C-12), 27.4 (Me-20), 25.0 (C-6), 26.9 (Me-19), 22.7 (C-
2), 21.1 (-OCOCH3), 11.4 (Me-18); (+)-LRESIMS m/z 399 [M+Na]+. 
 
Chromolactol (4.62): colorless oil (0.2 mg); [α]25D -3 (c 0.04, CHCl3); 1H NMR (CDCl3, 700 MHz) 
δ 6.18 (1H, d, J = 6.2, H-16), 5.54 (1H, s, H-15), 4.92 (1H, s, H-17a), 4.88 (1H, s, H-17b), 3.01 (1H, 
ddd, J = 11.4, 6.2, 5.3, H-13), 2.86 (1H, dd, J = 18.6, 11.4, H-12a), 2.76 (1H, br s, H-14), 2.75 (1H, 
dd, J = 18.6, 5.3, H-12b), 2.06 (1H, m, H-8), 1.72 (1H, m, H-7a), 1.67 (1H, m, H-1a), 1.65 (2H, m, 
H-6a, H-7b), 1.59 (1H, m, H-2a), 1.52 (1H, m, H-2b), 1.45 (1H, m, H-3a), 1.43 (1H, m, H-6b), 1.26 
(1H, m, H-5), 1.10 (1H, m, H-1b), 1.07 (1H, m, H-3b), 0.86 (6H, s, Me-19, Me-20), 0.67 (3H, s, Me-
18); 13C NMR (CDCl3, 175 MHz, data from HSQC and HMBC and HMBC) δ 175.4 (C-11), 148.2 
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(C-10), 111.5 (C-17), 108.9 (C-16), 104.1 (C-15), 58.8 (C-8), 58.7 (C-5), 58.5 (C-14), 45.2 (C-13), 
44.0 (C-9), 41.6 (C-3), 39.9 (C-1), 35.8 (C-12), 33.5 (C-4), 33.4 (Me-20), 24.8 (C-7), 20.8 (C-6), 20.7 
(Me-19), 19.9 (C-2), 14.2 (Me-18); (-)-HRESIMS m/z 333.2071 [M-H]- (calcd. for C20H29O4, 
333.2075). 
 
Cheloviolene C (4.65):343 colorless oil (1.7 mg); [α]25D -3 (c 0.09, CHCl3), Lit:343 optical rotation 
was not reported; 1H NMR (CDCl3, 500 MHz) δ 5.04 (1H, s, H-17a), 5.03 (1H, s, H-17b), 4.46 (1H, 
dd, J = 9.4, 7.8, H-16a), 4.04 (1H, dd, J = 11.6, 3.7, H-15a), 3.97 (1H, dd, 11.6, 6.6, H-15b), 3.87 
(1H, t, J = 9.4, H-16b), 2.91 (1H, dddd, J = 10.4, 9.4, 8.4, 7.8, H-13), 2.73 (1H, dd, J = 17.5, 8.4, H-
12a), 2.35 (1H, dd, J = 17.5, 10.3, H-12b), 2.25 (1H, ddd, J = 10.4, 6.6, 3.7, H-14), 2.04 (4H, m, -
OCOCH3, H-8), 1.66 (2H, m, H-7), 1.61 (2H, m, H-6), 1.56 (1H, m, H-1a), 1.53 (2H, m, H-2), 1.44 
(1H, dt, J = 12.5, 3.1, H-3a), 1.28 (1H, m, H-5), 1.15 (1H, td, 12.5, 4.6, H-1b), 1.06 (1H, td, J = 12.5, 
4.6, H-3b), 0.86 (6H, s, Me-19, Me-20), 0.67 (3H, s, Me-18); 13C NMR (CDCl3, 125 MHz, data from 
HSQC and HMBC and HMBC) δ 176.8 (C-11), 170.6 (-OCOCH3), 146.0 (C-10), 113.8 (C-17), 72.3 
(C-16), 66.2 (C-15), 58.9 (C-5), 57.4 (C-8), 49.4 (C-14), 43.5 (C-9), 41.3 (C-3), 40.2 (C-1), 37.3 (C-
13), 33.9 (C-12), 33.3 (C-4), 33.0 (Me-20), 26.1 (C-7), 21.0 (-OCOCH3), 20.5 (Me-19), 20.0 (C-6), 
19.8 (C-2), 13.7 (Me-18); (+)-LRESIMS m/z 385 [M+Na]+. 
 
Dendrillolide A (4.66):342,344 colorless oil (0.8 mg); [α]25D +9 (c 0.04, CHCl3), Lit:344 +87 (c 0.31, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.45 (1H, d, J = 6.2, H-15), 6.05 (1H, d, J = 4.4, H-16), 4.83 
(1H, s, H-17a), 4.56 (1H, s, H-17b), 3.14 (1H, dddd, J = 11.2, 9.7, 6.7, 4.5, H-13), 2.72 (1H, dd, J = 
18.0, 9.9, H-12a), 2.67 (1H, m, H-14), 2.53 (1H, dd, J = 18.0, 9.6, H-12b), 2.35 (1H, m, H-1a), 2.10 
(3H, s, -OCOCH3), 1.85 (1H, m, H-1b), 1.75 (1H, m, H-5), 0.97 (3H, s, Me-18), 0.97 (3H, s, Me-20), 
0.94 (3H, s, Me-19); (+)-LRESIMS m/z 399 [M+Na]+. 
 
6.5.2.3.!X-ray crystallography of norrisolide (4.3) 
The X-ray crystallographic analysis of 4.3 was conducted by Dr. Jack Clegg (School of 
Chemistry and Molecular Biosciences, UQ). Data were collected at 190(2) K using an Oxford Gemini 
Ultra employing confocal mirror monochromated Cu-Kα radiation generated from a sealed tube 
(1.5418 Å).531 Data integration and reduction were undertaken with either CrysAlisPro.531 Structures 
were solved using SHELXT.525 Multi-scan empirical absorption corrections, when applied, were 
applied to the data set CrysAlisPro.531 Data were refined and extended with SHELXL-2014532 using 
the OLEX-2 graphical user interface.524 In general, non-hydrogen atoms with occupancies greater 
than 0.5 were refined anisotropically. Carbon-bound hydrogen atoms were included in idealised 
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positions and refined using a riding model. Oxygen-bound hydrogen atoms were first located in the 
difference Fourier map before refinement.  
6.5.3.!Biological material of Ardeadoris egretta 
 An individual of A. egretta (#63) was obtained from a dive site near Lizard Island, QLD in 
October 2008 and was re-collected in October 2012 (#371). The third individual was collected near 
Gneerings Reef, Mooloolaba, QLD (#480) in March 2013. All individuals were dissected into mantle 
and gut prior to extraction.  
 
6.5.4.!Isolation and extraction of spongian diterpenes from Ardeadoris egretta 
The mantle tissues of A. egretta (#371 and #480) (8.5 g) were combined then extracted with 
acetone (7 x 10 mL). The concentrated acetone extract was subsequently partitioned against Et2O (4 
x 5 mL) to yield 233 mg of mantle extract. The extraction of combined gut tissues afforded 49 mg of 
gut extract. The mantle and gut tissues of A. egretta (#63) (4.9 g) were extracted separately to give 
57 mg mantle extract and 8 mg gut extract.  
The various mantle and gut extracts of A. egretta were combined based on similar 1H NMR 
spectra. A portion of each mantle and gut extract was set aside for bioassay. The remaining mantle 
(60 mg) and gut extracts (12 mg) were further analyzed.  The mantle extract was subjected to NP 
flash chromatography using a gradient of hexanes/DCM/EtOAc to yield seven fractions. Aplyroseol-
2 (4.15) (18 mg) was concentrated in fraction F. Fraction E contained a mixture of aplyroseol-9 (4.72) 
and 7α-acetoxy-8β,14β-diformylpodocarpane-13β-carboxylate (4.32) (1 mg).  Fraction B of NP flash 
chromatography was re-chromatographed by NP flash chromatography using a gradient of 
hexanes/EtOAc to yield 5 subfractions. Fraction 2 was purified by NP HPLC (10% EtOAc/hexanes) 
to afford dendrillol-sterol conjugate (4.73) (0.9 mg), isoagatholactone (4.74) (0.1 mg), ent-spongian-
16-one (4.75) (0.2 mg) and dendrillol-3 (4.76) (0.2 mg), in order of elution. 
NP flash chromatography of the gut extract using a gradient of hexanes/EtOAc gave seven 
fractions. Aplyroseol-2 (4.15) (2.3 mg) was eluted in fraction E. Purification of fraction D by NP 
HPLC (25% EtOAc/hexanes) yielded aplyroseol-2 (4.15) (0.1 mg), dendrillol-1 (4.20) (0.1 mg), 
aplyroseol-9 (4.72) (0.7 mg), dendrillol-3 (4.76) (0.3 mg) and 7α-hydroxydendrillol-3 (4.77) (0.1 
mg). 
 
Aplyroseol-2 (4.15):110,365 yellow oil (20.4 mg); [α]23D -40 (c 1.8, CHCl3), Lit:110,365 specific rotation 
was not reported; 1H NMR (CDCl3, 500 MHz) δ 6.30 (1H, d, J = 5.9, H-15), 5.47 (1H, s, H-17), 4.75 
(1H, t, J = 2.7, H-7), 2.86 (1H, dd, J = 11.2, 6.3, H-14), 2.75 (1H, dd, J = 10.7, 7.2, H-13), 2.13 (3H, 
s, -OCOCH3), 0.92 (3H, s, Me-20), 0.80 (3H, s, Me-19), 0.76 (3H, s, Me-18); (+)-LRESIMS m/z 415 
[M+Na]+. 
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Dendrillol-1 (4.20):362 colorless oil (0.1 mg); α]23D -53 (c 0.01, CHCl3), Lit:362 [α]20D -32 (c 1.0, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.10 (1H, d, J = 6.1, H-15), 5.49 (1H, s, H-17), 2.72 (1H, dd, 
J = 11.2, 7.4, H-13), 2.58 (1H, dd, J = 11.2, 6.1, H-14), 0.91 (3H, s, Me-20), 0.85 (3H, s, Me-18), 
0.83 (3H, s, Me-19); (+)-LRESIMS m/z 357 [M+Na]+. 
 
7α-Acetoxy-8β,14β-diformylpodocarpane-13β-carboxylate (4.32)330 as a mixture with 
aplyroseol-9 (4.72): yellow oil (1.0 mg); 1H NMR (CDCl3, 500 MHz) δ 9.98 (1H, s, H-17), 9.70 (1H, 
s, H-15), 5.88 (1H, t, J = 2.5, H-7), 3.67 (3H, s, -COOCH3), 3.27 (1H, td, J = 5.5, 1.8, H-13), 2.69 
(1H, br d, J = 5.9, H-14), 0.79 (3H, s, Me-19), 0.77 (3H, s, Me-20), 0.75 (3H, s, Me-18); (+)-
LRESIMS m/z 429 [M+Na]+. 
 
Aplyroseol-9 (4.72):328,363 colorless oil (0.7 mg); [α]23D -20 (c 0.07, CHCl3), Lit:328,363 [α]20D -6 (c 
1.0, CHCl3); 1H NMR (CDCl3, 500 MHz) see Table 4.6; (+)-LRESIMS m/z 429 [M+Na]+. 
 
Dendrillol-sterol conjugate (4.73): colorless oil (0.9 mg); [α]23D -69 (c 0.09, CHCl3); 1H NMR 
(CDCl3, 500 MHz) see Table 4.7; 13C NMR (CDCl3, 125 MHz) δ 175.3 (C-16), 170.1 (-OCOCH3), 
140.4 (C-25), 122.0 (C-26), 104.4 (C-15), 101.4 (C-17), 77.0 (C-23), 75.4 (C-7), 56.8 (C-34), 56.2 
(C-37), 52.2 (C-8), 51.7 (-COOCH3), 51.3 (C-14), 50.1 (C-29), 48.5 (C-5), 44.7 (C-9), 42.3 (C-33), 
41.9 (C-3), 39.7 (C-32), 39.6 (C-44), 39.1 (C-1), 38.3 (C-24), 38.2 (C-10), 37.3 (C-13, C-21), 36.6 
(C-30), 36.2 (C-42), 35.7 (C-40), 33.3 (C-18), 32.6 (C-4), 31.9 (C-27), 29.5 (C-22), 28.3 (C-36), 28.0 
(C-45), 24.5 (C-6), 24.2 (C-35), 23.7 (C-43), 22.7 (Me-46, Me-47), 22.0 (C-31), 21.4 (-OCOCH3), 
21.2 (C-19), 19.5 (C-12), 19.2 (C-39), 18.7 (C-41), 18.5 (C-2), 15.1 (C-20), 14.1 (C-11), 11.8 (C-38); 
(+)-LRESIMS m/z 815 [M+Na]+, (+)-HRESIMS m/z 815.5796 [M+Na]+ (calcd. for C50H80O7, 
815.5774). 
 
Isoagatholactone (4.74):355 colorless oil (0.1 mg); [α]23D -2 (c 0.01, CHCl3), Lit:355 [α]D +6 
(concentration and solvent were not reported); 1H NMR (CDCl3, 500 MHz) δ 6.87 (1H, dd, J = 7.0, 
3.5, H-12), 4.37 (1H, t, J = 9, H-15a), 4.05 (1H, t, J = 9, H-15b), 2.80 (1H, m, H-14), 2.35 (2H, m, 
H-11), 0.93 (3H, s, Me-18), 0.88 (3H, s, Me-17), 0.84 (3H, s, Me-20), 0.78 (3H, s, Me-19);  (+)-
LRESIMS m/z 325 [M+Na]+. 
 
Ent-Spongian-16-one (4.75):353 white solid (0.2 mg); α]23D -30 (c 0.02, CHCl3), Lit:353 [α]20D +53 (c 
1.0, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 4.21 (1H, d, J = 9.9, H-15a), 4.10 (1H, dd, J = 9.9, 5.6, 
H-15b), 2.52 (1H, t, J = 7.5, H-13), 2.08 (1H, dd, J = 7.8, 5.2, H-14), 1.82 (1H, dt, J = 12.3, 3.4, H-
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7a), 1.04 (1H, td, J = 12.3, 3.0, H-7b), 0.86 (3H, s, Me-18), 0.85 (3H, s, Me-17), 0.82 (3H, s, Me-20), 
0.80 (3H, s, Me-19) ; (+)-LRESIMS m/z 327 [M+Na]+. 
 
Dendrillol-3 (4.76):362 white solid  (0.5 mg); [α]25D +55 (c 0.02, CHCl3), Lit:362 specific rotation was 
not reported; 1H NMR (CDCl3, 500 MHz) see Table 4.6. (+)-LRESIMS m/z 371 [M+Na]+. 
 
7α-Hydroxy-dendrillol-3 (4.77): colorless oil (0.1 mg); [α]23D -54 (c 0.01, CHCl3); 1H NMR 
(CDCl3, 700 MHz) see Table 4.6; 13C NMR (CDCl3, 175 MHz) δ 178.1 (C-15), 174.4 (C-16), 73.1 
(C-17), 71.5 (C-7), 52.7 (-COOCH3), 48.2 (C-5), 48.0 (C-8), 45.6 (C-14), 44.2 (C-9); 42.4 (C-3), 39.7 
(C-13), 39.1 (C-1), 38.6 (C-10), 33.7 (Me-20), 33.3 (C-4), 27.7 (C-6), 22.9 (C-12), 22.1 (Me-19), 
19.1 (C-2), 17.1 (C-11), 14.8 (Me-18); (+)-LRESIMS m/z 387.2 [M+Na]+, (+)-HRESIMS m/z 
387.2142 [M+Na]+ (calcd. for C21H32O5, 387.2147). 
 
6.5.5.!Biological material of Miamira magnifica 
 A specimen of M. magnifica (#955) was collected at a dive site near North Stradbroke Island, 
QLD in November 2013. The specimen was dissected into mantle, gut and dorsal horn prior to 
extraction and chemical analysis.  
 
6.5.6.!Isolation and extraction of OH-PBDEs from Miamira magnifica 
The extraction of mantle (2.75 g), gut (0.91 g) and dorsal horn (0.09 g) tissues of M. magnifica 
followed the method described previously to yield 28 mg of mantle extract (dark green oil), 17.8 mg 
of gut extract (dark yellow oil) and 2.3 mg of dorsal horn extract (colorless oil). The mantle extract 
of M. magnifica was subjected to NP flash chromatography using a gradient of 
hexanes/DCM/EtOAc/MeOH to yield four fractions. Fraction A contained OH-PBDEs and was re-
chromatographed using a gradient of hexanes/EtOAc to give six fractions. Fraction 2 was purified 
with NP HPLC (5% EtOAc/hexanes) to obtain 2-(2’,4’-dibromophenoxy)-3,4,6-tribromophenol 
(4.85) (0.1 mg) and 2-(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.86) (0.2 mg). Fraction 3 was 
also subjected to NP HPLC (5% EtOAc/hexanes) to furnish 2-(2’,4’-dibromophenoxy)-3,4,6-
tribromophenol (4.85) (1.5 mg), 2-(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.86) (3 mg), 2-
(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) (0.2 mg) and 2-(2’,4’-dibromophenoxy)-3,5,6-
tribromophenol (4.89) (0.1 mg). Fraction 4 was collected as a mixture of 2-(2’,4’-dibromophenoxy)-
3,5-dibromophenol (4.87) and sterol (2 mg).  
Similarly, the gut extract of M. magnifica was separated using NP flash chromatography with 
a gradient of hexanes/DCM/MeOH to obtain six fractions. Fraction A of the NP flash chromatography 
was further purified by RP HPLC (80% MeCN/water with added 0.1% TFA) to afford 2-(2’,4’-
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dibromophenoxy)-3,5-dibromophenol (4.86) (2 mg), 2-(2’,4’-dibromophenoxy)-3,5-dibromophenol 
(4.87) (0.5 mg), 2-(2’,4’-dibromophenoxy)-3,4,5,6-tetrabromophenol (4.91) (0.1 mg) as well as 
mixtures containing 2-(2’,4’-dibromophenoxy)-3,4,5-tribromophenol (4.88) and 2-(2’,4’-
dibromophenoxy)-3,5,6-tribromophenol (4.89) (0.5 mg). 
Due to the limitation of material, the dorsal horn extract of M. magnifica was not purified 
further. The identification of OH-PBDEs 2-(2’,4’-dibromophenoxy)-3,4,6-tribromophenol (4.85), 2-
(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.86) and 2-(2’,4’-dibromophenoxy)-3,5-
dibromophenol (4.87) in the extract was carried out by dereplication analysis.  
 
6.5.7.!Methylation of 2-(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) 
 The methylation of 2-(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) was performed 
based on the methods described in the literature.533 Approximately 0.5 mg of 2-(2’,4’-
dibromophenoxy)-3,5-dibromophenol (4.87) (0.001 mmol) was dissolved in 1 mL of acetone and 
reacted with 62 µl of MeI (1 mmol) and a drop of water in the presence of 138 mg of K2CO3 (1 
mmol). The mixture was stirred for 24 hours at room temperature to yield 2-(2’,4’-dibromophenoxy)-
3,4-dibromoanisole (4.94). The mixture was then filtered and partitioned against CHCl3. The organic 
layer was collected and dried under N2 stream prior to NMR analysis. 
 
2-(2’,4’-dibromophenoxy)-3,4,6-tribromophenol (4.85):374 colorless oil (1.6 mg); 1H NMR 
(CDCl3, 500 MHz) see Table 4.13; (-)-LRESIMS m/z 575/577/579/581/583/585 [M-H]-. 
 
2-(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.86):366 white solid (5.2 mg); 1H NMR (CDCl3, 
500 MHz) δH 7.78 (1H, d, J=2.2, H-3’), 7.34 (1H, d, J=2.2, H-4), 7.29 (1H, dd, J=8.8, 2.2, H-5’), 
7.21 (1H, d, J=2.2, H-6), 6.43 (1H, d, J=8.8, H-6’), 5.54 (1H, br s, OH); (-)-LRESIMS m/z 
497/499/501/503/505 [M-H]-. 
 
2-(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87): colorless oil (0.5 mg); 1H NMR (CDCl3, 500 
MHz) see Table 4.12; 13C NMR (CDCl3, 125 MHz) δ 152.2 (C-1’), 149.1 (C-1), 140.3 (C-2), 136.4 
(C3’), 131.6 (C-5’), 131.2 (C-5), 120.0 (C-4), 117.1 (C-6), 116.0 (C-2’, C-3), 115.8 (C-6’), 112.8 (C-
4’); (-)-HRESIMS m/z 496.7042 [M-H]- (calcd. for C12H579Br4O2, 496.7029). 
 
2-(2’,4’-dibromophenoxy)-3,4,5-tribromophenol (4.88)373 as a mixture with 2-(2’,4’-
dibromophenoxy)-3,4,6-tribromophenol (4.85)374 and 2-(2’,4’-dibromophenoxy)-3,5,6-
tribromophenol (4.89):372 colorless oil (0.5 mg); 1H NMR (CDCl3, 500 MHz) see Table 4.13; (-)-
LRESIMS m/z 575/577/579/581/583/585 [M-H]-. 
Chapter 6: Experimental 
!
! 198!
2-(2’,4’-dibromophenoxy)-3,5,6-tribromophenol (4.89):372 colorless oil (0.1 mg); 1H NMR 
(CDCl3, 500 MHz) see Table 4.13; (-)-LRESIMS m/z 575/577/579/581/583/585 [M-H]-. 
 
2-(2’,4’-dibromophenoxy)-4,5,6-tribromophenol (4.90)373 as a mixture with 2-(2’,4’-
dibromophenoxy)-3,4,6-tribromophenol (4.85)374 and 2-(2’,4’-dibromophenoxy)-3,5,6-
tribromophenol (4.89):372 colorless oil (0.5 mg); 1H NMR (CDCl3, 500 MHz) see Table 4.13; (-)-
LRESIMS m/z 575/577/579/581/583/585 [M-H]-. 
 
2-(2’,4’-dibromophenoxy)-3,4,5,6-tetrabromophenol (4.91):371 colorless oil (0.1 mg); 1H NMR 
(CDCl3, 500 MHz) δ 7.78 (1H, d, J = 2.2, H-3’), 7.30 (1H, dd, J = 8.8, 2.2, H-5’), 6.39 (1H, d, J = 
8.8, H-6’); (-)-LRESIMS m/z 653/655/657/659/661/663/665  [M-H]-. 
 
2-(2’,4’-dibromophenoxy)-3,4-dibromoanisole (4.94): colorless oil (0.5 mg); 1H NMR (CDCl3, 500 
MHz) see Table 4.12; (-)-LRESIMS m/z 511/513/515/517/519 [M-H]-. 
 
6.5.8.!Biological material of Miamira miamirana 
 A specimen of M. miamirana (#1500) was obtained from Cairns Marine, QLD in June 2016. 
The specimen was dissected into mantle and gut tissues prior to extraction and chemical analysis.  
 
6.5.9.!Isolation and extraction of OMe-PBDEs from Miamira miamirana 
The extraction of both mantle (1.12 g) and gut tissues (0.32 g) of M. miamirana followed the 
methods described previously to yield 6.3 mg of mantle extract (reddish brown oil) and 3.4 mg of gut 
extract (pale yellow oil). NP flash chromatography of the mantle extract using a gradient of 
hexanes/EtOAc yielded six fractions. Fraction 2 contained a mixture of 2-(4’-bromo-2’-
hydroxyphenoxy)-4,6-dibromoanisole (4.105), 2-(4’,6’-dibromo-2’-hydroxyphenoxy)-4,6-
dibromoanisole (4.106) and 2-(4’,6’-dibromo-2’-methoxyphenoxy)-4,6-dibromoanisole (4.107) (1.3 
mg). Fraction 3 contained a mixture of 2-(4’-bromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.105) 
and 2-(4’,6’-dibromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.106) (1.2 mg). Fraction 4 was 
collected as a mixture of 2-(4’-bromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.105), 2-(4’,6’-
dibromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.106) and sterol (1.2 mg).  
Following the same separation method, fraction 2 of the gut extract was contained 2-(4’,6’-
dibromo-2’-methoxyphenoxy)-4,6-dibromoanisole (4.107) (0.4 mg). Compounds 2-(4’-bromo-2’-
hydroxyphenoxy)-4,6-dibromoanisole (4.105) and 2-(4’,6’-dibromo-2’-hydroxyphenoxy)-4,6-
dibromoanisole (4.106) were pooled in fraction 3 (0.2 mg) and 4 (0.3 mg). 
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2-(4’-bromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.105)380 isolated as a mixture with 2-
(4’,6’-dibromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.106):67 colorless oil (1.4 mg); 1H 
NMR (CDCl3, 500 MHz) see Table 4.14;  (-)-LRESIMS m/z 449/451/453/455 [M-H]-. 
 
2-(4’,6’-dibromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.106)67 isolated as a mixture with 2-
(4’-bromo-2’-hydroxyphenoxy)-4,6-dibromoanisole (4.105):380 colorless oil (1.4 mg); 1H NMR 
(CDCl3, 500 MHz) see Table 4.14; (-)-LRESIMS m/z 527/529/531/533/535 [M-H]- 
 
2-(4’,6’-dibromo-2’-methoxyphenoxy)-4,6-dibromoanisole (4.107):368 colorless oil (0.4 mg); 1H 
NMR (CDCl3, 500 MHz) see Table 4.14; (+)-LRESIMS m/z 565/567/569/571/573 [M+Na]+. 
 
6.6.!Experimental for Chapter 5 
6.6.1.!Biological material of Ceratosoma trilobatum 
A specimen of C. trilobatum (#1017) was collected at a dive site near Amity Point, QLD in 
June 2014. Two more specimens (#1031-2) were collected in Moreton Bay, QLD in July 2014. All 
specimens were dissected into mantle and gut tissues before chemical analysis.   
 
6.6.2.!Extraction and isolation of furanosesquiterpenes from Ceratosoma trilobatum 
Approximately 24 g of C. trilobatum mantle was extracted with acetone (5 x 100 mL) then 
partitioned against Et2O (6 x 15 mL) to yield 126 mg of bright orange oil. A portion of the mantle 
extract (53 mg) was tested for biological assay, whereas the remaining (73 mg) was proceeded for 
purification. NP flash chromatography of the mantle extract using a gradient of hexanes/DCM yielded 
five fractions. Fraction 1 (4 mg) was subsequently purified by NP HPLC (100% hexanes) to afford 
dendrolasin (5.1) (0.5 mg), furodysinin (5.8) (1.0 mg) and agassizin (5.26) (0.3 mg). 
The gut tissue of C. trilobatum (6 g) was extracted with acetone (7 x 25 mL), followed by 
partitioning against Et2O (3 x 10 mL) to give 83 mg of bright yellow oil. Approximately 41 mg of the 
gut extract was set aside for bioassay. NP flash chromatography of the remaining extract (42 mg) 
with a gradient of hexanes/DCM yielded three fractions. Fraction 1 (13 mg) was purified by NP HPLC 
(100% hexanes) to obtain dendrolasin (5.1) (6.3 mg), furodysinin (5.8) (1.3 mg), furodysin (5.14) 
(0.1 mg), a mixture of pallescensin A (5.16) and dihydropallescensin-2 (5.31) (0.2 mg), euryfuran 
(5.17) (0.4 mg) and agassizin (5.26) (0.1 mg).   
 
Dendrolasin (5.1):351 colorless oil (6.8 mg); 1H NMR (CDCl3, 500 MHz) δ 7.34 (1H, br t, J = 1.6, 
H-1), 7.21 (1H, br s, H-4), 6.28 (1H, br s, H-2), 5.17 (1H, t, J = 7, H-7), 5.08 (1H, t, J = 6.7, H-11), 
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1.68 (3H, br d, J = 1.8, Me-13), 1.60 (3H, br s, Me-15), 1.59 (3H, br s, Me-14); GC-MS m/z 218 
[M]+. 
 
Furodysinin (5.8):461 colorless oil (2.9 mg); [α]25D -5 (c 0.05, CHCl3), Lit:461 -54 (c 0.5, CHCl3); 1H 
NMR (CDCl3, 500 MHz) δ 7.21 (1H, br s, H-1), 6.24 (1H, d, J = 1.9, H-2), 5.62 (1H, br s, H-7), 1.66 
(3H, br s, Me-13,), 1.20 (3H, s, Me-15), 1.18 (3H, s, Me-14); GC-MS m/z 216 [M]+. 
 
Furodysin (5.14):461 colorless oil (0.1 mg); [α]25D -13 (c 0.01, CHCl3), Lit:461 -38 (c 0.1, CHCl3); 1H 
NMR (CDCl3, 500 MHz) δ 7.23 (1H, d, J = 1.9, H-1), 6.14 (1H, d, J = 1.9, H-2), 5.28 (1H, br s, H-
10), 1.69 (3H, br s, Me-15), 1.29 (3H, s, Me-13), 1.07 (3H, s, Me-14); GC-MS m/z 216 [M]+. 
 
Pallescensin A (5.16), isolated as a mixture with dihydropallescensin-2 (5.31):467 colorless oil (0.2 
mg); 1H NMR (CDCl3, 500 MHz) δ 7.18 (1H, d, J = 1.8, H-12), 6.11 (1H, d, J = 1.8, H-11), 1.19 
(3H, s, Me-13), 0.93 (3H, s, Me-14), 0.90 (3H, s, Me-15); GC-MS m/z 218 [M]+. 
 
Euryfuran (5.17), isolated as a mixture with furodysin (5.14):471 colorless oil (0.4 mg); 1H NMR 
(CDCl3, 500 MHz) δ 7.08 (1H, d, J = 1.4, H-15), 7.05 (1H, d, J = 1.4, H-14), 1.20 (3H, s), 0.94 (3H, 
s, Me-12), 0.90 (3H, s, Me-13); GC-MS m/z 218 [M]+. 
 
Agassizin (5.26):428 colorless oil (0.4 mg); [α]25D +25 (c 0.01, CHCl3); Lit:351 +125 (c 0.17, CHCl3); 
1H NMR (CDCl3, 500 MHz) δ 7.16 (1H, br s, H-12), 6.11 (1H, br s, H-13), 5.80 (1H, ddd, J = 9.0, 
5.0, 2.8, H-2), 5.67 (1H, d, J = 5.0, H-1), 5.47 (1H, dd, J = 9.0, 2.8, H-3), 3.61 (1H, d, J =15.4, H-
10a), 3.25 (1H, d, J =15.4, H-10b), 1.00 (3H, d, J = 7.2, Me-14), 0.87 (3H, s, Me-15); ECD (MeOH) 
266 nm (Δε +32); GC-MS m/z 214 [M]+. 
 
Dihydropallescensin-2 (5.31), isolated as a mixture with pallescensin A (5.16):481 colorless oil (0.2 
mg); 1H NMR (CDCl3, 500 MHz) δ 7.34 (1H, br t, J = 1.7, H-5), 7.20 (1H, br s, H-2), 6.26 (1H, br 
s, H-4), 4.80 (1H, br s, H-8’a), 4.58 (1H, br s, H-8’b), 0.91 (3H, s, Me-9’), 0.84 (3H, s, Me-10’); GC-
MS m/z 218 [M]+. 
 
6.6.3.!Biological material of Ceratosoma brevicaudatum 
An individual of C. brevicaudatum (#1180) was collected at a dive site near Coffs Harbor, 
NSW in October 2014. The specimen was dissected into mantle and gut tissues before chemical 
analysis.   
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6.6.4.!Extraction and isolation of furanosesquiterpenes from Ceratosoma brevicaudatum 
The mantle tissue of C. brevicaudatum (4 g) was extracted with acetone (7 x 5 mL) and 
subsequently partitioned against Et2O (3 x 5 mL) to yield 10 mg of bright orange oil. The mantle 
extract was then separated and purified with similar manner to the methods described previously to 
obtain a mixture of dendrolasin (5.1) and 6E,8Z,10E-dehydrodendrolasin (5.2) (0.1 mg), 6E,8E,10E-
dehydrodendrolasin (5.3) (0.1 mg), furodysinin (5.8) (0.5 mg), a mixture of euryfuran (5.17) and 
pallescensin B (5.23) (0.2 mg) as well as nakafuran-9 (5.21) (0.1 mg). 
The gut tissue of C. brevicaudatum (2 g) was prepared in the same way as described above to 
give 27 mg of brownish yellow oil. NP flash chromatography (a gradient of hexanes/DCM), followed 
by NP HPLC (100% hexanes) of the gut extract afforded a mixture of dendrolasin (5.1) and 
6E,8Z,10E-dehydrodendrolasin (5.2) (0.1 mg), 6E,8E,10E-dehydrodendrolasin (5.3) (0.1 mg), 
furodysinin (5.8) (0.1 mg), a mixture of euryfuran (5.17) and pallescensin B (5.23) (0.1 mg) and 
nakafuran-9 (5.21) (0.1 mg). 
The extraction of the horn tissue of C. brevicaudatum (17 mg) yielded 1.5 mg of pale yellow 
oil. NP flash chromatography (a gradient of hexanes/DCM) of the horn extract gave four fractions. 
Fraction 1 contained a mixture of dendrolasin (5.1), furodysinin (5.8), euryfuran (5.17) and 
pallescensin B (5.23) (0.3 mg). 
 
6E,8Z,10E-Dehydrodendrolasin (5.2), isolated as a mixture with dendrolasin (5.1):432 colorless oil 
(0.2 mg); 1H NMR (CDCl3, 500 MHz) δ 7.37 (1H, br t, J = 1.7, H-1), 7.28 (1H, m, H-4), 6.70 (1H, 
d, J = 16.0, H-7), 6.42 (1H, dd, J = 15.0, 1.3, H-10), 6.29 (1H, br s, H-2), 5.88 (1H, d, J = 11.0, H-
11), 5.78 (1H, dt, J = 15.5, 6.9, H-6), 5.62 (1H, dd, J = 15.0, 6.9, H-11), 3.30 (2H, d, J = 6.9, H2-5), 
2.37 (1H, o, J = 6.7, H-12), 1.85 (3H, s, Me-15), 1.02 (6H, d, J = 6.6, Me-13, Me-14); GC-MS m/z 
216 [M]+. 
 
6E,8E,10E-Dehydrodendrolasin (5.3):432 colorless oil (0.2 mg); 1H NMR (CDCl3, 500 MHz) δ 7.36 
(1H, br t, J = 1.7, H-1), 7.22 (1H, m, H-4), 6.31 (1H, ddd, J = 15.0, 11.0, 1.2, H-10), 6.27 (1H, br s, 
H-2), 6.15 (1H, d, J = 15.4, H-7), 5.96 (1H, d, 11.0, H-9), 5.74 (1H, t, J = 6.8, H-6), 5.69 (1H, dd, J 
= 14.7, 6.6, H-11), 3.24 (2H, d, J = 6.7, H2-5), 2.38 (1H, o, J = 6.7, H-12), 1.84 (3H, br d, J = 0.6, 
Me-15), 1.02 (6H, d, J = 6.8, Me-13, Me-14); GC-MS m/z 216 [M]+. 
 
Nakafuran-9 (5.21):486 colorless oil (0.2 mg); [α]25D +29 (c 0.01, CHCl3); 1H NMR (CDCl3, 500 
MHz) δ 7.11 (1H, d, J = 1.6, H-1), 6.06 (1H, d, J = 1.9, H-2), 3.17 (1H, br s, H-10), 1.59 (3H, s, Me-
14), 1.58 (3H, s, Me-15), 1.07 (3H, s, Me-13); GC-MS m/z 216 [M]+. 
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Pallescensin B (5.23), isolated as a mixture with euryfuran (5.17):487 colorless oil (0.3 mg); 1H NMR 
(CDCl3, 500 MHz) δ 7.09 (1H, d, J = 1.8, H-1), 6.05 (1H, d, J = 1.8, H-2), 5.83 (1H, dd, J = 7.5, 1.4, 
H-8), 3.45 (1H, td, J = 7.3, 2.3, H-9), 1.81 (3H, d, J = 1.8, Me-15), 0.94 (3H, s, Me-13), 0.79 (3H, s, 
Me-14); GC-MS m/z 216 [M]+. 
 
6.6.5.!Biological material of D. krusensternii 
A specimen of D. krusensternii (#110) was collected in Moreton Bay in September 2012 and 
was dissected into mantle and gut tissues before chemical analysis. 
 
6.6.6.!Extraction and isolation of drimane sesquiterpenes from D. krusensternii 
The extraction of 12 g of mantle and 9.5 g of gut tissues of D. krusensternii yielded 34 mg of 
mantle and 126 mg of gut extracts, respectively. Both extracts were combined after the 1H NMR 
profile for each extract were recorded. A portion of the combined extract was used for bioassay and 
the remaining was proceeded for chemical analysis (110 mg). The extract was then separated by NP 
flash chromatography with a gradient of 100% hexanes/ DCM. Fraction 1 retained the drimane 
sesquiterpenes and was further purified by RP HPLC (100% MeOH) to obtain cinnamolide (5.39) 
(1.6 mg) and drimane esters (5.33) (13 mg). The latter was re-subjected to RP HPLC (100% MeOH) 
to give nine fractions containing drimane esters (5.33) with different length of fatty acyl residues.  
 
6.6.7.!Preparation of FAME derivatives 
 Fractions containing drimane esters (5.33) were dissolved in 1 ml of dry methanol, then 10 
 µL of 37% HCl was added. The solution was refluxed at 60°C for an hour and the resulting mixture 
was concentrated under N2 stream. The dried mixture was re-dissolved in hexanes and was passed 
through silica pipette column eluting with 100% DCM. The eluted FAME was then taken to dryness 
for GC-MS and NMR analysis.  
 
Drimane esters (5.33):446 colorless oil (13 mg); 1H NMR (CDCl3, 500 MHz) δ 6.32 (1H, d, J = 2.0, 
H-11), 6.05 (1H, t, J = 2.0, H-12), 5.36 (overlapped vinyl protons, m), 1.29 (overlapped alkyl, m), 
0.88 (3H, s, Me-15), 0.83 (3H, s, Me-13), 0.81 (3H, s, Me-14). 
 
Cinnamolide (5.39):493 colorless oil (1.6 mg); [α]25D  -5 (c 0.16, CHCl3); Lit:493 -29 (c 3.5, CHCl3) 
1H NMR (MeOD, 500 MHz) δ 6.83 (1H, q, J = 3.8, H-7), 4.41 (1H, t, J = 9.2, H-11a), 4.08 (1H, t, J 
= 9.2, H-11b), 2.90 (1H, ddddd, J = 9.2, 9.2, 5.1, 3.6, 3.6, H-9), 2.45 (1H, ddd, J = 20.4, 4.2, 4.2, H-
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6a),  2.17 (1H, dddd, J = 20.4, 4.9, 5.0, 3.3, H-6b), 0.97 (3H, s, Me-13), 0.93 (3H, s, Me-14) and 0.83 
(3H, s, Me-15); GC-MS m/z 234 [M]+. 
 
6.6.8.!Biological material of Dendrodoris nigra 
 Four specimens of D. nigra #1046-1048, 1064 were collected at dive site near Cleveland 
Point, QLD in August 2014. The specimens were not dissected before chemical analysis. 
 
6.6.9.!Extraction and isolation of drimane sesquiterpenes from D. nigra 
 The extraction of D. nigra was carried out based on previous methods to yield 18.5 mg of 
whole body extract. Separation and purification of the extract by NP flash chromatography (a gradient 
of hexanes/DCM), followed by repetitive RP HPLC afforded 15 fractions containing drimane esters 
(5.33). The FAME derivatives were then prepared by the same method described above.    
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Appendix 1. Images of sponges and nudibranchs investigated in this study  
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Appendix 2. 1H NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3)!
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Appendix 3. DEPT-135 13C NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3) 
 
 
 
 
Appendix 4. 13C NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3) 
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Appendix 5. COSY NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3) 
 
 
 
Appendix 6. HSQC NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3) 
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Appendix 7. HMBC NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3) 
 
 
 
Appendix 8. HSQC-TOCSY NMR spectrum of acanthocyclamine A (2.45) (500 MHz, CDCl3) 
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Appendix 9. 1H NMR spectrum of 4-bromopyrrole-3-(N-hydroxymethyl) carboxamide (2.56) (500 
MHz, CDCl3) 
 
 
 
Appendix 10. 1H NMR spectrum of 4-bromopyrrole-3-(N-hydroxymethyl) carboxamide (2.56) (500 
MHz, CDCl3) 
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Appendix 11. 1H NMR spectrum of 4-bromopyrrole-3-(N-methoxymethyl) carboxamide (2.57) (500 
MHz, CDCl3) 
 
 
 
Appendix 12. HMBC NMR spectrum of 4-bromopyrrole-3-(N-methoxymethyl) carboxamide (2.57) 
(500 MHz, CDCl3) 
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Appendix 13. 1H NMR spectrum of germacra-1(10),5-dien-4β-ol (3.16) (500 MHz, CDCl3) 
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Appendix 14. COSY NMR spectrum of germacra-1(10),5-dien-4β-ol (3.16) (500 MHz, CDCl3) 
 
 
 
Appendix 15. HSQC NMR spectrum of germacra-1(10),5-dien-4β-ol (3.16) (500 MHz, CDCl3) 
 
 
 
Appendix 16. HSQC NMR spectrum of germacra-1(10),5-dien-4β-ol (3.16) (500 MHz, CDCl3) 
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Appendix 17. 1H NMR spectrum of guaiane diacetate (3.26) (500 MHz, CDCl3) 
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Appendix 18. COSY NMR spectrum of guaiane diacetate (3.26) (500 MHz, CDCl3) 
 
 
 
Appendix 19. HSQC NMR spectrum of guaiane diacetate (3.26) (500 MHz, CDCl3) 
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Appendix 20. HMBC NMR spectrum of guaiane diacetate (3.26) (500 MHz, CDCl3) 
 
 
 
Appendix 21. NOESY NMR spectrum of guaiane diacetate (3.26) (500 MHz, CDCl3) 
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Appendix 22. 1H NMR spectrum of germacra-1(10),4,6(7)-trien-5-ol (3.26) (500 MHz, CDCl3) 
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Appendix 23. COSY NMR spectrum of germacra-1(10),4,6(7)-trien-5-ol (3.26) (500 MHz, CDCl3) 
 
 
 
Appendix 24. HSQC NMR spectrum of germacra-1(10),4,6(7)-trien-5-ol (3.26) (500 MHz, CDCl3) 
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Appendix 25. HMBC NMR spectrum of germacra-1(10),4,6(7)-trien-5-ol (3.26) (500 MHz, CDCl3) 
 
 
 
Appendix 26. NOESY NMR spectrum of germacra-1(10),4,6(7)-trien-5-ol (3.26) (500 MHz, CDCl3) 
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Appendix 27. 1H NMR spectrum of 4,5-β-epoxy-α-muurolene (3.31) (500 MHz, CDCl3)                  
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Appendix 28. COSY NMR spectrum of 4,5-β-epoxy-α-muurolene (3.31) (500 MHz, CDCl3) 
 
 
 
Appendix 29. HSQC NMR spectrum of 4,5-β-epoxy-α-muurolene (3.31) (500 MHz, CDCl3) 
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Appendix 30. HMBC NMR spectrum of 4,5-β-epoxy-α-muurolene (3.31) (500 MHz, CDCl3) 
 
 
 
Appendix 31. NOESY NMR spectrum of 4,5-β-epoxy-α-muurolene (3.31) (500 MHz, CDCl3) 
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Appendix 32. 1H NMR spectrum of 11β-hydroxy-α-muurolene (3.38) (500 MHz, CDCl3) 
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Appendix 33. COSY NMR spectrum of 11β-hydroxy-α-muurolene (3.38) (500 MHz, CDCl3) 
 
 
 
Appendix 34. HSQC NMR spectrum of 11β-hydroxy-α-muurolene (3.38) (500 MHz, CDCl3) 
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Appendix 35. HMBC NMR spectrum of 11β-hydroxy-α-muurolene (3.38) (500 MHz, CDCl3) 
 
 
 
Appendix 36. NOESY NMR spectrum of 11β-hydroxy-α-muurolene (3.38) (500 MHz, CDCl3) 
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Appendix 37. 1H NMR spectrum of 5,6-α-epoxy-punaglandin-8 (3.54) (500 MHz, CDCl3) 
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Appendix 38. COSY NMR spectrum of 5,6-α-epoxy-punaglandin-8 (3.54) (500 MHz, CDCl3) 
 
 
 
Appendix 39. HSQC NMR spectrum of 5,6-α-epoxy-punaglandin-8 (3.54) (700 MHz, CDCl3) 
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Appendix 40. HMBC NMR spectrum of 5,6-α-epoxy-punaglandin-8 (3.54) (500 MHz, CDCl3) 
 
 
 
Appendix 41. NOESY NMR spectrum of 5,6-α-epoxy-punaglandin-8 (3.54) (500 MHz, CDCl3) 
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Appendix 42. 1H NMR spectrum of phyllodesmolide A (3.83) (500 MHz, CDCl3) 
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Appendix 43. COSY NMR spectrum of phyllodesmolide A (3.83) (500 MHz, CDCl3) 
 
 
 
Appendix 44. HSQC NMR spectrum of phyllodesmolide A (3.83) (500 MHz, CDCl3) 
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Appendix 45. HMBC NMR spectrum of phyllodesmolide A (3.83) (500 MHz, CDCl3) 
 
 
 
Appendix 46. NOESY NMR spectrum of phyllodesmolide A (3.83) (700 MHz, CDCl3) 
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Appendix 47. 1H NMR spectrum of phyllodesmolide B (3.84) (700 MHz, CDCl3) 
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Appendix 48. COSY NMR spectrum of phyllodesmolide B (3.84) (500 MHz, CDCl3) 
 
 
 
 
Appendix 49. HSQC NMR spectrum of phyllodesmolide B (3.84) (700 MHz, CDCl3) 
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Appendix 50. HMBC NMR spectrum of phyllodesmolide B (3.84) (700 MHz, CDCl3) 
 
 
 
 
Appendix 51. NOESY NMR spectrum of phyllodesmolide B (3.84) in a mixture with sarcophine 
(3.72), phyllodesmolide C (3.88) and bisepoxysarcophytoxide (3.89) (700 MHz, CDCl3) 
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Appendix 52. 1H NMR spectrum of phyllodesmolide C (3.88) (700 MHz, CDCl3) 
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Appendix 53. COSY NMR spectrum of phyllodesmolide C (3.88) (500 MHz, CDCl3) 
 
 
 
Appendix 54. HSQC NMR spectrum of phyllodesmolide C (3.88) (700 MHz, CDCl3) 
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Appendix 55. HMBC NMR spectrum of phyllodesmolide C (3.88) (700 MHz, CDCl3) 
 
 
 
Appendix 56. NOESY NMR spectrum of phyllodesmolide C (3.88) (700 MHz, CDCl3) 
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Appendix 57. 1H NMR spectrum of phyllodesmolide D (3.90) (700 MHz, CDCl3) 
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Appendix 58. COSY NMR spectrum of phyllodesmolide D (3.90) (500 MHz, CDCl3) 
 
 
 
Appendix 59. HSQC NMR spectrum of phyllodesmolide D (3.90) (700 MHz, CDCl3) 
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Appendix 60. HMBC NMR spectrum of phyllodesmolide D (3.90) (700 MHz, CDCl3) 
 
 
 
Appendix 61. NOESY NMR spectrum of phyllodesmolide D (3.90) (700 MHz, CDCl3) 
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Appendix 62. 1H NMR spectrum of phyllodesmolide E (3.91) (700 MHz, CDCl3) 
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Appendix 63. COSY NMR spectrum of phyllodesmolide E (3.91) (500 MHz, CDCl3) 
 
 
 
Appendix 64. HSQC NMR spectrum of phyllodesmolide E (3.91) (700 MHz, CDCl3) 
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Appendix 65. HMBC NMR spectrum of phyllodesmolide E (3.91) (700 MHz, CDCl3) 
 
 
 
Appendix 66. NOESY NMR spectrum of phyllodesmolide E (3.91) (700 MHz, CDCl3) 
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Appendix 67. 1H NMR spectrum of chromolactol (4.62) (700 MHz, CDCl3) 
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Appendix 68. COSY NMR spectrum of chromolactol (4.62) (700 MHz, CDCl3) 
 
 
 
Appendix 69. HSQC NMR spectrum of chromolactol (4.62) (700 MHz, CDCl3) 
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Appendix 70. HMBC NMR spectrum of chromolactol (4.62) (700 MHz, CDCl3) 
 
 
 
Appendix 71. NOESY NMR spectrum of chromolactol (4.62) (700 MHz, CDCl3) 
 
! 262!
Appendix 72. 1H NMR spectrum of dendrillol-sterol conjugate (4.73) (500 MHz, CDCl3) 
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Appendix 73. COSY NMR spectrum of dendrillol-sterol conjugate (4.73) (500 MHz, CDCl3) 
 
 
 
Appendix 74. HSQC NMR spectrum of dendrillol-sterol conjugate (4.73) (500 MHz, CDCl3) 
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Appendix 75. HMBC NMR spectrum of dendrillol-sterol conjugate (4.73) (500 MHz, CDCl3) 
 
 
 
Appendix 76. NOESY NMR spectrum of dendrillol-sterol conjugate (4.73) (500 MHz, CDCl3) 
 
! 265!
Appendix 77. 1H NMR spectrum of 7α-hydroxy-dendrillol-3 (4.77) (500 MHz, CDCl3) 
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Appendix 78. COSY NMR spectrum of 7α-hydroxy-dendrillol-3 (4.77) (500 MHz, CDCl3) 
 
 
 
Appendix 79. HSQC NMR spectrum of 7α-hydroxy-dendrillol-3 (4.77) (700 MHz, CDCl3) 
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Appendix 80. HMBC NMR spectrum of 7α-hydroxy-dendrillol-3 (4.77) (700 MHz, CDCl3) 
 
 
 
Appendix 81. NOESY NMR spectrum of 7α-hydroxy-dendrillol-3 (4.77) (700 MHz, CDCl3) 
 
 
! 268!
 
Appendix 82. 1H NMR spectrum of 2(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) (700 MHz, 
CDCl3) 
 
 
 
 
Appendix 83. COSY NMR spectrum of 2(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) (700 
MHz, CDCl3) 
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Appendix 84. HSQC NMR spectrum of 2(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) (700 
MHz, CDCl3) 
 
 
 
Appendix 85. HMBC NMR spectrum of 2(2’,4’-dibromophenoxy)-3,5-dibromophenol (4.87) (700 
MHz, CDCl3) 
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Appendix 86. ECL values of fatty acids from D. krusensternii and D. nigra 
 
Table A1. ECL values of fatty acids from D. krusensternii and D. nigra 
ECL Fatty acid 
14.54 13-Methyltetradecanoic acid (iso-15:0) 
14.73 12-Methyltetradecanoic acid (anteiso-15:0) 
15.00 Pentadecanoic acid (15:0) 
15.54 14-Methylpentadecanoic acid (iso-16:0) 
15.69 13-Methylpentadecanoic acid (anteiso-16:0) 
16.00 Hexadecanoic acid (16:0) 
16.29 9-Hexadecenoic acid (16:1n-7) 
16.58 15-Methylhexadecanoic acid (iso-17:0) 
16.73 14-Methylhexadecanoic acid (anteiso-17:0) 
17.00 Heptadecanoic acid (17:0) 
17.22 10-Heptadecenoic acid (17:1n-7) 
17.67 16-Methylheptadecanoic acid (anteiso-18:0) 
18.00 Octadecanoic acid (18:0) 
18.06 5-Octadecenoic acid (18:1n-13) 
18.20 9-Octadecenoic acid (18:1n-9) 
18.30 11-Octadecenoic acid (18:1n-7) 
18.70 5,9-Octadecadienoic acid (18:2) 
19.34 10-Nonadecenoic acid (19:1n-9) 
19.55 5,9-Nonadecadienoic acid (19:2) 
19.98 11-Eicosanoid acid (20:1n-9) 
 
